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1. Introduction 
 
The development of functional, well-defined materials for biological, pharmaceutical, and 
medicinal applications is one of the central challenges in current research. Due to their large 
diversity, polymers display an interesting class of compounds for this task. The development 
of living and controlled polymerization techniques enabled the possibility to synthesize well-
defined polymers with tunable properties. Most commonly applied polymerization methods 
are: (1) Anionic polymerizations,[1, 2] (2) cationic polymerizations[2, 3] and (3) controlled 
radical polymerizations[4] (in particular reversible addition-fragmentation chain transfer 
(RAFT),[5, 6] atom transfer radical polymerization (ATRP)[5, 7] and nitroxide-mediation 
polymerization (NMP)[8, 9]). Prominent examples of biomedically used polymers obtained by 
controlled or living polymerization techniques are poly(N,N-dimethylaminoethyl 
methacrylate) (PDMAEMA) (radical)[6, 10] and poly(ethylene glycol) (PEG, anionic).[11, 12] In 
recent years, another class of biocompatible polymers, namely poly(2-oxazoline)s (POx), has 
gained increasing attention.[13-16] In particular the water soluble poly(2-methyl-2-oxazoline) 
(PMeOx) and poly(2-ethyl-2-oxazoline) (PEtOx) show similar features as PEG, such as 
antifouling behavior (Chapters 2 and 3), a high biocompatibility, and the so called “stealth 
effect” (Chapter 4), but at the same time exhibit some advantageous properties such as a lower 
viscosity,[17, 18] a higher stability on surfaces,[19, 20] and a less laborious synthesis. POx are 
obtained by the living cationic ring-opening polymerization (CROP) of 2-oxazolines (Scheme 
1-1). By initiation with an electrophile (E), e.g. a functional triflate, tosylate, halide, or a 
strong protic or Lewis acid, a cationic oxazolinium species is formed. This leads to a 
weakening of the 2-oxazoline’s C-O bond and facilitates the nucleophilic attack of another 2-
oxazoline monomer. Thereupon, the C-O bond is broken and the ring opened repeating unit is 
obtained. Under appropriate conditions, no chain transfer or terminating reactions occur and 
the polymer chain growth propagates until all monomer is consumed. This allows the 
synthesis of block copolymers by sequential monomer addition. If a mixture of two or more 
monomers is polymerized, statistical or gradient copolymers are obtained, depending on the 
reactivity ratios of the respective monomers. Using microwave assisted synthesis, which  
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Scheme 1-1. Schematic representation of the synthesis of poly(2-oxazoline)s and the 
hydrolysis to LPEI. 
 
enables reactions under pressurized conditions and, thus, at temperatures above the boiling 
point of the solvent, it was demonstrated that the polymerization time can be reduced from 
several days or times > 8 hours to a few hours or minutes, respectively.[21-24] To terminate the 
polymerization nucleophiles (Nuc) such as water, sodium azide, amines, or carboxylic acids, 
are added, which become the ?-end group of the final polymer. The existence of a broad range 
of functional 2-substituted-2-oxazoline monomers, initiators (E), and terminating agents 
(Nuc), enables the synthesis of highly functional, well-defined polymers with fine-tuned 
properties. The solubility and crystallinity of the polymer is mainly influenced by the 
substituent in 2-position of the monomer (R), which forms the side chain in the final polymer. 
While polymers with short side chains (R ? C3) are water soluble and amorphous, POx with 
aromatic or long aliphatic side chains (R > C4) are water insoluble and semi-crystalline. An 
interesting aspect of the water soluble POx with R = C2 (PEtOx) and R = C3 (poly(2-
n/iso/cyclopropyl-2-oxazoline)) is that they exhibit a lower critical solution temperature 
(LCST) behavior, i.e. their aqueous solutions show phase separation at elevated 
temperatures.[25] The temperature where phase separation occurs, the so called cloud point, 
depends on different parameters such as the degree of polymerization (DP), the polymer 
concentration, or the used buffer system. It can also be influenced by the type of comonomer.  
Other interesting compounds are (co)polymers based on 2-(3-butenyl)-2-oxazoline 
(ButEnOx)[26-29] and 2-(9-decenyl)-2-oxazoline (DecEnOx).[30-34] Here, the double bonds can 
 
1. Introduction 
 
13 
 
Scheme 1-2. Schematic representation of the radical-mediated thiol-ene photoaddition 
mechanism. 
 
be used subsequently for the attachment of new functionalities in a post-polymerization 
modification step. A very efficient method for this purpose is the thiol-ene photoaddition 
reaction (Scheme 1-2).[35-37]  
Applying UV light and a photoinitiator (PI) a thiyl radical is formed, which is prone to 
undergo a reaction with an alkene group, whereupon a carbon radical is obtained. By transfer 
of the radical to another thiol moiety a new thiyl radical is formed and the reaction proceeds. 
This approach enables the straightforward introduction of additional functional moieties into 
the polymer, e.g. amines (Chapters 4 and 5.2) as well as saccharides and terpyridine (Chapter 
4.3). In this way, POx can be further fine-tuned for specific applications such as targeted drug 
delivery (Chapter 4.3) and gene delivery with cationic polymers (Chapter 5), both of 
significant interest in medical and pharmaceutical research. In particular cationic polymers are 
extensively studied, since they can be used as non-viral vectors, i.e. as carrier systems for 
genetic material (e.g. DNA, RNA).[38-41] One of the most prominent polymers for cationic 
gene delivery is linear poly(ethylene imine) (LPEI), a POx derivative that is obtained by acidic 
or basic hydrolysis (Scheme 1-1). However, LPEI suffers from an increasing cytotoxicity with 
increasing molar mass, while the transfection efficiency (TE) shows the contrary trend. 
Therefore, intensive efforts were made to synthesize polymers with high TE but low toxicity. 
A common method is the functionalization with biocompatible polymers, such as PEG or 
dextrans (Chapter 5.1). But also cationic polymers containing PEtOx or PMeOx as 
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biocompatible part, e.g. partially hydrolyzed PEtOx (PHPEtOx), PEtOx-block-LPEI, and 
amine functionalized POx, represent interesting compounds (Chapters 5.1 and 5.2).  
As mentioned above, the usage of microwave synthesizers resulted in an accelerated synthesis 
of POx but also in a faster hydrolysis to LPEI. Using high-throughput (HT) synthesis 
approaches with automated synthesis robots and microwaves, it is possible to obtain large 
polymer libraries. Unfortunately, the HT characterization of the biomedical and 
pharmaceutical properties is so far only rudimentarily developed and, thus, represents a 
“bottleneck” on the way to a fast and efficient development and screening of new gene 
therapies based on cationic polymers. As a consequence, an automated combinatorial HT 
workflow was developed using branched and linear poly(ethylene imine)s and validated by 
comparison with results from literature and manually performed experiments (Chapter 5.3). 
Another problem related to cationic polymers, besides the cytotoxicity, is the elucidation of 
structural information, in particular of high molar mass compounds. Here mass spectrometric 
methods, e.g. matrix-assisted laser/desorption ionization (MALDI) or electrospray ionization 
(ESI) time of flight (TOF) mass spectrometry (MS), often fail. Also molar mass determination 
by size exclusion chromatography (SEC) is problematic, due to strong interactions with the 
column material and missing calibration standards. Hence, it was investigated if asymmetric 
flow-field flow fractionation (AF4) can be used for the characterization of high molar mass 
cationic polymers (Chapter 5.4).  
LPEIs are not only interesting for gene delivery applications but also for the synthesis of 
LPEI-based hydrogels. These water insoluble, three dimensional networks are capable of 
taking up water up to a multitude of their own mass. Moreover, LPEI-based hydrogels are able 
to capture and release genetic material. Therefore, they are investigated for DNA biochip 
applications, where a separation of genetic material, e.g. from blood or feces, is necessary 
(Chapter 5.5). 
The goal of the thesis is the investigation of POx and their derivatives as versatile materials for 
life science applications. 
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2. Poly(2-oxazoline) modified surfaces – Attachment methods and 
applications 
 
Parts of this chapter have been published in P1) L. Tauhardt, K. Kempe, M. Gottschaldt, U. S. 
Schubert, Chem. Soc. Rev. 2013, 42, 7998-8011. 
 
Preventing the uncontrolled adhesion and adsorption of proteins, cells, bacteria, and other 
microorganisms onto surfaces, the so called fouling process, represents a major challenge for a 
wide range of applications such as medicine (e.g. medical devices, implants, drug delivery 
systems),[42, 43] mobility (e.g. ship hull coatings),[44, 45] food industry (e.g. packaging),[46] but 
also for membranes (e.g. in water purification systems),[47] microarrays, and (bio)sensors.[48] A 
widely used strategy for this task is the surface modification with poly(ethylene glycol) (PEG) 
and PEG-based copolymers.[19, 49] However, PEG suffers from a tense patent situation and is 
known to undergo degradation by (auto-)oxidation to form aldehydes and ethers, hampering 
its long-term application. Based on these issues, other polymer systems, such as poly(2-
oxazoline)s (POx), in particular the water soluble poly(2-methyl-2-oxazoline) (PMeOx) and 
poly(2-ethyl-2-oxazoline) (PEtOx), are investigated as alternative antifouling coating 
materials. They show similar properties as PEG but exhibit several advantages such as higher 
stability on surfaces,[50] lower viscosity,[17, 19] and a less laborious synthesis.[22] Moreover, POx 
meet the following criteria, which were found to be common for all antifouling polymers: 1) 
The presence of hydrophilic (polar) functional groups and hydrogen bond accepting groups as 
well as 2) the absence of a net charge and hydrogen bond donating groups.[19, 49]  
With regard to applications in coatings it is necessary to immobilize the POx on the surface. A 
weak binding onto the surface will lead to a loss of material over time. This will reduce the 
long term stability of the coating and is, thus, not sufficient. Therefore, the surface 
immobilization process plays an important role for the efficiency and stability of the coating. 
In general, there are three different methods to attach POx to a surface: 1) “Grafting onto”, 2) 
“grafting from” and 3) immobilization via electrostatic interactions.  
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“Grafting onto” can be accomplished in two different ways: 1) The coupling moiety is 
introduced to the polymer prior to surface attachment, e.g. by direct end-capping of the living 
polymer species with a silane coupling agent (Scheme 2-1A) or by applying the hydrosilation 
method reported by Chujo et al. at which a double bond is reacted with a trialkyloxysilane in 
the presence of chloroplatinic acid as catalyst.[51, 52] Also copper catalyzed 1,3-dipolar 
cycloaddition of triple bond containing POx to azide bearing surfaces was reported.[53, 54] 2) 
The coupling agent is attached to the surface first and the polymer is covalently bound in a 
next step, e.g. by photoinduced C-H insertion using benzophenon (Scheme 2-1B) or 
perfluorophenyl azide (Scheme 2-1C) derivatives.  
 
 
Scheme 2-1. Grafting onto approaches: A) End-capping with silane coupling agents, followed 
by surface attachment. Photoimmobilization via B) benzophenon and C) perfluorophenyl 
azide (PFPA) derivatives. 
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In the “grafting from” approach, the polymerization is started directly from the surface. To this 
end, suitable initiators (e.g. triflates and tosylates) have to be attached first (Scheme 2-2A, C). 
A special case is the self-initiated photografting and photopolymerization (SIPGP) of 2-
isopropenyl-2-oxazoline followed by the CROP of another 2-oxazoline (Scheme 2-2B).[55]
The immobilization via electrostatic interactions is the weakest form of binding, and can be 
established, e.g. between negatively charged Nb2O5-coated silicon wafers and the positive 
charged poly(L-lysine)-graft-PMeOx as shown by Konradi and Pidhatika.[19, 20, 50, 56, 57]
Investigations showed that these types of coatings are also able to withstand intensive washing 
processes and the attack of hydrogen peroxide solution. 
 
 
Scheme 2-2. Schematic representation of the surface initiated CROP of POx using A) 
different initiators, B) self-initiated photografting and photopolymerization of 2-isopropenyl-
2-oxazoline followed by CROP of POx, and C) surface initiated CROP of POx on gold 
surfaces using different initiators. 
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Depending on the immobilization method and the structure of the used polymer, two types of 
POx coatings can be distinguished. First, linear, brush-like POx coatings, with only a single 
POx chain per surface grafting unit (Scheme 2-1, Scheme 2-2A,C), and second, POx-based 
comb polymer coatings, where more than one POx chain per grafting unit is attached to the 
surface via another polymer backbone (e.g. PLL) (Scheme 2-2B). The latter can exhibit a 
bottle brush-like structure, also referred to as molecular or cylindrical brushes, at high side 
chain grafting densities. 
POx-modified surfaces are of significant interest for applications were the adhesion and 
adsorption of proteins, cells, bacteria, and microorganisms needs to be prevented, e.g. in 
medicine (e.g. for implants), microfluidic devices, and (bio)sensors. Different studies, using a 
single type of bacteria (e.g. E. coli),[19, 50, 57] cells (e.g. fibroblasts),[58, 59] or proteins (e.g. 
bovine serum albumin)[60-62] showed that POx exhibit good antifouling properties. An example 
is the nearly complete reduction of the fibronectin (Fn) adsorption (Figure 2-1) and HUVEC 
cell adhesion on PEtOx and PMeOx bottle brush-like coatings.[55] Moreover, POx-based 
coatings were found to be more stable against oxidation than PEG coatings, making them 
promising materials for antifouling applications, where a high long-term stability is 
essential.[19, 20] 
However, POx-modified surfaces are not only interesting for controlling protein adsorption 
and cell adhesion, but also for other applications, e.g. dip-pen nanolithography. Here, PMeOx 
coatings on atomic force microscope tips helped in overcoming problems in direct-write 
patterning of viruses and cells.[63, 64] 
 
Figure 2-1 Fluorescence microscopy of fibronectin (Fn) adsorption on bottle brush-like POx 
coatings on glass reveals a good Fn adsorption on (a) poly(2-n-propyl-2-oxazoline) and no 
??????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????53. © 
2012 John Wiley and Sons. 
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3. Poly(2-oxazoline)s as coating material for antifouling applications 
 
Parts of this chapter have been published in P2) L. Tauhardt, M. Frant, D. Pretzel, M. Hartlieb, 
C. Bücher, G. Hildebrand, B. Schröter, C. Weber, K. Kempe, M. Gottschaldt, K. Liefeith, U. 
S. Schubert; J. Mater. Chem. B 2014, 2, 4883-4893. 
 
As shown above, POx represent promising materials for antifouling coatings when exposed to 
certain proteins, cells, bacteria, or microorganisms. However, under real life condition more 
than one type of protein, cell, or bacteria will attack. Moreover, the long-term stability of POx 
coatings has not been investigated yet, but plays an important role when it comes to 
application, e.g. in water sensors or medical devices. On this account, the antifouling 
properties of PEtOx coatings and their stability has been studied under “real live”-mimicking 
conditions. To this end, PEtOx of different molar masses, bearing an amine end group for the 
surface attachment, were synthesized using a new, straight-forward approach via potassium 
phthalimide end-capping, followed by hydrazinolysis (Scheme 3-1, Table 3-1).  
 
 
Scheme 3-1. Schematic representation of the synthesis of amine end-functionalized PEtOx. 
 
Table 3-1. SEC data of the different PEtOx 
Polymer Monomer DP Mn (g/mol)a) PDIa) 
P1 EtOx 20 2,460 1.12 
P2 EtOx 40 3,790 1.15 
P3 EtOx 60 5,175 1.14 
P4 EtOx 80 5,990 1.19 
a)Determined by SEC (eluent: CHCl3 + TEA + iPrOH (94:4:2), calibration: PS). 
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1H NMR spectra revealed end-capping efficiencies of 100%. Moreover, no peaks for OH end 
groups, which are obtained when the reaction is quenched with water or air moisture, are 
visible in the MALDI-TOF mass spectra of both phthalimide and amine end-functionalized 
PEtOx (Figure 3-1).  
For a stable and covalent attachment of the polymer to surface a “grafting onto” approach was 
used, which allows the detailed characterization of the polymer before attaching it to the 
surface and, thus, enables the discussion of structure-property relationships. As coupling 
agents a (3-glycidyloxypropyl)trimethoxysilane (GOPTMS) and cyanuric chloride modified 
tetraether lipid (TEL) were chosen. Covalent binding was achieved by reaction of the amine 
end group of PEtOx with the epoxy unit of the silane or with the cyanuric chloride of the TEL 
moiety, respectively (Scheme 3-2).  
The suitability of the attachment method via GOPTMS and TEL, respectively, was proven 
using a fluorescein labeled PEtOx (Fluo-PEtOx) (Figure 3-2). The coating process was further 
monitored by means of X-ray photoelectron spectroscopy (XPS), showing the appearance of a 
nitrogen signal after the PEtOx coating process. Water contact angle measurements of air-
dried and swollen coatings revealed a higher hydrophilicity of the swollen samples, ascribed to 
the formation of PEtOx hydrates. 
 
1550 1600 1650 1700
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99
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1450 1500 1550
m/z
99
B)
 
Figure 3-1. Expanded region of the MALDI-TOF mass spectrum of A) phthalimide end-
capped PEtOx20 and B) the amine end group bearing PEtOx20. 
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Scheme 3-2. Schematic representation of the PEtOx coating process using GOPTMS and a 
TEL linker.
 
 
Figure 3-2. Fluorescence microscope images of A) uncoated glass, B) Fluo-PEtOx attached 
via GOPTMS, and C) Fluo-PEtOx attached via TEL and D) scratched sample of GOPTMS 
attached Fluo-PEtOx ???????????????????. 
 
Fouling studies were performed in a flow chamber under more "real-life" relevant conditions 
using a synthetic river water model containing five different bacteria. PEtOx modified glass 
samples exposed to this mixture for 15 h showed a reduction of the bioadhesion of up to 66% 
with no significant differences between the two different linkers (Figure 3-3). The best results 
were obtained applying a PEtOx with a DP of 20 attached via a tetraether lipid linker, which 
showed the lowest biofilm formation and the highest amount of dead bacteria. In addition, the 
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Figure 3-3. Bioadhesion on PEtOx coatings of different DP (20, 40, 60, and 80) to the glass 
slides via a silane (Si) and a tetraether lipid (TEL) linker (standard deviation is related to the 
total bioadhesion (sum of dead and vital bacteria)) as well as laser scanning images of the 
stained biofilms on glass and 20 (TEL) ???????????????????. 
 
stability of the PEtOx coatings against different types of stress has been investigated. The 
resistance against chemical stress, caused e.g. by fresh and salt water, was investigated over 12 
weeks using dam and North Sea water, respectively. The durability of the coatings against 
abrasion in particle containing water is essential in the field of environmental monitoring. 
Based on environmental data a corresponding test solution containing aluminum oxide and 
silicon carbide particles was prepared. Mechanical stress was simulated by placing the glass 
slides into this solution and stirring for 8 hours a day over 1 week. In order to verify their 
thermal stability, the samples were exposed to a defined heating plan for 14 days with 
????????????? ???????? ?? ???? ??? ????No destruction of the polymer coatings was observed, 
demonstrating the capability of the films for long term applications.  
In conclusion, POx represent a suitable class of polymers for antifouling coatings. They are 
able to reduce biofouling up to 66% and they are stable against thermal, mechanical, and 
chemical stress. 
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Bode, J. Czaplewska, K. Kempe, M. Gottschaldt, U. S. Schubert, J. Polym. Sci., Part A: 
Polym. Chem. 2014, 52, 2703–2714. 
 
4.1. Poly(2-oxazoline)s as poly(ethylene glycol) alternative 
Besides being potential candidates for replacing PEG in antifouling coatings, POx are also 
investigated as PEG alternative for various (bio)medical and pharmaceutical applications. One 
of the major tasks in pharmacy is shielding drugs from degradation and rapid clearance from 
the body, but also improving the water solubility of hydrophobic drugs. Nowadays, the most 
frequently used polymer for this task is the “gold standard” PEG. It can be applied to 
encapsulate drugs or for the formation of water soluble drug conjugates. Moreover, PEG 
shows the so called “stealth effect”, i.e. the suppression of nonspecific interactions with the 
blood components, which leads to a reduced blood clearance rate and results together with the 
enhanced permeability and retention (EPR) effect in a prolonged blood circulation time of the 
drug.[11] However, although only observed in a limited number of patients, concerns regarding 
immune responses,[65] formation of PEG-antibodies,[66] an accelerated blood clearance (ABC) 
phenomenon after multiple applications,[67] and non-biodegradability of PEG resulting in the 
body accumulation of high molar mass PEGs,[68] arose with an increasing number of clinical 
trials and a more profound experience with PEG in humans. Other drawbacks are the tendency 
of PEG to undergo degradation by (auto-)oxidation, resulting in the formation of ethers, 
peroxides, and aldehydes,[19, 20, 69-71] its high viscosity in water,[17, 18] and the possible 
contamination with toxic synthesis side products, e.g. 1,4-dioxane. Additionally, a tense patent 
situation regarding PEG complicates the introduction of new formulations to the market. As a  
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Scheme 4-1. Schematic representation of the synthesis of PMeOx and PEtOx. 
 
consequence, intensive efforts have been made to look for alternative stealth polymers. One of 
the polymer classes investigated in this context are POx, in particular the water soluble 
PMeOx and PEtOx.[18] Their synthesis from low toxic MeOx and EtOx by CROP (Scheme 
4-1) is less demanding than the preparation of PEG by anionic ring-opening polymerization of 
highly toxic and explosive ethylene oxide, and yields polymers with well-defined molar 
masses and narrow molar mass distributions (Table 4-1, Figure 4-1). Moreover, POx exhibit a 
high stability against oxidation[20] and have a lower viscosity in water.[17, 18] 
To investigate their potential as PEG alternative, PMeOx and PEtOx of different molar masses 
have been synthesized. While self-synthesized PMeOx (P5-P8) and PEtOx (P9-P11, P13-  
 
Table 4-1. SEC data of the different PMeOx and PEtOx samples. 
Polymer Monomer DPa) Mn (theo) (g/mol)a) Mn (SEC) (g/mol)b) PDIb) 
P5 MeOx 23 2,000 3,700 1.17 
P6 MeOx 47 4,000 6,700 1.20 
P7 MeOx 118 10,000 12,300 1.39
P8 MeOx 236 20,000 19,000 1.44 
P9 EtOx 4 400 - - 
P10 EtOx 21 2,080 3,700 1.11 
P11 EtOx 41 4,060 6,500 1.11 
P12c) EtOx 50d) 8,456 20,100 2.37 
P13 EtOx 103 10,200 12,800 1.15 
P14 EtOx 207 20,500 22,900 1.18 
P15 EtOx 379 37,500 41,000 1.25 
P16c) EtOx 504d) 17,939 74,100 4.13 
P17c) EtOx 2017d) 48,882 229,000 4.63 
a)Determined by 1H NMR spectroscopy; b)determined by SEC (eluent: DMAc + 0.21% LiCl, 
calibration: PS); c)commercial sample; d)DP calculated from the molar mass given by the 
supplier. 
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Figure 4-1. SEC curves of A) PMeOx, B) PEtOx and C) commercial PEtOx. 
 
P15) exhibited monomodal distributions, commercially obtained PEtOx (P12, P16, P17) 
showed bimodal distributions with PDI values twice to four times higher as for self-
synthesized polymers (Figure 4-1, Table 4-1), deriving from chain-transfer reactions.[72] 
Moreover, their molar masses revealed a large deviation from the declared values (Table 4-1), 
ascribed to the loss of reaction control, when the polymerization is aimed for high DPs, i.e. 
DP > 300 for PEtOx and DP > 100 for PMeOx.[22] 
The biocompatibility studies of PMeOx and PEtOx in comparison to commercial PEGs of 
similar molar masses were performed under standardized conditions. Many of the polymers 
used in medical applications or as drug delivery system come into close contact with blood 
plasma and blood cells, in particular after systemic administration. Therefore, the influence of 
the polymers on the red blood cell hemolysis and aggregation was investigated. Independent 
of the pharmaceutical quality, incubation time, and polymer concentration, none of the PEGs 
and POx revealed values of hemolysis higher than 1.6%, indicating no detectable disturbance 
of the red blood cell membranes. According to the ASTM standard F756-00 a release of 
hemoglobin between 0 and 2% is regarded as non-hemolytic. Additionally, the potential of 
PMeOx, PEtOx, and PEG to aggregate red blood cells, an undesired phenomenon leading to 
circulatory side effects and even lethal toxicity, was studied. Neither the PEGs nor the PMeOx 
showed red blood cell aggregation even at the highest concentration of 80 mg/mL. For PEtOx 
a molar mass and concentration dependency was observed. PEtOx up to 50 kDa showed 
results comparable to PEG, with the exception of P15 and P16 at 80 mg/mL where a slight 
aggregation was observed. PEtOx of 200 kDa (P17) revealed the highest aggregating effect 
with no aggregation at 20 mg/mL, slight aggregation at 40 mg/mL, and high aggregation at 
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concentrations above 60 mg/mL. Cytotoxicity was investigated by means of lactate 
dehydrogenase (LDH) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay. LDH is released from the cell when the membrane is damaged. However, the 
LDH release of both the PEG and the POx treated cells was in the range from 0 to 8.5% even 
after 4 hours at the highest polymer concentration of 80 mg/mL. This is below the cytotoxic 
level of 10% and indicates that no damage of the cellular membranes occurred. For both, the 
PEG and the POx, the MTT assay revealed a moderate, time, concentration, and molar mass 
dependent cytotoxicity but only after long term treatment and at concentrations higher than the 
typically used dose (Figure 4-2). In conclusion, PMeOx and PEtOx exhibit similar properties 
as PEG and, therefore, represent good PEG alternatives. 
 
Figure 4-2. Cytotoxicity of PEG, PEtOx, and PMeOx in dependency of time, concentration, 
and molar mass. The cell viability was determined by MTT assay. Values below the marked 
line at 70% viability were regarded as cytotoxic according to ISO-10993-5. Data are presented 
as mean standard deviation of seven determinations. 
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4.2. Zwitterionic poly(2-oxazoline)s 
Another class of materials that exhibits an excellent biocompatibility, but also antifouling 
behavior, are poly(betaine)s, i.e. polymers comprising a zwitterionic structure. In particular 
poly(2-methacryloyloxyethyl phosphorylcholine)s are of high interest as they are applied, e.g. 
for soft contact lenses. Other widely used zwitterionic polymers are poly(carboxybetaine)s and 
poly(sulfobetaine)s. An outstanding property of these polymers is their excellent blood 
compatibility which, in some cases, is going along with an anticoagulant activity, leading to a 
prolongation of the blood clotting time.[73-77] This is important with regard to medical 
applications, e.g. medical devices, implants, and drug delivery systems, where 
thrombogenicity is an issue. As a consequence, it was studied if POx based betaines show a 
similar behavior. To this end, a POx precursor, consisting of EtOx and ButEnOx, was 
synthesized and their polymerization kinetic under the conditions chosen was investigated. As 
already reported for the methyl triflate initiated copolymerization of EtOx and ButEnOx at 
70 ???? ??????????? ????????? ?????????? ????????? ??? ???? ??? ????ed a first-order kinetic behavior 
(Figure 4-3A).[29] However, due to the higher temperature, the polymerization proceeded much 
faster with polymerization constants of kp(EtOx) = 0.206 L mol-1 s-1 and kp(ButEnOx) = 
0.188 L mol-1 s-1(Table S1, Figure S1A). The similar conversions of both monomers are a 
reliable indication for the formation of a random copolymer. In addition, characterization by 
size exclusion chromatography (SEC) showed a growing molar mass with time (Figure 4-3B). 
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Figure 4-3. A) First-order kinetic plots of the copolymerization of EtOx (square) and 
?????????????????????????????????? ??????monomer concentration of 1 M in acetonitrile and a 
[MeOTs]/[EtOx]/[ButEnOx] ratio of 1:16:4 (conversions were determined by GC 
measurements). B) SEC curves of the kinetic study after different times. 
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Scheme 4-2. Schematic representation of the synthesis of zwitterionic POx. 
 
With the obtained kinetic data, an amine end-functionalized P(EtOx30-stat-ButEnOx10) was 
prepared in a controlled way using the same synthesis route as described for the amine end-
functionalized PEtOx (Chapter 3). The amine end group can be used for surface attachment, 
e.g. in antifouling coatings, or for labeling. Investigations by 1H NMR spectroscopy revealed 
that the ButEnOx double bonds remained intact (Figure 4-4) and, hence, can be exploited for 
thiol-ene photoaddition of 2-dimethylaminoethanethiol hydrochloride (Scheme 4-2). The 
resulting polymer with tertiary amine groups (P21), was the basis for the betainization process 
using 1,3-propanesultone and ?-propiolactone analog to the synthesis of poly(N,N-
dimethylaminoethyl methacrylate) (PDMAEMA)-based betaines.[78, 79] The final zwitterionic 
polys(sulfobetaine)s and poly(carboxybetaine)s and the intermediates were investigated by 
means of 1H NMR spectroscopy and SEC (Table 4-2), showing the success of the reactions. 
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Figure 4-4. 1H NMR spectrum of (top) phthalimide end-capped (P18) and (bottom) amine 
end-functionalized P(EtOx30-stat-ButEnOx10) (P19) (300 MHz, CD3OD). 
 
Table 4-2. SEC data of the zwitterionic POx as well as the starting material and intermediates 
measured on different SEC systems. 
Polymer Composition 
(End group) 
DMAc + 0.21% 
LiCla) 
CHCl3 + TEA + 
iPrOH (94:4:2)a) 
Mn (g/mol) PDI Mn (g/mol) PDI 
P18 EtOx30:ButEnOx10 (phthalimide) 6,860 1.16 4,590 1.16 
P19 EtOx30:ButEnOx10 (NH2) 6,980 1.19 3,920 1.16 
P20 EtOx30:tAmOx·HCl (NH2) 7,740 1.20 4,820 1.18 
P21 EtOx30:tAmOx10 (NH2) 7,860 1.24 4,720 1.19 
P22 EtOx30:SBOx10 (NH2) 8,200 1.35 -a) -a) 
P23 EtOx30:CBOx10 (NH2) 8,150 1.59 3,640 1.27 
P24 EtOx40 (NH2) 6,600 1.21 4,830 1.15 
a)Calibration against PS. 
4. Poly(2-oxazoline)s in systemic applications 
 
30 
To evaluate the biocompatibility of the sulfobetaine POx (SB-POx, P23) and the 
carboxybetaine POx (CB-POx, P24), their influence on the erythrocyte aggregation, the blood 
viscosity, the platelet activation, the complement activation, and the blood coagulation were 
studied and compared to a PEtOx homopolymer (DP = 40). In addition, the cytotoxicity and 
hemolytic activity was investigated. Neither PEtOx nor the zwitterionic polymers revealed any 
cytotoxic or hemolytic effect at concentrations up to 10 mg mL?1. Also no erythrocyte 
aggregation could be observed. Measurements showed a slightly increased blood viscosity, 
which was within the physiological tolerable range and could be fully attributed to the intrinsic 
viscosity of the added polymer. Therefore, no substantial interactions of the polymers with 
blood components, leading to changes of the blood viscosity itself, were observed. In a 
subsequent step, it was investigated if the polymers have any influence on the platelet 
activation, which is a very early event in the complex process of primary hemostasis, i.e. the 
process which causes bleeding to stop. A polymer induced malfunction of the platelets could 
either provoke excessive bleeding, or, in case of exceeding platelet activity, a life-threatening 
vessel clogging by spontaneous blood clot formation. It was found that both PEtOx and the 
zwitterionic POx had no influence on the platelet activation. In addition, no influence of the 
polymers on the activation of the complement system, as a part of the body’s innate immune 
response, was observed. While all polymers did not influence the extrinsic blood coagulation 
pathway, anticoagulant activity via components of the intrinsic and/or the common 
coagulation pathway was observed for the CB-POx and to a lesser extent for the SB-POx. Pure 
PEtOx showed no anticoagulant behavior at all. Neither a prolongation nor a reduction of the 
blood clotting time was observed.  
In conclusion, zwitterionic POx are potential candidates for materials that come in contact 
with blood or blood components. Possible applications are antithrombogenic membranes (e.g. 
for blood dialysis), targeted delivery approaches with the aim to increase the blood circulation 
time, but also the improvement of the hemocompatibility of biomaterials for in vivo 
diagnostics and implants. 
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4.3. Poly(2-oxazoline)s as potential anticancer drugs 
Poly(2-oxazolines) are not only interesting as anticoagulant materials but also as basis for the 
development of other therapeutic agents, such as anticancer drugs. Anticancer drugs, such as 
the well-known cisplatin, often suffer from severe side effects such as renal toxicity, 
gastrointestinal toxicity, and neurotoxicity as well as acquired and intrinsic cisplatin resistance 
of various cancer types.[80-83] Owing to this, today’s research focuses on the selective transport 
of the drug to the cancer cells by passive and active targeting. This can be achieved either 
exploiting the EPR effect (passive targeting) or by functionalization of the drug with bioactive 
substances such as proteins (e.g. transferrin), hormones (e.g. estrogen), amino acids, folic acid, 
and saccharides.[83-85] In particular the latter are interesting, as cancer cells commonly exhibit 
an altered sugar metabolism, e.g. a high glucose consumption for energy production.[83] 
Moreover, they possess specific saccharide receptors exclusively expressed by certain cancers. 
Wild et al. reported, that a poly(pentafluorostyrene) (PPFS) based glycopolymer, carrying 
galactose (Gal) as targeting unit and a terpyridine (tpy) chelated Pt(II) species as active agent, 
has a higher anticancer activity than cisplatin, even in cell growth/division inhibitor-resistant 
cells. The mechanism of action is apoptosis, i.e. programmed cell death, which is induced by 
DNA-intercalation and well-known for square-planar tpy-Pt(II) complexes.[86-88] However, due 
to the PPFS backbone, the polymer suffered from a poor water solubility. This problem can be 
overcome by using copolymers of the water soluble PEtOx and ButEnOx, whose double bonds 
can be exploited to attach sugar targeting units as well as the cytotoxic Pt(II) species (Scheme 
4-3). To this end, P(EtOx30-stat-ButEnOx10) (P19) was first partially functionalized with 6-
([2,2':6',2''-terpyridin]-4'-yloxy)hexane-1-thiol, as platinum chelating moiety, using the thiol-
ene photoaddition reaction. The success of the reaction was shown by a growing molar mass 
as measured by SEC (Table 4-3) and appearing tpy signals in the aromatic region of the 1H 
NMR spectrum. Moreover, an absorption of the tpy unit was detected in the UV detector of 
the SEC, which was congruent with the RI signal of the polymer (Figure 4-5). 
In a next step the targeting sugar units were attached to the polymer backbone by the reaction 
of the remaining double bonds with acetyl protected thioglucose (Ac4GlcSH) and 
thiogalactose (Ac4GalSH), respectively (Scheme 4-3). To ensure a full functionalization of the 
ButEnOx units an excess of thio-sugar was used and removed after reaction by preparative  
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Scheme 4-3. Schematic representation of the synthesis of sugar and platinum containing POx. 
 
size exclusion chromatography. Characterization by 1H NMR spectrometry revealed the 
successful conversion, since all double bond signals disappeared, while new peaks, typical for 
acetylated sugars, were observed (for Glc see Figure 4-6). 
SEC analysis revealed an increasing molar mass with no change of the PDI value in case of 
Glc and an insignificant change for Gal (Table 4-3).  
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Table 4-3. SEC data of the prepared poly(2-oxazoline)s. 
Polymer Composition Mn (g/mol)a) PDIa) 
P19 EtOx30:ButEnOx10 6,980 1.19 
P25 EtOx30:ButEnOx6:tpyButOx4 8,000 1.21 
P26 EtOx30:Ac4GlcButOx6:tpyButOx4 9,340 1.21 
P27 EtOx30:Ac4GalButOx6:tpyButOx4 9,360 1.23 
P28 EtOx30:GlcButOx6:tpyButOx4 11,980 1.22 
P29 EtOx30:GalButOx6:tpyButOx4 11,800 1.23 
P30 EtOx30:GlcButOx6:PtButOx4 11,560 1.23 
P31 EtOx30:GalButOx6:PtButOx4 12,370 1.29 
a)Determined by SEC (eluent: DMAc + 0.21% LiCl, calibration: PS). 
 
Subsequent deprotection with sodium methoxide yielded free hydroxyl groups on the sugar 
moieties, which are important for targeting and good water solubility. The 1H NMR spectra 
revealed a shift of the sugar signals, known from other sugar functionalized POx,[89, 90] and the 
disappearance of the peaks of the acetyl protecting groups at around 2 ppm (Figure 4-6). The 
tpy signals remained unchanged. Another proof for the successful deprotection was the 
disappearance of the C=O band of the acetyl protecting groups at 1,747 cm-1 (Glc) and 1,745 
cm-1 (Gal), respectively, in the FT-IR spectra (for Glc see Figure 4-5B). SEC characterization 
revealed a change in molar mass (Table 4-3). Although the theoretical molar masses are lower 
after the reaction, a shift to higher molar masses was observed. This finding was reported 
earlier for other sugar decorated POx and is ascribed to the increasing hydrodynamic volume 
in DMAc.[90] 
In the last step the active Pt(II) species, which can induce cell death, was obtained by 
complexation reaction of tpy and platinum, using a very efficient and mild route with 
Pt(COD)Cl2 in water. The side product cylcooctadiene was removed by washing the aqueous 
phase with diethyl ether. Characterization by 1H NMR spectroscopy showed a broadening of 
the tpy signals, indicating the successful complexation (Figure 4-6).  
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Figure 4-5. A) Overlay of the SEC curves of P25 measured with an UV (280 nm and 405 nm) 
and a RI detector, respectively. B) ATR-FT-IR spectra of protected (P26) and deprotected 
(P28) galactose glycopolymers. 
 
 
 
Figure 4-6. 1H NMR spectra of (top) P(EtOx30-stat-(Ac4GlcButOx)6-stat-tpyButOx4) P26, 
(middle) P(EtOx30-stat-GlcButOx6-stat-tpyButOx4) P28, and (bottom) P(EtOx30-stat-
GlcButOx-stat-PtButOx4) P30 (300 MHz, CD3OD). 
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SEC analysis after complexation revealed a shoulder at lower elution volumes, i.e. higher 
molar mass, for glucose (P30) but to a higher extent for the galactose functionalized polymer 
(P31). Consequently, the PDI values are increasing, but do not exceed 1.30 (Table 4-3). This 
finding might be ascribed to polymer-polymer coupling and led in case of fructose after 
deprotection (no Pt complexation) to the formation of a cross-linked hydrogel (data not 
shown).  
Although having hydrophilic and hydrophobic domains, the polymers showed no self-
assembly in water even at a concentration of 2 mg mL-1. Dynamic light scattering (DLS) 
measurements gave only hydrodynamic radii of about 3 to 4 nm belonging to the free polymer 
chains. 
To investigate the potential of the platinum containing glycopolymer as anti-cancer drug, their 
in vitro cytotoxicity and influence on blood integrity was studied and compared to cisplatin. 
The hemolytic activity, i.e. the potential for damaging the cell membranes of erythrocytes, was 
investigated by photometrical determination of the hemoglobin release caused by the 
incubation with different concentrations of the glycopolymers and cisplatin (Figure 4-7A). 
Adverse hemolytic side reactions with red blood cells, representing the major cellular 
compartment of the blood, were observed in a concentration dependent manner. 
The cytotoxicity was examined against mouse fibroblast L929 cells, human embryonic kidney 
cells HEK 293, and human hepatocytes HepG2 (Figure 4-7B). For both, cisplatin and the two 
glycopolymers, a dose dependent cytotoxicity was observed, with a higher activity of cisplatin 
at equimolar platinum amounts. However, cisplatin is a small molecule and, hence, in vivo the 
major part is excreted fast from the body (elimination half-life of 43 min),[91, 92] provoking the 
need for a high dosage which results in more severe side effects. In contrast, PEtOx-based 
polymers are known to show the so-called “stealth effect”, prolonging the blood circulation 
time, which can lead to an accumulation of the active compound in cancer tissue (EPR effect). 
Moreover, the attached sugar moieties might very likely promote the uptake by cancer cells, 
since neoplastic cells overexpressed sugar receptors on their cell surface. Therefore, it is 
assumed that the glycopolymers, although having a lower in vitro activity than cisplatin, might 
have a better performance in vivo. Assuming the need of a relatively low in vivo concentration 
necessary for cytotoxic performance and effectiveness, the observed hemolytic activity of the 
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Figure 4-7. A) Photometric determination of hemolytic activity of cisplatin and the 
glycopolymers Glc-Pt(II) (P30) and Gal-Pt(II) (P31????????????????????????????????????????????
X-100 (1%) served as positive and PBS as negative control. Experiments were run in triplicate 
and were repeated once; data are presented as the mean percentage ± SD of hemolytic activity 
compared to the positive control set as 100%. B) Cell viability of L929 mouse fibroblasts, 
human embryonic kidney cells HEK 293, and human hepatocytes HepG2 after incubation with 
glycopolymers Glc-Pt(II) (P30) / Gal-Pt(II) (P31) and cisplatin at different concentrations for 
24 hours. Cells incubated only with culture medium served as control. The cell viability was 
determined by XTT assay according to ISO 10993-5. Data are expressed as mean ± SD of six 
determinations 
 
glycopolymers at higher concentrations as assessed in vitro might not be of clinical 
importance. 
To conclude, platinum containing 2-oxazoline-based glycopolymers represent promising 
candidates for anticancer therapy, but a screening of their in vivo performance is necessary. In 
addition, the chosen synthetic approach allows the variation of the sugar/platinum content and 
with it the adjustment of the cytotoxic activity of the polymer. 
 
5. Poly(2-oxazoline)-based cationic polymers for gene delivery 
 
37 
 
5. Poly(2-oxazoline)-based cationic polymers for gene delivery 
 
Part of this chapter have been / will be published in P7) M. Bauer, L. Tauhardt, H. M. L. 
Lambermont-Thijs, K. Kempe, R. Hoogenboom, U. S. Schubert, D. Fischer, in preparation. 
P8) L. Tauhardt, K. Kempe, U. S. Schubert, J. Polym. Sci., Part A: Polym. Chem. 2012, 50, 
4516-4523. P9) S. Ochrimenko,# A. Vollrath,# K. Kempe, L. Tauhardt, S. Schubert, U. S. 
Schubert, D. Fischer, Carbohydr. Polym. 2014, 113, 597-606. P10) A. C. Rinkenauer,# L. 
Tauhardt,# F. Wendler, K. Kempe, M. Gottschaldt, A. Träger, U. S. Schubert, Macromol. 
Biosci., accepted 07.10.2014. P11) A. C. Rinkenauer,# A. Vollrath,# A. Schallon, L. Tauhardt, 
K. Kempe, S. Schubert, D. Fischer, U. S. Schubert, ACS Comb. Sci. 2013, 15, 475-482. P12) 
M. Wagner, C. Pietsch, L. Tauhardt, A. Schallon, U. S. Schubert, J. Chromatogr. A 2014, 
1325, 195-203. P13) C. Englert, L. Tauhardt, M. Hartlieb, K. Kempe, M. Gottschaldt, U. S. 
Schubert, Biomacromolecules 2014, 15, 1124–1131. 
 
Gene delivery and gene knockdown/silencing using DNA or RNA drugs are alternative 
approaches investigated for anti-cancer therapy but also for the healing of other diseases 
caused by genetic disorders. However, due to rapid degradation by serum nucleases nucleic 
acids are unstable under in vivo conditions and, hence, need to be protected. This can be 
accomplished using cationic polymers as transport carriers (vectors). By electrostatic 
interactions with the phosphates of nucleic acids their primary, secondary, or tertiary amines 
are able to complex genetic material, forming the so called “polyplexes” (Figure 5-1). The 
protected genetic material enters the cells by endocytosis. The low intracellular pH value 
causes the protonation of the cationic polymer inside the endosome. The accumulation of 
protons, brought into the cell by the endosomal ATPase is accompanied by the influx of 
chloride counter ions, leading to a large increase of ion concentration and an osmotic swelling 
of the endosome. Moreover, the protonation causes internal charge repulsion, resulting in the 
expanding of the polymeric network. This volume increase leads to the rupture of the 
endosome membrane and the polyplex is released into the cytosol. This mechanism is often 
referred to as “proton-sponge-effect”[93] and is controversially discussed since also other ways
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Figure 5-1. Schematic representation of a gene transfer using plasmid DNA and cationic 
polymers as non-viral vector.[94] 
 
of uptake were discovered. After the release from the polyplex, the RNA remains in the 
cytosol, while plasmid DNA (pDNA) is taken up into the nucleus. Besides being used as non-
viral vector for gene delivery, LPEI also represents an interesting starting material for the 
synthesis of hydrogels for DNA captures and release. Here, the synthesis, characterization, and 
pharmaceutical investigation of LPEI, LPEI modifications with biocompatible materials, and 
cationic poly(2-oxazoline)s are reported and will be discussed in the following subchapters 
 
5.1. Linear poly(ethylene imine)s and approaches to reduce their cytotoxicity 
The “gold standard” for gene delivery is linear poly(ethylene imine) (LPEI), a POx derivative 
obtained by acidic or basic hydrolysis of the amide bonds (Scheme 5-1). Using microwave 
reactors, it is possible to synthesize LPEIs in a highly reproducible manner, which is important 
with regard to pharmaceutical screenings and applications.[95, 96] Unfortunately, the harsh 
synthesis conditions are tolerated only by a limited number of end groups such as hydroxyl, 
amine, or azide.[96, 97] This fact diminishes the possibilities of a selective functionalization 
without destroying secondary amine groups, which are essential for the binding of the nucleic 
acids. However, the functionalization of LPEI is necessary, since it has not only a poor water 
solubility at temperatures below its melting point[95, 96] but also shows an increasing 
cytotoxicity with growing molar mass, while the transfection efficiency (TE) shows the 
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opposite trend.[98, 99] Investigations to overcome this problems aim at the modification with 
biocompatible, water soluble compounds such as PEG.[100-105] Another approach, that was 
investigated, is the usage of partially hydrolyzed POx, in particular partially hydrolyzed 
PEtOx (PHPEtOx) (Scheme 5-1). Using microwave synthesizers, the degree of hydrolysis 
(DH) can be accurately and easily adjusted via the hydrolysis time. In this way, PHPEtOx with 
an overall DP of 200 and different degrees of hydrolysis have been prepared (P32-P35, Table 
5-1), and the influence of the charge density on different parameters, such as the polyplex size, 
the transfection efficiency, and the cytotoxicity, has been studied. For comparison, LPEIs 
(P37-P42) with DPs resembling the number of ethylene imine units in the PHPEtOx have 
been synthesized (Table 5-1). 
Biological investigations revealed steadily decreasing cell viabilities with increasing molar 
mass for LPEI. While PHPEtOx and LPEIs with a DP < 175 were non-toxic even at a high 
polymer nitrogen to DNA phosphate (N/P) ratio of 50, LPEIs with a DP ? 175 reduced the cell 
viability below the critical value of 70% (Figure 5-2). However, although having similar or 
even lower polyplex sizes and comparable zeta potentials, the PHPEtOx showed significantly 
reduced transfection efficiencies compared to the corresponding LPEIs (Figure 5-2). This is 
ascribed to the reduced polyplex stability, leading to an insufficient protection of the DNA 
against enzymatic degradation. The poor DNA binding capacity of the PHPEtOx can be 
explained with the statistical distribution of the ethylene imine units within the copolymer. 
Some of the amine groups are not usable for an efficient DNA complexation, since the amine 
sequence is either too short or sterically blocked by the adjacent ethyl side chains. In addition, 
the antifouling character of the PEtOx hampers the interaction with the genetic material. 
 
 
Scheme 5-1. Schematic representation of the synthesis of partially hydrolyzed poly(2-ethy-2-
oxazoline) (PHPEtOx) and linear poly(ethylene imine) (LPEI). 
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Table 5-1. SEC data of the different synthesized PHPEtOx and LPEIs. 
Polymer EtOx:LPEIa) Degree of 
hydrolysis (%)a) 
M (1H NMR) 
(g/mol)a) 
Mn (SEC) 
(g/mol)b) 
PDIb) 
P32 158:42 21 17,500 33,010 1.38 
P33 118:82 41 15,260 26,160 1.54 
P34 88:112 56 13,580 19,290 1.73 
P35 50:150 75 11,450 11,100 1.85 
P36 28:172 86 10,220 13,810 1.64 
P37 0:40 > 97 1,760 10,900 1.12 
P38 0:80 > 97 3,480 16,800 1.22 
P39 0:100 > 97 4,340 21,100 1.16 
P40 0:150 > 97 6,490 27,400 1.27 
P41 0:175 > 97 7,570 19,340 1.33 
P42 0:200 > 97 8,650 17,450 1.57 
a)Calculated from 1H NMR spectroscopy, b)determined by SEC (eluent: 
hexafluoroisopropanol; calibration: PS).
 
 
Figure 5-2. Comprehensive illustrations the relationships between the physicochemical and 
biological properties of PHPEtOx and LPEI polyplexes formed at N/P 25 (A) Z-average and 
(B) zeta potential of the polymers were plotted against the cell viability while transfection 
efficiency is illustrated by the icon size (the larger the icon size, the higher the transfection 
efficiency). 
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One possible approach to avoid the problem of sterically shielded ethylene imine units is the 
design of (well-defined) block copolymers of PEtOx and LPEI. As shown above, the acidic or 
basic hydrolysis of POx only yields statistically cleaved copolymers, making the synthesis of 
POx-LPEI block copolymers challenging. However, it has been reported that the sterical 
hindrance and, therefore, the type of side chain significantly influences the rate of 
hydrolysis.[95, 106] The more bulky the rest is, the slower the POx side chain is cleaved. This 
leads to the following order for the rate of hydrolysis: H > Me > Et > Ph. Since water 
solubility is a prerequisite for biological application, only polymers based on 2-H-2-oxazoline 
(HOx), MeOx, EtOx, or 2-isopropyl-2-oxazoline (iPrOx) are suitable as starting material. 
Unfortunately, the hydrolysis rates of PMeOx and PEtOx do not differ significantly for a 
selective hydrolysis. However, tests showed that poly(2-H-2-oxazoline) (PHOx) can be fully 
hydrolyzed to LPEI within 10 minu???????????? ????????????????????? ??????????????????????
Under the same conditions PEtOx is only hydrolyzed by 2% after 1 min, 6% after 5 min, and 
8% after 10 min, respectively. When the reaction time was increased to 4 h the DH was about 
12%. Based on this observation, it was investigated if PEtOx-b-LPEI can be obtained by 
selective basic hydrolysis of P(EtOx-b-HOx) (Scheme 5-2). To this end, the HOx monomer 
was synthesized applying an optimized procedure compared to earlier literature reports. 
Investigations of the homopolymerization kinetics revealed the living character of the 
polymerization, i.e. a linear first order kinetic plot was obtained. The polymerization rate was 
calculated to be kp = 0.0193 L mol-1 s-1. PHOx was characterized by means of 1H NMR 
spectroscopy and MALD-TOF-MS, showing the successful polymerization. 
 
 
Scheme 5-2. Schematic representation of the synthesis of PEtOx-block-LPEI. 
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In the next step, P(EtOx-b-HOx) was prepared by sequential monomer addition. To determine 
the exact length of the starting block, always a reference PEtOx homopolymer was 
synthesized by reacting a part of the stock solution under the same conditions. A problem that 
arose during the polymerization of P(EtOx-b-HOx) is the precipitation during the 
polymerization, limiting the maximal length of the PHOx block. Moreover, the polymer 
becomes insoluble in anything but water, when the DP of the HOx block becomes too high. 
This was also observed for PHOx homopolymers and is ascribed to the formation of strong 
hydrogen bonds between the polymer molecules, due to interactions of the oxygen and 
hydrogen of the formyl side chains. This assumption is supported by infrared (IR) 
spectroscopy measurements on PHOx homopolymers, where a broad band at 3400 cm-1, 
typical for hydrogen bonds, can be found. A good EtOx to HOx ratio was found to be n/m = 
4/1. For this ratio the polymer is still soluble in other polar solvents such as methanol, DMSO, 
and N,N-dimethylacetamide. Three different P(EtOx-b-HOx) with a EtOx/HOx ratio of 4/1 
and their corresponding PEtOx reference homopolymers were synthesized and characterized 
by 1H NMR spectroscopy, MALDI-TOF-MS and SEC (Table 5-2), showing the formation of 
the copolymers. 
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Figure 5-3. A) ATR-FT-IR of PHOx and B) kinetics of the hydrolysis of P(EtOx-b-HOx) 
(100 ?????? ??????. The degree of hydrolysis was determined by 1H NMR spectroscopy. 
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Table 5-2. SEC data for the different P(EtOx-b-HOx) copolymers and the corresponding 
reference PEtOx homopolymers measured using different SEC systems. 
Polymer EtOx:HOx DMAc + 2.1% LiCl Water + 0.1% TFA + 0.05 M NaCl 
Mn (g/mol)a) PDIa) Mn (g/mol)a) PDIa) 
P43 20 : 0 1,950 1.12 1,870 1.16 
P44 20 : 5 3,100 1.27 1,980 1.23 
P45 20 : 0 1,780 1.11 1,730 1.17 
P46 20 : 5 2,280 1.17 1,850 1.29 
P47 40 : 0 3,240 1.16 2,240 1.37 
P48 40 : 10 4,660 1.26 2,420 1.40 
a)Calibration against PEG. 
 
In a last step, the hydrolysis kinetics of the different P(EtOx-b-HOx) under basic condition 
(3 M NaOH) at 100 ??? ????? ?????????????? ???? ??????? ??? ??????????? ??? ????? ?????? ????
determined by 1H NMR spectroscopy. The assumption that the PHOx block hydrolyzes much 
faster than the PEtOx block could be confirmed. The side chain cleavage in the PEtOx block 
was only about 5% for n/m = 40/10 and 14% for n/m = 20/5 when full cleavage of the PHOx 
side chain was achieved. This is in good agreement with the DH for the basic hydrolysis of the 
reference PEtOx homopolymers. Moreover, it was found that the copolymer with n/m = 20/5 
hydrolyzed much faster than the copolymer with doubled block lengths. However, the block 
copolymer with n/m = 40/10 could be hydrolyzed much more selectively (Figure 5-3B). The 
obtained PEtOx-b-LPEI could be characterized by 1H NMR spectroscopy and MALD-TOF-
MS. Additional SEC measurements revealed a shift of the SEC curve after hydrolysis. 
However, due to missing standards, it was not possible to obtain reliable molar masses and 
PDI values for this type of cationic polymers. In addition, the synthetic problems caused by 
the PHOx block hamper the preparation of PEtOx-b-LPEIs with pharmaceutical relevant 
molar masses. Further investigations on developing alternative synthesis routes or the 
identification of suitable solvents for the polymerization of HOx are required. 
Another approach to reduce the cytotoxicity of LPEI is its modification with dextrans. To this 
end, primary amine bearing LPEIs of different molar masses (860 and 1,720 g/mol) have been 
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prepared (Scheme 5-1) and coupled to dextran using: A) Reductive amination of aldehyde 
functionalized dextran (CHO-dex), B) EDC promoted coupling of LPEI to carboxymethylated 
dextran (CM-dex), and C) carbamate formation via activation of dextran with 4-nitrophenyl 
carbonate-substituted dextran (NPC-dex) followed by reaction with LPEI (Scheme 5-3).[107-109] 
While reductive amination and EDC coupling were found to be well-suited techniques for the 
synthesis of dextran-graft-linear poly(ethylene imine) (dex-g-LPEI), the carbamate formation 
method resulted in cross-linking during the reaction of 4-nitrophenyl carbonate-activated 
dextran with the LPEI, yielding insoluble products at higher DS. Therefore, this approach was 
not further investigated.  
Applying the described methods, CM-dex-g-LPEIs and CHO-dex-g-LPEIs with varying 
degrees of substitution (DS) and varying LPEI chain lengths (n = 20, 40) have been prepared 
to investigate the influence of the linking strategy on the physicochemical properties (complex 
size, surface charge, DNA binding and stabilization), the transfection efficiency, and the 
biocompatibility. It was found that the method used to couple the LPEIs to dextran 
significantly affects the biological properties, while the physicochemical properties were only 
 
 
Scheme 5-3. Functionalization of dextran by (1) oxidation, (2) carboxymethylation, and (3) 4-
nitrophenyl carbonate-activation and subsequent reaction with LPEIs via (A) reductive 
amination, (B) EDC coupling and (C) carbamate formation. 
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marginally affected. Independent from the linking strategy, the DS, and molar mass of LPEI, 
all polymers formed stable polyplexes with a positive surface charge and hydrodynamic 
diameters between 70 and 113 nm (in water). Moreover, all dex-g-LPEI/DNA polyplexes 
exhibited a good cyctocompatibility. However, a remarkable influence of the linking strategy 
on the transfection efficiency was observed. Despite a lower LPEI content, cationic dextrans 
obtained by EDC coupling exhibited a more than one order of magnitude increased transgene 
expression than the CHO-dex-g-LPEIs. In comparison, complexes formed from the low molar 
mass LPEIs showed almost no transgene expression. Blood compatibility tests revealed a 
higher red blood cell aggregation compared to the non-conjugated LPEIs, with CM-dex-g-
LPEIs showing a lower erythrocyte aggregation activity than CHO-dex-g-LPEIs. The better 
hemocompatibility of the CM-dex-g-LPEIs is ascribed to their polyelectrolyte character and 
also known from other zwitterionic polymers (Chapter 4). The negatively charged carboxyl 
groups within the CM-dex backbone reduce the positive charge caused by the LPEI chains, 
accomplishing an overall charge that is advantageous for pDNA release and transfection 
efficiency. 
In conclusion, the modification of LPEI with biocompatible compounds represents a suitable 
method to reduce its cytotoxicity. However, the TE might be reduced, due to the formation of 
less stable polyplexes and resulting enzymatic degradation. 
 
5.2. Cationic poly(2-oxazoline)s 
As reported, PHPEtOx show less cytotoxicity than LPEI but also display a lower TE with 
increasing PEtOx content.[110, 111] In addition, a decrease of the overall positive charge went 
along with a reduction of the polyplex stability and, hence, led to an inefficient cellular uptake 
and endosomal release. Moreover, the functionalization with PEG or hydrophilic POx (e.g. 
PMeOx, PEtOx) can result in an inefficient delivery, due to a reduced interaction with genetic 
material and the cellular membranes caused by the cell- and protein-repellent character of the 
polymers.[49, 56, 112-114] To overcome this drawback, additional polymer features have to be 
considered. Besides modifying polycations with “stealth” polymers,[11, 17] the introduction of 
more neutral or hydrophobic characteristics has been discussed for gene delivery 
applications.[115, 116] It is known from the development of antimicrobial POx that the 
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introduction of long alkyl groups leads to an enhanced membrane interaction.[117] Hence, it is 
assumed that the cellular uptake of modified cationic polymers, which is often reduced to the 
“stealth effect”, can be improved by introducing hydrophobic moieties. 
Based on this, the influence of hydrophobicity, amine type, and amine content on the 
transfection behavior was systematically investigated. To this end, cationic copolymers were 
prepared by thiol-ene photoaddition of primary and tertiary amines to POx copolymers of 
different side chain hydrophobicity, namely P(MeOx-co-ButEnOx) and P(MeOx-co-
DecEnOx) (Scheme 5-4). MeOx was chosen as biocompatible comonomer to improve the 
water-solubility which is limited for P(EtOx-co-ButEnOx) and P(EtOx-co-DecEnOx) due to 
the LCST behavior of PEtOx.[118]  
 
 
 
Scheme 5-4. Schematic representation of the synthesis of cationic POx. 
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???????????????????????????????????????? ????????????????????????????????????????????with a 
[MeOTs]/[MeOx]/[ButEnOx] ratio of 1:90:10 and a total monomer concentration of 2 M in 
acetonitrile. Similar to the EtOx/ButEnOx (Chapter 4.2) copolymerization, first-order kinetic 
plots are obtained (Figure 5-4A). Having a higher polymerization rate, MeOx (kp = 
0.095 L mol-1 s-1) is incorporated faster into the polymer chain than ButEnOx (kp = 0.052 L 
mol-1 s-1) indicative for the formation of a gradient copolymer. This is contrary to the 
copolymerization of EtOx and ButEnOx, where both monomers are incorporated with nearly 
the same rate. Characterization by size exclusion chromatography (SEC) revealed an 
increasing molar mass with increasing time (Figure 5-4B). The copolymerization kinetics of 
MeOx and DecEnOx were reported earlier by Dargaville et al..[30]  
The obtained results were used to prepare copolymers with a varying amount (10 to 50 mol%) 
of DecEnOx or ButEnOx, respectively, and an overall DP of 200 (Scheme 5-4). The polymers 
were obtained with acceptable PDI values for MeOx containing copolymers with DP > 100 
(Table 5-3). In the next step, tertiary amine groups were introduced by thiol-ene photoaddition 
of 2-dimethylaminoethanethiol hydrochloride. Primary amines were obtained by thiol-ene 
reaction with 2-(Boc-amino)ethanethiol, followed by deprotection with trifluoroacetic acid. To 
investigate the influence of the side chain hydrophobicity and the sulfur position in more 
detail, the 40 mol% ButEnOx containing copolymer was reacted with 6-amino-1-hexanethiol 
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Figure 5-4. A) First-order kinetic plots of the copolymerization of MeOx and ButEnOx in 
????????????? ??? ???? ??? ????? ?? ?????? ???????? ?????????????? ??? ?? ?? ???? ??
[MeOTs]/[MeOx]/[ButEnOx] ratio of 1:90:10 (conversions were determined by GC 
measurements). B) SEC curves of the kinetic investigation. 
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Table 5-3. SEC data of the different cationic POx and their intermediates (Boc = protected 
primary amine, p = primary, t = tertiary, h = hexamethylene spacer). 
MeOx-co-ButEnOx MeOx-co-DecEnOx 
Polymer MeOx : 
ButEnOx 
Amine Mna) 
(g/mol) 
PDIa) Polymer MeOx : 
DecEnOx 
Amine Mna) 
(g/mol) 
PDIa) 
P49 180 : 20 - 22,800 1.43 P69 180 : 20 - 19,800 1.47 
P50 160 : 40 - 23,300 1.46 P70 160 : 40 - 25,500 1.47 
P51 140 : 60 - 23,300 1.49 P71 140 : 60 - 19,800 1.45 
P52 120 : 80 - 22,200 1.56 P72 120 : 80 - 22,900 1.63 
P53 100 : 100 - 20,300 1.48      
P54 180 : 20 Boc 26,000 1.43 P73 180 : 20 Boc - - 
P55 160 : 40 Boc 29,000 1.46 P74 160 : 40 Boc - - 
P56 140 : 60 Boc 29,500 1.47 P75 140 : 60 Boc - - 
P57 120 : 80 Boc 32,000 1.50 P76 120 : 80 Boc - - 
P58 100 : 100 Boc 27,700 1.47      
P59 180 : 20 p 24,100 1.44 P77 180 : 20 p 23,600 1.51 
P60 160 : 40 p 23,200 1.40 P78 160 : 40 p 31,600 1.43 
P61 140 : 60 p 27,400 1.40 P79 140 : 60 p 30,500 1.54 
P62 120 : 80 p 29,100 1.52 P80 120 : 80 p 38,100 1.62 
P63 100 : 100 p 28,500 1.26      
P64 180 : 20 t 20,440 1.43 P81 180 : 20 t 20,300 1.49 
P65 160 : 40 t 19,560 1.43 P82 160 : 40 t 28,100 1.47 
P66 140 : 60 t 18,120 1.45 P83 140 : 60 t 23,900 1.37 
P67 120 : 80 t 20,180 1.35 P84 120 : 80 t 30,300 1.57 
P68 120 : 80 p, h  34,200 1.31      
a) Determined by SEC (eluent: DMAc + 0.21% LiCl, calibration: PS). 
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hydrochloride. The intermediates and the final products were characterized by means of 
1H NMR spectroscopy and SEC, confirming the successful synthesis. All in all, an 18-
membered copolymer library was obtained and systematically investigated with regard to: 1) 
The ability of the copolymers to interact with pDNA and the cellular membrane, 2) their 
cellular uptake, 3) cytotoxicity, and 4) the transfection outcome. 
The biological studies revealed that hydrophobic chains enhance the interaction with the 
cellular membrane. However, independent of the sulfur position polymers with long 
hydrophobic side chains (P68-P84) showed a high cytotoxicity, hemolysis, and LDH release, 
making them not suitable for gene delivery applications. POx with short side chains and 
tertiary amines were found to be biocompatible, but the interaction with the pDNA was too 
weak to efficiently protect the genetic material. Hence, the pDNA was released into the 
transfection media or inside the endosomes as demonstrated by heparin assay, and cellular 
uptake studies. For polymers with short side chains and primary amines, the optimal amine 
content was found to be at 40 mol%. While higher amine contents showed cytotoxic effects, 
polymers with a lower amine mol% revealed decreased TE values. 
Table 5-4. Overview of all polymers with regard to the pharmaceutical characteristics and 
bottlenecks of the transfection process. Probable reasons for transfection failure or drawbacks 
are described as comments. Cytotoxicity (AlamarBlue), hemolysis and LDH were classified 
with 0 for no effect, 0.5 for middle occurrence, and 1 for high occurrence. 
 
5. Poly(2-oxazoline)-based cationic polymers for gene delivery 
 
50 
As a consequence P62, a polymer with a short ButEnOx based linker and a primary amine 
unit, was identified as material exhibiting superior properties to LPEI. It not only showed high 
transfection efficiencies similar to that of LPEI, but is non-toxic, even at high concentrations. 
 
5.3. High-throughput screening of pharmaceutical properties of cationic polymers 
As demonstrated, it is possible to synthesize large libraries of LPEI, PHPEtOx, and other 
cationic polymers, using synthetic robots and microwave synthesizers. A problem that arises 
from this large number of different polymers is the fast and efficient screening of their 
pharmaceutical properties. Commonly used techniques, such as the determination of binding 
affinity and polyplex stability by gel electrophoresis, are time-consuming and, hence, not 
suitable. However, the analysis and characterization of the biological and pharmaceutical 
properties of cationic polymers and their polyplexes in a high throughput (HT) manner is 
essential when polymer libraries with a large number of members are investigated. To this 
end, an automated combinatorial workflow was developed and validated by comparing the 
outcome with results of “classical” tests and literature values. Due to their wide-spread use 
and, hence, the excellent availability of data, linear (LPEI) and branched poly(ethylene 
imine)s (BPEI) of different DPs (n = 20, 200, and 600) were applied as model transfection 
agents. The automated formation of the polyplexes by complexation with pDNA was achieved 
using a liquid handling robot. The advantage of such a pipetting system is the possibility to 
systematically alter different parameters, such as the pH value, the buffer system, but also the 
polymer concentration. Polyplexes with different N/P ratios (N/P = 2.5, 5, and 10) were 
prepared and automatically distributed into different well plates for parallel analysis studies. 
The size of the polyplex was measured using a dynamic light scattering (DLS) plate reader, 
yielding average radii below the critical uptake size of 500 nm. Instead of using the elaborate 
and slow gel retardation assay, which is not suitable for the well plate format, the DNA 
binding and release properties were investigated using a fluorescence displacement assay with 
ethidium bromide (EB) and a heparin assay, respectively. Upon the formation of 
pDNA/polymer interelectrolyte complexes, EB is displaced from the DNA strand, leading to a 
decreased fluorescence signal. When heparin, a polyanion and a good competitor to negatively 
charged pDNA, is added to the polyplexes, the pDNA is released and EB can be intercalated 
again, leading to an increase in fluorescence intensity. The changes in fluorescence intensity 
5. Poly(2-oxazoline)-based cationic polymers for gene delivery 
 
51 
 
can be easily monitored using a fluorescence plate reader. In a similar manner the cytotoxicity 
of the polyplexes can be investigated. After seeding the cells into the well plate and incubation 
with polyplex suspension, the cell viability was detected by staining with the fluorescent dye 
Hoechst 33324, which crosses the cell membrane and stains the chromosomal DNA of the 
attached cells. The TE of the polyplexes was quantified using the enhanced green fluorescent 
protein (EGFP). Again a fluorescence plate reader was used for the determination of the 
fluorescence intensity. The measurements were complemented by microscope analysis, 
showing a good correlation between both methods. 
The results obtained with the HT screening method corresponded well to results obtained by 
standard experiments and to literature values. Hence, the developed HT method is suitable for 
the investigation and characterization of large polymer libraries. Moreover, it enables the 
possibility to systematically vary different screening parameters, such as the pH value, the 
buffer system, N/P ratios, and concentrations. 
 
5.4. Characterization of cationic polymers 
A problem that arises for cationic polymers is their detailed characterization, in particular 
when they have a high molar mass. Determination of the molar mass distribution and the end 
groups by means of MALDI- and ESI-TOF-MS can only be done for polymers with a low DP 
and PDI, or even fail completely due to ionization issues. Moreover, the multiple charges can 
result in complex ESI spectra which are difficult to interpret. Molar mass determination by 
1H NMR spectroscopy can only be applied, if the polymer has a low DP so that the end 
groups, as reference for the mass calculation, are still visible. SEC characterization is also 
problematic, due to often strong column interactions of the positively charged polymers and 
the missing standards. The latter leads to large deviations between the calculated molar masses 
and values obtained from SEC measurements (e.g. Table 5-1). Viscosimetry is applicable, but 
suffer the drawback that the constants in the Kuhn-Mark-Houwink-Sakurada equation are not 
available for most cationic polymers. Techniques based on colligative phenomena are 
handicapped due to the required determination of the degree of protonation in water and with 
it the amount of species having counterions. Further important characterization methods like 
static light scattering (SLS) and analytical ultracentrifugation (AUC) only yield limited 
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information about the polydispersity index (PDI) of a sample. However, parameters like molar 
mass, radius, architecture, intermolecular interactions, and conformation strongly influence the 
resulting properties, and, hence, their knowledge is essential when structure-property 
relationships should be elucidated. A powerful tool with regard to the characterization of high 
molar mass samples is asymmetric flow-field flow fractionation (AF4), a technique where the 
polymers are separated in a trapezoidal channel according to their diffusion coefficient.[119] In 
contrast to chromatographic methods like SEC, the separation is achieved without any porous 
packing material but by applying a cross-flow perpendicular to the direction of the sample 
flow through a semipermeable membrane with a defined molar mass cut-off (MWCO). A 
detailed overview on AF4 is given elsewhere.[120] When coupled to UV/RI and multi angle 
laser light scattering (MALLS) detectors, AF4 can be used for the characterization of high 
molar mass LPEIs and other cationic polymers as validated by comparison with results 
obtained from analytical ultracentrifugation (AUC) and 1H NMR. The values obtained from 
the AF4-MALLS (Figure 5-5) and the Zimm-plot, e.g. for LPEI600 (Mn = 24.3 kg/mol, Mw = 
32.0 kg/mol, PDI = 1.32), differed only slightly from the theoretical Mn, which was, in this 
case, calculated from the [M]/[I] ratio used for the synthesis of the PEtOx precursor. This 
slight difference probably derived from weighing errors, which are increased at high [M]/[I] 
ratios, since only a very small amount of initiator is required. With regard to the refractive 
index increment, which is essential for molar mass calculation by AF4, the studied PEIs 
reached the lower detection limit of the MALLS detector (low signal to noise ratio). In 
particular, low molar mass LPEIs (< 10 kg/mol) did not show a reliable light scattering signal, 
which can be distinguished from the baseline. A molar mass of 15 to 20 kg/mol was found to 
be the acceptable minimum for LPEI. For the low molar mass polymers the radius of gyration 
could not be obtained. Here, the minimum is around 8 to 10 nm.[121]  
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Figure 5-5. AF4 fractogram with the corresponding cross-flow rate and molar masses of 
LPEI600 (solvent: water + 0.02% NaN3). 
 
5.5. LPEI hydrogels for DNA capture and release 
Another field of application of LPEI, besides its use as vector in gene delivery, are DNA 
biochips. They play an important role in the analysis of genetic material and, hence, are 
interesting for applications in medicine and pharmacy as well as agriculture and food industry. 
In particular pathogens are of high interest. They can be detected by hybridization of their 
unique DNA/RNA sequences with DNA/RNA strands containing complementary nucleic acid 
sequences bound to the DNA chip. However, an essential prerequisite for a successful 
detection is the isolation, concentration, and purification of the nucleic acids from highly 
complex samples, such as blood and feces.[122] LPEI-based hydrogels are investigated as 
promising materials for this task, since they can bind and release DNA. Moreover, hydrogels 
have a higher loading capacity compared to two-dimensional systems, allowing the isolation 
of more genetic material. 
The most common way to synthesize LPEI hydrogels is the cross-linking of the amine groups 
with difunctional compounds such as diisocyantes and diglycidyl ethers.[123-127] A major 
drawback of this method is that the amount of free secondary amine groups that remain after 
the cross-linking process cannot be determined, due to the insolubility of the product. 
However, knowing the exact amount of amine groups is essential for the calculation of the 
binding capacity. Therefore, the cross-linking has to be performed not via the amines but by 
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exploiting other functional groups. Widely-used functional moieties, e.g. for the synthesis of 
POx-based hydrogels, are double bonds. [30, 31, 128-130] Using dithiols they can be cross-linked 
via thiol-ene reaction. However, double bonds did not tolerate the harsh hydrolysis conditions 
of the LPEI synthesis and, hence, had to be introduced by post-hydrolysis modification. This 
was accomplished by the reaction of LPEI with N-succinimidyl-4-pentenate (Scheme 5-5). 
Appling this approach, it is possible to exactly calculate the amount of amine groups from the 
1H NMR spectrum of the obtained PButEnOx-co-LPEI precursors. PButEnOx-co-LPEIs with 
a total DP of 580 and degrees of functionalization (DF) between 15 and 95% have been 
prepared. Subsequent cross-linking via thiol-ene photoaddition using bis-functional 3,6-
dioxaoctane-1,8-dithiol yielded stable hydrogels for DF above 18%. Their water uptake is 10 
times more efficient from liquid phase than from the gas phase. Swelling values between 23 
and 74% could be observed, dependent on the degree of cross-linking. The highest water 
uptake was shown by a hydrogel made from a PButEnOx-co-LPEI with a DF of 50%. 
However, for a fast DNA binding, the swelling values need to be improved, since DNA was 
taken up rather slowly, indicating a diffusion controlled process. Nevertheless, both the 
PButEnOx-co-LPEIs and nearly all hydrogels (exception: Hydrogels with 36% LPEI) were 
able to bind DNA, with a strong dependency on the LPEI content. Moreover, upon heparin 
addition the DNA was released up to 90% from the copolymers at room temperature after 
32 min and up to 50% fro????????????????????????????????????????????????????e DNA release 
 
 
Scheme 5-5. Schematic representation of the synthesis of LPEI hydrogels. 
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from the hydrogels after 80 min can be ascribed to the slow, diffusion controlled process that 
was also observed for the DNA uptake. Since elevated temperatures accelerate the diffusion, a 
release within this period of time was only observed at elevated temperatures. 
In conclusion, LPEI-based hydrogels, obtained by thiol-ene cross-linking of PButEnOx-co-
LPEI, represent interesting compounds for the application in DNA biochips, since they are 
able to bind and release DNA. However, due to their low swelling values, the DNA uptake 
and release is rather slow and, hence, needs to be accelerated, e.g. by taking PHPEtOx instead 
of LPEI as starting materials. 
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6. Summary 
 
Investigations within the scope of this thesis showed that poly(2-oxazolines) are promising 
alternatives for poly(ethylene glycol) (PEG), a polymer that is well-known and intensively 
used in many application fields, e.g. for drug delivery and antifouling coatings. Under 
conditions adopted to “real life” poly(2-ethy-2-oxazoline) (PEtOx) coatings attached to glass 
surfaces via a tetraether lipid and a silane linker, respectively, were able to reduce the biofilm 
formation on the substrate up to 66%. Moreover, the water soluble poly(2-methyl-2-oxazoline) 
(PMeOx) and PEtOx showed an excellent biocompatibility comparable to that of PEG. No 
hemolytic activity could be observed and cytotoxic effects only occurred after long term 
treatment at concentration much higher than the typically used therapeutic dose. By 
copolymerization with 2-(3-butenyl)-2-oxazoline (ButEnOx) and subsequent post-
polymerization functionalization it was possible to synthesize zwitterionic, POx-based 
poly(sulfobetaine)s and poly(carboxybetaine)s, which showed a high biocompatibility and 
anticoagulant properties, i.e. they elongated the blood clotting time. Modified copolymers of 
EtOx and ButEnOx were further studied as potential materials for anticancer therapy. Thiol-
ene photoaddition of terpyridine to the double bonds enabled the possibility for subsequent 
platinum complexation. In addition, the double bonds were exploited for the functionalization 
with sugars, i.e. glucose and galactose, as active targeting units. Investigation of the 
cytotoxicity of the final polymers against different cell lines showed the potential of the 
platinum containing glycopolymer as anticancer drugs. 
Another important field for potential application of POx and their derivatives is gene delivery. 
In particular the “gold standard” linear poly(ethylene imine) (LPEI), a derivative obtained by 
acidic or basic hydrolysis of POx, is intensively investigated. To improve its water solubility 
and to reduce the cytotoxicity, while maintaining a high transfection efficiency (TE), a range 
of synthetic approaches for the modification with biocompatible compounds have been 
performed. Moreover, the influence of the structural changes on different parameters such as 
polyplex stability, cytotoxicity, and transfection efficiency has been investigated. In a first 
approach, partially hydrolyzed PEtOx (PHPEtOx) with different degrees of hydrolysis have  
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Figure 6-1. Overview of the versatility of poly(2-oxazoline)s and linear poly(ethylene imine) 
and the topics investigated within the thesis. 
 
been prepared by adjusting the hydrolysis time. They were found to have a low cytotoxicity 
but showed a significantly decreased TE. The reason for this is the insufficient protection of 
the DNA against enzymatic degradation, due to the reduced polyplex stability. The latter is 
caused by the repellent character of PEtOx and the statistical distribution of the ethylene imine 
units within the copolymer, leading to sterically blocked amines and too short amine 
sequences for DNA binding. To overcome this problem, the synthesis of PEtOx-b-LPEI by 
selective, basic hydrolysis of P(EtOx-b-HOx) was investigated. Although a high selectivity for 
the HOx cleavage was observed, only polymers with short LPEI blocks and a maximal 
EtOx/LPEI ratio of 4/1 could be prepared. This was caused by the starting material P(EtOx-b-
HOx), which precipitated during the polymerization when the degree of polymerization of the 
HOx block became larger. The resulting low molar masses of the PEtOx-b-LPEIs hampered 
the performance in pharmaceutical applications. Thus, the functionalization with another 
biocompatible compound, namely dextran, has been investigated. LPEIs of different molar 
masses bearing primary amine end groups were coupled to dextran applying different linking 
strategies. The best results were obtained from LPEIs attached to carboxymethylated dextran 
(CM-dex). These materials had a higher TE than the pure LPEIs and LPEIs coupled to 
aldehyde functionalized dextran (CHO-dex-g-LPEIs) and exhibited a lower erythrocyte 
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aggregation activity. This is ascribed to their polyelectrolyte character, which in general has a 
positive influence on the biocompatibility of compounds. 
It was observed, and also reported in literature that the modification of LPEI with 
biocompatible, “stealth” polymers often decreases the polyplex stability. Due to the repellent 
character the interaction with the genetic material and the cell membranes is reduced. 
However, it is known from the development of antimicrobial POx that the introduction of 
alkyl groups enhances the interaction with the cellular membrane, a prerequisite an efficient 
for cell uptake and transfection. Therefore, an 18-member POx-based copolymer library with 
varying side chain lengths and hydrophobicity, varying amounts of amine (10 to 50%), and 
different types of amine (primary, tertiary) has been prepared and systematically investigated. 
It could be shown that polymers primary amines in the side chain are more efficient in 
protecting and delivering DNA. Moreover, it was found that polymers with longer alkyl side 
chains show an increased interaction with the cellular membrane. However, polymers with 
very long hydrophobic side chains had a high cytotoxicity, since they damaged the cellular 
membrane. The best compound was found to be a P(MeOx-co-ButEnOx)-based copolymer 
with primary amine groups and an amine content of 40 mol%. Here, no cytotoxicity but a TE 
similar to that of LPEI was observed. 
The large number of synthesized polymers made it necessary to develop a high throughput 
(HT) method for the screening of the physicochemical and pharmaceutical properties. Using 
automated pipetting robots as well as fluorescence and DLS plate readers, different 
parameters, such as the pH value, the buffer system, the N/P ratio, and the concentration, 
could be systematically varied and their influence could be studied in a fast and efficient way. 
The obtained results corresponded well to results from “classical” experiments and to 
literature values. 
A problem that occurred was the determination of the molar masses of the cationic polymers. 
Missing SEC standards and strong interactions with the columns, but also the failing of other 
methods, e.g. MALDI- and ESI-TOF-MS, due to multiple reasons, make their characterization 
challenging, in particular at high molar masses. Asymmetric flow-field flow fractionation 
(AF4) coupled to UV/RI and a multi angle laser light scattering detectors was found to be a 
suitable technique for this task. 
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Besides being investigated as vector for gene delivery, LPEIs were further used as starting 
materials for the synthesis of hydrogels. It could be shown, that LPEI-based hydrogels are 
capable to bind and release DNA, making them interesting compounds for DNA biochip 
applications. 
To conclude, it could be shown that POx and its derivatives represent promising materials for 
a wide range of potential applications, such as antifouling coatings, drug and gene delivery. 
The presented results contribute to the understanding of structure-property relationships and 
will be the basis for the synthesis of further tailor-made polymers for various applications. 
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7. Zusammenfassung 
 
Untersuchungen im Rahmen dieser Arbeit konnten zeigen, dass Poly(2-oxazoline) (POx) eine 
vielversprechende Alternative zu Poly(ethylenglycol) (PEG) darstellen. Letzteres Polymer 
findet in vielen Bereichen Verwendung, so zu Beispiel als Material für Antifouling-
Beschichtungen und im Wirkstofftransport. Unter lebensnahen Versuchsbedingungen gelang 
es mit Hilfe von Poly(2-ethy-2-oxazolin) (PEtOx)-Beschichtungen die Bildung von Biofilmen 
auf Glasoberflächen um 66% zu reduzieren. Dafür wurden die PEtOx-Beschichtungen mittels 
eines Tetraetherlipides bzw. eines Silanhaftvermittlers kovalent an Glassubstrate gebunden. Es 
konnte weiterhin gezeigt werden, dass die wasserlöslichen Polymere Poly(2-methyl-2-
oxazolin) und PEtOx eine ausgezeichnete Biokompatibilität, vergleichbar zu der von PEG, 
aufweisen. Auch wurde keine hemolytische Aktivität beobachtet und zytotoxische Effekte 
traten erst nach Langzeitbehandlung mit Konzentrationen oberhalb der normalerweise 
verwendeten therapeutischen Dosis auf. Durch Copolymerisation mit 2-(3-Butenyl)-2-
oxazolin (ButEnOx) und anschließende Funktionalisierung wurden zwitterionische, POx-
basierte Poly(sulfobetaine) und Poly(caboxybetaine) synthetisiert. Diese besaßen eine hohe 
Biokompatibilität und wirkten koagulanzhemmend, d.h. sie verlängerten die 
Blutgerinnungszeit. Modifizierte Copolymere aus EtOx und ButEnOx wurden weiterhin als 
potentielle Substanzen für die Krebstherapie untersucht. Durch Thiol-En-Photoaddition von 
Terpydridin an einen Teil der Doppelbindungen und anschließende Komplexierung von Platin 
konnte ein Antikrebswirkstoff erhalten werden. Um die Selektivität für Krebszellen zu 
erhöhen wurden die restlichen Doppelbindungen mit Zucker-Einheiten, d.h. Glukose bzw. 
Galaktose, funktionalisiert. Untersuchungen der zytotoxischen Wirkung auf verschiedene 
Zelllinien zeigten das therapeutische Potential der Platin-haltigen Glykopolymere. 
Ein weiteres bedeutendes Anwendungsgebiet von POx und deren Derivate ist der Gentransfer. 
Insbesondere der „Goldstandard“ lineares Poly(ethylenimin) (LPEI), eine Verbindung welche 
durch saure oder basische Hydrolyse von POx entsteht, wird heutzutage intensiv untersucht. 
Um die Wasserlöslichkeit zu verbessern und die Zytotoxizität, unter Beibehaltung einer hohen 
Transfektionseffizienz (TE), zu verringern, wurde LPEI mit einer Reihe von biokompatiblen  
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Figure 7-1. Übersicht über Vielfältigkeit von Poly(2-oxazolinen) und linearem 
Poly(ethylenimin) sowie über die Themen, welche im Rahmen der Arbeit untersucht wurden. 
 
Verbindungen modifiziert. Anschließend wurde der Einfluss dieser strukturellen 
Veränderungen auf verschiedene Parameter, wie z.B. Polyplexstabilität, Zytotoxizität und TE, 
untersucht. In einem ersten Ansatz wurden partiell hydrolysierte PEtOx (PHPEtOx) 
hergestellt, deren Hydrolysegrad über die Reaktionszeit gesteuert wurde. Es zeigte sich, dass 
die PEtOx-Einheiten zwar die Zytotoxizität reduzierten, jedoch sank gleichzeitig die TE 
signifikant. Als Ursache dafür wurde eine reduzierte Polyplexstabilität ausgemacht, welch zu 
einem ungenügenden Schutz der DNA vor enzymatischen Abbau führte. Die schlechte DNA-
Bindungskapazität der PHPEtOx beruht auf dem proteinabweisenden Charakter von der 
PEtOx-Bestandteile und der statistische Verteilung der Ethylenimine-Einheiten innerhalb der 
Copolymere. Letzteres erschwert eine stabile DNA-Bindung, da einige Amingruppen auf 
Grund ihrer kurzen Sequenz oder sterischer Abschirmung durch benachbarte PEtOx-Einheiten 
nicht für die DNA-Komplexierung zur Verfügung stehen. Um dieses Problem zu lösen, wurde 
die Synthese von PEtOx-LPEI-Blockcopolymeren durch selektive, basische Hydrolyse von 
P(EtOx-b-HOx untersucht. Obwohl eine hohe Selektivität für die Abspaltung der HOx-
Seitenketten beobachtet wurde, konnten nur Polymere mit kurzen LPEI-Blöcken und einem 
maximalen EtOx/LPEI-Verhältnis von 4/1 hergestellt werden. Die Ursache dafür liegt in der 
Synthese des Ausgangsstoffs P(EtOx-b-HOx). Das Produkt fiel bei hohen 
Polymerisationsgraden des HOx-Blocks aus. Die daraus resultierende geringe Molmasse der 
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erhaltenen PEtOx-b-LPEIs verhinderte eine erfolgreiche pharmazeutische Anwendung. Aus 
diesem Grund wurde die Funktionalisierung mit einem anderen biokompatiblem Material, 
Dextran, untersucht. LPEIs unterschiedlicher Molmasse wurden über ihre primären 
Endgruppen auf verschiedene Arten an Dextran gekoppelt. Die besten Ergebnisse erzielten 
LPEIs, welche an carboxymethyliertes Dextran (CM-dex) gebunden waren. Diese CM-dex-g-
LPEIs zeigten eine höhere TE als nichtfunktionalisierte LPEIs und LPEIs, welche an 
aldehydfunktionalisiertes Dextran gekoppelt wurden. Auch führten sie zu einer zu geringeren 
Erythrozyten Aggregation. Diese Beobachtung kann ihrem Polyelektrolytcharakter 
zugeschrieben werden, welcher oft einen positiven Einfluss auf die Biokompatibilität hat 
(siehe zwitterionische POx). 
In den meisten Fällen reduzierte die Modifizierung von LPEI mit biokompatiblen „Stealth-
Polymeren“ die Polyplexstabilität, da ihr abweisender Charakter die Wechselwirkung mit dem 
genetischen Material und den Zellmembranen verringerte. Von der Entwicklung 
antimikrobieller POx ist bekannt, dass das Einführen von Alkygruppen die 
Zellmembranwechselwirkung verbessern kann. Diese ist Voraussetzung für die erfolgreiche 
Aufnahme durch die Zelle und damit für die Transfektion. Aus diesem Grund wurde eine 
Bibliothek aus 18 Copolymeren hergestellt, wobei die Seitenkettenlänge und -hydrophobizität, 
der Amingehalt (10 bis 50%) und die Art des Amins (primär, tertiär) variiert wurden. 
Systematische Untersuchungen ergaben, dass primäre Amine eine höhere Effizienz beim 
Schutz und Transport der DNA aufweisen. Das Einführen von längeren Alkylseitenketten 
erhöhte die Wechselwirkung mit der Zellmembran. Jedoch zeigten Polymere mit sehr langen, 
hydrophoben Seitenketten eine hohe Zytotoxizität, da sie die Zellmembran zerstörten. Ein 
P(MeOx-co-ButEnOx)-basiertes Copolymer mit einem Amingehalt von 40 mol% lieferte die 
besten Resultate. Es war nicht zelltoxisch, wies jedoch eine TE vergleichbar zu LPEI auf. 
Die große Anzahl an Polymer machte es notwendig eine Hochdurchsatzmethode für die 
Untersuchung der physikochemischen und pharmazeutischen Eigenschaften zu entwickeln. 
Durch die Verwendung von Fluoreszenz- und DLS-Analysemethoden sowie von 
Pipettierrobotern konnten verschiedene Parameter, wie der pH-Wert, das Puffersystem, das 
N/P-Verhältnis und die Konzentration, variiert und deren Einfluss studiert werden. Die 
erhaltenen Ergebnisse waren vergleichbar zur Literatur und zu Ergebnissen aus klassischen 
Experimenten.  
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Ein Problem stellte die Molmassenbestimmung der kationischen Polymere dar. Fehlende 
Standards für die Größenausschlusschromatographie und starke Wechselwirkungen mit dem 
Säulenmaterial, sowie das Versagen andere Methoden aus den verschiedensten Gründen, 
erschweren ihre Charakterisierung, insbesondere bei hohen Molmassen. Die an UV/RI- und 
Mehrwinkellaserlichtstreu-Detektoren gekoppelte asymmetrische Fluss-Feld-Fluss-
Fraktionierung stellte sich als brauchbare Methode für diese Aufgabe heraus. 
LPEIs wurden nicht nur als Gentransfervektoren untersucht, sie dienten auch als 
Ausgangsstoffe für die Synthese von Hydrogelen. Es konnte gezeigt werden, dass LPEI-
basierte Hydrogele in der Lage sind DNA zu binden und wieder frei zu setzen, was sie zu 
interessanten Materialen für die Verwendung in DNA-Biochips macht. 
Zusammenfassend konnte gezeigt werden, dass POx und ihre Derivate vielversprechende 
Materialien für ein großes Feld von Anwendungen darstellen, so z.B. für Antifouling-
Beschichtungen, den Wirkstofftransport bzw. den Gentransfer. Die beschrieben Ergebnisse 
tragen zum besseren Verständnis von Struktur-Eigenschafts-Beziehungen bei und stellen die 
Grundlage für die Synthese weitere maßgeschneiderter Polymere für verschiedenste 
Anwendungen. 
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AF4 Asymmetric flow-field flow fractionation 
ATR-FT-IR Attenuated total reflection Fourier transform infrared  
ButEnOx 2-(3-Butenyl)-2-oxazoline 
CHO-dex Aldehyde functionalized dextran 
CM-dex Carboxymethylated dextran 
CROP Cationic ring-opening polymerization 
DecEnOx 2-(9-Decenyl)-2-oxazoline 
DH Degree of hydrolysis 
DMAc N,N-Dimethylacetamide 
DMPA 2,2-Dimethoxy-2-phenylacetophenone 
DNA Deoxyribonucleic acid 
DP Degree of polymerization 
ESI Electrospray ionization 
EtOx 2-Ethyl-2-oxazoline 
Gal Galactose 
GC Gas chromatography 
Glc Glucose 
GOPTMS (3-Glycidyloxypropyl)trimethoxysilane 
HT High-throughput 
LPEI Linear poly(ethylene imine) 
MALDI Matrix assisted laser desorption ionization 
MALLS Multi angle laser light scattering 
MeOH Methanol 
MeOx 2-Methyl-2-oxazoline 
MeOTs Methyl tosylate 
NMR Nuclear magnetic resonance 
[M]/[I] [Monomer] / [initiator] 
MS Mass spectrometry 
PDI Polydispersity index 
pDNA Plasmid DNA 
PEG Poly(ethylene glycol) 
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RNA Ribonucleic acid 
RI Refractive index 
SEC Size exclusion chromatography 
TE Transfection efficiency 
TEL Tetraether lipid 
TOF Time of flight 
Tpy Terpyridine  
UV Ultraviolet 
?? Microwave 
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Poly(2-oxazoline) functionalized surfaces: from
modification to application
Lutz Tauhardt,ab Kristian Kempe,wab Michael Gottschaldtab and
Ulrich S. Schubert*abc
Poly(2-oxazoline)s (POxs) are a versatile class of biocompatible polymers, which have been investigated
as poly(ethylene glycol) (PEG) alternatives. In recent years, POxs have drawn significant attention as
coatings for antifouling applications. In this tutorial review diﬀerent approaches to immobilize POxs on
surfaces as well as properties and applications of POx coated surfaces will be presented.
Key learning points
(1) Approaches to immobilize poly(2-oxazoline)s on surfaces
(2) Antifouling properties of poly(2-oxazoline) coated surfaces
(3) Parameters that influence the (antifouling) properties of poly(2-oxazoline) coated surfaces
(4) Applications of poly(2-oxazoline) coated surfaces
1. Introduction
Controlling the adhesion or adsorption of cells, proteins,
bacteria and other microorganisms onto surfaces is of enormous
importance for medicine (e.g. implants, medical devices, drug
delivery carriers), the food industry (e.g. packaging), andmobility
(e.g. ship hull coatings), but also for (bio)sensor and microarray
applications.1,2 Depending on the application either the promo-
tion (e.g. osseointegration of implants) or the prevention of the
adhesion (e.g. antifouling coatings) is desired. A widely used
strategy for the latter is the surface modification with
poly(ethylene glycol) (PEG) and PEG-based copolymers.1,2 How-
ever, PEG suﬀers from a tense patent situation and is known to
undergo degradation by (auto-)oxidation to form aldehydes and
ethers.1,2 Because of these problems poly(2-oxazoline)s (POxs), in
particular the water soluble poly(2-methyl-2-oxazoline) (PMeOx)
and poly(2-ethyl-2-oxazoline) (PEtOx), are investigated as alter-
native (coating) materials. POxs show similar properties to PEG
(e.g. antifouling, ‘‘stealth eﬀect’’)3 but in addition they have
several advantages such as higher stability,4 lower viscosity,1
and a less demanding synthesis.5 Moreover, a broad variety of
oxazoline monomers, as well as functional initiators and termi-
nating agents, allows the synthesis of tailor-made POx.6 With
regard to coating applications, it is necessary to immobilize the
POx on the surface. However, a weak binding onto the surface
would reduce the long term stability of the coating and is thus
not suﬃcient. Therefore, the surface immobilization process
plays an important role in the eﬃciency and stability of the
coating. Using diﬀerent POxs for surface functionalization
(‘‘POxylation’’) is an emerging field and immobilizationmethods
have not been reviewed yet. Here, we provide an overview of
general approaches to attach POxs to diﬀerent surfaces, as well
as the properties and applications of the POx coated surfaces.
2. Synthesis of poly(2-oxazoline)s and
methods for their surface immobilization
2.1 Synthesis of poly(2-oxazoline)s
POxs can be synthesized by cationic ring-opening polymerization
(CROP) (Scheme 1). The living character of the CROP allows the
synthesis of well-defined polymers with low polydispersity index
(PDI) values and adjustable molar masses. Moreover, a broad
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variety of diﬀerent oxazoline monomers (defined by R), functional
initiators (e.g. triflates, tosylates, organic iodides or bromides) and
terminating agents (i.e. nucleophiles) is available and allows the
tuning of the polymer properties. Often used POxs are PEtOx
(R = Et), PMeOx (R = Me), and poly(2-isopropyl-2-oxazoline)
(PiPrOx). The utilization of microwave-assisted synthesis proce-
dures enables the polymerization in minutes to a few hours.5
2.2 Termination with coupling agents or amine
functionalized surfaces (‘‘grafting onto’’)
The oldest way to obtain POxs that can be attached to surfaces is
the direct end-capping of the living polymer species with silane
coupling agents such as (3-aminopropyl)triethoxysilane (APTES),7,8
(3-aminopropyl)triethoxysilane (APTMS),9,10 sodium (3-mercapto-
propyl)trimethoxysilane (MPTMS),11 and (4-aminobutyl)dimethyl-
methoxysilane (ABDMMS)12,13 (Fig. 1).
Another way to introduce a silane functionality to POx is the
hydrosilation method by Chujo et al.7,9 Here, a double bond
initiated (e.g. by allyl tosylate) or terminated (e.g. by diallylamine)
POx is reacted with trialkyloxysilane in the presence of chloro-
platinic acid as a catalyst (Scheme 2).
Multifunctional initiators or terminating agents enable the
possibility to introducemore than one silane group.7,8 The grafting
of the silane coupling agent functionalized POx onto the surface
can be achieved by heating a solution of the polymer together with
the particular object (e.g. silicon wafer, glass slide) that is supposed
to be coated.10–12
Besides termination with a coupling agent, it is also possible
to quench the living oxazolinium species directly with an amine
functionalized surface (e.g. APTES modified surfaces). Yoshikawa
and Tsubokawa et al. applied this method to graft PMeOx onto
inorganic fibers,14 such as glass, alumina, and carbon fibers, but
also onto ultrafine silica15 and carbon black.16 In a similar
approach, Fujiki et al.17 and Yoshikawa et al.18 first grafted
poly(amidoamine) (PAMAM) dendrimers onto APTES functiona-
lized glass fibers and silica using Michael addition. By amination
of the terminal ester groups of PAMAM with ethylenediamine or
hexamethylenediamine, amine end groups were obtained and
used to terminate living PMeOx chains (Scheme 3).
The grafting of POxs onto gold surfaces can be achieved via
disulfide or other sulfur bearing groups which can be introduced
Scheme 1 Schematic representation of the polymerization of 2-oxazolines.
Fig. 1 Diﬀerent coupling agents that can be used for the direct termination
of the living oxazolinium species and the binding of such end-capped POxs onto
the surface.
Scheme 2 Schematic representation of the hydrosilation of POx.
Scheme 3 Schematic representation of the preparation of PMeOx terminated
PAMAM dendrimers on glass surfaces.
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through the initiator. Lehmann and Ru¨he utilized tosylates of
o,o0-dihydroxy alkyl disulfides for the initiation of the oxazoline
polymerization and subsequently attached the POx onto the gold
surface via chemisorption of the sulphur.19
2.3 ‘‘Clicking’’ onto the surface
Azide modified surfaces can be ‘‘POxylated’’ by means of
copper-catalyzed azide–alkyne cycloaddition (CuAAC, ‘‘click’’
reaction). For this purpose, POx functionalized with an alkyne
end group or side chain can be applied.
By means of CuAAC, Haensch et al. attached propargyl
initiated PEtOx onto azide functionalized silicon wafers
(Scheme 4).20 In a similar manner, Lind et al. prepared micro-
patterned conductive devices on which the poly(styrene) azide
(PS–N3) surface was coated with PMeOx.
21
Manzenrieder et al. used copolymers of 2-(pent-4-ynyl)-
2-oxazoline (PynOx) and MeOx or EtOx (Fig. 2), but also alkyne
initiated PMeOx and PEtOx to stabilize virus-like particles. The
P(MeOx-co-PynOx) and P(EtOx-co-PynOx) were immobilized on
azide functionalized particle surfaces via the alkyne side chain.
2.4 Surface initiated polymerization (‘‘grafting from’’)
Besides grafting the POxs onto the surface by the introduction
of terminal coupling groups (e.g. silanes or azides) or direct
quenching of the living species with an amino group bearing
surface, it is also possible to initiate the polymerization directly
from the surface. For this so called ‘‘grafting from’’ approach
an initiator has to be attached to the surface prior to the
polymerization (Scheme 5). In the case of silica this can be
accomplished by the reaction with silanes bearing initiating
moieties like tosylate (OTos),19 triflate (OTf), p-nitrobenzyl
sulfonate (ONs),22 and bromine23 or iodine (Scheme 5a).24–26
Gold surfaces can be ‘‘POxylated’’ using thiols with the same
initiator groups (Scheme 5c).27–29
Another method exploits the self-initiated photografting and
photopolymerization (SIPGP) of 2-isopropenyl-2-oxazoline (iPrEnOx)
followed by the CROP of another oxazoline (Scheme 5b).30
First, iPrEnOx is photografted and photopolymerized onto the
activated surface (e.g. with APTMS). The oxazoline ring of the
resulting poly(2-isopropenyl-2-oxazoline) (PiPrEnOx) is subse-
quently attacked with an initiator (e.g. MeOTf). To the living
oxazolinium species another oxazoline is added and polymer-
ized by CROP. The SIPGP of iPrEnOx and the subsequent CROP
lead to a bottle brush-like structure of the POx.
2.5 Photoimmobilization
A straightforward approach to obtain POx functionalized surfaces
is the photoimmobilization. Two diﬀerent ways are described in
the literature, using either benzophenone (BP) or perfluorophenyl
azide (PFPA) derivatives (Scheme 6).
In the case of BP derivatives the photoimmobilization occurs
via a benzophenone diradical which is formed upon UV irra-
diation and can attack the polymer at the backbone but also at
the side chain. A widely utilized method is the attachment of
4-(30-chloro-dimethylsilyl)propyloxybenzophenone onto silicon
or SiO2 surfaces, followed by UV light initiated photoimmobi-
lization of the POx (Scheme 3a).31–35 This procedure was not
only applied to immobilize POx, but also for a large variety of
other polymers such as PEG, chitosan, and poly(ethylene
imine). Besides modifying the surface with a benzophenone
derivative it is also possible to use a benzophenone functiona-
lized polymer. Samuel et al. attached benzophenone to the
linear poly(ethylene imine) (LPEI) units of partially hydrolyzed
PEtOx (PHPEtOx) (Scheme 3b).36 The resulting copolymer of
PEtOx, LPEI and poly(2-benzophenone-2-oxazoline) (PBPOx)
was immobilized through the PBPOx units onto a poly(methyl
methacrylate) (PMMA) film which was deposited on a gold
coated lanthanum surface.
For the PFPA derivatives the photoimmobilization takes
place by formation of a singlet perfluorophenyl nitren, which
is created by the loss of N2 under UV irradiation and can form
covalent bonds with the POx via a CH insertion reaction
(Scheme 3c). This reaction can also be triggered using heat
instead of UV.37 The ‘‘POxylation’’ of silicon, glass and gold
surfaces can be achieved by using PFPA–silane and PFPA–
disulfide, respectively.37–43
2.6 Other ways to attach POx onto a surface
Konradi and Pidhatika functionalized Nb2O5-coated silicon
wafers with poly(L-lysine)-graft-P(MeOx) (PLL-g-PMeOx) copolymers,
which have a bottle brush-like structure (Scheme 7a).1,4,44–46 PLL-g-
PMeOx copolymers of different side chain grafting densities were
prepared by reaction of the PLL backbone with glutaric acid or ethyl
piperidine-4-carboxylate end-capped PMeOx. The surface immobi-
lization of the copolymers occurs via spontaneous self-assembly,
caused by multiple electrostatic interactions between the negatively
charged Nb2O5-coated silicon wafer and the polycationic PLL back-
bone. Although attached only by electrostatic interactions, the
obtained POx monolayers are stable on the surface. They stand
intensive washing processes and the attack of hydrogen peroxide
solution.
Lehmann and Ru¨he reported the attachment of PHPEtOx
onto surfaces bearing N-hydroxysuccinimide self-assembled
Scheme 4 Schematic representation of the immobilization of POx by ‘‘clicking’’
onto the surface.
Fig. 2 Schematic representation of P(AlkylOx-co-PynOx).
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Scheme 5 Schematic representation of the surface initiated CROP of POx using (a) diﬀerent initiators, (b) self-initiated photografting and photopolymerization of
2-isopropenyl-2-oxazoline followed by CROP of POx, and (c) surface initiated CROP of POx on gold surfaces using diﬀerent initiators.
Scheme 6 Schematic representation of the photoimmobilization of POx by (a and b) benzophenone and (c) PFPA derivatives.
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monolayers (SAMs).19 Here, the binding occurred via the PEI
units of the PHPEtOx. In a similar approach, carboxylic acid
functionalized surfaces were ‘‘POxlyated’’ by amidation reaction
of the COOH moieties with PEI units of partially hydrolyzed
PMeOx (PHPMeOx) (Scheme 7b). Jeon et al. utilized this proce-
dure to graft PMeOx onto multiwalled carbon nanotubes.47
Another ‘‘POxylation’’ method, using carboxylic acid func-
tions as well, was introduced by Agrawal et al.48 Copolymers of
poly(2-carboxyethyl-2-oxazoline) (PCarbEtOx) and poly(2-isopropyl-
2-oxazoline) (PiPrOx) (Fig. 3a) were grafted onto poly(glycidyl
methacrylate) (PGMA)-coated silicon. The high reactivity of
the epoxy groups of PGMA towards the COOH groups of the
PCarbEtOx leads to the chemical attachment of the POx chains
in a brush-like conformation.
The surface immobilization of POx via epoxy units cannot only
be achieved with PGMA, but also by POx having epoxy groups.
Trumbo coated steel panels by cross-linking of side chain
epoxidized poly(2-(dec-9-enyl)-2-oxazoline) (PDecEnOx) (Fig. 3b)
with diamines or anhydrides.49
3. Properties and applications of POx
modified surfaces
POx functionalized surfaces are of significant interest for
applications where the adhesion and adsorption of proteins,
cells, bacteria, and other microorganisms need to be con-
trolled, e.g. in medicine (e.g. for implants), microfluidic devices,
and (bio)sensors. In most applications, coating with POx aims
to reduce or suppress the unwanted adsorption of proteins
(i.e. protein fouling) or the undesired adhesion of cells, bac-
teria, and microorganisms (i.e. biofouling), respectively. For
this purpose, the POxs used have to meet the following criteria,
which were found to be common for all antifouling polymers:
(1) the presence of hydrophilic (polar) functional groups and
hydrogen bond accepting groups as well as (2) the absence of a
net charge and hydrogen bond donating groups.1,2 Hence, all
antifouling investigations focused on water soluble POxs with
short side chains (e.g. PEtOx, PMeOx) and their water soluble
copolymers.
POx coatings are so called biopassive coatings, since most
POxs do not actively kill the bacteria or cells but only prevent
their adhesion. By introduction of end groups with a quaternary
ammonium species, bioactive (i.e. actively killing) POx can be
obtained.50 To the best of our knowledge, no investigations on
surface attached bioactive POx have been reported yet. There-
fore, this chapter will focus on biopassive, anti-adhesive, and
repellent coatings.
Depending on the immobilization method and the structure
of the used polymer, two types of POx coatings can be distin-
guished. First, linear, brush-like POx coatings, with only a
single POx chain per surface grafting unit (Fig. 4a), and second,
POx-based comb polymer coatings, where more than one POx
chain per grafting unit is attached to the surface via another
polymer backbone (e.g. PLL) (Fig. 4b). The latter can exhibit a
bottle brush-like structure, also referred to as molecular or
cylindrical brushes, at high side chain grafting densities.
However, there are major issues which complicate the
comparison of the published studies: (1) the diversity of POx
attachment and, thus, the diﬀerent surface architecture, (2) the
applied test regimes, i.e. the use of diﬀerent test conditions,
diﬀerent types of cells, bacteria, etc., and (3) the usage of
diﬀerent analytical tools with diﬀerent detection limits.
3.1 Properties of linear, brush-like POx coatings and their
application for controlling cell adhesion and protein
adsorption
In most cases of the above presented immobilization methods,
the surface will be coated with a single, linear POx chain per
grafting unit. Such POxylated surfaces exhibit a brush-like
structure.
Scheme 7 Schematic representation of the surface immobilization of (a) bottle
brush-like PLL-g-PMeOx and (b) partially hydrolyzed POx.
Fig. 3 (a) P(CarbEtOx-co-iPrOx) and (b) epoxidized PDecEnOx. Fig. 4 (a) Linear, brush-like POx coatings and (b) bottle brush-like POx coatings.
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The properties of POx functionalized surfaces are influenced
in multiple ways. An important parameter of POx coatings is
their swelling behavior, since it directly influences the anti-
fouling properties. Theoretical calculations for hydrated PEG
attached to a hydrophobic substrate showed that upon protein
approach the PEG chains are compressed and water molecules
are removed from the hydrated polymer.2 This not only leads to
a repulsive elastic force of the compressed chain but also to a
thermodynamically unfavorable state. The magnitude of the
resulting repulsive force was found to be influenced by the
polymer chain length and the surface grafting density. An
increased chain length causes greater protein repulsion. Coat-
ings with water soluble POxs, i.e. PMeOx and PEtOx, are
expected to show a similar behavior.
The swelling behavior of POx coated substrates can be
investigated measuring either the weight change of the sample
or the variation of the film thickness. Using the latter method a
maximum swelling ratio rmax for POx coatings can be defined
as the maximal swelling film thickness dmax divided by the
initial dry film thickness d0:
rmax = dmax/d0 (1)
Swelling measurements by Chujo et al. revealed that PEtOx-
modified silica gel can absorb water up to 2.4-times of its own
weight, depending on the DP.8 For longer side chains (butyl,
octyl) the water adsorption decreased. Other solvents, such as
N,N-dimethylsulfoxid, n-propanol, or toluene, were adsorbed to
a lower extent by all POxs.
Rehfeldt et al. investigated the static and dynamic swelling
behavior of diﬀerent chain lengths of APTMS end-capped
PMeOx and PEtOx grafted onto SiO2.
10 By measuring the
equilibrium film thickness as a function of relative humidity
(static swelling) and the change in film thickness as a function
of time after abrupt change in the relative humidity (‘‘osmotic
shock’’) (dynamic swelling), the authors observed that both
the static and the dynamic swelling behavior are dependent on
the polymer chain length but not on the type of side chain
(Table 1).
Swelling behavior investigations by Lehmann and Ru¨he
showed that the film thickness of PEtOx monolayers attached
to gold can increase up to 50% upon exposure to humid air
(rmaxB 1.45).
19 The d0 for these films (obtained by a ‘‘grafting onto’’
approach via thiol) increased with the degree of polymerization
(DP = 5 to 150) but rapidly leveled oﬀ at about 3.5 nm (DP Z 50).
Using a tosylate initiated ‘‘grafting from’’ approach on a silica
substrate the authors were able to obtain PEtOx monolayers with
d0 = 20 to 30 nm for DPs > 600. The swelling ratio of this kind of POx
coatings was higher (rmaxB 2) than that observed for the ‘‘grafting
onto’’ gold approach.
Jordan et al. grafted ABDMMS functionalised PEtOx with
long alkyl end groups onto silica substrates (Fig. 1).12 X-ray
reflection studies showed that the obtained polymer film (total
film thickness of 3.5 nm) was composed of two layers, a
polymer sublayer of 1.75 nm and a polymer supported alkyl
layer of 1.5 nm.12,27 The values were obtained from water-
swollen layers, where a phase separation of the amphiphilic
ligands into a hydrophilic polymer layer and a layer of the
tethered alkyl moieties occurred. In another approach Jordan
and Ulman coated the gold substrate with PEtOx by surface
initiated CROP using triflate of surface tethered 11-hydroxy-
undecanethiolate (HUT) as an initiator.27 The end-capping with
N,N-dioctadecylamine resulted in a triple layer structure that is
similar to the structure reported for the ‘‘grafting onto’’ of
ABDMMS functionalized PEtOx. For a DP of 10 a film thickness
of 9.1 nm was obtained. By swelling in water for 24 h, it
increased to 11.3 nm. When rinsed with the poor solvent
diethyl ether the film thickness decreased to 8.4 nm. Even after
multiple cycles of swelling and deswelling, nearly identical
values were obtained (rmax = 1.2 to 1.35). With B1.3 nm for
the self-assembled monolayer of HUT and B1.5 nm for the
terminal alkyl moiety, the polymer interlayer is 8.5 nm.
All these measurements show that the film thickness and
the film quality, and with it the swelling ratio rmax, are
dependent on the surface, the immobilization method, the
used spacer, the polymer end group, and the DP. However,
due to the diversity of the described systems and the diﬀerent
methods to analyze the films, it is not possible to draw some
exact conclusions on how the DP influences the swelling
behavior.
Another important parameter is the grafting density. It can
be influenced by the concentration of the coupling agent40 or
the polymer,39 respectively. A lower concentration of the coupling
agent will lead to a lower grafting density due to less available
binding sides on the surface. In a similar manner, a very low
polymer concentration will reduce the grafting density, since not
all binding sides will be saturated. However, a higher concen-
tration of both, the coupling agent or the polymer, will increase the
grafting density only to a certain point. If all binding sides on the
substrate are covered, the excess of coupling agent or polymer
cannot bind anymore. These assumptions are confirmed by
investigations on the film thickness and grafting density of PEtOx
films which were photoimmobilized using PFPA–silane. Bartlett
and Yan38 and Kim et al.41 prepared spin coated PEtOx films of
various thicknesses by adjusting the polymer solution concen-
tration (1 to 20 mg mL1) (Fig. 5b). After removal of the excess
polymer, the film thickness was always between 3.1 and 3.2 nm
for PEtOx with Mw = 200000 g mol
1, and 2.8 nm for Mw =
50000 g mol1. A similar film thickness (3 nm) was obtained by
Prucker et al. when they immobilized PEtOx of the same molar
mass (50000 g mol1) on a benzophenone modified silicone
Table 1 Maximum swelling values of diﬀerent POxs on diﬀerent surfaces
Polymer DP End group Spacer Surface d0 (nm) rmax
PMeOx 15 CH3 APTMS SiO2 1.82–2.17
a 2.7–3.4
PEtOx 15 CH3 APTMS SiO2 1.24–2.08
a 2.8–3.5
PEtOx 30 CH3 APTMS SiO2 2.44–3.97
a 1.6–1.8
PEtOx 150 Piperidine C11H22S Au 3.1
b B1.45
PEtOx 10 N(C18H37)2 C11H22S Au 8.4–9.1
c 1.2–1.35
a Determined at B4% relative humidity by ellipsometry.10 b Deter-
mined at 0% relative humidity by surface plasmon resonance (SPR)
spectroscopy.19 c Determined by ellipsometry.27
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surface.35 This can be explained by the fact that the CH insertion
reaction, which leads to the polymer binding, only occurs at the
interface between the radical (benzophenone/nitrene) intermediate
and the adjacent polymer chain. Therefore, excess polymer
cannot bind and is washed away. However, investigations with
PEtOx of different molar masses showed that the film thickness
can be influenced by the DP.37–42 It was observed that a higher
molar mass (higher DP) leads to an increased film thickness
(Fig. 5c).38,42 Another parameter that influences the film thick-
ness is the used solvent.39 From a poor solvent more polymer can
be adsorbed onto the substrate than from a good solvent when
strong solvent–substrate interactions are absent. Due to the
favorable solvation of the polymer in a good solvent, the repul-
sion between segments of the adsorbed polymer, but also
between the adsorbed and the solvated polymer, is higher. This
decreases the amount of polymer that is deposited at the surface
and, thus, the grafting density and film thickness. Investigations
by Wang et al. revealed that also the polarity of the used solvent
influences the properties of the obtained film.42 PEtOx was
immobilized on PFPA functionalized surfaces using solutions
in ethanol, water, and chloroform. The film prepared from
chloroform solution had more hydrophobic domains exposed
to the surface and was, therefore, slightly more hydrophobic
than the films prepared from polar solvents, as revealed by
contact angle measurements. In the case of photoimmobiliza-
tion by benzophenone and PFPA derivatives the film thickness
can also be influenced by the irradiation time (Fig. 5d).35,40,41 Up
to a certain point, a longer irradiation leads to an increasing film
thickness. After this the film thickness does not increase any-
more. The immobilization by PFPA–silane cannot only occur by
UV irradiation but also by heating.37 Here, the same effect of the
heating time on the film texture can be observed. After an
increase with heating time, the film thickness levels off to a
constant value. As mentioned above, ‘‘POxylated’’ surfaces are
investigated to control the adhesion or adsorption of cells.
Depending on the field of interest either a promoted or a
reduced cell adhesion is desired. An example for the former
are medical implants (e.g. heart valves), where xenophobic
reactions need to be suppressed and the implant integration
has to be improved by controlled adhesion of the appropriate
cells (i.e. osteoblasts, fibrocytes, etc.). In the case of implants in
heart and vascular surgery, calcification is the major problem,
causing aneurismatic degradation and vascular obliteration.32–34
Hence, the patients have to be placed permanently on anti-
coagulation medication to prevent a thrombus. To inhibit the
calcium binding the formation of a dense layer of healthy cells
Fig. 5 (a) PFPA–silane film thickness as a function of soaking time. (b) Immobilized PEtOx (Mw = 200000 g mol
1) film thickness as a function of concentrations.
(c) Immobilized PEtOx film thickness as a function of molar mass. Solutions of 10 mg mL1 of PEtOx in chloroform were used. (d) Immobilized PEtOx film thickness as a
function of UV irradiation time. Solutions of 10 mg mL1 of PEtOx (Mw = 200 000 g mol
1) in chloroform were used for spin coating. Reproduced with permission from
ref. 40. r 2007 Elsevier.
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on the implant needs to be accomplished. To this end, the
groups of Ru¨he and Dahm investigated the suitability of several
polymer coatings on glass to adhere rat and sheep fibrocytes as
well as human umbilical vein endothelial cells (HUVEC)
(Table 2).32–34 Among these polymers, PEtOx (Mw = 380000 gmol
1)
showed a promoted cell growth and a good adhesion of the
cells, in particular for HUVECs. Sheep and rat fibroblast
showed a slightly reduced cell growth compared to the glass
reference. In a next step, a porcine heart valve was coated with
PEtOx (Fig. 6) via benzophenone photoimmobilization.34
A stable surface-attached hydrogel was obtained.
In the case of bone implants small gaps between the bone
and the implant remain, opening possibilities for an attack of
particles and bacteria, which can cause a chronic inflammatory
response followed by the loosening and failure of the implant.31
Here, the coating needs to be repellent for the particles and
bacteria, but at the same time has to promote the adhesion of
osteoblasts directly after the implantation. Adden et al. studied
a large number of benzophenone photoimmobilized polymer
coatings on glass regarding their ability to support the adhe-
sion and proliferation of murine mesenchymal precursor stem
cells (C3H10T1/2), expressing human bone morphogenetic
protein 2 (BMP2) (Table 2).31 The cells were generated
from mouse blastocyst and are able to diﬀerentiate into dis-
tinct mesenchymal lineages, depending on the stimulus. By
the exogenous addition or recombinant expression of the
BMP2, osteoblasts, chondrocytes, and adipocytes are devel-
oped. While poly(diethyl(p-vinylbenzyl)phosphonate) (PVBP)
and poly(methacrylic acid) (PMAA) allowed an excellent cell
growth, PEtOx (Mw = 500 000 g mol
1) revealed only a weak cell
adhesion, and was therefore not suitable to promote the
integration of bone implants. The bad cell growth can be
ascribed to the protein repellent character of PEtOx. Since the
cell-surface adhesion is mediated by cell-adhesive proteins, a
reduced protein adhesion will result in a poor cell growth.
The protein resistance of PEtOx was also reported by Wang
et al.42,43 Using fluorescence imaging, ellipsometry, and surface
plasmon resonance (SPR) imaging, they studied the adsorption
of bovine serum albumin (BSA) onto silicon wafers, glass slides,
and gold surfaces coated with PFPA-photoimmobilized PEtOx
of diﬀerent molar masses (Mw = 5000 to 500 000 g mol
1). The
authors observed that the antifouling properties are influenced
by the molar mass, the film thickness, and the used solvent. A
higher molar mass and with it an increased film thickness, led
to a higher polymer surface concentration and, hence, better
protein repellency. Therefore, PEtOx with Mw = 500 000 g mol
1
had the best protein-resistance. In addition, it was shown that
on PEtOx coatings prepared from chloroform solution, the BSA
adsorption was slightly increased compared to films prepared
from the polar solvents. This behavior was ascribed to the
higher hydrophobicity of the film, caused by the formation of
hydrophobic domains which are exposed on the surface. Based
on these results, Wang et al. produced carbohydrate micro-
arrays where PEtOx films were incorporated as antifouling
coatings.42 Binding studies with fluorescein isothiocyanate
(FITC) labeled concanavalin A (FITC-Con A) on the diﬀerent
carbohydrates (mannose, glucose, etc.), revealed the reduction
of the non-specific adsorption of FITC-Con A on the PEtOx
coated samples. In this way the signal to noise ratio of the
carbohydrate microarrays could be improved.
Lehmann and Ru¨he investigated the adsorption of fibrino-
gen on gold surfaces coated with PEtOx of diﬀerent DP bound
through a thioalkyl spacer.19 By measuring the film thickness
by SPR spectroscopy, the authors observed that the amount
of adsorbed fibrinogen decreases with increasing DP, due to
the decreasing influence of the relatively hydrophobic o,o0-
dihydroxy alkyl spacer. At a DP of 150 the surface was almost
Table 2 Diﬀerent polymers photoimmobilized via benzophenone, their molar
mass and film thickness as well as the seeding behavior of diﬀerent cell lines
according to microscopic appearance of the cell layer. Combined and adapted
from ref. 31 and 33
Polymer Mw (g mol
1) d (nm) Rat Fc Sheep Fc HUVEC C3H10T1/2
PEtOx 380 000 6.0 2–3 2 1 —a
PEtOx 500 000 11.2 —a —a —a 4
PAA 4 000 000 26.2 3 4 3–4 —a
PAA 50 000 6.3 —a —a —a 3b
PHEMA 2000 000 22.2 2 2 3–4 —a
PHEMA 250 000 3.0 —a —a —a 3c
Chitosan 400 000 6.1 2 1–2 2 —a
PMTA 30 000 4.1 2 2 1 —a
PMTA —a 3.1 —a —a —a 3–4c
PEI 600 000 4.0 1–2 2 1 —a
PMAA 70 000 3.9 1 1 1 —a
PMAA 254 000 2.5 —a —a —a 1
PDMMA 270 000 9.9 3 4 3–4 —a
PDMAA —a 11.3 —a —a —a 4
PAAm 5800 000 10.3 4 2–3 4 —a
PVA 140 000 2.5 2 1 4 —a
PVBP 630 000 6.1 —a —a —a 1
a Not determined. b Inhomogeneous growth on some samples. c Some
samples with clearly better cell growth. Fc = fibrocytes; HUVEC = human
umbilical vein endothelial cells; C3H10T1/2 = murine mesenchymal
precursor stem cells; PAA = poly(acrylic acid); PHEMA = poly(2-hydro-
xyethyl methacrylate); PMTA = poly[2-(methacryloyloxy)-ethyltrimethy-
lammonium chloride]; PEI = poly(ethylene imine); PMAA =
poly(methacrylic acid); PDMMA = poly(N,N-dimethyl acrylamide);
PAAm = poly(acrylamide), PVA = poly(vinyl alcohol); PVBP =
poly[diethyl(p-vinylbenzyl) phosphonate]. 1 = Excellent growth (compar-
able to the reference), 2 = growth less than on reference, 3 = less than
50% of the surface covered or small agglomerates, 4 = single cells or
abnormal morphology.
Fig. 6 Deposition of a surface-attached PEtOx on the tissue of a porcine heart
valve. Both BP photoimmobilized PEtOx and pure PEtOx were deposited in
diﬀerent areas of the tissue. Only the polymer containing the photoreactive
group underwent crosslinking during illumination with UV light and formed a
stable surface-attached hydrogel. The reference polymer was washed oﬀ during
the subsequent extraction of the sample in water. Reproduced with permission
from ref. 34. r 2004 Elsevier.
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completely resistant against nonspecific adsorption, as demon-
strated by minimal adsorption of fibrinogens (0 to 0.3 nm). The
fibrinogen repellency of PEtOx coatings was also reported by
Samuel et al. who photoimmobilized PHPEtOx-co-PBPOx on the
surface of a microfluidic device via the benzophenone units
attached to the polymer backbone.36 Even when stored for
several weeks in PBS buﬀer solution, the PEtOx coating
remained stable and protein repellent.
Lind et al. produced micropatterned electronic devices for
cell-capturing purposes (Fig. 7).21 The conductive pattern con-
sisted of poly(3,4-ethylenedioxythiophene) (PEDOT) on a PS–N3
substrate. On top of the PEDOT pattern they placed peptide
modified PEGs, which were coupled onto the PEDOT azide
(PEDOT–N3) surface via the alkyne initiator group of the PEGs.
As peptides the amino acid sequence Gly-Arg-Gly-Asp-Ser
(GRGDS), inducing specific cellular attachment via the RGD
motif, and the scrambled sequence GRDGS, that does not
induce specific cell attachment, have been used. The GRGDS–
PEG and GRDGS–PEG were placed in an alternating manner. To
reduce nonspecific cell-binding on the PS–N3 substrate
between the microelectrodes, a PMeOx layer was introduced
by CuAAC. Cell adhesion studies with 3T3 fibroblasts, which
were allowed to adhere for 1 h under stationary flow conditions
in a microfluidic setup, followed by applying a defined flow for
a specified time to detach and remove weakly bound cells,
revealed a good cell adhesion on the GRGDS microelectrodes.
As expected, the GRDGS functionalized electrodes as well as the
PMeOx coated gaps between the microelectrodes, exhibited
only a minor cell attachment (Fig. 7).
3.2 Bottle brush-like POx coatings and their (antifouling)
properties
Unlike linear POx coatings with only a single polymer chain per
surface grafting unit, POx-based comb polymers possess multi-
ple POx chains linked to another polymer backbone which is
attached to the surface. Such materials can be prepared in three
diﬀerent ways: (1) by grafting the POx chains via a reactive
group onto another polymer backbone (‘‘grafting onto’’), (2) by
initiating the oxazoline polymerization directly from the polymer
backbone (‘‘grafting from’’), and (3) by using a POx-macroinitiator,
e.g. PEtOx end-capped with methacrylic acid (‘‘grafting through’’).
An important parameter for comb polymers is the (POx) side
chain grafting density (a) on the polymer backbone. It is
defined as the number of POx-grafted backbone units divided
by the total number of backbone units. The side chain grafting
a can be influenced by the amount of initiator (‘‘grafting
from’’), the addition of co-monomers (‘‘grafting from’’ and
‘‘grafting through’’) or the amount of POx that should be
coupled to the other polymeric backbone (‘‘grafting onto’’). At
high POx side chain grafting densities a bottle brush-like
structure is formed. At low grafting densities, the POx side
chains are too separated to form such a bottle brush-like
structure (‘‘mushroom’’ regime). In particular, the bottle
brush-like structures were found to have high potential for
antifouling applications. They share the structural motif with
proteoglycans, which are a major component of the extra-
cellular matrix and play an important role in cell adhesion.30
Zhang et al. reported the synthesis of surface attached POx
bottle brushes by SIPGP of 2-isopropenyl-2-oxazoline followed
by the surface initiated living CROP of diﬀerent oxazolines,
namely MeOx, EtOx, and 2-n-propyl-2-oxazoline (nPrOx)
(Scheme 5b).30 Using fluorescence microscopy, the authors
investigated the influence of diﬀerent parameters on the
adsorption of the protein fibronectin (Fn) (Fig. 8). Variation
of the side chain hydrophilicity revealed a comparable low Fn
adsorption for the hydrophilic PEtOx and PMeOx (r6 ng cm2),
near to the detection limit around 1 ng cm2. In contrast, a high
Fn adsorption was observed for the more hydrophobic PnPrOx
side chains (90 ng cm2). Moreover, the side chain length was
found to have a significant influence. While very short PMeOx
chains (m = 6) adsorbed about 45 ng cm2 of Fn, the protein
adsorption was eﬀectively suppressed with longer side chain
lengths (r11 ng cm2 for m = 18). Variation of the POx side
chain end group showed that its polarity has a very small
influence on the protein repellency compared to other structural
and compositional parameters. While ethyl isonipecotate and
piperidine end-capped PMeOx had a low Fn adsorption, the
value for N-Boc-piperazine end-capped PMeOx was slightly higher,
due to the higher hydrophobicity of the terminal tert-butyl moiety.
Fig. 7 Specific adhesion of 3T3 fibroblasts to PEDOT–N3/PEDOT microelectrodes
electroclicked with alkyne–PEG–GRGDS (green) versus corresponding PEDOT–
N3/PEDOT microelectrodes electroclicked with alkyne–PEG–GRDGS (red) as well
as PMeOx–alkyne (red) re-exposed between the electrodes. Adapted and repro-
duced with permission from ref. 21. r 2012 American Chemical Society.
Fig. 8 Fluorescence microscopy of Fn adsorption on bottle brush-like POx
coatings on glass reveals a good adsorption on (a) PnPrOx and no adsorption
on (b) PEtOx and (c) PMeOx. Fn adsorption was performed for 1 h in a
50 mg mL1 solution of labeled Fn in PBS at pH = 7.4 and 37 1C. Reproduced
with permission from ref. 30. r 2012 John Wiley and Sons.
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Although bearing the most hydrophilic end group (–OH),
piperidinol end-capped PMeOx had the highest Fn adsorption.
This finding is in accordance with the criteria for antifouling
polymers. The hydrogen bonding donor properties of the
hydroxy group decrease the protein repellency. In a next step,
Zhang et al. investigated the adhesion behavior of HUVEC to
POx bottle brush modified surfaces.30 Since the attachment
of cells to a solid surface is mediated by adsorbed proteins,
the HUCEC seeding and cultivation was performed after the
(attempted) Fn adsorption. It was found that even moderate Fn
adsorption leads to cell adhesion. In contrast, on all surfaces
that effectively suppressed the Fn attachment the adhesion or
spreading of HUVEC was inhibited. The prevention of HUVEC
adhesion shows that bottle brush-like POx coatings are better
suitable for antifouling coatings, since photoimmobilized linear
POx promoted the growth of HUVEC as shown by the groups of
Ru¨he and Dahm.32,33
The higher eﬃciency of bottle brush-like structures can be
ascribed to the higher POx amount per grafting unit, which
eﬀectively prevent the adsorption of proteins and, thus, the
adhesion of cells.
Using another approach, Konradi and Pidhatika synthesized
bottle brush-like POx by grafting PMeOx onto a PLL back-
bone.1,4,44–46 The resulting PLL-g-PMeOx was attached onto
negatively charged Nb2O5 through electrostatic interaction with
the positively charged PLL backbone (Scheme 4). Polymers
with PMeOx side chains of varying molar masses (Mw = 4000
to 8000 g mol1) and different side chain grafting densities
(a = 0.05 to 0.77) were prepared. For comparison PLL-g-PEGs,
having side chains with the same molar masses and compar-
able grafting densities as the PMeOx polymers, were synthe-
sized. The coated Nb2O5 substrates were investigated in terms
of their repellency of full human serum protein and Escherichia
coli bacteria, as well as their stability. The adsorbed polymer,
bacteria, and protein mass, as well as the average surface
density of the PMeOx chains and the film thickness were
quantified by means of optical waveguide lightmode spectro-
scopy (OWLS) and variable-angle spectroscopic ellipsometry
(VASE). In OWLS the adsorbed mass is recorded as a function
of time (Fig. 9). After the adsorption of the copolymer, the
surface was rinsed with a buffer solution, exposed to full
human serum, and rinsed again. The resistance towards the
protein adsorption derives from a difference in the adsorbed
mass before and after treatment with full human serum and
rinsing with buffer solution. In this way, it was observed that
the extent of polymer adsorption to the Nb2O5 substrate and,
thus, the surface charge (zeta potential z) and the protein
repellency, is dependent on the side chain grafting density a
and the side chain molar mass. With increasing PMeOx graft-
ing density the zeta potential of the PLL-g-PMeOx becomes
more negative. The amount of adsorbed polymer mass as a
function of a passes through a maximum and becomes zero at
extremely high side chain grafting densities, whereas the
bacteria and protein mass adsorption follows an inverse trend
(Fig. 10). At low side chain grafting densities (a E 0.05 to 0.1)
the surface was positively charged due to the excess of lysine
units. However, as a result of polymer adlayer defects, the
adsorption of serum proteins could be observed. With increas-
ing a, the amount of adsorbed polymer mass increased,
whereas the serum adsorption decreased. The optimum was
reached at medium side chain grafting densities (a E 0.22 to
0.33), with the highest mass of the adsorbed polymer on the
substrate, a zeta potential z that was close to neutral and a
serum adsorption below the detection limit of the OWLS
instrument of B1 to 2 ng cm2. At higher POx side chain
grafting densities (aZ 0.56), more and more positive charges of
the PLL backbone are eliminated. Moreover, steric, energetic,
and kinetic effects along with the reduced copolymer flexibility
Fig. 9 Mass plot obtained by in situ optical waveguide lightmode spectroscopy
(OWLS) showing the surface adsorption of PLL-g-PMeOx [PMeOx (5000 g mol1)/
Lys = 0.22] on Nb2O5 and its subsequent exposure to full human serum. Adapted
and reproduced with permission from ref. 44.r 2008 American Chemical Society.
Fig. 10 Quantitative comparison of the PLL (20 kDa)-g-PmeOx (5 kDa) (blue
squares) and PLL (20 kDa)-g-PEG (5 kDa) (red squares) adsorbed mass as a
function of the side chain grafting density (number of PEG and PMeOx side
chains per lysine unit, respectively). The adsorbed protein mass after subsequent
exposure of PLL-g-PMOXA- (blue circles) and PLL-g-PEG-covered surfaces (red
circles) to full human serum shows a minimum at the highest polymer coverage.
Zero grafting density corresponds to the bare PLL backbone. Adapted and
reproduced with permission from ref. 44. r 2008 American Chemical Society.
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led to an inhomogenously and incompletely covered surface
and, subsequently, to a lower protein repellency. As a result of
the incomplete coverage and the loss of positive charges, the
z of the surface becomes more and more negative, with increas-
ing PMeOx grafting density. At very high side chain grafting
densities (a Z 0.77) nearly every lysine unit carries a PMeOx
chain and the polymer adsorption to the negatively charged
substrate was fully inhibited. Hence, a monolayer of serum
proteins was adsorbed with a mass >200 ng cm2 similar to
blank Nb2O5.
Moreover, it was found that the optimal a depends on molar
mass of the side chain (Fig. 11). The higher the side chain
molar mass, the lower the optimal grafting density. As a result
of this, the minimal number of side chain monomer units per
surface area that is required to obtain fully resistant surfaces is
lower for PLL-g-PMeOx than for PLL-g-PEG. PLL-g-PMeOx
monolayers reach full repellency already at approximately
10 to 12 monomer units per nm2 (n per nm2), whereas
for PLL-g-PEG approximately twice the amount is necessary
(Z20 nEG per nm
2), since an ethylene glycol monomer unit has
only half the molar mass of a MeOx repeating unit. However,
an exact a is not decisive to obtain highly protein-repellent
surfaces, since the minimum in serum adsorbed mass is
rather broad.
In addition to the serum protein adsorption behavior,
Pidhatika et al. investigated the adhesion of E. coli K12 bacteria
at varying ionic strengths of the solution.1,4,45 The E. coli strains
were genetically engineered either to lack or to express type
1 fimbriae. Fimbriae are thin, hair-like proteinaceous appen-
dages of the bacterial cell membrane, which can interact with
surfaces through specific and non-specific interactions and,
therefore, can mediate non-specific adhesion. Both used E. coli
strains had a net negative charge at all investigated ionic
strength.
Non-fimbriated bacteria behaved like hard, negatively
charged particles and their adhesion seemed to be mainly
driven by electrostatic interactions (Fig. 12a). Therefore, at
low ionic strength the bacterial adhesion was high for low a
(‘‘mushroom’’ type) and pure PLL (positive z). At high side
chain grafting densities and pure Nb2O5 the bacteria adhesion
was suppressed due to the repulsion between the negatively
charged surface and the negative bacteria surface. At physiolo-
gically relevant salt concentrations (160 mM) the influence of
electrostatic interactions is reduced and, hence, the adhesion is
mostly governed by PMeOx surface density. Here, bacteria
adhesion followed a similar trend as described for the protein
adsorption. Independent of the ionic strength a medium side
chain grafting density (a = 0.3) showed the best antifouling
properties.
Fig. 11 Serum adsorbed mass as a function of the side chain monomer surface
density for PLL-g-PMeOx (5 kDa) (black full squares), PLL-g-PEG (1 kDa) (open
triangles), PLL-g-PEG (2 kDa) (open circles), and PLL-g-PEG (5 kDa) (open squares).
Adapted and reproduced with permission from ref. 45. r 2008 Swiss Chemical
Society.
Fig. 12 Average numbers of (a) non-fimbriated and (b) fimbriated E. coli bacteria adhered on 4  104 mm2 area after incubation in a protein-free buﬀer medium of
either 1 mM or 160 mM ionic strength present on the diﬀerent model surfaces: bare Nb2O5 and Nb2O5 coated with PLL and PLL-g-PMeOx with diﬀerent grafting
densities (a = 0.09, 0.33, and 0.56). Adapted and reproduced with permission from ref. 4. r 2010 Elsevier.
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However, fimbriated E. coli revealed a diﬀerent behavior
(Fig. 12b). Due to the high length of the E. coli fimbriae (up to a
micron), interactions between the negative bacterial body net
charge and the surface can be neglected. Instead, the bacterial
adhesion mainly occurs through fimbrial tip protein adhesion,
which is driven by van der Waals, electrostatic, and in parti-
cular by hydrophobic interactions. Since the latter is the main
driving force for the adhesion of fimbriated E. coli, all charged
surfaces, i.e. pure PLL and Nb2O5 as well as PLL-g-PMeOx with a
low or high a, showed bacterial fouling.
At low ionic strength primary (directly at the Nb2O5 surface)
and secondary (on top of the polymer adlayer) adsorptions,
caused by electrostatic interactions, play a role, whereas only
primary adsorption occurs at high ionic strength. Hence, the
behavior is again similar to that of non-fimbriated bacterial
and serum proteins. For both ionic strengths, only dense brush
monolayers, consistent with a medium a, eﬀectively inhibited
bacterial adhesion by reducing primary and secondary adsorp-
tion of the fimbrial tip proteins by preventing short-range van
der Waals and hydrophobic interactions between the bacteria
and the surface, and shielding attractive electrostatic forces.
Both PLL-g-PMeOx and PLL-g-PEG of optimal grafting density
were found to reduce E. coli adhesion too1% compared to the
blank Nb2O5 substrate.
45
Pidhatika et al. further investigated PLL-g-PMeOx and PLL-
g-PEG bottle brush coatings as to their long time stability which
is an important parameter for antifouling coatings.1,46 The
authors prepared a solution containing 10 mM hydrogen per-
oxide, 10 mM 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic
acid (HEPES), and 150 mM NaCl at a pH of 7.4. This mixture
mimics a physiological solution in the presence of an oxidative
substance secreted by cells and bacteria.
When treated with this mixture, the PLL-g-PMeOx coatings
only degenerated to less than 20%, while the PLL-g-PEG film
thickness decreased up to 60%. Subsequent exposure to full
human serum showed that the PLL-g-PMeOx remained largely
protein repellent, in contrast to PLL-g-PEG where a strong
protein adsorption was observed.
3.3 Other applications
‘‘POxylated’’ surfaces are not only interesting for controlling
protein adsorption and cell adhesion, but also for other
applications.
POx coatings can be applied in dip-pen nanolithography
(DPN). DPN is a direct-write scanning probe method which uses
‘‘ink’’-coated atomic force microscope (AFM) tips to transport
ink materials, such as dissolved proteins or peptides, to a
surface. The driving force for the material transport is molec-
ular diﬀusion through a water meniscus formed between the
tip and the substrate surface. Unfortunately, for larger (bio)-
materials, such as viruses and bacteria, the transport and
deposition through the water meniscus is a challenging task.
However, the group of Lim demonstrated that PMeOx-coated
tips are suitable to overcome this problem and can be applied
for the direct-write patterning of adeno-associated viruses
(AAVs)25 and bacteria cells (E. coli JM 109)24 by DPN (Fig. 13).
By adsorbing the ink, the surface immobilized PMeOx forms a
swollen hydrogel, which reduces the denaturation and desicca-
tion of the ink as well as the associated viruses or bacteria.
When brought into contact with an amine-functionalized sur-
face, the ink solution diﬀuses out of the nanoporous hydrogel
on the tip and onto the surface. Compared to classical DPN,
where the ink diﬀusion is meniscus mediated, the diﬀusion
barrier within the PMeOx-hydrogel is very small and, therefore,
allows the transport of larger bioparticles. A further beneficial
eﬀect of PMeOx is the already described biomolecule repel-
lency, which enhances the diﬀusion from the hydrogel. In
addition, the diﬀusion is driven by electrostatic interactions
between the positive amine-functionalized surface of the sub-
strate and the negatively charged surface of the AAVs or
bacteria, respectively. However, upon patterning the E. coli
bacteria died. This behavior was attributed to cell membrane
damage that occurred during the drying step of the patterning
process. By means of fluorescence microscopy it was shown
that the bacteria coated to the AFM tip were still alive after
40 min, when a mixture of glycerol and tricine was used as
carrier ink. This mixture not only protects E. coli bacteria from
drying and denaturing while on the tip, but also increases the
viscosity and interaction of the ink solution and, thus, facil-
itates the bacterial cell delivery during the patterning process.
As a result of this, the cell death has to take place by denatura-
tion on the surface rather than the DPN itself. The problem of
cell death was overcome by coating the amine-functionalized
surface with lysogeny broth (LB) agar, which is commonly used
for growing cells. Using this method, all bacteria remained alive
even when a high contact force was applied for the deposition.
Another application of ‘‘POxylated’’ surfaces is the immobi-
lization and stabilization of nanoparticles (NPs). Agrawal et al.
reported P(CarbEtOx-co-iPrOx) (Fig. 3a) layers which were
obtained by reacting the epoxy groups of PGMA coated on silica
with the carboxyl groups of the PCarbEtOx units.48 A brush-like
Fig. 13 Representation of ‘‘stamp-on’’ DPN of bacterial cells on modified
surfaces. Reproduced with permission from ref. 24. r 2012 American Chemical
Society.
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conformation of the POx chains was obtained and used for the
stabilization of Au NPs. Compared to other conventional sur-
face modification techniques, such as self-assembled mono-
layers (SAMs), the usage of such P(CarbEtOx-co-iPrOx) brushes
has some advantages: (1) the easy and controllable introduction
of the polymer, (2) a high polymer surface density, (3) a high
stability and robustness of the grafted layers, (4) biocompat-
ibility, (5) temperature responsiveness due to the PiPrOx, and
(6) the presence of numerous polar functionalities, i.e.
unreacted carboxyl groups, amino groups in the backbone,
and carbonyl groups in the POx side chain, which can be
exploited to bind the NPs. In addition the immobilized Au
NPs show excellent catalytic and optical properties. Therefore,
the developed system has great application potential in areas
such as catalysis, sensors, medicine, and optics.
4. Conclusions
Poly(2-oxazoline)s are a highly interesting class of polymers for
many applications. The first two members of the aliphatic
homologue series, namely poly(2-methyl-2-oxazoline) and
poly(2-ethyl-2-oxazoline), do not only show the so called
‘‘stealth eﬀect’’ and exhibit similar antifouling properties to
PEG, but also have other beneficial properties such as a higher
stability and a lower viscosity. Moreover, they are less demand-
ing in their synthesis and a broad range of diﬀerent oxazoline
monomers, functional initiators and terminating agents is
available, allowing the synthesis of tailor-made polymers by
CROP with adjustable properties.
An emerging application field of POxs is their use as anti-
fouling coatings. However, POx coatings cannot only be applied
for the control of cell adhesion and protein adsorption, but also
for the stabilization of inorganic nanoparticles, such as Au NPs,
and in nanolithography. POx coatings can be prepared using
diﬀerent approaches, such as ‘‘grafting from’’, ‘‘grafting onto’’,
photoimmobilization or immobilization by electrostatic inter-
actions. Diﬀerent parameters influence the properties of POx
coatings, namely: the surface and side chain grafting density,
the film thickness, the type of (co)polymer and related to this
their hydrophobicity and swelling behavior. Depending on the
immobilization method and the structure of the used polymer,
two types of POx coatings can be distinguished: (1) linear POx
coatings with only a single chain per surface grafting unit, and
(2) bottle brush-like POx coatings which exhibit multiple POx
chains per grafting unit and are attached to the surface via
another polymer backbone. Both coating types can endow
surfaces with antifouling properties. However, as reported to
date, in particular POx bottle brushes show excellent antifoul-
ing properties.
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Amine end-functionalized poly(2-ethyl-2-
oxazoline) as promising coating material for
antifouling applications†
Lutz Tauhardt,ab Marion Frant,c David Pretzel,ab Matthias Hartlieb,ab Christian Bu¨cher,c
Gerhard Hildebrand,c Bernd Schro¨ter,d Christine Weber,ab Kristian Kempe,‡ab
Michael Gottschaldt,ab Klaus Liefeithc and Ulrich S. Schubert*abe
The antifouling behavior of diﬀerent poly(2-ethyl-2-oxazoline) (PEtOx) coatings was investigated under
“real live” conditions. Amine end-functionalized PEtOx of diﬀerent molar masses have been prepared
using a new and straightforward, two step synthesis method. Subsequently, the PEtOx were attached to
glass surfaces via a tetraether lipid and a common silane, respectively. The polymers and coatings were
characterized using techniques such as 1H NMR spectroscopy and MALDI-TOF-MS as well as XPS and
contact angle measurements. In a next step, the coatings were exposed to the simultaneous attack of
ﬁve diﬀerent bacteria in synthetic river water. A clear reduction of the bioﬁlm formation was observed. In
addition, the stability of the coatings against thermal, mechanical, and chemical stress was studied.
Introduction
Preventing the uncontrolled adhesion and adsorption of
proteins, cells, bacteria, and other microorganisms onto
surfaces, the so called fouling process, represents a major
challenge for a wide range of applications such as medicine (e.g.
medical devices, implants, drug delivery systems),1,2 mobility
(e.g. ship hull coatings),3,4 food industry (e.g. packaging),5 but
also for membranes (e.g. in water purication systems),6
microarrays, and (bio)sensors.7
In principle one can distinguish between two types of anti-
fouling coatings: (1) bioactive coatings that cause a direct or
indirect inactivation of adherent microorganisms or biolms by
either releasing an antifouling agent (e.g. biocides), or by killing
the cells, bacteria, or microorganisms on contact using specic
molecules (e.g. quarternized polymers), and (2) biopassive
coatings, which reduce fouling due their protein and cell
repellent character without interfering with the proliferation
cycle or the cell metabolism.8–10 However, coatings that are
bioactive or release antifouling agents suﬀer from a loss of
activity over time. In case of bioactive coatings self-deactivation
occurs due to the fact that dead cells or microorganisms adhere
to the active layer, cover it and, therefore, allow the adhesion
and proliferation of new cells on the cell debris.10 Coatings that
release antifouling agents lose their activity when all antifouling
agent (e.g. biocide) is consumed. Moreover, they are harmful to
the environment, since the released antifouling agents are not
only active on the surface that should be protected and, hence,
can kill in a nonselective way or accumulate in microorganisms,
animals (e.g. sh), and plants.11,12 An approach to overcome
these issues is the covalent binding of the antifouling coatings
onto the surface. In particular biopassive coatings are prom-
ising, since they are not self-deactivating and do not release
toxic and polluting compounds. Recently published studies
have led to the conclusion that materials for biopassive coating
have to meet the following criteria: (1) the presence of hydrogen
bond accepting and hydrophilic (polar) groups, and (2) the
absence of hydrogen bond donating groups and net charges.8,13
If we otherwise accept, that the formation of a hydration layer
(water barrier) is a vital prerequisite to build up anti-adhesive
surfaces with non-fouling properties hydrogen bond accepting
groups are of the same importance as hydrogen bond donating
groups.14 Based on the possibility to tune their properties,
polymers can be adapted to a wide range of requirements and,
thus, represent an interesting class of compounds for such
surface tethered antifouling coatings. A widely used polymer for
biopassive and repellent coatings is poly(ethylene glycol)
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(PEG).8,15–18 However, PEG is known to undergo degradation by
(auto-)oxidation to form ethers and aldehydes, hampering its
long-term application.13,19–22 On this account, poly(2-oxazoline)s
(POx), in particular the water soluble poly(2-methyl-2-oxazoline)
s (PMeOx) and poly(2-ethyl-2-oxazoline)s (PEtOx), are investi-
gated as alternative coating materials.13,19,23–31 Compared to the
synthesis of PEG by anionic polymerization, the preparation of
POx by cationic ring-opening polymerization (CROP) is less
labor demanding, but also yields well-dened polymers with
controlled molar masses and low polydispersity index (PDI)
values. Moreover, a broad variety of functional electrophilic
initiators, nucleophilic terminating agents, and 2-oxazoline
monomers allows the synthesis of well-dened (co)polymers
and the tuning of the polymer properties.32 It was shown that
POx coatings have similar antifouling properties as PEG, but are
stable in an oxidizing environment.13,19 However, up to now all
antifouling investigations on POx surfaces were performed
under laboratory conditions using only a single type of protein
(e.g. bronectin,29,30 bovine serum albumin27,28), cell (e.g. bro-
blasts24), or bacterium (e.g. E. coli13,25,26). A review on methods to
attach POx to surfaces as well the properties and applications of
POx functionalized surfaces was published recently.33
The chemical long-term stability of antifouling coatings is
mandatory and can be greatly improved by covalent tethering of
the polymers to the surface via linker molecules. Recently, tet-
raether lipids (TEL), i.e. bipolar membrane spanning lipids
from thermoacidophilic archaea, were presented as an inter-
esting new class of linker molecules.34–39 By a simple self-
assembling process, a stable, highly ordered impermeable TEL
monolayer (4 nm) with biomembrane-like properties is
formed. The covalent immobilization of this thin lipid layer on
surfaces can be achieved easily when the lipid headgroups are
functionalized with cyanuric chloride.35–37,39 An outstanding
property of TELs is their excellent stability against oxidation,
acidic and basic hydrolysis as well as biodegradation, which is
based on the fully saturated character of the methyl branched
alkyl chains.34 Moreover, biocompatibility analyses revealed
that TELs are both nontoxic and immunologically inert and,
additionally, exhibit antifouling activity.35–38Hence, the usage of
TEL linkers to attach POx to surfaces is highly interesting.
Here, we report the antifouling behavior of amine end-
functionalized PEtOx, covalently bound to glass substrates
using two diﬀerent methods: (1) attachment via epoxide ring-
opening reaction of a common glycidyl ether silane tethered to
the surface as described in literature, e.g. for PEG,15,40 and (2)
immobilization via the cyanuric chloride functionalized head-
groups of a TEL linker. To this end, a new approach to
synthesize amine end-functionalized POx was developed. PEtOx
of diﬀerent chain lengths were prepared and characterized by
1H NMR spectroscopy, matrix-assisted laser desorption/ioniza-
tion time of ight laser mass spectrometry (MALDI-TOF-MS),
and size exclusion chromatography (SEC). The PEtOx coatings
were analyzed by contact angle measurements and X-ray
photoelectron spectroscopy (XPS). The subsequent antifouling
investigations were performed in synthetic river water using a
microbiological mixed culture consisting of ve diﬀerent types
of bacteria. Biolm formation and the stability of the coatings
were studied using confocal laser scanning microscopy.
Methods and materials
General methods and surface characterization
Used chemicals, instruments, and characterizationmethods are
described in the ESI.†
Synthesis of phthalimide end-capped PEtOx (1)
A solution of initiator (MeOTs), monomer (EtOx), and solvent
(acetonitrile) was prepared with a total monomer to initiator
ratio of [M]/[I] ¼ 20, 40, 60, and 80, respectively. The total
monomer concentration was adjusted to 4 M. The solution was
heated at 140 C in amicrowave synthesizer for a predetermined
time. Aer cooling to room temperature a 2-fold excess of
potassium phthalimide was added and the reactionmixture was
stirred overnight at 70 C. The reaction mixture was ltered and
the solvent removed. The residue was dissolved in chloroform
and washed twice with a saturated aqueous solution of NaHCO3
and once with brine. The organic phase was dried over sodium
sulfate. Aer ltration, the polymer was concentrated under
reduced pressure, precipitated into ice-cold diethyl ether, and
dried at 40 C under reduced pressure.
Synthesis of amine end-capped PEtOx (2)
Phthalimide end-capped PEtOx was dissolved in ethanol and a
10-fold excess of hydrazine monohydrate was added. The reac-
tion mixture was heated under reux overnight. Aer cooling to
room temperature, a concentrated hydrochloric acid was added
to adjust the pH value to 2–3. The precipitate was removed by
ltration and the ethanol was evaporated. The residue was
dissolved in water and aqueous sodium hydroxide solution
until the pH value reached 9–10. The aqueous solution was
extracted thrice with chloroform. The organic phase was dried
over sodium sulfate, concentrated, and precipitated into ice-
cold diethyl ether. The white precipitate was ltered oﬀ and
dried at 40 C under reduced pressure.
Synthesis of uoresceine labeled P(EtOx-stat-AmOx)
(Fluo-PEtOx) (5)
The starting material P(EtOx36-stat-AmOx4) (4) was synthesized
as reported earlier.41
P(EtOx36-stat-AmOx4) (1 g, 242mmol) was dissolved in DMSO
(50 mL). 5(6)-Carboxyuorescein N-hydroxysuccin-imide ester
(114.5 mg, 242mmol, 1 eq. per polymer chain) and TEA (2.5 mL)
were added to the solution and the reaction was stirred for 3 h.
Subsequently, the product was precipitated in cold diethyl ether
(700 mL), ltered oﬀ, dissolved in methanol (20 mL) and
precipitated again into diethyl ether (200 mL). The polymer was
obtained as orange solid (1.039 g, 95%).
Coating procedure for silane on borooat® 33 glass slides
Prior to use, each side of the glass slides was cleaned in oxygen
plasma for 15 min. In a glove box, the glass slides were treated
4884 | J. Mater. Chem. B, 2014, 2, 4883–4893 This journal is © The Royal Society of Chemistry 2014
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with (3-glycidyloxypropyl)trimethoxysilane for 1 h and subse-
quently rinsed with dry DMF. One side of the glass slide was
covered with the respective polymer solution in DMF (200 mg
mL1) at a concentration of 3 mL cm2 (64 mg cm2). Then, a
second glass slide was put on top (face-to-face assembly). Aer 2
days at room temperature, the slides were separated, intensely
rinsed with deionized water and air-dried.
Coating procedure for tetraether lipid on borooat® 33 glass
slides
Preparation of TEL vesicle emulsion. Themain phospholipid
included in dried biomass of Sulfolobus acidocaldarius was
isolated and puried as described earlier.39 The head-groups of
the extracted tetraether lipid were activated by reuxing with
cyanuric chloride over 1 week in dry chloroform/methanol
(1 : 1).
The activated lipids were dissolved in dry chloroform/
methanol 1 : 1, sodium bicarbonate (1.5 g per 100 mg lipid) was
added and a thin lipid layer at the sides of the ask was formed.
Subsequently, the solvents were removed completely under
reduced pressure. The lipid lm was hydrated with pure water
at a nal lipid concentration of about 2 mg mL1. Further
treatment in an ultrasonic bath at 50 C for 15minutes yielded a
cloudy lipid emulsion consisting of large multilamellar vesicles.
Aerwards, the emulsion was extruded through a polycarbonate
membrane (pore diameter 100 nm).
Coating. The glass substrates were puried as follows: (1)
sonication in diluted detergent solution (Blanchipon®, Optical
II), (2) incubation in ethanol and 35% nitric acid, and (3) storing
in de-ionised water. Subsequently, the surfaces were activated
with nitric acid and by exposure to UV irradiation. Aer amino
silanization using 3-(ethoxydimethylsilyl)propylamine the
substrates were cleaned with chloroform, methanol, and water.
TEL coating was performed via liposome spreading in a PTFE
reaction chamber by incubation with a freshly prepared lipid
emulsion at 70 C overnight.39 Finally, the coated substrates
were sonicated in chloroform for 10 minutes and dried with
pressurized air. In a next step, the PEtOx were immobilized on
the TEL-coated glass by coupling the amine end group of the
polymer with the cyanuric chloride moiety of the TEL. The
reaction was performed in borate buﬀer solution (10 mg PEtOx
per mL, pH ¼ 8.5) at 60 C overnight. Subsequently, the glass
slides were extensively rinsed with distilled water and dried
under ambient conditions.
Preparation of synthetic river water medium
The synthetic river water was prepared by dissolving calcium
chloride dihydrate (34.6 mg L1), magnesium sulfate heptahy-
drate (112.3 mg L1), sodium bicarbonate (126.0 mg L1),
monopotassium phosphate (4.35 mg L1), sodium nitrate (85.0
mg L1), glucose (6.6 mg L1), and pepton (2.0 mg L1) in
distilled water.
Five typical microorganisms with a high potential of biolm
formation were isolated from the river Ruhr near Mu¨hlheim
(Germany): Aeromonas hydrophila/caviae, Sphingomonas pauci-
mobilis, Pasteurella spp., Aeromonas salmonicida, and
Leuconostoc spp. The microorganisms were precultivated at 30
C overnight on a shaker (100 rpm) in a special water medium
(pH 7) consisting of: yeast extract (0.5 g mL1), peptone (0.5 mg
mL1), casein hydrolysate (0.5 mg mL1), glucose (0.5 mg
mL1), sodium pyruvate (0.3 mg mL1), starch (0.5 mg mL1),
dipotassium hydrogenphosphate (0.3 mg mL1), and monop-
otassium phosphate (0.05 mgmL1). Bacteria were harvested by
centrifugation at 4000g for 15 min. The pellet was washed twice
with synthetic river medium to remove other particle-like
components that may have an impact on the kinetic process. A
constant cell concentration of 2  106 cells per mL synthetic
river water was adjusted.
Investigation of the biolm formation
Polymer coated sterilized glass slides were incubated in ow
chambers. Prior to use, all probes were sterilized using ethanol
(70%). Subsequently, the coated glass slides were placed in a
ow chamber running with bacteria containing synthetic river
water at a ow rate of 0.3 mL min1 at room temperature. Aer
incubating for 15 hours, a rinsing cycle with pure cultivation
medium was performed to remove non-adhered microorgan-
isms from the surface. The bioadhesion was evaluated bymeans
of confocal laser scanning microscopy. To this end, the
adherent microorganisms were stained using a LIVE/DEAD®
BacLight™ Bacterial Viability Kit (MoBiTec, Germany). At each
sample ten images of biolms were taken at diﬀerent positions
in the ow channel by confocal laser scanning microscopy
(LSM710, Zeiss microscopy, Germany, Plan Apochromat 5/
0.16). The surface area covered by microorganisms was quan-
tied by soware supported analysis of the microscopy images
(Volocity improvision®). Bioadhesion experiments were per-
formed in triplicate.
Stability tests
Stability tests were performed on Fluo-PEtOx coated glass slides
attached via TEL and silane linker, respectively.
Investigation of the resistance against chemical stress.
Samples were incubated at room temperature over 12 weeks in
an upright position in closed boxes on a shaker (75 rpm) lled
with sterile ltrated water of a drinking water dam (Neustadt/
Ilm, Germany) and salt water from the North sea, respectively.
Media were changed weekly.
Investigation of the resistance against mechanical stress.
Resistance against mechanical stress was investigated using
aluminum oxide and silicon carbide particles in distilled water,
based on environmental data. The test solution comprised 150
mg particles per liter. The particle size was distributed as
follows: Ø 320 mm ¼ 0.4%, Ø 120 mm ¼ 41%, Ø 20 mm ¼ 31.8%,
Ø 9 mm ¼ 26.8%. Samples were incubated at room temperature
in a closed beaker glass with stirring (750 rpm) corresponding
to a streaming of 2 m s1. Over 1 week a permanent change
between 8 h rotation time and 16 h resting time without rota-
tion was realized.
Investigation of the resistance against thermal stress. In
order to investigate thermal stability the samples were placed in
distilled water and exposed to a dened temperature protocol
This journal is © The Royal Society of Chemistry 2014 J. Mater. Chem. B, 2014, 2, 4883–4893 | 4885
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with 25 cycles between 2 and 38 C and an incubation period of
14 days. Dwell time at each temperature was 1 h.
Image analysis. Aer each stress procedure uorescence
image data of the Fluo-PEtOx coated samples were recorded by
confocal laser scanning microscopic method (LSM710, Zeiss
microscopy, Germany, Plan Apochromat 5/0.16). The record-
ings were made with uniform measurement parameters (gain,
oﬀset, pinhole, average, etc.) to allow a comparison of results
among each other but also to untreated coatings as a proof of
the layer stability.
Results and discussion
Synthesis and characterization of amine end-capped
poly(2-ethyl-2-oxazoline)s
PEtOx of diﬀerent molar masses were synthesized with the aim
to covalently bind the polymer to the surface via an epoxide
bearing silane and a cyanuric chloride functionalized tetraether
lipid (TEL), respectively. Since it is known that both epoxides
and cyanuric chloride can react quite easily with amines, PEtOx
bearing an amine end group were prepared using a new
synthesis route.
The synthesis of an amine end-functionalized poly(2-oxazo-
line) (POx) was already described in literature. Lin et al. termi-
nated the living oxazolinium species directly with ammonia in
acetonitrile.42 However, the authors only obtained a degree of
functionalization of about 80%. As an alternative three step
method, Park et al. quenched the reaction mixture with a
methanolic NaOH solution.43 The resulting hydroxyl end group
was then reacted with phthalimide in the presence of triphe-
nylphosphine and diethyl azodicarboxylate to yield a POx with a
phthalimide end group. In a nal step, the amine end group
was obtained by treatment with hydrazine monohydrate.
However, this procedure led only to an amine end group func-
tionalization eﬃciency of 62%. An additional problem,
reducing the eﬃciency of this method, is the possible formation
of ester end groups instead of hydroxyl end groups, when the
reaction is quenched.44–46 These esters need to be hydrolyzed to
hydroxyl groups before the polymer can be further functional-
ized. To overcome the drawbacks of these methods, a new
synthesis route to synthesize amine end-functionalized PEtOx
was developed (Scheme 1). In this approach the living cationic
species is quenched directly with an excess of potassium
phthalimide, saving one step compared to the method
described by Park et al. Moreover, the end-capping eﬃciency is
quantitative according to 1H NMR spectroscopy and MALDI-
TOF-MS.
The 1H NMR spectrum of 1 (Fig. 1 top) shows a broad signal
around 7.76 ppm deriving from the aromatic protons of the
phthalimide unit (4 protons). By correlation with the signals at
about 3 ppm, which are associated with the CH3 a-end group (3
protons), the quantitative functionalization with the desired u-
end group is conrmed. The broad peak at 3.44 ppm derives
from the polymer backbone. The side chain signals can be
found at 1.11 ppm (CH3) and 2.32 ppm (CH2), respectively. Due
to a diﬀerent chemical environment, the backbone CH2 group
adjacent to the phthalimide is shied to 3.83 ppm.
The MALDI-TOFmass spectrum of 1 shows two distributions
that can be assigned to the sodium adduct of phthalimide end-
capped PEtOx (Fig. 2). The methyl-initiated species derives from
the initiation of the polymerization with methyl tosylate. The
proton-initiated species is formed by chain transfer reactions
occurring during the polymerization.47,48 A hydroxyl end group
bearing species could not be observed. This fact further
underlines the complete functionalization and is in accordance
with the results from 1H NMR analysis. Moreover, the measured
isotopic patterns match with the calculated isotopic patterns of
the assigned species.
The phthalimide end-capped PEtOx 1 were subsequently
treated with hydrazine monohydrate to obtain the amine
functionalized polymers (2).43,49 Characterization of the product
by 1H NMR spectrometry revealed the success of the reaction
(Fig. 1 bottom). Aer the hydrazinolysis, the signals of the
aromatic phthalimide end group and the CH2 group adjacent to
the phthalimide disappeared quantitatively.
The MALDI-TOF mass spectrum of 2 shows two major
distributions which belong to the sodium adducts of methyl
and proton initiated PEtOx bearing an amine end group (Fig. 3).
The initial phthalimide-bearing species could not be detected
Scheme 1 Schematic representation of the synthesis of amine end-
functionalized PEtOx.
Fig. 1 1H NMR spectra of phthalimide (1a, top) and amine (2a, bottom)
end-functionalized PEtOx (300 MHz, solvent CDCl3).
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anymore. In addition, the measured and the calculated isotopic
pattern coincide.
The presented synthesis route was used to prepare amine
functionalized PEtOx (2) with diﬀerent molar masses, namely
2000, 4000, 6000, and 8000 g mol1 (n ¼ 20, 40, 60, and 80),
which can be achieved simply by variation of the [M]/[I] ratio
applied for the CROP. Characterization by size exclusion chro-
matography (SEC) revealed PDI values between 1.12 and 1.19
(Table 1).
Fluorescein labeled PEtOx
To prove the suitability of the attachment methods and to
investigate the stability of the obtained PEtOx layers against
diﬀerent types of stress, a uorescein labeled PEtOx (Fluo-
PEtOx, 5) was used. To this end, a copolymer with an amine
monomer content of 10% and an overall degree of polymeri-
zation (DP) of 40 (P(EtOx36-stat-AmOx4), 4) was synthesized by
copolymerization of EtOx and a tert-butyloxycarbonyl (Boc)-
protected amine group containing 2-oxazoline followed by
deprotection (Scheme 2).41 In a next step one amine group was
labeled using a uorescein-NHS ester derivative. The reaction of
this activated acid with amine groups is highly eﬃcient under
basic conditions and was, therefore, performed with triethyl-
amine (TEA) as a base. Purication was accomplished by
repeated precipitation into diethyl ether to eliminate traces of
unreacted uorescein. The successful labeling of the copolymer
was conrmed by SEC, which provided congruent UV (485 nm)
and RI-detector traces (Table 1 and Fig. S1†). Moreover, no
signal of unreacted uorescein was detected. In addition, 1H
NMR spectroscopy shows the characteristic peaks of uorescein
with broadening attributed to the attachment to the polymer
chain (Fig. S2†).
Fig. 3 (A) MALDI-TOF mass spectrum of amine functionalized PEtOx.
(B) An expanded region of the spectrum (right), the structural assign-
ments for the diﬀerent distributions as well as the calculated and
measured isotopic pattern of the peak at m/z ¼ 1540 (left).
Table 1 SEC-data of the diﬀerent POx
Sample EtOx : BocOx : AmOx : F Mn
a (g mol1) PDIa
2a 20 : 0 : 0 : 0 2460 1.12
2b 40 : 0 : 0 : 0 3790 1.15
2c 60 : 0 : 0 : 0 5175 1.14
2d 80 : 0 : 0 : 0 5990 1.19
3 36 : 4 : 0 : 0 5300 1.08
4 36 : 0 : 4 : 0 5400 1.12
5 36 : 0 : 3 : 1 5500 1.18
a Determined by SEC (eluent: CHCl3/2-propanol/TEA, calibration with a
PS standard).
Fig. 2 (A) MALDI-TOF mass spectrum of phthalimide end-capped
PEtOx. (B) An expanded region of the spectrum (right), the structural
assignments for the diﬀerent distributions as well as the calculated and
measured isotopic pattern of the peak at m/z ¼ 1670 (left).
This journal is © The Royal Society of Chemistry 2014 J. Mater. Chem. B, 2014, 2, 4883–4893 | 4887
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Coating of glass slides with PEtOx of diﬀerent molar masses
using diﬀerent spacers
To investigate their suitability for the prevention of bio-
adhesion, the PEtOx polymers (2a–d) were immobilized on
borooat® 33 glass employing either (1) a silane based linker or
(2) a TEL linker (Scheme 3). In case of coupling via a silane
based linker, the glass slides were rst treated with (3-glycidy-
loxypropyl)trimethoxysilane (GOPTMS). Subsequently, PEtOx of
diﬀerent molar masses were attached by reaction of the epoxide
unit of GOPTMS with the end group of the polymer (Scheme 3A
route 1). For the coupling via a TEL linker (Scheme 3B) the
terminal hydroxyl groups of the lipid were modied with cya-
nuric chloride to enable the covalent coupling to the glass
surfaces as well as the covalent binding of PEtOx on top of the
lipid membrane (Scheme 3A route 2). The TEL functionalized
glass slides were coated with PEtOx with the samemolar masses
as for route 1.
Characterization of the polymer thin lms
In order to examine the suitability of the attachment methods
and the quality of the PEtOx coatings, uorescein labeled PEtOx
was graed to the diﬀerent linker molecules in the same way as
the PEtOx homopolymers. By means of laser scanning micros-
copy it could be shown that homogenous Fluo-PEtOx lms are
obtained for both the GOPTMS and the TEL linker (Fig. 4).
The coating process with the PEtOx homopolmyers was
further monitored by means of X-ray photoelectron spectros-
copy (XPS). Using this method information on the chemical
composition of surface layers, which are only a couple of
nanometers thick, can be obtained. A comparison of the
nitrogen 1s signal of pure borooat glass, the diﬀerent linkers,
and the diﬀerent PEtOx lms showed the successful coating
(Fig. 5). While on pure glass and GOPTMS treated substrate, no
nitrogen was found, the TEL coated glass shows a nitrogen
signal due the cyanuric chloride moieties. Moreover, the
nitrogen signal intensity increased signicantly aer attaching
the PEtOx.
Water contact angle measurements on air-dried and
hydrated polymer coatings were performed with the aim to
investigate the wetting behavior of the surface tethered PEtOx
lms (Fig. 6). Both, samples that were coated with GOPTMS and
TEL linker, respectively, displayed an increased water contact
angle compared to the reference borosilicate glass (aer treat-
ment with argon plasma). Subsequent PEtOx graing further
increased the water contact angles for GOPTMS attached
samples. In case of TEL linked PEtOx only for a DP of 20,
referred to as 20(TEL), an increased contact angle could be
observed when compared to pure TEL. For all other chain
lengths the contact angle is in the same range as for pure TEL or
even decreased. These changes in wettability indicate a
successful coating of the substrates with the linkers and PEtOx,
respectively.
In the air-dried state, surfaces that were coated with PEtOx
via a GOPTMS linker display water contact angles in a rather
wide range between 57 and 85. The variations for surfaces that
were coated with PEtOx via TEL linkers are narrower, ranging
from 53 to 70. While for coatings attached through TEL
decreasing contact angles with increasing chain lengths could
be observed, no trend could be found for GOPTMS attached
PEtOx.
Scheme 2 Schematic representation of the synthesis of amine containing POx and labeling of the polymer with ﬂuorescein.
4888 | J. Mater. Chem. B, 2014, 2, 4883–4893 This journal is © The Royal Society of Chemistry 2014
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Aer swelling in water, the coatings display reduced contact
angles. This nding is ascribed to the hydration of the hygro-
scopic, hydrophilic PEtOx. Again a clear trend to reduced
contact angles for longer polymer chains can be found for TEL
attached coatings. Moreover, the diﬀerence in contact angles
between air-dried and hydrated state (Dq) increases with the
chain length from 0.7 for n ¼ 20(TEL) to 18.1 for n ¼ 80(TEL).
This observation indicates that longer polymers can bind/
absorb more water molecules and, thus, should have a higher
antifouling potential. This is in accordance with theoretical
calculation for PEG.8 For GOPTMS tethered lms such tendency
could not be observed. Here, a constant Dq of 10 was
determined.
An important parameter with regard to the antifouling
properties is the graing density,33 which is in general calcu-
lated either from the lm thickness28,50 or the weight loss of the
sample upon heating.51,52 However, due to technical reasons
(e.g. monolayer, glass substrate) the determination of these
parameters was not possible. To ensure the highest possible
graing density an excess of polymer was used.
Scheme 3 (A) Schematic representation of the PEtOx coating process using GOPTMS (route 1) and a TEL (route 2) linker, respectively, and (B) of
the TEL linker structure.
Fig. 4 Confocal laser scanning microscopy images of (A) uncoated
glass, (B) Fluo-PEtOx attached via GOPTMS, (C) Fluo-PEtOx attached
via TEL, and (D) scratched sample of Fluo-PEtOx attached viaGOPTMS
(scale bar: 100 mm).
This journal is © The Royal Society of Chemistry 2014 J. Mater. Chem. B, 2014, 2, 4883–4893 | 4889
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Antifouling properties of the diﬀerent PEtOx coatings
The antifouling properties of the diﬀerent PEtOx-coated glass
slides were investigated in ow-through chambers that allow
a continuous cross ow of synthetic river water under
reproducible conditions over an arbitrary period of time.
Based on the water composition of the river Ruhr near
Mu¨hlheim (Germany), ve diﬀerent microorganisms with a
high potential of biolm formation were chosen, namely:
Aeromonas hydrophila/caviae, Sphingomonas paucimobilis,
Pasteurella spp., Aeromonas salmonicida, and Leuconostoc spp.
Aer 15 hours incubation the adherent microorganisms were
stained using a LIVE/DEAD® BacLight™ Bacterial Viability Kit
and investigated by means of confocal laser scanning
microscopy. A clear reduction of the bioadhesion, induced by
the PEtOx coatings, was detected (up to 66% compared to
uncoated glass), with no signicant diﬀerences between lms
attached via GOPTMS and TEL, respectively, suggesting that
similar graing eﬃciencies are reached (Fig. 7). Although in
case of TEL linkers the hydrophilicity of swollen PEtOx
samples increased with the chain length and longer chains
should, therefore, have a higher antifouling potential, an
inuence of the molar mass on the cell adhesion could not be
observed. Also the bacterial viability rate was hardly aﬀected.
Only the samples 40(Si) and 20(TEL) showed higher devia-
tions. While on 40(Si) nearly no dead cells could be found, the
20(TEL) coating showed a reduced cell viability. In addition,
20(TEL) shows the lowest overall bioadhesion, making it the
best coating produced within this study. However, from an
Fig. 5 (A) Typical XPS spectrum of a TEL-PEtOx coating. (B) Overlay of the nitrogen 1s signals of bare boroﬂoat glass as well as the diﬀerent
linkers and coatings.
Fig. 6 Water contact angles of the diﬀerent PEtOx-coatings in dry and hydrated state (data are presented as mean  standard deviation for n ¼
45). The numbers indicate the diﬀerent DPs of PEtOx (20, 40, 60 and 80), linkers are given in brackets.
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use-oriented point of view, i.e. for large scale applications, the
attachment via GOPTMS is favored, since similar results are
obtained and the coating process is easier. Moreover,
GOPTMS, in contrast to TEL, is easily available in large
amounts.
Antifouling properties of immobilized PEG- and POx-based
coatings have been widely reported in the literature.8,14–20 Due to
the diﬀerent, more real life test conditions, e.g. attack of
multiple bacteria and synthetic river water medium, a
comparison of the obtained results to other POx or PEG coat-
ings, reported in literature, is diﬃcult.
Stability of the PEtOx coatings
An important parameter with regard to their application, e.g. as
sensor coatings, is the stability of the PEtOx lms. To this end,
Fluo-PEtOx coated glass slides, attached through GOPTS and
TEL spacer, respectively, were exposed to three diﬀerent types of
stress: (1) chemical stress, (2) mechanical stress and (3) thermal
stress. The resistance against chemical stress, caused e.g. by
fresh and salt water, was investigated over 12 weeks using dam
and North Sea water, respectively. The durability of the coatings
against abrasion in particle containing water is essential in the
eld of environmental monitoring. Based on environmental
data a corresponding test solution containing aluminum oxide
and silicon carbide particles was prepared. Mechanical stress
was simulated by placing the glass slides into this solution and
stirring for 8 hours a day over 1 week. In order to verify their
thermal stability, the samples were exposed to a dened heating
prole for 14 days with temperatures between 2 and 38 C.
Subsequent analysis by means of confocal laser scanning
microscopy showed that the coatings withstood the diﬀerent
types of stress (Fig. 8).
Conclusion
The potential of PEtOx coatings to prevent bioadhesion under
“real life” conditions was investigated. To this end, amine end-
functionalized PEtOx of four diﬀerent molar masses have been
prepared applying a new and straightforward synthesis method.
The polymers obtained were characterized by MALDI-TOF mass
spectrometry, 1H NMR spectroscopy, and size exclusion chro-
matography, which showed the successful introduction of u-
amine groups. PEtOx were attached to glass surfaces through
silane and tetraether lipid based linkers. The surface immobi-
lization of PEtOx was investigated by uorescence microscopy
measurements of surfaces modied with uorescently labeled
PEtOx as well as by XPS investigations, which showed the
presence of nitrogen signals aer the PEtOx coating process.
Contact angle measurements of air-dried and swollen coatings
revealed a higher hydrophilicity of the swollen samples,
ascribed to the formation of PEtOx hydrates. Fouling studies
were performed in a ow-through chamber under “real-life”
relevant conditions using a synthetic river water model con-
taining ve diﬀerent bacteria. PEtOx modied glass samples
exposed to the synthetic river water for 15 h showed a bio-
adhesion reduction of up to 66% with no signicant diﬀerences
between the two diﬀerent linkers. The best results were
obtained by PEtOx with 20 repeating units attached via a tet-
raether lipid linker, which revealed the lowest biolm forma-
tion and the highest amount of dead bacteria. In addition, the
stability of the PEtOx coatings towards chemical, mechanical,
and thermal stress was investigated. No signicant destruction
of the polymer layer was observed, demonstrating the capability
of the lms for long term applications.
The present study underlines the potential of POx for anti-
fouling coatings and is in agreement with other studies.33
Fig. 7 Bioadhesion on PEtOx coatings of diﬀerent DP (20, 40, 60, and 80) to the glass slides via a silane (Si) and a tetraether lipid (TEL) linker
(standard deviation is related to the total bioadhesion (sum of dead and vital bacteria)) as well as confocal laser scanning microscopy images of
the stained bioﬁlms on glass and 20 (TEL).
This journal is © The Royal Society of Chemistry 2014 J. Mater. Chem. B, 2014, 2, 4883–4893 | 4891
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However, at the chosen, more realistic conditions, a
complete reduction of biolm formation could not be observed.
Further investigations have to be performed and will aim at the
application of mixtures of PEtOx with diﬀerent molar masses as
well as PEtOx of diﬀerent architectures to result in a denser
packing of the polymer chains on the surface. Another inter-
esting aspect is probably the graing of polyhydrophilic and
polyzwitterionic entities to form a stable supercial water
barrier. Future tests will have to show whether the presented
coatings are able to maintain their antifouling behavior under
real life conditions, i.e. the simultaneous acting of bacteria and
stresses.
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Fig. S1. SEC curves of amine containing POx 4 and Fluo-PEtOx 5 (eluent: CHCl3/2-
propanol/TEA).
Fig. S2 1H NMR spectrum of PEtOx-FITC (300 MHz, solvent CD3OD).
Methods and materials
General
Dry acetonitrile, MeOx and methyl tosylate (MeOTs) were obtained from Acros Organics, distilled to dryness over 
barium oxide (BaO), and stored under nitrogen. Dry N,N-dimethylformamide (DMF) was purchased from Acros 
Organics, (3-glycidyloxypropyl)-trimethoxysilane from ABCR, hydrazine monohydrate and potassium phthalimide 
from Fluka. Triethylamine was distilled over calcium hydride prior use. 
Borofloat 33 glass slides were purchased from Schott (Jena, Germany) and cleaned using a low-pressure oxygen plasma 
instrument from Diener Electronic (Nagold, Germany). The Initiator Sixty single-mode microwave synthesizer from 
Biotage, equipped with a noninvasive IR sensor (accuracy: ±2%), was used for polymerizations under microwave 
irradiation. Prior to use, the microwave vials were heated at 110 °C overnight and allowed to cool to room temperature 
under a nitrogen atmosphere. Proton (1H) nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AC 
300 MHz at 298 K. Chemical shifts are reported in parts per million (ppm, δ scale) relative to the residual signal of the 
deuterated solvent. Size exclusion chromatographies (SEC) of the PEtOx were measured on a Shimadzu system 
equipped with a SCL-10A VP system controller, a DGU-14A degasser, a LC-10AD VP pump, a RID-10A refractive 
index detector and a PSS SDV column running with chloroform, triethylamine (TEA), and 2-propanol (94:4:2) as 
eluent. The Techlab column oven was set to 50 °C. Molar masses were calculated using a polystyrene (PS) standard. 
The MALDI-TOF-MS spectra were recorded utilizing an Ultraflex III TOF/TOF (Bruker Daltonics GmbH, Bremen, 
Germany), equipped with a frequency-tripled Nd:YAG laser, operating at a wavelength of 355 nm. All spectra were 
measured in the positive reflector mode using trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile 
(DCTB) with sodium iodide as matrix. XPS measurements were performed on an EA200-ESCA-system (SPECS 
Surface Nano Analysis GmbH, Berlin, Germany).
X-ray photoelectron spectroscopy (XPS)
XPS investigations were carried out with an EA200-ESCA-system (SPECS) using nonmonochromatic Al Kα radiation 
(hν = 1486 eV). The samples have been measured as received under constant conditions (ϑ = 0°). The nitrogen 1s 
photoemission signals have been background subtracted and smoothed.
Contact angle measurements
Determination of water contact angles has been carried out with a computer controlled contact angle measuring system 
(DCA20, dataphysics, Germany) using the sessile drop technique (drops of 3 μL). In order to evaluate expected 
hydration effects of the PEtOx-layers, both dry and swollen samples were characterized. To obtain the latter, the coated 
glass slides were swollen in distilled water for 30 min. Prior to the determination, excess of water on the surface was 
removed with pressurized air. The presented contact angles are an average from 15 measurements at 5 different surface 
points (n = 45).
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Poly(2-ethyl-2-oxazoline) as Alternative for
the Stealth Polymer Poly(ethylene glycol):
Comparison of in vitro Cytotoxicity and
Hemocompatibility
Marius Bauer, Christian Lautenschlaeger, Kristian Kempe, Lutz Tauhardt,
Ulrich S. Schubert, Dagmar Fischer*
1. Introduction
Poly(ethylene glycol) (PEG) currently represents the gold
standard for stealth polymers in drug delivery and is to
date theonly stealthpolymer thatmade it to themarket.[1,2]
The success story began about 20 years ago, when the
ﬁrst PEGylated drug Adagen1 received approval. Many
others, mostly PEG-protein conjugates followed.[2] How-
ever, although only observed for a limited number of
patients, concerns regarding immune responses,[3] forma-
tion of PEG-antibodies,[4] an accelerated blood clearance
(ABC) phenomenon after multiple applications,[5] and non-
biodegradability of PEG resulting in body accumulation of
high-molar-mass PEGs[6] arose with an increasing number
of clinical trials and a more profound experience with PEG
in humans. In addition, a tense patent situation regarding
PEG complicates the introduction of new formulations to
the market. Hence, intensive efforts were made to search
for alternative stealth polymers.
Full Paper
M. Bauer, C. Lautenschlaeger, Prof. D. Fischer
Department of Pharmaceutical Technology, Institute of
Pharmacy, Friedrich-Schiller University Jena, Otto-Schott-Strasse
41, 07745 Jena, Germany
E-mail: dagmar.ﬁscher@uni-jena.de
Dr. K. Kempe, L. Tauhardt, Prof. U. S. Schubert
Laboratory of Organic and Macromolecular Chemistry (IOMC),
Friedrich-Schiller-University Jena, Humboldtstr. 10, 07743 Jena,
Germany
Prof. U. S. Schubert, Prof. D. Fischer
Jena Center for Soft Matter (JCSM), Friedrich-Schiller-University
Jena, Humboldtstr. 10, 07743 Jena, Germany
Limitations of PEG in drug delivery have been reported from clinical trials. PEtOx (0.4–40 kDa)
as alternative is synthesized by a living, microwave-assisted polymerization, and is directly
compared to PEG of similar molar mass regarding cytotoxicity and hemocompatibility. In
short-term treatments, both types of polymers are well
tolerated even at high concentrations. Moderate con-
centration andmolar mass dependent cytotoxic effects
occurred only after long-term incubation at concen-
trations higher than therapeutic doses. PEtOx pos-
sesses not only an easy route of synthesis and
beneﬁcial physicochemical characteristics such as
low viscosity and high stability, which are advan-
tageous over PEG, but additionally in vitro toxicology
comparable to PEG.
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In recent years poly(2-oxazoline)s (POx) which were
already discovered in the 1960s have been discussed as
potential alternatives for PEG as stealth polymers.[7]
They can be synthesized easily by the living cationic
ring-opening polymerization (CROP) of 2-substituted
2-oxazolines, thus offering the advantage of a straight-
forward control of the degree of polymerization and the
polymer architecture, and to obtain polymers with low
polydispersity indices (PDI) in high quality. Since classical
bulk polymerizations took several hours to several days,
the commercial spreading of POx was limited. In the
last years, the introduction of microwave-assisted
polymerization techniques increased the synthesis speed
by a factor of up to 350 while allowing at the same time
to improve the livingness of the polymerization, making
poly(2-oxazolines) easily[8] available and more attractive
for commercialization. For the use as stealth polymers,
poly(2-methyl-2-oxazoline) (PMeOx) and poly(2-ethyl-2-
oxazoline) (PEtOx) were investigated. Physicochemical
properties such as the non-ionic character, a broad
solubility in hydrophilic and lipophilic solvents, and a high
ﬂexibilityof themainchainwere found tobe comparable to
PEG.[9] Even though only available to a limited extent,
biopharmaceutical studies revealed that pharmacokinetics
of POx-modiﬁed drug delivery systems are comparable
to PEG. PMeOx and PEtOx conjugated liposomes showed
a prolonged blood circulation time with preferential
distribution comparable to PEGylated liposomes in liver,
spleen, and kidney after 24h.[7] PEtOx conjugates of
biomolecules like uricase, catalase, ribonuclease, insulin,
and albumin demonstrated the stealth effect of POx.[10]
The safety of 10 and 20 kDa POx was shown in vivo in
rats after intravenous administration with maximum
tolerated doses higher than 2 g  kg1 and without any
signs of toxicity.[10]
Although, many studies have been published dealing
with the cyto- and hemocompatibility of PEG, only few
publications have dealt with such experiments regarding
PEtOx.[9,11–13] POx with varying alkyl chains, and molar
masseswere shown to have no signiﬁcant cytotoxic effects
up to 5mg mL1 on RAT-2 cells and did not induce
immunological effects.[12] POx block copolymers of differ-
ent architectures were well tolerated by mammalian
cells.[13]Nonetheless, anysystematic investigationofPEtOx
in particular in direct comparison to PEG under standar-
dized conditions is still missing. Comprehensive hemo-
compatibility studies of PEtOx were not yet reported.
Additionally, already published studies are difﬁcult to
compare since they used different test conditions, different
cell types, and polymers of different origin and purity.
Therefore, in the present study, a large set of PEtOx was
systematically analyzed in a comprehensive cyto- and
hemotoxicity study indirect comparison toPEG, aimingata
systematic analysis of the inﬂuenceofpolymermolarmass,
polymer concentration, incubation time, polymer purity,
and source of the polymers.
2. Experimental Section
2.1. Commercial Polymers
Six commercial PEGswithmolarmassesof 0.4, 2, 4, and20kDa (Carl
Roth, Karlsruhe, Germany), 10 kDa (Merck, Darmstadt, Germany),
and 40kDa (Serva, Heidelberg, Germany) were selected. All PEGs
werepurchasedinpharmaceutical gradeaccordingto theEuropean
Pharmacopeia 6.8 (Ph. Eur. 6.8) except 10 kDa PEG, which was only
available as chemical grade. Commercially available PEtOxs were
obtained from Polysciences Europe GmbH (Eppelheim, Germany)
(5 kDa) and Sigma-Aldrich (Deisenhofen, Germany) (50 and
200 kDa).
2.2. Synthesis of Poly(2-ethyl-2-oxazoline)
The initiator 60 single-modemicrowave synthesizer from Biotage,
equipped with a non-invasive infrared sensor (accuracy: 2%),
was used for polymerizations under microwave irradiation.[8]
Microwave vials were heated to 110 8C overnight and allowed
to cool to room temperature under an argon atmosphere before
usage. All polymerizations were carried out with temperature
control. Methyl tosylate and 2-ethyl-2-oxazoline (EtOx) (Acros
Organics, Geel, Belgium) were distilled to dryness over barium
oxide (BaO) and stored under argon. A stock solution of
acetonitrile (Sigma-Aldrich), initiator (methyl tosylate), and
monomer EtOx was prepared. The total monomer concentration
was adjusted to 4M with a total monomer-to-initiator ratio of
4, 20, 40, 100, 200, and 400, respectively. The stock solutions
were divided into 4–5 vials, which were heated to 140 8C in the
microwave synthesizer for a pre-determined time. After cooling,
a sample for the determination of the monomer conversion by
1H NMR spectroscopy was prepared.
The following puriﬁcation procedure was applied for all PEtOx
samples. A 15-fold excess of aqueous sodium carbonate (Sigma-
Aldrich) was added to the polymerization mixture, which was
stirred at 100 8C overnight. Subsequently, the two-phase solution
was dilutedwith dichloromethane; the organic phasewaswashed
three times with water and saturated sodium chloride solution
and dried overMgSO4. The polymerwas concentrated in vacuo and
precipitated into ice-cold diethyl ether. The PEtOx samples with a
molarmass of 0.4 and 2 kDawere re-dissolved inwater and stirred
with amberlite (basic loaded) for 24h. After ﬁltration andwashing
of the resin thewaterwas evaporated under reduced pressure. The
polymer was re-dissolved in dichloromethane and precipitated
into ice-cold diethyl ether. All polymer samples were kept under
reduced pressure at 40 8C for 4d. Subsequently, the polymers were
lyophilized.
2.3. Physicochemical Characterization of the
Polymers
Molar masses and polydispersity indices were determined for
all commercial and non-commercial polymers. Size exclusion
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chromatography (SEC) measurements were performed using
an Agilent system equipped with a SCL-10A system controller,
a LC-10AD pump, a RID-10A refractive index detector, and both
a PSS Gram30 and a PSS Gram1000 column in series, whereby,
N,N-dimethylacetamide with 2.1mg mL1 LiCl was applied as an
eluent at 1mL min1 ﬂow rate and the column oven was set to
40 8C. The system was calibrated with PEG (0.4–1000kDa) and
polystyrene (0.4–44.7 kDa) standards (Polymer Standard Service,
Mainz, Germany) using a third order polynomial ﬁt. 1H NMR
spectra were recorded on a Bruker AC 300MHz spectrometer at
room temperature with deuterated chloroform as solvent. The
chemical shifts were given in ppm relative to the signal from
residual non-deuterated solvent.
2.4. Preparation of Polymer Stock Solutions
PEG solutions were prepared by dissolving the polymer in highly
puriﬁed water with a concentration twice as high as the required
ﬁnal concentration and sterilized by autoclaving. To reach the ﬁnal
concentration they weremixedwith double concentrated Roswell
Park Memorial Institute 1640 culture medium (RPMI 1640, PAA,
Pasching, Austria). PEtOx solutions were directly prepared in RPMI
1640 culture medium and sterilized by ﬁltration (0.2mm, VWR
International, Darmstadt, Germany). Filterability was tested by
gravimetric measurement of aqueous stock solutions at highest
concentrations of 80mg mL1. Therefore, 1mL stock solution and
1mLﬁltratewere transferred into tareglassvials and lyophilized in
aAlpha1-2/LDPlus freeze dryer (MartinChrist, OsterodeGermany)
at a pressure of 0.006mbar for 48h. Samples were weighed on a
Sartorius RC 210 P semi-micro balance (Sartorius, Goettingen,
Germany). Serial dilutions with concentrations between 5 and
80mg mL1 were prepared. pH and osmolarity of the polymer
solutions were routinely measured with a pHmeter 1140 (Mettler
Toledo, Giessen, Germany) and a semi-microosmometer (Knauer,
Berlin, Germany), respectively.
2.5. Cell Culture
L929mouse ﬁbroblasts (German Collection ofMicroorganisms and
Cell Cultures, Braunschweig, Germany) were incubated in RPMI
1640 culture medium containing 10% fetal calf serum Gold (FCS
Gold, PAA) and 2 103 M glutamine at 37 8C, 5% CO2, and 95%
relative humidity. Cells were routinely tested with standard test
kits for absenceof squirrelmonkey retrovirus (QIAamp1DNAMini
kit, Qiagen, Hilden, Germany) and mycoplasma (Venor1GeM,
Minerva Biolabs, Berlin, Germany).
2.6. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) Assay
The MTT assay was performed according to a modiﬁed method of
Mosmann[14] and Fischer et al.[15] L929mouse ﬁbroblasts (8500 per
well) were seeded into 96-well microtiter plates (Greiner Bio-One,
Frickenhausen, Germany) and incubated for 24h. Subsequently,
the culture mediumwas replaced by 100mL serial dilutions of the
polymers. After 3, 12, and 24h polymer solutions were removed
and 200mL MTT solution (0.5mg mL1, Sigma), prepared in RPMI
1640 without FCS, were added for 4 h. MTT solution was aspirated
and the formazane crystals were dissolved in 200mL dimethyl
sulfoxide (Carl Roth). Absorbance was measured at 570nm
wavelength inamicroplate reader (FluostarOPTIMA,BMGLabtech,
Offenburg, Germany). Culture medium without cells was used to
calibrate the zero absorbance (blank). For the determination of 0%
viability (positive control), cells were treated with a 0.02%
thiomersal solution (Synopharm, Barsbu¨ttel, Germany) in culture
medium. For 100% viability (negative control), cells were kept only
in cell culturemedium. After subtracting the blank fromall values,
the cell viability (%) was calculated as absorbance of test polymer
dividedbyabsorbanceofnegativecontrol times100%.According to
ISO10993-5[16], a cell viability lower than70% in comparison to the
negative control was regarded as cytotoxic. All experiments were
run in seven parallel experiments and were repeated once.
Additionally, changes in cell morphology and detachment of cells
from the dish were observed with a Leica inverse phase contrast
microscope (Leica DM IL, Leica, Germany) equipped with an
objective (Achromat 10/0.20 Phaco 1a, Leica, Germany) of 100
magniﬁcation. The results were classiﬁed according to the staging
system of ISO 10993-5.
2.7. Lactate Dehydrogenase (LDH) Assay
L929mouse ﬁbroblasts (100 000 per well) were cultured in 12-well
cell culture plates (Greiner Bio-One) in RPMI 1640 with 10% FCS.
After 48h incubation, the cell culture medium was removed and
replacedby2mL well1polymersolution.Serialpolymerdilutions
with concentrations of 40, 60, and 80mg mL1 were prepared in
RPMI 1640 cell culture mediumwithout FCS and phenol red (PAA).
Aliquots of 120mL per well were collected from the supernatant
after 0, 1, 2, and 4h of exposure. The LDH concentration was
determined by using a commercial LDH cytotoxicity assay kit
(Cayman, Ann Arbor, USA) according to the manufacturer’s
protocol. The LDH release (%) is deﬁned as the ratio of LDH released
by the test compounds over total LDH in treated cells. For
determination of total LDHpositive controlswere performedusing
a 0.1% Triton X-100 solution (Ferak, Berlin, Germany). Cells only
treatedwith culturemediumwere used as negative control. A LDH
release of less than 10% was regarded as non-toxic effect level.[17]
2.8. Hemolysis of Erythrocytes
The hemolytic activity of the polymerswas investigated according
to a modiﬁed method of Parnham and Wetzig.[18] Blood was
collected inheparinized-tubes fromsheep. Plasmawas removedby
centrifugation at 4500g for 5min (Eppendorf Centrifuge 5804R,
Eppendorf, Hamburg, Germany). The pellet was washed three
times with cold 1.5103 M phosphate-buffered saline pH¼ 7.4
(PBS) by centrifugation at 4500g for 5min andwas resuspended in
the same buffer. The red blood cell suspensions were used within
24h after collection. For the experiments, stock solutions were
dilutedwithPBS ina ratioof 1:6.67 to receive thenecessarynumber
oferythrocytes. PolymersolutionswerepreparedinPBSbufferwith
concentrations of 40, 60, and 80mg mL1. They were mixed 1:1
witherythrocytesand incubated inawaterbathat37 8Cfor60min.
Hemoglobin release was determined by spectrophotometric
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analysis of the supernatant at 544nmafter centrifugationat 2400g
for 5min (Eppendorfmini spin, Eppendorf). As positive control, 1%
Triton X-100 solutionwas used. The negative control was received
bytreatingerythrocyteswithPBS.Thepercentageofhemolysiswas
calculated according to
Hemoglobin release of 0–2, 2–5, or >5% of the total
release was classiﬁed as non-hemolytic, slightly hemolytic,
or hemolytic, respectively, according to the ASTM F756-08
standard.[19] Experiments were run in triplicate and were
repeated once.
2.9. Erythrocyte Aggregation Assay
A modiﬁed method from Ogris et al.[20] was applied for testing
the erythrocyte aggregation of the polymers by microscopy.
Polymers were dissolved in PBS buffer with concentrations
up to 80mg mL1. The erythrocytes were isolated as
described above. Erythrocyte suspensions (100mL) containing
9.4106 erythrocytes mL1weremixedwith thesamevolumeof
test compounds in a 24-well plates (Nunc, Roskilde, Denmark).
Cells were incubated at 37 8C for 2 h. Erythrocyte aggregation
was evaluated by microscopic observations (Leica DM IL,
Achromat 10/0.20 Phaco 1a objective, 200 magniﬁcation)
classifying the results in three stages. At stage 1, the erythrocytes
stayed discrete in suspension, no aggregation was detectable.
Stage 2 showed a moderate aggregation with rouleau
formation but the majority of erythrocytes were discrete. In
stage 3, almost all erythrocytes were aggregated in clusters. For
determination of stage 1, erythrocytes were treated with PBS as
negative control. Positive controls were treated with 30mg mL1
25 kDa branched poly(ethylene imine) (bPEI, kind gift of BASF
corporation, Ludwigshafen, Germany) and were classiﬁed as
stage 3.[21] The experiments were run in duplicate and were
repeated once. Each data point is presented as the mean of four
experiments.
2.10. Photometric Erythrocyte Aggregation Assay
Erythrocyte aggregation of two selected polymers 0.4 and
200 kDa PEtOx as well as 25 kDa bPEI were additionally tested
using a photometric method according to Cardoso et al.[22]
Test polymer solutions were prepared in dilutions ranging
from 10 to 80mg mL1. 25 kDa bPEI as positive control was
tested up to a maximum concentration of 40mg mL1. Each
polymer dilution with a volume of 50mL was mixed with
50mL of erythrocyte suspension (9.4 106 erythrocytes mL1)
in a clear ﬂat bottomed 96-well plate (Greiner Bio-One).
Cells were incubated under vigorous shaking at 37 8C for 2 h.
Absorbance was measured at 645 nm in a microplate reader.
Negative controls were cells only treated with PBS. Blank
values were determined with PBS and subtracted from
the sample values. Absorbances of the test solutions lower
than the negative control were regarded as aggregation.
Results were additionally checked by microscopic observation
after the measurement. Tests were run in triplicate and
repeated once.
3. Results
3.1. Synthesis and Physicochemical Characterization
of the Polymers
In the following experiments, PEGs with molar masses in
the range from 0.4 to 40 kDa (corresponding to 8–900
repeating units) were investigated, representing polymers
that are typically used in pharmaceutical and medical
applications. With exception of PEG 10 kDa, all PEGs were
purchased in pharmaceutical grade with deﬁned limited
concentrations of impurities like dioxane (max. 0.0001%),
ethylene oxide (max. 0.0001%), and formaldehyde (max.
0.0015%). PEG 10 kDa was not tested according to the
speciﬁcations of Ph. Eur. becausenomonograph is available
for this particular polymer length. The theoretical molar
masses of PEG given by the suppliers correlated well with
the weight-average (Mw) and number-average (Mn) molar
mass determinedby SEC (Figure 1aandTable 1a). Themolar
mass distribution of PEG was found to be low, with a
maximum of 1.09 for polymers 4kDa up to 1.19 for
PEG >5kDa.
For comparison to PEG, six PEtOx with molar masses in
the same range as the PEGs (0.4–40 kDa consistent with 4,
20, 40, 100, 200, and 400 repeating units) were synthesized
by living CROP. PEtOxs were soluble in water, ethanol,
methanol, acetonitrile, tetrahydrofuran, chloroform,
dichloromethane, and N,N-dimethylacetamide. For the
synthesis of a set of PEtOxs, a series of stock solutions
containing MeOT (initiator), EtOx (monomer), and acetoni-
trile (solvent) were prepared and polymerized under
microwave irradiation at 140 8C for pre-determined times
yieldingclearandcolorlesspolymer solutions. Thedegreeof
polymerization was adjusted by choosing different mono-
mer-to-initiator ratios. In order to guarantee the same
chemical structure of all polymers as well as to remove
initiator traces, the reaction mixture was treated with
aqueous sodium carbonate at 100 8C after microwave
polymerization, resulting in the formationof ahydroxyend
group. The quenching of the polymerization with water
would lead to twodifferentendgroups (hydroxylandester),
which could have an inﬂuence on the properties, in
particular of the shorter polymers.[23] In order to remove
residualmonomerandsolvents, thepolymerswerepuriﬁed
Hemolysisð%Þ ¼
ðAbsorptionsample  BlanksampleÞ  ðAbsorptionnegative control  Blanknegative controlÞ
Absorptionpositive control  Blankpositive control
 100% (1)
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by several washing steps, precipitation in ice-cold diethyl
ether, drying in vacuo, and lyophilization. PEtOx with
shorter chain length (<20 repeating units) were addition-
ally treated with amberlite in aqueous solution to remove
residual tosylate. The puriﬁed 0.4 kDa PEtOx was clear,
semi-solid, and colorless, whereas polymers with higher
molar masses were white powders. The purity of all
polymers was tested by 1H NMR spectroscopy, which
additionally revealed a good agreement of the theoretical
and experimental molar masses (Table 1b). The analysis
by SEC conﬁrmed that the PEtOx homopolymers were
synthesized with narrow molar mass distributions
(Table 1b and Figure 1b) comparable to commercial PEG
(Table 1a). Mn, Mw, and PDI of 0.4 kDa PEtOx could not be
determined by SEC because of the overlap of the polymer
and the solvent signal. In addition, three commercial PEtOx
with 5, 50, and 200 kDa were investigated. In these cases,
the obtained molar masses showed a large deviation from
the declared values with PDI values twice to four times
higher as for non-commercial PEtOx (Figure 1c).
3.2. Preparation of Polymer Solutions
For cell culture experiments, sterile solutions of the
polymers were required. PEG solutions were autoclaved
under standard conditions according toPh. Eur. 6.8 at 121 8C
and 2 bar for 15min. After sterilization, the PEG solutions
were clear, colorless, and particle-free. Autoclaving was
chosen as sterilization technique for PEG since the viscosity
of the high molar mass PEG stock solutions inhibited
a quantitative sterile ﬁltration. Additionally, this high
viscosity limited also the biological test of polymer
concentrations higher than 80mg mL1. PEtOx solutions
were sterilized by ﬁltration using a 0.2mmcellulose acetate
ﬁlter. The ﬁltered and afterwards freeze dried 0.4 and
200 kDaPEtOxsolutionsshowedarecoveryof101and102%
in the ﬁltrate, respectively, demonstrating the ﬁlterability
of PEtOx. Osmolarity and pHvalue of the polymer dilutions
in cell culture medium were routinely measured to avoid
unspeciﬁc cytotoxic effects. Both types of polymers had no
inﬂuence on the pH value of the cell culture medium. In
the case of the serial dilutions in PBS, all values were in
physiological range between 7.2 and 7.6. The osmolarity of
the polymer solutions was measured by freezing point
depression. Cell culture medium alone has an average
osmolarity of 280 mosmol  kg1. Previous experiments
have shownthatosmolaritiesup to400mosmol  kg1were
well tolerated by L929 cells without a decrease in cell
viability or morphological changes (data not shown).
Osmolarities higher than 400 mosmol  kg1 were only
detected for 0.4 kDa PEG and 0.4 kDa PEtOx at 60 and
80mg mL1 as well as for 2 kDa PEG at a concentration of
80mg mL1. For all other polymers and investigated
concentrations, osmolarities in the range from 280 to 390
mosmol  kg1 were measured.
3.3. Inﬂuence of Polymer Concentration, Molar Mass,
Incubation Time, and Polymer Purity on Metabolic
Cell Activity
The MTT assay was chosen as a test for the inﬂuence of
the polymers on the metabolic activity of L929 mouse
ﬁbroblasts, which were used as target cells since they are
Figure 1. SEC traces of commercial PEG (0.4 kDa–40kDa; a), syn-
thesized PEtOx (0.4–40 kDa; b), and commercial PEtOx (5, 50, and
200 kDa; c). Synthesized PEtOx was obtained by microwave-
assisted living CROP at 140 8C in acetonitrile with methyl tosylate
as initiator.
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recommended by many standard institutions like the
International Organization for Standardization (ISO) or
ASTM International (formerly known as American Society
for Testing and Materials) as reference cell line for
biomaterial testing.[16,24] In preliminary experiments,
MTT assays performed with pure polymer solutions with-
out the addition of cells showed that the presence of
test polymers up to 80mg mL1 had no inﬂuence on the
chemical reaction of the assay and the spectrophotometric
measurement (data not shown). L929 mouse ﬁbroblasts
were incubated with the polymers for 3, 12, and 24h
(Figure 2). According to ISO 10993-5, a cell viability 	70%
was regarded as non-toxic.
Untreated cells were used as negative control and were
set as 100% viable cells. Thiomersal solution (0.02%) as
positivecontrol reducedthemeancellviability to3.5%(data
not shown).Noneof thePEGs causedanycytotoxic effect on
cell viability (>70%) after 3 h, as shown in Figure 2a. After
12h (Figure 2b) and 24h (Figure 2c), a concentration- and
molar mass-dependent effect on cell viability could be
observed. Low molar mass PEGs (0.4, 2, and 4 kDa) as well
as the 10 kDa PEG of non-pharmaceutical quality revealed
onlymoderate cytotoxic effects at	60mg mL1 after 12h.
In contrast, high molar mass PEGs (20 and 40 kDa)
were found to be non-toxic, with cell viabilities being
above 70%. Comparable proﬁles were received after 24h.
Up to 40mg mL1, all PEGs were found to be non-toxic.
At higher concentrations for 0.4–4 kDa PEGs, only a slight
decrease of cell viability between 0.5% (0.4 kDa PEG) and
8.4% (4 kDa PEG) could be detected compared to 12h. Again,
10 kDa PEG demonstrated the highest toxicity of all PEGs
tested.
After 3h, the biocompatibility of PEtOx was found to be
comparable to PEG. Treatment of L929 cells with PEtOx
up to 80mg mL1 did not change their metabolic activity
(>70%). After longer incubation times, the cell viabilitywas
inﬂuenced by PEtOx in a concentration, time, and molar
mass dependent manner as also observed for PEG. Up to
40mg mL1 all other polymers revealed no cell damaging
effect after 12h except 0.4 kDa PEtOx. At higher concentra-
tions, the two lowmolarmass PEtOx (0.4 and 2 kDa) aswell
as 20 kDa PEtOx decreased the cell viability below 70%,
whereasall otherpolymerswere found tobenon-toxic. This
wasmore pronounced after 24h than after 12h. In contrast
to 0.4 kDa PEG, the 0.4 kDa PEtOx caused a complete loss of
cell viability at 80mg mL1 after 12h and 40mg mL1
after 24h. PEtOx with the highest molar mass (50 and
200 kDa) were well tolerated. The 5 and 10 kDa polymers
reduced the activity of the cells to <70% only at
80mg mL1, whereas 2, 20, and 40 kDa PEtOx revealed
moderate cytotoxic effects starting at 20mg mL1.
Additionally, L929 mouse ﬁbroblasts were microscopi-
cally investigated before and after treatment with the
polymers. Untreated L929 ﬁbroblasts are adhesive, spindle-
Table 1. Physicochemical characterization of weight-average (Mw) and number-average (Mn) molar mass and PDI values of PEG and PEtOx.
Sample Expt. molar massa)
[Da]
Mn
b)
[Da]
Mw
b)
[Da]
PDIb)
0.4 kDa PEG 345 378 1.09
2 kDa PEG 1845 2009 1.09
4 kDa PEG 3994 4182 1.05
10 kDa PEG 9776 10 801 1.10
20 kDa PEG 19 002 21 595 1.14
40 kDa PEG 31 612 37 741 1.19
0.4 kDa PEtOx 400 – – –
2 kDa PEtOx 2 080 3660 4063 1.11
4 kDa PEtOx 4 060 6460 7171 1.11
5 kDa PEtOxc) 8 456 20 082 47 594 2.37
10 kDa PEtOx 10 200 12 750 14 663 1.15
20 kDa PEtOx 20 500 22 900 27 022 1.18
40 kDa PEtOx 37 500 41 000 51 250 1.25
50 kDa PEtOxc) 17 939 74 074 305926 4.13
200 kDa PEtOxc) 48 882 229 010 1 071767 4.68
a)Determined by means of 1H NMR spectroscopy; b)Determined by means of SEC [N,N-dimethylacetamide containing 2.1mg mL1 LiCl;
PEG standards for PEG samples, polystyrene standards for PEtOx samples]; c)Commercial PEtOx samples.
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shaped cells growing to conﬂuent monolayers (Figure 3a).
For the classiﬁcation of the toxic effects were treated
with thiomersal as positive control. A reduction of the total
cell number (Figure 3b) could be observed. Microscopic
observations correlated well with the results of the
quantitativeMTT assay. An intactmonolayer or only slight
changes in morphology were detectable for non-toxic
polymers. Examples of 40 kDa PEtOx and 40 kDa PEG were
shown in Figure 3c and d. Cell detachment from the dish
bottom, reduced growth and an increased number of
spherically shaped cells as shown for 10 kDa PEG and
20 kDa PEtOx in Figure 3e and f as well as for 0.4 kDa
PEtOx (Figure 3g and h) were detected in the case of the
toxic effect levels determined in the MTT assay.
3.4. PEG and PEtOx Show No
Membrane-Damaging Effect
Membrane damaging effects of PEG and
PEtOx were quantiﬁed by the LDH assay
asan indicator for early toxicity. Polymers
were tested at the three-highest concen-
trations (40, 60, and 80mg mL1) of the
MTT assay for a maximum incubation
time of 4h (Figure 4). Pure polymer
solutions up to 80mg mL1, which were
analyzed in the samemanner as prepara-
tions with cells, conﬁrmed that the LDH
assay was not affected by the presence
of the test polymers. Absorbances were
comparable to the blank values deter-
mined with cell culture medium without
FCS (data not shown). At the beginning of
theexperiment (0 h), samplesweredrawn
for conﬁrmation of the intactness of the
L929 mouse ﬁbroblasts. LDH release of
these samples was in the range from 0 to
8.5%, that is, lower than 10%, which is
regarded as cytotoxic effect level indicat-
ing that the cells were intact at the
beginning of the experiment. After 1–
4h incubation (Figure 4), the mean LDH
release for all PEGs and PEtOx was not
higher than 10% indicating that PEG and
PEtOx did not damage the cellular
membranes and both were found to be
comparable. For comparison, sponta-
neous LDH release of untreated cells
was in the range of 0.1–4.5%.
3.5. Blood Compatibility of PEG and
PEtOx
The interactions of the PEG and PEtOx
polymers with erythrocytes as major
blood components and one of the ﬁrst contact partners
after systemic administration were investigated with
regard to red blood cell hemolysis and aggregation. The
release of hemoglobinwasused toquantify the erythrocyte
membranedamaging effect of thepolymers. The treatment
of red blood cells with PBS buffer and 1% Triton X-100
solution provided 0 and 100% hemolysis, respectively.
Erythrocytes were incubated with 40, 60, and 80mg mL1
polymer solution for 1h. Independent of the polymer type,
pharmaceutical quality, incubation time, and polymer
concentration, noneof thePEGandPEtOxpolymers showed
values of hemolysis higher than 0.6% indicating no
detectable disturbance of the red blood cell membranes
(data not shown). According to theASTM standard F756-00,
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Figure 2. Cell viability of L929 mouse ﬁbroblasts after treatment with PEG (a-c) and
PEtOx (d–f) up to 80mg mL1 after 3, 12, and 24h incubation. Values below the marked
line at 70% viability were regarded as cytotoxic according to ISO 10993-5. The cell
viability was determined bymeans of anMTT assay. Data are presented asmean SD of
seven determinations.
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a hemoglobin release between 0 and 2% was regarded as
non-hemolytic. For comparison negative controls had a
mean hemolysis of 1.02%.
Additionally, thepotential of PEGandPEtOx to aggregate
red blood cells as an undesired phenomenon leading
to circulatory side effects and even lethal toxicity was
microscopically visualized after 2 h incubation (Figure 5).
For classiﬁcation of the intensity of the effects a three-stage
classiﬁcation system was applied (Table 2) as described in
the Section 2. PBS buffer was used as negative control and
did not show any sign of cluster formation (stage 1,
Figure 5a). Treatment with 25 kDa bPEI at 30mg mL1 as
positive control caused the formation of aggregates (stage
3, Figure 5b). None of the PEGs showed any red blood
cell aggregation even at the highest concentration of
80mg mL1. As representative examples, the results for
PEGs with the lowest (0.4 kDa) and highest (40 kDa) molar
mass are shown in Figure 5c and d, respectively. Therefore,
PEG polymers were tested only at the highest concentra-
tions of 60 and 80mg mL1, whereas PEtOx polymers
were investigated from 20 to 80mg mL1 (Table 2b).
No aggregates (stage 1) were visible with all PEtOx
polymers at 20mg mL1. PEtOx up to 40 kDa showed
results comparable to PEG (Figure 5e), with one exception;
the treatment of erythrocytes with
40 kDa PEtOx at 80mg mL1 caused
slight aggregation at stage 2 (Figure 5g).
PEtOx 50 kDa was tolerated up to
60mg mL1 (Figure 5f) but represented
a stage 2 at 80mg mL1 (Figure 5h). In
case of 200 kDa PEtOx which showed
the highest aggregating effect, a
concentration dependent potential to
aggregate erythrocytes could be detected
(Figure5i–l), startingat40mg mL1 (stage
2, Figure 5j) and reached the maximum at
60 and 80mg mL1 (stage 3, Figure 5k
and l) with formation of large clusters.
To receive additionally quantitative
information, we established an assay to
quantify erythrocyte aggregation by
absorbance measurements with a stan-
dard plate reader and report for the ﬁrst
time its use for the biological character-
ization of polymers. Light emitted
through sample suspensions is scattered
by erythrocytes and reduces the amount
of light reaching the detector. The higher
the amount of free erythrocytes, the
higher is the determined absorbance of
thesuspension.Whenerythrocytesaggre-
gate to clusters and sediment, the total
absorption area of free erythrocytes is
reduced, resulting in a lower light scatter-
ing and, consequently, a lower detectable absorption. To
avoid interferences with the absorbance of hemoglobin,
measurementswere performed at awavelength of 645nm.
Negative controls treatedwith PBSwere used to determine
the absorbance of non-aggregating erythrocytes. Prelimin-
ary experiments conﬁrmed that sample suspensions with
anabsorbancebelowthenegativecontrol couldbe regarded
as aggregating (data not shown). Data are shown for a
serial dilution of the positive control 25 kDa bPEI with a
maximum concentration of 40mg mL1 as well as for
PEtOx polymers with the highest (200 kDa) and the
lowest (0.4 kDa) molar mass tested in serial dilutions up
80mg mL1 (Figure 6). Erythrocyte suspensions treated
with 25 kDa bPEI showed a concentration dependent
decrease of absorbance (Figure 6a) starting at 5mg mL1
and correlated with an increasingly strong cluster forma-
tion by microscopy. The erythrocyte aggregation of bPEI
concentrations <5mg mL1 were rated as stage 1 while
concentrations 	5mg mL1 were rated as stage 3. The
absorbance of 0.4 kDa PEtOx up to 80mg mL1 was
comparable to the values of the negative control
(Figure 6b) indicating that no aggregation occurred. This
correlateswellwith the results ofmicroscopic observations
(Table 2b). For 200 kDa PEtOx, a concentration dependent
Figure 3. Microscopic analysis of L929 mouse ﬁbroblasts after treatment with PEG and
PEtOx compared to untreated (negative control) (a) and 0.02% thiomersal treated
(positive control) (b) cells (100). Cells treated with test polymers in non-toxic effect
levels were comparable with the negative control as shown for 40 kDa PEG (c) and
40 kDa PEtOx (d) at 40mg mL1 after 12 h incubation. Changes in cell detachment and
morphology were observed for toxic polymer concentrations. The observable effects
were similar for all tested polymers as exemplarily shown for 10 kDa PEG (e), 20 kDa
PEtOx (f) at 80mg mL1 as well as 0.4 kDa PEtOx at 40 and 80mg mL1 (g and h) after
24 h incubation.
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decrease in the absorbance was detected (Figure 6c), which
follows a linear regression (R2¼ 0.9899). Only the absor-
bances at concentrations of 10 and 20mg mL1 were
comparable to the negative control. Higher concentrations
revealed an absorbance below the negative control,
corresponding to an increased erythrocyte aggregation.
Although the positive control PEI and 200 kDa PEtOx
(80mg mL1) were both ranked as stage 3 by microscopy,
PEI was characterized by a higher decrease of absorption
values with higher concentrations in the quantitative
assay, which correlates with the formation of larger
erythrocyte clusters compared to PEtOx.
4. Discussion
Several disadvantages of PEG, such as the
demanding polymerization process with
undesired impurities in the product,
formation of peroxides, limited stability,
high viscosity, and accumulation in
some organs with formation of vacuoles
because of the desiccant nature of PEG,[2]
have triggered the investigation of
PEtOx as alternative to PEG. In the present
study, various PEtOx were systematically
analyzed as potential alternative for
PEG in direct comparison with regard to
cyto- and hemocompatibility.
Polymers with molar masses from 0.4
to 40 kDa were selected, representing
biomedically and pharmaceutically rele-
vant sizes for PEG applications. PEG with
molar masses below 0.4 kDa were
reported to be not suitable for medical
applications due to degradation to toxic
diacid and hydroxyacid metabolites by
alcohol and aldehyde dehydrogenase in
humans.[25] Whereas PEGs below 10kDa
aremainly used to shield particulate drug
carriers or antibodies against opsoniza-
tion, high molar mass PEGs (>10 kDa)
were typically bound to smaller drug
molecules to decrease their renal excre-
tion.[26] In our study, several PEtOx were
synthesized by a fast and highly con-
trolledpolymerizationprocedure forming
chemically well-deﬁned polymers with
lowPDIvaluesandahighpurity similar to
commercially available PEtOx. With the
exception of 5 kDa PEtOx, only molecules
with molar masses (50 and 200 kDa)
higher than that used for PEG are com-
mercially available. Special attentionwas
directed toward the extensive puriﬁca-
tion of the polymers in order to exclude
any side effects of byproducts. Differences in cyto- and
hemotoxicity between the commercial and the non-
commercial PEtOx were not obvious although the com-
mercial polymers showed a signiﬁcantly broader molar
mass distribution as it is obvious from the bimodal SEC
traces. The upper concentrations for the PEtOx testing
varied between different publications from 5 to
20mg mL1.[12,13] In the present study, 80mg mL1 was
selected as the highest possible concentration limited by
the high viscosity of PEG solutions, whereas PEtOxwas still
low viscous under these conditions. The lower viscosity of
20–40 kDa PEtOx compared to PEG was also demonstrated
Figure 4. Time- and concentration-dependent membrane damaging effect of PEG (a–d)
and PEtOx (e–h) on L929 mouse ﬁbroblasts after 0, 1, 2, and 4h. The membrane
damaging potential was determined by quantiﬁcation of cytosolic LDH released into
the cell culturemedium after treatmentwith 40, 60, and 80mg mL1 polymer solution.
A LDH release higher than 10% (plotted line) was regarded as cytotoxic effect level.
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by Viegas et al.,[10] thus allowing easier pharmaceutical
formulation, ﬁlterability, and syringeability of PEtOx even
at higher concentrations. The selected concentrations up to
80mg mL1 are higher than therapeutically used doses
and represent a worst case scenario, which could be
reached, for example, by overdosing or repeated adminis-
trationandaccumulationof thepolymers in thebody.Up to
now, the concentration of PEG in commercially used
drug conjugates for systemic administration is lower than
1mg mL1 per dose. To avoid unspeciﬁc cytotoxic effects,
all polymer solutions were adjusted to physiological pH
and tolerable osmolarity. Although an osmolarity above
300 mosmol  kg1 is considered as cytotoxic, our pre-
liminary experiments showed that osmolarities up to
400 mosmol  kg1 were well tolerated by L929 cells,
comparable with literature data on the investigation of
bovine aortic endothelium cells.[27]
After short incubation times, results of different assays
such as MTT and LDH assay correlated well. More
speciﬁcally, after 3h (MTT) and 4h (LDH) no changes in
metabolic activity and LDH release could be detected for
both types of polymers, independent of molar mass or
polymer concentration. The comparison
of the results of the hemolysis assay
and the LDH assay, which both analyze
membrane damaging effects, showed
comparable results despite the differ-
ences between ﬁbroblasts and erythro-
cytes regarding membrane composition
and glycocalyx.[28,29]
PEG as well as PEtOx were found to be
highly biocompatible polymers in MTT
and LDH assays. For both types of poly-
mers, cytotoxicity was found to be
dependent on time, concentration, molar
mass, and purity of the polymers. While
PEG was found to be non-toxic up to
40mg mL1 even after 24h, PEtOx
showed some inhibition of cell prolifera-
tion at 20–40mg mL1. These moderate
cytotoxic effects occurred only after long-
term treatments of 12 and 24h. Prolong-
ing the incubation time from 12 to 24h
slightly increased the effects. Further-
more, the cytotoxicity was strongly
dependent on the molar masses. Low
molar mass polymers of both polymer
groups up to 10 kDa as well as 20 and
40 kDa PEtOx, affected the cell viability
more profoundly than polymers with
higher molar mass. The 10 kDa PEG
demonstrated the highest cytotoxicity
of all tested PEGs, whichmight be related
to a higher amount of impurities due to
the non-pharmaceutical quality. At this point, it should
be noted that long-term toxicity of concentrations
>40mg mL1 of 0.4 kDa PEG and 0.4 kDa PEtOx as well
as of 80mg mL1 of 2 kDa PEG could also be caused by
osmolarity values higher than the well tolerated 400
mosmol  kg1. As single reason, however, this explanation
is insufﬁcient since0.4 kDaPEtOxcausedahigher reduction
of the cell viability than 0.4 kDa PEG despite comparable
osmolarities. For PEtOx, comparable toxicity data were
reported by Kronek et al.[12] testing polymers with 2–
67.3 kDa up to 5mg mL1 in rat RAT-2 cells over 48h.
Macrophages challenged by 67.3 kDa PEtOx did not exert
decreased functionality.[12] In agreement with our data,
Kronek et al.[12] reported a slightly higher toxicity of PEtOx
withmolarmasses lower than 1.6  104 g mol1whichwas
ascribed to the cytotoxic activity of EtOx monomer traces,
thusemphasizing thenecessityofpuriﬁcation.Here, during
the extensive puriﬁcation steps of the non-commercial
PEtOx, the monomer was completely removed and it can
thus be excluded as a reason for cytotoxic reactions.
However, the experiments showed a reduction of cell
viability although no membrane damage was observed.
Figure 5. Representative micrographs of red blood cell aggregation of PEG and PEtOx at
378C after 2 h incubation (200), (a) negative control (PBS); (b) positive control
(30mg mL1 25 kDa bPEI); (c) 0.4 kDa PEG (80mg mL1); (d) 40 kDa PEG (80mg mL1);
); (e) 40 kDa PEtOx (60mg mL1; (f) 50 kDa PEtOx (60mg mL1); (g) 40 kDa PEtOx
(80mg mL1); (h) 50 kDa PEtOx (80mg mL1); (i–l) 200 kDa PEtOx (20, 40, 60, and
80mg mL1).
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Luxenhofer et al.[13] could show that POxs were generally
taken up by endocytosis while uptake rate and efﬁciency
increased with increasing hydrophobicity. To be taken up
by 50% of the target cells the required concentration of a
PEtOx homopolymer was 180-fold higher than the con-
centration of themost efﬁcient block copolymer consistent
of a PEtOx and poly(2-butyl-2-oxazoline) block.[13] The data
conﬁrmed our results since very high concentrations of
hydrophilic PEtOxwere required toenter thecells and inour
case causing a reduction of the cell viability. Additionally,
the polymer concentration was found to play a key role in
toxicity sincePEtOxaccumulationwithincellswas foundto
be dependent on the polymer concentration.[12]
The low cytotoxicity of PEG as compared to other
polymers such as poly(L-lysine), dextran, etc. was shown
by several authors.[30,31] PEG is generally regarded as safe
and non-toxic. But comparable with our results in the cell
viability experiments different studies showed that the
biocompatibility of PEG is strongly related to the molar
mass. Independent of the chosen test animal or application
route in vivo studies revealed that with a decreasingmolar
mass the lethal doses of PEG decrease.[32] Similar results
wereobtained in invitroexperiments forPEGswithvarying
molar masses investigated for the use as cell protector
against mechanical damage. Under the chosen conditions
0.4 kDa PEG inhibited the cell growth>50%. In contrast for
PEG> 1.4 kDa no negative effects or even an increased cell
growth was observed.[33] Although, the concentrations
used in these studies were lower than 1% (m V1),
comparable data were obtained in our experiments even
at higher concentrations.
Hemolytic activity could be observed neither for PEG nor
for PEtOx at 0.4–200 kDa up to 80mg mL1 demonstrating
a comparable behavior. This correlates well with the
erythrocyte compatibility up to 10mg mL1 reported for
PEtOx by Viegas et al.,[10] who suggested a protective effect
of the non-ionic, hydrophilic polymers on cell membranes
in the same way as plasma proteins act in providing
hemocompatibility against stress and exogenous inﬂu-
ences.[34] For low molar mass PEG (<1kDa), a relationship
between hemolysis, polymer concentration, and polymer
molar mass was reported by several authors.[35,36] The
lower the molar mass and the higher the polymer
concentration, the higher was the damage of the erythro-
cytes which was suggested to be caused by an increase in
osmolarity.[37] This effect was more pronounced for PEGs
with a molar mass <400 Da than for PEGs with larger
sizes.[36] Our results correlated well with these ﬁndings.
To date no studies on erythrocyte aggregation have been
published for PEtOx. Up to 40 kDa and 80mg mL1,
erythrocyte aggregation was comparable for PEG und
PEtOx, with the exception of 40 kDa PEtOx starting to form
moderate aggregates at the highest concentration. Higher
molar mass PEtOx (50–200 kDa) demonstrated concentra-
tion- and molar mass-dependent effects on erythrocytes.
For PEG, the data correlate well with observations by
Table 2. Classiﬁcation (1: no erythrocyte aggregation, 2: slight aggregation with rouleau formation, 3: severe aggregation with three-
dimensional cluster formation) of the erythrocyte aggregation of PEG and PEtOx after 2 h incubation. The experiments were run in duplicate
and were repeated once. Each data point is presented as the mean of four experiments.
Sample Erythrocyte aggregation
20mgmL1 40mgmL1 60mgmL1 80mgmL1
0.4 kDa PEG 1 1
2 kDa PEG 1 1
4 kDa PEG 1 1
10 kDa PEG 1 1
20 kDa PEG 1 1
40 kDa PEG 1 1
0.4 kDa PEtOx 1 1 1 1
2 kDa PEtOx 1 1 1 1
4 kDa PEtOx 1 1 1 1
5 kDa PEtOx 1 1 1 1
10 kDa PEtOx 1 1 1 1
20 kDa PEtOx 1 1 1 1
40 kDa PEtOx 1 1 1 2
50 kDa PEtOx 1 1 1 2
200 kDa PEtOx 1 2 3 3
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Geller et al.[38] and Levtov et al.,[39] reporting concentration-
andmolarmass-dependent effects on erythrocyte aggrega-
tion. Aggregating effects could be observed only for
PEGs with very low (<1 kDa) or very high molar masses
(>20 kDa). In Viaspan, which is a solution for preservation
and storage of organ transplants, 20–35 kDa PEGs reduced
the deformation and sedimentation of erythrocytes and
inhibited the aggregation of red blood cells compared to
hydroxyethyl starch.[40] Armstrong et al.[41] suggested that
the inﬂuence of a non-ionic polymer on red blood cell
aggregation is the consequence of its hydrodynamic radius
and that the speciﬁc type of a given macromolecule is of
onlyminor importance. When added towhole blood, 6 kDa
PEG inhibited erythrocyte aggregation whereas 20 kDa
PEG promoted aggregation.[38] These ﬁndings could not be
conﬁrmed in our experiments since no aggregation was
detected with all PEGs independent of molar mass and
concentration. Possible explanations were given by differ-
ences in the experimental settings, especially the use of full
bloodbyGeller etal.[38] comparedtoPBS inourexperiments.
5. Conclusion
In a directly comparative study, PEGs and PEtOxs with
pharmaceutically relevant molar mass were tested regard-
ing cytotoxicity and hemocompatibility under standar-
dized conditions. PEG and PEtOx were well tolerated by
mouseﬁbroblasts aswell as by red blood cells. Both types of
polymers showed comparable properties in the therapeu-
tically relevant dose range demonstrating the potential of
PEtOx as an adequate candidate to substitute PEG with
regard to biological compatibility. Moderate cytotoxic
effects occurred only in the MTT assay after long-term
incubation (12 and 24h) at higher concentrations andwere
dependent on polymer concentration, molar mass, and
polymer purity. Compared to PEG, PEtOxs could be
synthesized without toxic side products with comparable
molar mass ranges, and PDI values as well as additional
beneﬁcial physicochemical properties like high stability
and low viscosity. Referring to our results we can conclude
that PEtOx could be a promising alternative for PEG.
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ABSTRACT: Since poly(2-methyl-2-oxazolines) (PMeOx) attract
high attention for the potential use in drug delivery, cytotoxic-
ity, and hemocompatibility of a set of PMeOxs with molar
masses in the range from 2 to 20 kDa are systematically inves-
tigated under standardized conditions in terms of molar mass,
concentration and time dependency. PMeOx polymers are well
tolerated in red blood cell aggregation and hemolysis assays
without any damaging effects even at high concentrations up
to 80 mg/mL. Only in long term cytotoxicity tests PMeOx poly-
mers moderately influence cell viability in a time, concentra-
tion, and molar mass dependent manner. Referring to these
results it can be concluded that PEtOx could be promising non-
ionic hydrophilic polymers for many biomedical applications
without any cyto- and hemotoxic effects at typically used thera-
peutic doses. VC 2013 Wiley Periodicals, Inc. J. Polym. Sci., Part
A: Polym. Chem. 2013, 51, 1816–1821
KEYWORDS: biocompatibility; hemocompatibility; hydrophilic
polymer; poly(2-methyl-2-oxazoline); ring-opening poly-
merization
INTRODUCTION The use of the hydrophilic, nonionic
poly(2-methyl-2-oxazoline) (PMeOx) in biomedical and
pharmaceutical applications has enormously evolved during
the last years.1,2 On the one hand, PMeOx can be considered
chemically as a poly(ethylene imine) (bPEI) backbone with
amide-bonded side groups. On the other hand, these polymers
were also described as pseudopeptides or bioinspired poly-
mers due to their structural relation to polypeptides. In
contrast to peptides, the tertiary amine groups of PMeOx can-
not be recognized by enzymes for hydrolytic cleavage which
provides high stability in the biological environment.3
Since the early 90s several studies are available reporting
the use and importance of PMeOx as a component of drug
delivery systems such as peptide, protein, and lipid conju-
gates as well as for liposomes and micelles (for reviews, see
e.g., refs. 1 and 2). Miyamoto et al.4 demonstrated that the
covalent binding of PMeOx to liver catalase influenced the
enzyme activity dependent on polymer molar mass and
degree of conjugation. Furthermore, it was possible to pre-
serve the enzymatic activity in organic solvents due to an
increase of solubility provided by the conjugated PMeOx.4
Amphiphilic block copolymers of PMeOx and poly(2-butyl-2-
oxazoline)s were tested as micellar carrier systems for the
delivery of hydrophobic drugs such as paclitaxel. The results
revealed a low intrinsic toxicity of the micelles and a high
micellar drug uptake without loss of drug activity.5 Similar
results were received for micelles formed of block copoly-
mers with hydrophobic poly(L-lactide) or poly(e-caprolac-
tone) and PMeOx.6,7
Many of the observed effects were found to be comparable
to the beneficial properties of poly(ethylene glycol) (PEG)
with regard to stealth behavior, biodistribution, and biocom-
patibility. PMeOx can induce a stealth effect in a similar way
as PEG when grafted on liposomes or surfaces.8,9 Clearance
from the blood was similar for PEG and PMeOx, whereas
for instance the more lipophilic poly(2-ethyl-2-oxazoline)
(PEtOx) was removed somewhat faster.10 Liposomes deco-
rated with PMeOx were characterized by a prolonged blood
circulation time and a preferential organ distribution in
liver, spleen, and kidney after 24 h.8,10 Protein-repellent
and non-fouling, antimicrobial effects after coating of
PMeOx to surfaces, for example, of implants, biosensors or
nanoparticles quantitatively reached the excellent properties
of PEG.9,11
Additional Supporting Information may be found in the online version of this article.
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A requirement for the administration of PMeOx in patients is
the biocompatibility of PMeOx which was first demonstrated
in vivo by Goddard et al.12 after intravenous injection in
mice. It was reported that PMeOx did not accumulate in
organs and can be rapidly cleared from the blood stream.13
Only some high molar mass PMeOx polymers were found in
skin and muscle tissue.12 However, in vitro hemocompatibil-
ity data are not available for PMeOx to the best of our
knowledge and in vitro cytotoxicity data are limited. Kronek
et al.14 investigated only one PMeOx polymer with 8.5 kDa
in a [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide] (MTT) assay and found no cytotoxic effects up to a
concentration of 5 mg/mL after 24 and 48 h. Luxenhofer
et al.15 used only two PMeOx derivatives of about 4 kDa,
however modified with piperazine and Boc-piperazine, to
demonstrate the biocompatibility of PMeOx in a cytotoxicity
(MTT) assay over up to 24 h. More information is only avail-
able for copolymers with PMeOx.15
Consequently, in the present study in vitro cytotoxicity and
hemocompatibility of pure PMeOx polymers with a wide
range of molar masses from 2 to 20 kDa were systematically
investigated under standardized conditions to close the gaps.
In particular, the influence of polymer molar mass, polymer
concentration and incubation time was investigated.
RESULTS AND DISCUSSION
Four PMeOx polymers with pharmaceutical and biomedical
relevant molar masses from 2 to 20 kDa were synthesized as
described in the Supporting Information. All PMeOxs were
obtained as white crystalline powders. Identity and purity of
the polymers were proven by means of 1H NMR spectros-
copy and size exclusion chromatography analysis which con-
firmed that the PMeOx polymers were synthesized with
defined molar masses and acceptable molar mass distribu-
tion [polydispersity index (PDI) values < 1.45] (Fig. 1 and
Supporting Information Table S1).
Before administration of the PMeOxs to cells, potential non-
specific effects of the polymer solutions falsifying the results
of the toxicity tests were excluded. Polymer loss due to
incomplete passage of PMeOx through the sterile filter could
be excluded by comparing the mass of unfiltered and filtered
stock solutions after freeze drying (data not shown). pH val-
ues and osmolarities of all stock solutions were routinely
measured before application to the cells. The pH values of all
polymer solutions were comparable to the corresponding
pure medium. Osmolarities of the stock solutions ranged
from 335 to 420 mosmol/kg (Supporting Information Table
S2). Differences were attributed to varying polymer molar
mass and type of medium. A MTT assay using culture
medium of different osmolarities (280–650 mosmol/kg)
demonstrated that osmolarities up to 490 mosmol/kg were
well tolerated by L929 cells without morphological changes
or decrease in cell viability up to 24 h (Supporting Informa-
tion Fig. S1). Only the highest osmolarity of 650 mosmol/kg
showed a reduction of the cell viability to 34% after 24 h
which correlates well with reports for other cell types.16
Many of the polymers used in medical applications or as
drug delivery system come into close contact with blood
plasma and blood cells, in particular after systemic adminis-
tration. Therefore, the influence of PMeOx polymers on the
aggregation behavior and hemolysis of sheep erythrocytes
was investigated. Erythrocyte aggregation of PMeOx was
qualitatively visualized by microscopy and quantitatively
measured by UV/Vis spectrophotometry. Quantitative meas-
urements determined the changes in absorbance based on
different light scattering of aggregated and non-aggregated
erythrocytes as described by Cardoso et al.17 who showed
that with increasing degree of aggregation the sample
absorbance decreased. Serial dilutions of the four PMeOx
polymers (20–80 mg/mL) without addition of erythrocytes
showed absorbances (maximum A ¼ 0.083) comparable to
phosphate buffered saline (PBS) blank values (A ¼ 0.039).
Consequently, a polymer related error of the measurement
could be excluded. The selection of polymer concentrations
was based on the reported concentrations of previous
studies of other non-ionic hydrophilic polymers.18 These con-
centrations represent the worst case scenario such as over-
dosing or polymer accumulation in the body. As negative
control red blood cells were treated only with PBS showing
no signs of aggregation. A 25 kDa branched bPEI solution
(30 lg/mL) was used as positive control causing strong
aggregation with formation of three-dimensional clusters due
to its high cationic charge as described before.19
In quantitative measurements no signs of aggregation could
be observed for any of the PMeOx polymers. Regardless of
the used concentration or molar mass of all four polymers
no erythrocyte aggregation dependent decline of absorption
could be detected (Fig. 2). Values were found to be in the
range of PBS as negative control with a mean value of 0.589
6 0.081. All values of the polymer solutions were higher
than that of 25 kDa bPEI as positive control (0.228 6
0.123). The results were verified qualitatively by microscopic
observation. Erythrocyte aggregation was classified with a
three stage classification system as described in the Support-
ing Information. Stage 3 was determined with 25 kDa bPEI
FIGURE 1 SEC diagram, showing the refraction index (RI)
depending on eluted polymer volume (Vel) of the PMeOx
synthesized by microwave-assisted living cationic ring-opening
polymerization at 140 C with methyl tosylate as initiator and
acetonitrile as solvent.
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[Supporting Information Fig. S2(a)] whereas erythrocytes
suspended in PBS were classified as stage 1 [Supporting
Information Fig. S2(b)]. Independent of polymer molar mass
and concentration all tested PMeOx solutions did not show
any aggregation and were therefore classified as stage 1
[Supporting Information Fig. S2(c–f)]. These data confirmed
the results of the spectrophotometric measurements.
Hemolysis caused by PMeOx polymers was quantified by the
release of hemoglobin as an indicator for erythrocyte mem-
brane damage. Erythrocytes were incubated with PMeOx
solutions at 20–80 mg/mL for 1 h as well as with PBS buffer
as negative control and 1% Triton X-100 as positive control
(100%). Release of hemoglobin between 0 and 2% was
regarded as non-hemolytic as defined in the ASTM (Ameri-
can Society for Testing and Materials) standard F756-08.20
All PMeOxs did not show values higher than 1.06% regard-
less of their molar mass and concentration indicating that
they did not disturb the erythrocyte membranes (data not
shown). For comparison, the mean hemolysis of the negative
control was 0.31%.
Taken the hemocompatibility data together, the 2–20 kDa
PMeOx polymers demonstrated an excellent blood compati-
bility comparable to other non-ionic hydrophilic polymers
such as PEG,18 PEtOx,18,21 and polyglycerol.22
For further investigations of the influence of PMeOx poly-
mers on the membrane integrity as an early indicator for
toxicity, short term incubations were performed with fibro-
blast cell cultures using a lactate dehydrogenase (LDH)
assay. The release of LDH into culture medium was detected
after 0–4 h polymer treatment using concentrations of 40,
60, and 80 mg/mL (Fig. 3). According to official guidelines
L929 mouse fibroblasts were used as cell line for the cyto-
toxicity experiments.23,24 As described by Choksakulnimitr
et al.25 a LDH release > 10% was regarded as cytotoxic.
Assays performed with polymer solutions up to 80 mg/mL
without the addition of cells showed that the test polymers
itself had no influence on the chemical reactions of the assay
and the spectrophotometric measurement (data not shown).
The membrane integrity of L929 mouse fibroblasts at the
beginning of the experiment was determined by drawing
samples directly after the addition of the test polymers. Up
to 4 h treatment with PMeOx polymers up to 20 kDa LDH
values ranged from 0.1 to 8.1% (Fig. 3), confirming the
intactness of the cells even at the highest concentration of
FIGURE 2 Concentration dependent spectrophotometric quantification of erythrocyte aggregation after PMeOx polymer treatment
at 37 C for 2 h. Absorbance was measured at 645 nm. Data are presented as mean 6 SD (n ¼ 3).
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80 mg/mL. Spontaneous LDH release of the negative control
ranged in comparison from 1.5 to 1.9%. Results of the
experiments correlated well with data of the hemolysis tests
and demonstrated that under the chosen conditions the
presence of PMeOx polymers had no influence on the mem-
brane integrity of sheep erythrocytes and L929 mouse fibro-
blasts independent of the polymer molar mass.
Long-term treatments were investigated via MTT tests with
incubation times of 3, 12, and 24 h, respectively (Fig. 4). A
preliminary experiment performed with the PMeOx solutions
without cells confirmed that the presence of test polymers
up to 80 mg/mL did not affect the chemical reaction of the
assay and the spectrophotometric measurement (data not
shown). Cell viability of 100% was obtained from cells
treated only with culture medium (negative control). As posi-
tive control a 0.02% thiomersal solution which reduced the
average cell viability to 0.23%, was used. According to the
specifications of ISO 10993-5, cell viability <70% was
regarded as cytotoxic.
As shown in Figure 4(a,b), after 3 and 12 h incubation 4,
10, and 20 kDa PMeOx had no influence on the cell viabil-
ity of L929 cells. Only 2 kDa PMeOx at the highest concen-
tration of 80 mg/mL reduced the cell viability to about 60
and 44%, after 3 and 12 h, respectively. After 24 h a con-
centration, time, and molar mass dependent increase in cy-
totoxicity could be detected. At the highest concentration
only 20 kDa PMeOx showed a cell viability higher than
70%. From the results of the MTT assay it could by con-
cluded that the molar mass of the polymers seems to play
an important role for the biocompatibility of PMeOx. Micro-
scopic observations made before and after the polymer
treatment confirmed the results of the MTT assay. L929
fibroblasts treated with culture medium or non-toxic poly-
mer solutions were adhesive, grew as confluent monolayers
and were typically spindle-shaped. Cells treated with thio-
mersal solution and toxic polymer solutions showed a
reduction of the total cell number as well as changes in
morphology such as rounding and detachment from the
dish bottom.
The high biocompatibility at concentrations < 40 mg/mL is
comparable with data from the literature. PMeOx with molar
masses of 4 and 8.5 kDa tested at maximum concentrations
of 20 and 5 mg/mL, respectively, showed no reduction of
cell viability.14,15
CONCLUSION
Concluding the in vitro toxicity studies, no toxic effects of
the PMeOx polymers of molar masses up to 20 kDa could be
detected in red blood cells and short term L929 cell (LDH)
assays. Only in long term treatments (MTT assay) at concen-
trations higher than typically used in biomedical applica-
tions, polymers were found to moderately influence the
viability of cells in a time, concentration, and molar mass de-
pendent manner. Unspecific effects such as changes of pH
FIGURE 3 Concentration dependent LDH release of PMeOx polymers after treatment for 0 h (a), 1 h (b), 2 h (c), 4 h (d). LDH levels
lower than 10% (plotted line) were regarded as non-toxic. Results are presented as mean 6 SD of three determinations.
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG ARTICLE
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2013, 51, 1816–1821 1819
value or osmolarity of the medium by the polymer solutions
could be excluded. Therefore, PMeOx represents a promising
polymer for many biomedical applications, since it possesses
not only an easy synthetic access and beneficial physico-
chemical characteristics like low viscosity and high stability,
but additionally excellent in vitro toxicological features.
EXPERIMENTAL
Experimental details including polymerization procedure,
physicochemical properties, and biological investigations are
provided in the Supporting Information.
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Experimental Section 
 
Synthesis and Physicochemical Characterization of Poly(2-methyl-2-oxazoline) 
Prior to use, the microwave vials were heated at 110 °C overnight and allowed to cool down 
to room temperature under an argon atmosphere. All polymerizations were performed under 
controlled temperature in an initiator sixty single-mode microwave synthesizer from Biotage, 
equipped with a non-invasive IR sensor (accuracy: ±2%). Methyl tosylate and 2-methyl-2-
oxazoline (MeOx, Acros Organics, Geel, Belgium) were distilled to dryness over barium 
oxide (BaO) and stored under argon. A stock solution of dry acetonitrile (Acros Organics, 
Geel Belgium), 2-methyl-2-oxazoline (MeOx) (monomer), and methyl tosylate (initiator) was 
prepared with a total monomer concentration of 4 M. As total monomer-to-initiator ratios 23, 
47, 118, and 236 were chosen. The stock solutions were divided over 4 to 5 vials and heated 
in the microwave synthesizer at 140 °C for a predetermined time. After cooling to room 
temperature, samples for the determination of the molar mass (distribution) by size exclusion 
chromatography and the monomer conversion by 1H NMR spectroscopy were prepared. 
Subsequently, the solvent was removed. The polymers were re-dissolved in dichloromethane 
and precipitated in ice-cold diethyl ether. After drying under reduced pressure at 40 °C, the 
polymers were dissolved in water and stirred with basic loaded amberlite for 24 h. The resin 
 - 2 - 
was filtered off, the polymer was washed with water, and the solvent was evaporated under 
reduced pressure. The polymer samples were dried for several days at 40 °C in vacuo, 
followed by lyophilization. 
Molar masses and polydispersity indices were determined by size-exclusion chromatography 
(SEC) on an Agilent Technologies 1200 Series size-exclusion chromatography system 
equipped with a G131A isocratic pump, G1329A autosampler, G1362A refractive index 
detector as well as a PSS Gram 30 and a PSS Gram 1000 columns both placed in series. As 
eluent a 2.1% lithiumchloride solution in N,N-dimethylacetamide, running at 1 mL/min flow 
rate and a column oven temperature of 40 °C, was used. Molar masses were calculated against 
polystyrene standards. 1H NMR spectra were recorded on a Bruker AC 300 MHz 
spectrometer at room temperature with deuterated chloroform as solvent. The chemical shifts 
were given in ppm relative to the signal from residual non-deuterated solvent. 
 
Aggregation Behavior of Red Blood Cells 
Erythrocyte aggregation of poly(2-methyl-2-oxazoline) (PMeOx) polymers was quantitatively 
determined by a modified spectrophotometric method according to Cardoso et al.[1] and 
qualitatively by light microscopy with a modified method of Ogris et al.[2] Sheep blood was 
collected in heparinized-tubes. Erythrocytes were separated by centrifugation at 2880 g for 5 
min (Eppendorf Centrifuge 5804R, Eppendorf, Hamburg, Germany) and washed three times 
with ice cold phosphate buffered saline (PBS) (8 mM disodium hydrogen phosphate, 1.5 mM 
potassium dihydrogen phosphate, 137 mM sodium chloride and 2.7 mM potassium chloride) 
via centrifugation at 2,880 g for 5 min. Finally, erythrocytes were resuspended in PBS (9.4 
million erythrocytes/mL). PMeOx solutions were prepared in PBS and sterilized by filtration 
(0.2 μm, VWR international, Darmstadt, Germany). To test the filterability of PMeOx 
gravimetric measurements of aqueous polymer stock solutions (80 mg/mL) before and after 
filtration were performed.  
 - 3 - 
Osmolarity and pH of the PMeOx stock solutions were routinely measured with a ?350 pH 
meter (Beckman Coulter, Krefeld, Germany) and a semi-micro osmometer (Knauer, Berlin, 
Germany). Negative controls were obtained by incubating the erythrocytes with buffer 
solution. Branched poly(ethylene imine) (30 μg/mL 25 kDa bPEI, kind gift of BASF 
corporation, Ludwigshafen, Germany) was used as positive control. For the experiments, 
polymer solutions or the controls each in a volume of 50 μL were placed in a clear flat 
bottomed 96-well culture plate (Greiner Bio-One, Frickenhausen, Germany). Afterwards, 50 
μL erythrocyte suspension were added to each well and the plates were incubated under 
vigorous shaking at 37 °C for 2 h. Absorbance was measured at 645 nm in a Fluostar 
OPTIMA microplate reader (BMG Labtech, Offenburg, Germany). Blank values were 
obtained by measuring pure PBS and the received values were substracted from the sample 
values. Two different parameters of the curves were evaluated. Firstly, the curve progression 
with increasing polymer concentrations and, secondly, the differences between the absorbance 
values of the samples, the negative and positive control. Simultaneously, qualitative 
erythrocyte aggregation was investigated with a Leica inverse phase contrast microscope 
(Leica DM IL, Leica, Wetzlar, Germany) equipped with an objective (Achromat 20/0.30 
Phaco 1a objective, Leica) at 200× magnification. The degree of aggregation was classified 
with a three-stage system. Discrete erythrocytes staying free in suspension were rated as stage 
1 and corresponded to the treatment with PBS. Low aggregation with the formation of few 
rouleaux but with the majority of cells still discrete was ranked as stage 2. Stage 3 was 
determined with 25 kDa bPEI causing almost all erythrocytes to aggregate in large clusters. 
All experiments were run in triplicate and repeated once. 
 
Quantification of Red Blood Cell Hemolysis  
A modified spectrophotometric method of Parnham and Wetzig was used to detect the 
hemolytic activity of PMeOx.[3] Erythrocyte suspensions and polymer dissolutions were 
 - 4 - 
prepared as described above. Spontaneous hemolysis was determined by the treatment with 
PBS (negative control). Erythrocytes treated with 1% Triton X-100 (Ferak, Berlin, Germany) 
provided the 100% hemolysis value (positive control). Polymer or control solutions (500 μL) 
were placed in a 96-deepwell plate (Nunc, Roskilde, Denmark) and mixed with 500 μL 
erythrocyte suspension followed by an incubation under shaking at 37 °C for 1 h and a 
centrifugation at 2,250 g for 5 min (Eppendorf Centrifuge 5804R). One hundred μL 
supernatant were sampled and transferred in a clear flat bottomed 96-well culture plate 
(Greiner Bio-One). Solutions of all samples and controls were additionally added on the same 
plate to determine the blank values. Hemoglobin released in the supernatant was quantified at 
544 nm with a Fluostar Optima plate reader and the percentage hemolysis was calculated 
according to the following equation: 
Equation 1: 
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control
Positive
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control
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BlankAbsorption
BlankAbsorptionBlankAbsorption
Hemolysis  
Results were evaluated according to specifications of the ASTM (American Society for 
Testing and Materials) F756-08 standard which describes a hemoglobin release of >5%, 2% 
to 5%, 0% to 2%, of the total release as hemolytic, slightly hemolytic, non-hemolytic, 
respectively.[4] Experiments were run in triplicate and were repeated once.  
 
Lactate Dehydrogenase (LDH) Assay 
L929 mouse fibroblasts were received from the German Collection of Microorganisms and 
Cell Cultures (DSMZ, Braunschweig, Germany). The cells were incubated at 37 °C, 5% CO2 
and 95% relative humidity (r.h.) in Roswell Park Memorial Institute 1640 culture medium 
(RPMI 1640) (PAA, Pasching, Austria) containing 10% fetal bovine serum Gold (FBS Gold) 
(PAA) and 2 mM glutamine. L929 cells (100,000/well) were seeded in 12-well cell culture 
plates (Greiner Bio-One) in RPMI 1640 with 10% FBS and incubated for 48 h. Afterwards, 
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culture medium was aspirated and sample solutions were added (2 mL/well). Polymer 
solutions (40, 60, 80 mg/mL, respectivly) were prepared in RPMI 1640 medium without FBS 
and phenol red (PAA) and sterilized by filtration. After 0, 1, 2 and 4 h incubation 120 μL 
aliquots were drawn from the supernatant. Released LDH was determined by a LDH 
dependent dye conversion using a commercial cytotoxicity assay kit (Cayman, Ann Arbor, 
USA) for spectrophotometric quantification at 490 nm. Spontaneous LDH release was 
obtained by treatment of the cells with culture medium (negative control). Complete cell lysis 
and 100% LDH release was determined with 0.1% Triton X-100 solution (positive control). 
Blanks were obtained from the measurement of pure culture medium. As described by 
Choksakulnimitr et al.[5] a percental LDH release > 10% was regarded as cytotoxic and 
calculated with the following equation: 
 
Equation 2. 
 
Cell Viability Assay  
The (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (MTT) assay was 
performed according to a modified method of Fischer et al.[6] and Mosmann.[7] Briefly, 
PMeOx stock solutions were prepared in RPMI 1640 with 10% FBS and sterilized by 
filtration. L929 cells (8,500 cells/well) were seeded into 96-well plates (Greiner Bio-One) and 
incubated at 37 °C in RPMI 1640 with 10% FBS for 24 h. Afterwards, culture medium was 
replaced by 100 μL PMeOx solutions (5 to 80 mg/mL). Samples were aspirated after 3, 12 
and 24 h, and 200 μL MTT (0.5 mg/mL, Sigma) in RPMI 1640 without FBS were added. 
After further 4 h incubation the MTT solution was aspirated and the formazane crystals were 
dissolved in 200 μL dimethyl sulfoxide (Carl Roth, Karlsruhe, Germany). Samples were 
analyzed with a Fluostar Optima microplate reader at 570 nm. Zero absorbance (blank) was 
obtained by the measurement of pure culture medium. Cells incubated with culture medium 
? ?
? ? 100*ntrolPositiveco
Sample
Sample A
A
LDHrelease ?
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served as negative control (100% viability). Thiomersal (0.02%) in culture medium was used 
as positive control decreasing the cell viability to 0%. Cell viability (%) was calculated after 
subtracting the blank from all values with the following equation: 
 
Equation 3. 
 
Results were evaluated as given in the ISO 10993-5 which describe cell viability below 70% 
in comparison to the negative control as cytotoxic.[8] Experiments were run in 7 parallel 
experiments and were repeated once. Morphological changes of the fibroblasts were 
additionally investigated with an inverse phase contrast microscope with an Achromat 10/0.20 
Phaco 1a objective (Leica) at 100x magnification. Evaluation was performed using the staging 
system of ISO 10993-5.  
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Figure S1. Influence of osmolarity on the cell viability of L929 mouse fibroblasts after 3 h, 12 h and 
24 h incubation testing cell culture medium of osmolarities up to 650 mosmol/kg. Cell viability was 
determined by MTT assay. Data are presented as mean ± SD of seven determinations. 
 - 8 - 
 
 
Figure S2. Representative light microscopic photographs (magnification: 200x) of erythrocyte 
aggregation induced by PMeOx at the highest concentration of 80 mg/mL after 2 h incubation. (a) 
Positive control (30 μg/mL 25 kDa bPEI); (b) negative control (PBS buffer); (c) 2 kDa PMeOx; (d) 4 
kDa PMeOx; (e) 10 kDa PMeOx; (f) 20 kDa PMeOx.  
 - 9 - 
Table S1 Physicochemical characteristics of the PMeOx polymers. The experimental molar mass was 
calculated by 1H NMR spectroscopy, number average (Mn) and polydispersity index (PDI) values were 
determined by SEC (eluent: N,N-dimethylacetamide containing 2.1 g/L LiCl; polystyrene standards).  
Polymer 
Experimental 
molar mass 
(Da) 
Mn 
(kDa) PDI
 
2 kDa PMeOx 2,000 3,700 1.17 
4 kDa PMeOx 4,000 6,700 1.20 
10 kDa PMeOx 10,000 12,300 1.39 
20 kDa PMeOx 20,000 19,000 1.44 
 
 
Table S2 Osmolarities of PMeOx polymer stock solutions at 80 mg/mL in PBS buffer and RPMI culture 
medium with 10% FCS (for MTT assay) and without FCS (for LDH assay).  
Polymer PBS buffer (mosmol/kg) 
RPMI with 10% 
FCS 
(mosmol/kg) 
RPMI without 
FCS 
(mosmol/kg) 
Reference 
(pure buffer or 
medium without 
PMeOx) 
280 280 280 
2 kDa PMeOx 365 420 335 
4 kDa PMeOx 365 400 345 
10 kDa PMeOx 366 360 335 
20 kDa PMeOx 358 340 335 
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Zwitterionic poly(2-oxazoline)s as promising
candidates for blood contacting applications†
Lutz Tauhardt,ab David Pretzel,ab Kristian Kempe,‡ab Michael Gottschaldt,ab
Dirk Pohlersc and Ulrich S. Schubert*abd
Wereport thesynthesisofhighlyhemo-andcytocompatiblezwitterionic2-oxazoline-basedpoly(sulfobetaine)s
andpoly(carboxybetaine)s,whichdemonstrate beneﬁcial anticoagulant activity. Thepolymerswereobtainedby
thiol–ene photoaddition of a tertiary amine-containing thiol onto an alkene-containing precursor copoly-
(2-oxazoline), followed by betainization with 1,3-propansultone and b-propiolactone. The polymers and their
intermediates were characterized by means of 1H NMR spectroscopy and size exclusion chromatography.
The inﬂuence of the zwitterionic polymers on the aggregation and hemolysis of erythrocytes, the
whole blood viscosity, the platelet and complement activation as well as the blood coagulation has been
studied in detail. In addition, the cytotoxicity of the materials has been evaluated. It was found that the
zwitterionic POx show no negative interactions with blood. Moreover, anticoagulant activity via the intrinsic
and/or the common coagulation pathway was observed. The high hemocompatibility and the low
cytotoxicity as well as the beneﬁcial anticoagulant activity of the presented zwitterionic poly(2-oxazoline)s
demonstrate their potential for the use in biomedical applications.
Introduction
Zwitterionic polymers, also known as poly(betaine)s, are of
signicant interest as coating materials for medical devices,
implants and drug delivery systems. Due to their hydrophilic,
protein repellent character, they have been investigated as
antifouling coatings for the reduction of non-specic adhesion
and adsorption of proteins, microorganisms and eukaryotic
cells.1–4 The most prominent zwitterionic polymer is poly-
(2-methacryloyloxyethyl phosphorylcholine). It can be obtained
by the controlled radical polymerization of the commercially
available 2-methacryloyloxyethyl phosphorylcholine5,6 and is
used as coating material, e.g., in contact lenses.7,8 Other widely-
used zwitterionic polymers are poly(sulfobetaine)s and poly-
(carboxybetaine)s. Generally, they are obtained either by
controlled radical polymerization of appropriate zwitterionic
monomers, which are usually based on 2-(N,N-dimethylamino)-
ethyl methacrylate (DMAEMA),1–4,9–12 or by post-polymerization
modication of poly(DMAEMA) (co)polymers.13,14 An
outstanding property of these polymers is their excellent blood
compatibility which, in some cases, is going along with an
anticoagulant activity leading to a prolongation of the blood
clotting time.10–12,15,16 This is important within medical appli-
cations where thrombogenicity is undesired.
In a dissolved state, anticoagulant polymers are of particular
interest as heparin mimetics. Heparin, a well-known poly-
saccharide with multiple negative charges per repeating unit, is
a widely used anticoagulant reagent for the treatment and
prevention of thrombosis, which can result from operations,
blood transfusions, or dialysis. However, being obtained from
animal tissues sources, the use of heparin comes along with
some problems, e.g. contaminations, a heterogeneous eﬀec-
tiveness depending on the isolated batches, and most impor-
tantly, heparin can lead to autoimmune diseases in long term
treated patients.17 Therefore, biocompatible anticoagulant
polymers, which can be synthesized in a standardized proce-
dure yielding products with identical chemical and functional
characteristics, display a promising alternative to heparin salts.
Anticoagulant polymers are also of interest for drug delivery
and diagnostic approaches. Here, the prevention of non-specic
and immunologic interactions of the carriers (nanoparticles,
micelles, vesicles, etc.) with the various blood components (e.g.
cells, proteins), represents an important task.
By using biocompatible, anticoagulant “stealth” polymers an
improved stability and blood circulation time can be reached,
promoting the diagnostic or therapeutic functions.18
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If such anticoagulant polymers can be additionally attached
to solid surfaces, the application eld is further enlarged and
includes the biomedically relevant area of implant material
functionalization. Existing synthetic biomaterials introduced
into the human body, e.g. as implantable devices, oen suﬀer
from problems associated with surface-induced thrombosis,
clot formation, and infection. Implants coated with non-
thrombogenic, biocompatible materials would not only reduce
the need for aggressive anticoagulant therapies, they would also
be benecial for cardiovascular applications, where the blood
response to articial materials, including thrombosis and
platelet deposition, limits the long-term eﬃcacy. The surface
modication of these devices with anticoagulant polymers
could increase their working life span due to an increased
biocompatibility.19
Furthermore, zwitterionic, anticoagulant polymers are
promising materials for extracorporeal blood contacting appli-
cations, in particular dialysis membranes, which are massively
used to separate metabolites from blood of patients with
nephrologic diseases. Here the blocking of the membrane pores
by blood clot formation and biofouling needs to be prevented.
A class of polymers with a high biocompatibility and anti-
fouling properties are poly(2-oxazoline)s (POx), in particular the
water soluble (co)polymers based on 2-methyl-2-oxazoline
(MeOx) and 2-ethyl-2-oxazoline (EtOx).20–28 They exhibit similar
properties as poly(ethylene glycol) (PEG),29 but have some
additional advantages such as a lower viscosity23,30 and a less
demanding synthesis, since no gaseous and highly toxic
starting materials have to be used. Although having excellent
blood compatibility, there are no reports on anticoagulant POx
to the best of our knowledge. In contrast, a study published
recently showed that POx-based copolymers have no impact on
the blood clotting time.31 The synthesis of POx by living cationic
ring-opening polymerization (CROP) and the broad variety of
functional 2-oxazoline monomers, initiators, and terminating
agents, enable the preparation of tailor-made polymers, with
adjustable molar masses, narrowmolar mass distributions, and
tunable properties.32–37 Previously, well-dened (co)polymers
based on 2-(3-butenyl)-2-oxazoline (ButEnOx)38–40 and
2-(9-decenyl)-2-oxazoline (DecEnOx)41–45 have been reported,
which provide a platform for eﬃcient post-polymerization
modications via thiol–ene photoaddition and, thus, enable the
introduction of further functionalities.
Here we report the synthesis of zwitterionic POx and the
evaluation of their blood compatibility with the focus on blood
clotting. To this end, a double bond containing copolymer of
ButEnOx and EtOx was prepared. Modication with 2-dime-
thylaminoethanethiol hydrochloride by thiole–ene addition
resulted in the introduction of tertiary amine pendant groups.
Subsequent functionalization with 1,3-propansultone and
b-propiolactone yielded zwitterionic POx, a sulfobetaine POx
(SB-POx) and a carboxybetaine POx (CB-POx), respectively. For
comparison, a PEtOx homopolymer was prepared. All polymers
were characterized by 1H NMR spectroscopy and size exclusion
chromatography (SEC). The inuence of the polymers on the
aggregation and hemolysis of erythrocytes, the whole blood
Scheme 1 Schematic representation of the synthesis of zwitterionic POx.
5752 | Polym. Chem., 2014, 5, 5751–5764 This journal is © The Royal Society of Chemistry 2014
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viscosity, the platelet and complement activation as well as the
blood coagulation was studied. Moreover, their cytotoxic activity
was investigated.
Results and discussion
Synthesis of amine end-functionalized P(EtOx30-stat-
ButEnOx10) and PEtOx40
The synthesis of water-soluble zwitterionic POx was accom-
plished via the post-polymerization modication of ButEnOx-
based copolymers. First, the kinetics of the copolymerization of
EtOx and ButEnOx has been investigated. As already reported for
the methyl triate initiated copolymerization at 70 C, also the
methyl tosylate initiated reaction at 140 C shows a rst-order
kinetic behavior (Fig. S1A†).40 The observed linear increase of
ln([M]0/[M]t) with time, demonstrates a constant concentration
of propagating species indicative of a living polymerization
mechanism. However, due to the higher temperature, the poly-
merization proceeded much faster with polymerization
constants of kp(EtOx) ¼ 0.206 L mol1 s1 and kp(ButEnOx) ¼
0.188 L mol1 s1 (Table S1, Fig. S1A†). The similar conversions
of both monomers indicate the formation of a random copol-
ymer. In addition, characterization by size exclusion chroma-
tography (SEC) showed an increasing molar mass with time and
narrow molar mass distributions (Table S1, Fig. S1B†).
For the intended synthesis of zwitterionic POx, amine end-
functionalized P(EtOx30-stat-ButEnOx10) (2) was prepared as a
starting material in an easy, two-step procedure (Scheme 1). To
this end, the living species of the CROP was quenched with
potassium phthalimide. The end-capping eﬃciency was
calculated to be 100% according to 1H NMR spectroscopy
(Fig. S1†). Subsequent hydrazinolysis yielded a terminal amine
group, which can be used for further reactions, e.g. labeling or
surface attachment. While the double bond signals at 5.87 ppm
and 5.04 ppm remained unchanged, the signal of the phthali-
mide end-group disappeared in the 1H NMR spectrum, indi-
cating the success of the reaction (Fig. S1†). Characterization by
SEC revealed a narrow molar mass distribution for both phtha-
limide and amine end-functionalized polymers (Table S1†) with
monomodal distributions (Fig. S2†). For comparison an amine
end-functionalized PEtOx homopolymer with a degree of poly-
merization of 40 has been prepared using the same procedure.
Thiol–ene photoaddition and betainization
In the next step the double bonds of the ButEnOx repeating units
were functionalized with 2-dimethylaminoethanethiol hydro-
chloride by thiol–ene photoaddition reaction. The resulting
tertiary amine group is essential for the subsequent betainiza-
tion with 1,3-propansultone and b-propiolactone, respectively.
The hydrochloride, which hampered the direct betainization
under various conditions, was neutralized by dissolving the
polymer in water and adding aqueous NaOH up to a pH of 14.
Aer removing the water, the polymer was separated from the
resulting salt by extraction with chloroform. The structure of the
obtained P(EtOx30-stat-tAmOx10) (3) resembles that of poly-
(DMAEMA), a well-known starting material for the synthesis of
zwitterionic polymers. Characterization by 1H NMR spectros-
copy did not only show the success of the thiol–ene photo-
addition, i.e. the disappearance of the double bond signals, but
Fig. 1 1H NMR spectra of P(EtOx30-stat-tAmOx10) (top) before and (bottom) after treatment with aqueous NaOH (300 MHz, CD3OD).
This journal is © The Royal Society of Chemistry 2014 Polym. Chem., 2014, 5, 5751–5764 | 5753
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also a shi of the signals of the CH3 groups of the tertiary amine
and the adjacent CH2 group to lower ppm values aer treatment
with aqueous NaOH (Fig. 1). SEC measurements revealed an
increasing molar mass aer the photoaddition (Table S2†).
In the last step, the zwitterionic structures were formed by
reacting P(EtOx30-stat-tAmOx10) with 1,3-propansultone (60 C)
and b-propiolactone (room temperature), respectively, in
acetonitrile for one day. The successful quaternization of the
tertiary amine group was proven by 1H NMR spectroscopy
(Fig. 2). The signals for the methyl groups attached to the amine
group were shied to higher ppm values. Moreover, new peaks,
deriving from the methylene groups between the quaternized
nitrogen and the head groups of the betaines, are visible.
Depending on the system, characterization by SEC showed
either an increasing (solvent: DMAc + 0.21% LiCl) or a
decreasing (CHCl3 + TEA + iPrOH (94 : 4 : 2)) molar mass when
compared to the PEG standards. On the SEC system running
with DMAc + 0.21% LiCl both polymers show a shoulder at
lower elution volumes, i.e. higher molar masses. The shoulders
were observed neither for the startingmaterials on both systems
nor for the sulfobetaine POx (SB-POx) when measured on a SEC
system running with CHCl3+ TEA + iPrOH (94 : 4 : 2). They
probably derive from strong interactions of the zwitterionc
polymers with the particular column, since chain coupling is
very unlikely. The carboxybetaine POx (CB-POx) was only soluble
in DMAc so that a direct comparison was not possible.
In vitro cytotoxicity
To prove the applicability of the prepared zwitterionic polymers
for biomedical applications, the in vitro biocompatibility was
investigated. Therefore, the cytocompatibility of the polymers
was studied following a standardized protocol.
The in vitro cytotoxicity was evaluated on the basis of an XTT
assay using mouse broblast L929 cells and human hepatocytes
HepG2 (Fig. 3A). Neither PEtOx nor the zwitterionic polymers
revealed any cytotoxic eﬀect aer 24 h incubation at diﬀerent
concentrations (ranging from 0.1 to 10mgmL1). A detailed live/
dead microscopy study of the polymer treated cells conrmed
theirmembrane integrity (exclusionof reduorescentpropidium
iodide (PI) from cell nuclei) and their excellent viability (strong
green uorescence of uorescein diacetate (FDA) in cytoplasm)
(Fig. 3B). In summary, no cytotoxic eﬀect caused by the zwitter-
ionic polymers was observed. These results conrm the low
cytotoxicities previously reported for POx homopolymers and
copolymers20–24,26,27,34,46–48 as well as zwitterionic materials.49–51
Erythrocyte aggregation and hemolysis
As blood is the rst contact partner within the human body
during intravenous administration, the polymers were tested
for their general blood compatibility.
Adverse side reactions with red blood cells were evaluated in
terms of erythrocyte aggregation and hemolysis upon polymer
incubation. To assess the inuence of the zwitterionic polymers
on the red blood cell membrane, the hemolytic activity was
measured photometrically by means of hemoglobin release
aer potential damage of erythrocytes. The polymers were
investigated at diﬀerent concentrations (1, 5, and 10 mg mL1)
in comparison to phosphate buﬀered saline (PBS) as negative
and Triton-X100 as positive control. Both, the PEtOx and the
zwitterionic polymers revealed a hemoglobin release below 2%,
proving that they do not damage the erythrocyte membrane
(Fig. 4A). Furthermore, the induction of erythrocyte aggregation
was investigated to assess the blood compatibility of the poly-
mers. Formation of aggregates, which could lead to an impeded
Fig. 2 1H NMR spectra of the POx-based (top) poly(sulfobetaine) and (bottom) poly(carboxybetaine) (300 MHz, CD3OD).
5754 | Polym. Chem., 2014, 5, 5751–5764 This journal is © The Royal Society of Chemistry 2014
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blood ow, was analyzed by UV/Vis absorption measurements
for diﬀerent polymer concentrations (1, 5, and 10 mg mL1) in
comparison to phosphate buﬀered saline (PBS) as negative and
branched poly(ethylene imine) (bPEI) as positive control
(Fig. 4B). No cluster formation was observed photometrically in
the polymer treated samples and the negative control. In
contrast, the positive control clearly exhibited a cell cluster
formation. These results could be conrmed microscopically
(Fig. 4C).
To conclude, no adverse side reactions with red blood
cells, representing the major cellular compartment of the
blood, were observed for the two zwitterionic polymers and
the PEtOx reference polymer. On that basis, all three poly-
mers were submitted to an even more detailed blood
compatibility analysis. This included the analysis of possible
impacts on undesired alterations of the blood viscosity,
platelet activation, complement factor activation, and nally a
detailed look at possible modulations of the coagulation
pathways.52
Blood viscosity
Polymers entering the blood stream could possibly interfere
with diﬀerent blood components, such as plasma proteins and
cellular membrane structures of blood cells, leading to a critical
change of the whole blood viscosity. Since an appropriate blood
viscosity is crucial for the proper function of blood, alterations
would have a severe impact on the cardiovascular system and
heart function. Measuring the blood viscosity following incu-
bation with polymers allows the unspecic estimation of strong
mutual reactions of the polymers with whole blood components.
The whole blood viscosity was measured aer the addition of
the polymers in diﬀerent concentrations (1, 5, and 10 mg mL1,
respectively). Todistinguishbetweena change in viscosity caused
by the intrinsic viscosity of the polymer and a polymer mediated
interaction or aggregation of blood components, the viscosities
of the blood/polymer solutions as well as the corresponding
solutions containing only polymer (in PBS) at equivalent
concentrations were compared. It turned out that the concen-
tration dependent increase of the blood viscosity can be fully
attributed to the intrinsic viscosity of the added polymer (Fig. 5).
As a consequence, no substantial interactions of the polymers
with blood components leading to an increase or decrease of the
blood viscosity were observed. The slightly increased values
obtained by the addition of highly concentrated polymer solu-
tions are in the physiological tolerable range.53 Besides, it is
rather unlikely, that a biomedically used polymer will be
administered to the blood ow at such high concentrations.
Platelet activation
The activation of platelets at sites of damaged blood vessels
displays a very early event in the complex process of primary
hemostasis, which is nally leading to the plug like coagulation
of blood via the formation of brin stabilized platelet aggre-
gates. By introducing a polymeric material this sensitive system
can be fatally destabilized. A malfunction of platelets could
provoke excessive bleeding, whereas an exceeding platelet
activity would cause spontaneous blood clot formation result-
ing in a life-threatening clogging of vessels.
Immunologically, platelets can be distinguished from other
blood cells by the constitutive expression of the surface antigen
CD42.Additionally, theCD62p (P-selectin)membraneglycoprotein
is exclusively induced on activated platelets. The latter marker was
used to identify the status of activation in human platelets upon
incubation with the polymers. The measurement of the CD42/
CD62p co-expression in platelet samples treatedwith the polymers
at diﬀerent concentrations (1, 5, and 10mgmL1) and incubation
times (10 and 30 min) revealed that there was no eﬀect of the
zwitterionic polymers as well as the PEtOx control polymer on the
CD62p expression in CD42 positive cells. The percentage of acti-
vated platelet phenotype in terms of CD62p positive cells stayed at
the constant low level of the control sample treated only with PBS.
To exclude measurement errors, platelets of the positive
control were treated with thrombin, an endogenous inducer of
platelet activation. Within 10 min an immediate up-regulation
of up to 95% of the CD62 expression was observed, indicating
the sensitivity and proper setup of the assay (Fig. 6).
Fig. 3 (A) Cell viability of L929 mouse ﬁbroblasts and human hepa-
tocytes HepG2 after incubation with zwitterionic polymers up to 10
mg mL1 for 24 hours. Cells incubated with polymer free culture
medium served as control. The cell viability was determined by XTT
assay according to ISO 10993-5. Data are expressed as mean  SD of
six determinations. (B) Representative bright ﬁeld and ﬂuorescence
micrographs of Hoechst 33342/FDA/PI stained L929 mouse ﬁbroblast
cells (upper panel) and human hepatocytes HepG2 (lower panel)
cultured for 24 hours in the presence of 10 mg mL1 of CB-POx
(identical results for SB-POx and PEtOx). (1) Light ﬁeld image, (2) blue
ﬂuorescent Hoechst 33342 dye labels nuclei of all cells present, (3)
green ﬂuorescent FDA dye indicates cytoplasm of vital cells, (4) red
ﬂuorescent PI signals tag nuclei of dead cells, and (5) overlay of
Hoechst 33342 dye ﬂuorescence and green ﬂuorescence of the FDA
dye.
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Complement activation
A polymer introduced into the human organism is very likely to
be recognized as a foreign substance by the interaction with the
complement system, which plays a crucial role in the detection,
opsonization and clearance of the host components,
microorganisms and cells. Complement factors are a group of
proteins acting in diﬀerent cascade like activation pathways,
including the interaction of complement factors with antibody–
antigen complexes and bacterial carbohydrates as well as the
binding to foreign surfaces. As a consequence, either macro-
phages recognize and phagocytose these elements or so called
membrane attack complexes lead to a lysis of opsonized cells.54
Even though the complement activation pathways are very
complex they share the generation of the enzyme C3-convertase,
which is able to activate complement component C3 creating
C3b and C3a. Hence the anaphylatoxin C3a was used within a
commercial immunoassay kit to detect the general activation of
the complement system upon interaction with the zwitterionic
polymers.52,55 C3a levels were measured aer incubation for 10,
30, and 60 min with diﬀerent concentrations of the polymers
(1, 5, and 10 mg mL1) and compared to a saline control and
C3a low/high standards (Fig. 7). No activation of the comple-
ment system was observed following the incubation with the
zwitterionic polymers and the PEtOx control. In all cases the
C3a levels remained on the level of the negative control con-
taining only saline.
Similar results were found in a previous study analyzing the
eﬀect of zwitterionic structures on blood compatibility issues
where only a slight increase of the C3a concentration occurred
compared to the negative control.56
Fig. 4 Blood compatibility of PEtOx and zwitterionic POx-based polymers. (A) Photometric determination of hemolytic activity after incubation
with diﬀerent polymer concentrations for 1 h at 37 C. Triton X-100 (1%) served as positive and PBS as negative control. Experiments were run in
triplicate and were repeated once; data are presented as the mean percentage SD of hemolytic activity compared to the positive control set as
100%. (B) Photometric determination of the erythrocyte aggregation after 2 h incubation at 37 Cwith polymers. 25 kDa bPEI (50 mgmL1) served
as positive and PBS as negative control. Experiments were run in triplicate and were repeated once; data are presented as the mean measured
absorbance  SD. (C) Representative micrographs of red blood cell aggregation after 2 h incubation at 37 C with polymers. PBS served as
negative and 25 kDa bPEI (50 mg mL1) as positive control.
Fig. 5 Blood compatibility of PEtOx and zwitterionic POx-based
polymers concerning their inﬂuence on the whole blood viscosity:
relative viscosity of the polymer solutions in PBS and in whole blood.
Experiments were run in quadruplicate at three inclination angles, data
are presented as the mean percentage  SD.
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Fig. 6 (A) FACS analysis of polymer mediated platelet activation measured by determination of CD62p/CD42 co-expression after 10 min
incubation. Experiments were run in triplicate, data are presented as percentage of platelets positive for both CD62p and CD42 epitopes SD. (B)
Representative dot-plots for the expression of CD62p and CD42 of a CB-POx treated sample and a thrombin treated positive control after 10min
incubation and, additionally, staining pattern of the isotype control. Non activated cells are in the lower right panel and only positive for CD42,
cells in the upper right panel of the dot plot diagrams are double positive for CD62p and CD42, indicating an activated platelet phenotype. The
absence of non-speciﬁc binding of the antibodies is proven by the very low ﬂuorescence signal of the platelets in the isotype control, where all
cells are located in the lower left panel. (C) Histogram plots. The faint colored graphs indicate the value of the isotype control and green/red
graph of the sample stained with the speciﬁc CD42 and CD62p antibodies.
Fig. 7 Complement activation by the polymers measured by determination of C3a levels after 10 min, 30 min, and 60 min incubation.
Experiments were run in triplicate and data are presented as the mean measured absorbance  SD of three determinations.
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Regarding the complement activation by POx-based mate-
rials, the literature reports divergent properties ranging from an
inert behavior to a slight or clear activation of the complement
system. In all cases, POx with diﬀerent ratios of hydrophilic and
hydrophobic domains have been investigated.31,57,58 Their
amphiphilic character resembles the structural setup of bio-
logical membranes which are, amongst others, a prominent
target of complement factors and thus might explain the
complement activation by these materials. In contrast, the POx-
based zwitterions in the present study are composed of a
copolymer with a clear hydrophilic character, which very likely
leads to the absence of any complement system activation.
Blood coagulation
The viscosity measurements of polymer treated whole blood
samples already proved that there was no signicant induction
of blood coagulation mediated by the zwitterionic polymers. A
deeper insight into possible interactions with the blood coag-
ulation system and a possibly altered coagulation ability of the
blood was gained by measuring parameters for the intrinsic (in
vivo triggered by contact to collagen exposed in damaged tissue)
and the extrinsic (in vivo activated by tissue factor released from
damaged tissue) pathway, which are both activating the nal
common coagulation pathway (conversion of brinogen into
brin).59 In the secondary hemostasis reaction, the coagulation
factors mediate the strengthening of the platelet plug formed in
the primary hemostasis reaction. An aberration of the cascade-
like activation of the coagulation factors, which are mainly
proteases and glycoprotein cofactors, could lead to pathologies
such as uncontrolled bleeding or thromboembolism. Even
though the division of coagulation into two pathways is origi-
nating from the substances used in the laboratory to initiate the
clotting (silica for the intrinsic and thromboplastin for the
extrinsic pathway) and, hence, is almost an articial division,
the activated partial thromboplastin time (APTT) and the
prothrombin time (PT) are routinely used to examinemainly the
intrinsic and extrinsic pathways, respectively. Since they both
end up in the nal common pathway, they indirectly demon-
strate the status of that pathway.
The PT assay revealed that for both the zwitterionic POx and
the PEtOx reference but also for the saline control, all PT values
were ca. 10 s, tting into the clinically normal range of 7 to 10 s
(Fig. 8A). It has to be mentioned at that point, that the PT assay,
which is using thromboplastin (a mixture of tissue factor and
phospholipids) as coagulation initiator, is preferentially sensi-
tive to coagulation factors II, V, VII and X and brinogen.60,61
Hence, the results suggest that an interaction of the zwitterionic
polymers with these components of the extrinsic and common
blood coagulation pathway can be excluded.
In contrast, the APTT values for the zwitterionic polymers
show a clear elongation of the time, which is required to form a
brin clot in the plasma. As measured with the Pathrombin SL
activator (Fig. 8B), the APTTs for theCB-POx at all concentrations
Fig. 8 Eﬀects of the polymers on the coagulation detected by (A) the prothrombin time (PT) and (B and C) the activated partial thromboplastin
time (APTT); after 5 min incubation. Experiments were run in triplicate and data are presented as the mean measured  SD. Hatched area
indicates the range of values judged as clinically normal.
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weremuch longer than the clinical range of 26 to 42 s [206 s (1mg
mL1); 220 s (5 mg mL1);[240 s (10 mg mL1)]. Also the SB-
POx induced a retarded, but less pronounced, coagulation time
depending on the used concentration [40 s (1 mg mL1); 92 s
(5 mg mL1); 109 s (10 mg mL1)]. Interestingly, PEtOx without
zwitterionic groups showed no inuence on the coagulation
characteristics (all APTT around 30 s), proving its completely
inert properties in this assay. These results were conrmed by
using a second APTT activator (SyntASiL), known to be sensitive
to even more coagulation factors (Fig. 8C).
The elongation in coagulation times, mediated by the zwit-
terionic polymers, indicates an anticoagulant activity most
probably via the intrinsic pathway and/or the common coagu-
lation pathway. This assumption is based on the fact that an
activation of extrinsic pathway components (as detectable by
the applied PT assay) was not observed and the APTT assays
utilized in this study are sensitive to a broad range of coagula-
tion factors from all three pathways (factors II, V, VIII, IX, X, XI
and XII).62–65
However, due to the partially overlapping specicity of the
assays and the many coagulation factors involved in the
diﬀerent pathways, one can only speculate about the interac-
tions of the investigated polymers with specic coagulation
factors. It is very likely that the sulfobetaine/carboxybetaine
groups interact with one or more of the downstream clotting
factors, but due to the above mentioned complexity of the
coagulation system, our preliminary study on the coagulation
pathways does not give suﬃcient information to speculate on
the mechanism of coagulation factor–polymer interactions.
Nevertheless, it is known that zwitterionic polymers based on
carboxy- and sulfobetaine functionalities exhibit anticoagulant
activity, mainly attributed to the high hydrophilicity and the
overall charge neutrality of the structures.9–12,15,16,56,66
From a methodological point of view, it might also be taken
into account that the tested zwitterionic polymers interfere
with the activation agents (silica particles and phospholipids),
which are necessary for the induction of the coagulation in
vitro. It is imaginable that, e.g., the surface of the silica parti-
cles could be shielded by the polymers creating an interfacial
hydration layer around these particles attenuating the activa-
tion reaction.
Conclusion
The blood compatibility of zwitterionic POx has been investi-
gated with special focus on the anticoagulant activity. There-
fore, a 2-oxazoline-based poly(carboxybetaine) (CB-POx) and a
poly(sulfobetaine) (SB-POx) have been prepared by post-poly-
merization modication of P(EtOx30-b-ButEnOx10). For
comparison a PEtOx homopolymer with the same overall degree
of polymerization (DP ¼ 40) has been synthesized. The poly-
mers were characterized by means of 1H NMR spectroscopy and
SEC, showing the suitability of the used synthesis route via
thiol–ene photoaddition with a tertiary amine-containing thiol
species followed by betainization. In vitro experiments revealed
an excellent cytocompatibility of both the PEtOx and the zwit-
terionic POx-based polymers, since no viability reduction
occurred in L929 mouse broblasts and human hepatocytes
HepG2 aer incubation with the polymers. Moreover, no
adverse reactions with human blood occurred in terms of
alterations of the whole blood viscosity. Also, no harmful eﬀects
were observed for the zwitterionic polymers and PEtOx in terms
of an induction of erythrocyte aggregation or lysis accompanied
by the absence of undesired platelet activation.
Additionally, no interference with the immune activation via
the complement system was detected. Exceedingly, an antico-
agulant activity via the components of the intrinsic and/or the
common coagulation pathway was observed for the poly-
(carboxybetaine)s and to a lesser extent for the poly-
(sulfobetaine)s, but not for the PEtOx reference.
The presented properties of the zwitterionic polymers make
them promising alternatives to the widely used anti-
thrombogenic heparin and further investigations concerning
the possible mode of action and in vivo activity should be per-
formed. Moreover, the zwitterionic polymers display promising
candidates for blood contacting materials, such as anti-
thrombogenic membranes (e.g., for blood dialysis) and
implants. In addition, their excellent biocompatibility
combined with their anticoagulant activity could be useful for
diagnostic and targeted delivery systems with the aim to reduce
unspecic interactions with blood components and thereby
increase their blood circulation time.
Experimental section
Chemicals and instrumentation
1,3-Propanesultone was obtained from Sigma Aldrich. Dry
acetonitrile, 2-dimethylaminoethanethiol hydrochloride,
b-propiolactone, EtOx, and methyl tosylate (MeOTs) were
purchased from Acros Organics. ButEnOx was prepared as
described earlier.40 EtOx, ButEnOx, and MeOTs were distilled to
dryness over barium oxide (BaO), and stored under nitrogen.
The synthesis of P(EtOx) homopolymer is described elsewhere.23
The amine end-functionalization was performed according to
the here reported procedure.
1H NMR spectra were recorded on a Bruker AC 300 MHz at
298 K. Chemical shis are reported in parts per million (ppm, d
scale) relative to the residual signal of the deuterated solvent.
Size exclusion chromatography (SEC) investigations of the
polymers were measured on two systems: (1) an Agilent Tech-
nologies 1200 Series gel permeation chromatography system
equippedwith a G1329A autosampler, a G131A isocratic pump, a
G1362A refractive index detector, and both a PSS Gram 30 and a
PSS Gram 1000 column placed in series. As eluent a 0.21% LiCl
solution in N,N-dimethylacetamide (DMAc) was used at 1 mL
min1 ow rate and a column oven temperature of 40 C. (2) A
Shimadzu system equippedwith a SCL-10AVP system controller,
a DGU-14A degasser, a LC-10AD VP pump, a RID-10A refractive
index detector and a PSS SDV column running with chloroform,
triethylamine (TEA), and 2-propanol (94 : 4 : 2) as eluent. The
Techlab column oven was set to 50 C. For both systems, molar
masses were calculated against poly(styrene) standards.
For the photometric absorbance measurement, a TECAN
Innite M200 PRO plate reader (TECAN, Crailsheim, Germany)
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was used tomeasure the absorption of samples from (a) the XTT
cytotoxicity assay (570 nm with a background correction of the
optical density (OD) at 690 nm), (b) the hemolysis of erythro-
cytes (540 nm with a background correction of the OD at
690 nm), (c) the photometric evaluation of erythrocyte aggre-
gation (645 nm), and (d) the activation of complement factors
C3a and SC5b-9 (450 nm). Each well containing the sample was
measured in four diﬀerent spots each with 10–25 ashes per
scan. The evaluation of platelet activation was performed by
ow cytometry (FC) measured on a Beckmann Coulter Cytomics
FC-500 equipped with Uniphase Argon ion laser, 488 nm,
20 mW output and analyzed with the Cytomics CXP soware.
The blood coagulation time was spectroscopically determined
with the clinical coagulation analyzer BCS XP 1.1 (Siemens
Healthcare Diagnostics, Marburg, Germany). Viscosity
measurements were conducted on an AMVn rolling ball
viscometer (Anton Paar, Graz, Austria) and the density of the
solutions was measured by a densitometer (DMA 4100, Anton
Paar, Graz, Austria). To visualize the viability of cells aer
incubation with the polymers, the blue/red/green uorescence
signal of cells cultured in a 96 well plate and stained with
Hoechst 33342/uorescein diacetate (FDA)/propidium iodide
(PI) was observed on a uorescence microscope (Cell Observer
Z1, Carl Zeiss, Jena, Germany) equipped with a mercury arc UV
lamp and the appropriate lter combinations for excitation and
detection of emission. Images of a series were captured with a
10 objective using identical instrument settings (e.g. UV lamp
power).
Erythrocyte aggregation was observed microscopically using
an inverse light microscope (Zeiss AX 10 Vert A1, 100 and 400
magnication).
Synthesis of phthalimide end-capped P(EtOx30-stat-
ButEnOx10) (1)
A solution of initiator (MeOTs), solvent (acetonitrile), and
monomers (EtOx, ButEnOx) was prepared with a [EtOx]/[ButE-
nOx]/[I] ratio of 30 : 10 : 1. The total monomer concentration
was adjusted to 3 M. The solution was heated at 140 C in a
microwave synthesizer for a predetermined time and subse-
quently cooled to room temperature. A 2-fold excess of potas-
sium phthalimide was added and the reaction mixture was
stirred at 70 C overnight. Aer ltration, the solvent was
removed. The residue was dissolved in dichloromethane and
washed with water, a saturated aqueous solution of NaHCO3,
and brine. The organic phase was dried over sodium sulfate,
ltered, and concentrated. Aer precipitation into ice-cold
diethyl ether, the polymer was dried at 40 C.
1H NMR (300 MHz, CD3OD): d 7.78–7.91 (br, CH of phthali-
mide), 5.79–5.95 (m, CH¼CH2), 4.92–5.13 (br, CH¼CH2), 3.35–
4.00 (br, CH2 backbone), 2.91–3.15 (m, initial CH3), 2.07–2.78
(br, CH2 side chains), 0.82–1.39 (br, CH3 side chain).
Synthesis of amine end-functionalized P(EtOx30-stat-
ButEnOx10) (2)
Phthalimide end-capped P(EtOx30-stat-ButEnOx10) was dis-
solved in ethanol and reuxed overnight with a 10-fold excess of
hydrazine monohydrate. Aer cooling to room temperature, the
pH was adjusted to 2–3 using concentrated HCl. The precipitate
ltered oﬀ and the ethanol was evaporated. Aer dissolving the
residue in water, aqueous NaOH was added up to pH 9 to 10.
The aqueous phase was extracted thrice with chloroform. The
combined organic layers were dried over sodium sulfate,
concentrated, and precipitated into ice-cold diethyl ether. The
white precipitate was ltered oﬀ and dried at 40 C under
reduced pressure.
1H NMR (300 MHz, CD3OD): d 5.79–5.95 (m, CH¼CH2), 4.91–
5.12 (br, CH¼CH2), 3.39–3.99 (br, CH2 backbone), 2.92–3.15 (m,
initial CH3), 2.10–2.68 (br, CH2 side chains), 0.83–1.81 (br, CH3
side chain).
Functionalization with 2-dimethylaminoethanethiol
hydrochloride (3)
A 5% solution of P(EtOx30-stat-ButEnOx10), 0.1 mol%
2,2-dimethoxy-2-phenylacetophenone (DMPA) per double bond,
and a 2-fold excess per double bond of 2-dimethylaminoetha-
nethiol hydrochloride in methanol was degassed with nitrogen
for 30 min. Subsequently, the reaction mixture was stirred in a
UV chamber (l ¼ 365 nm) overnight. The solvent was evapo-
rated. The polymer was dissolved in water and aqueous NaOH
was added up to pH 14. Aer evaporation of the water, chloro-
form was added and the salt removed by ltration. The organic
phase was dried over sodium sulfate, ltered, concentrated
under reduced pressure, and precipitated into ice-cold diethyl
ether. The product was dried under reduced pressure at 40 C
for three days.
1H NMR (300 MHz, CD3OD): d 3.30–3.72 (br, CH2 backbone),
2.83–3.04 (m, initial CH3), 2.20–2.77 (br, CH2 side chains), 2.04–
2.20 (br, N–CH3 side chains), 0.72–1.37 (br, CH3 side chain).
Betainization with 1,3-propanesultone (4)
To a 5% solution of P(EtOx30-stat-tAmOx10) in dry acetonitrile a
2-fold excess of 1,3-propanesultone per tertiary amine group
was added. The reaction mixture was stirred at 60 C overnight.
Subsequently, the solvent was concentrated and the polymer
precipitated into ice-cold diethyl ether. The product was dried
under reduced pressure at 40 C for three days. At last, the
product was dissolved in a small amount of water and
lyophilized.
1H NMR (300 MHz, CD3OD): d 3.39–3.99 (br, CH2 backbone),
3.09–3.27 (br, N–CH3), 2.11–3.08 (br, CH2 side chains), 1.47–1.87
(br, CH2 side chain), 0.81–1.46 (br, CH3 side chain).
Betainization with b-propiolactone (5)
To a 4.5% solution of P(EtOx30-stat-tAmOx10) in dry acetonitrile
a 1.1-fold excess of 1,3-propanesultone per tertiary amine group
was added. The reaction mixture was stirred at room tempera-
ture for one day. Aer evaporation of the solvent, the polymer
was puried by preparative size exclusion chromatography
(Sephadex® SX-1, solvent: dichloromethane). The product was
dried under reduced pressure at 40 C for three days. At last, the
product was dissolved in a small amount of water and
lyophilized.
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1H NMR (300 MHz, CD3OD): d 3.35–3.95 (br, CH2 backbone),
3.03–3.23 (br, N–CH3), 2.12–3.03 (br, CH2 side chains), 1.47–1.93
(br, CH2 side chain), 0.81–1.44 (br, CH3 side chain).
Polymer cytotoxicity
For the cytotoxicity experiments, the mouse broblast cell line
L929 and the human hepatocyte cell line HepG2 were
purchased from a commercial cell bank (Cell line service,
Eppelheim, Germany). The cells were routinely cultured as
follows: Cell culture media [Dulbecco's modied eagle's
medium (DMEM) for L929 cells and DMEM/F-12 for HepG2
cells] were supplemented with 10% fetal calf serum, 100 UmL1
penicillin, and 100 mg mL1 streptomycin (all components from
Biochrom, Berlin, Germany) at 37 C in a humidied atmo-
sphere with 5% (v/v) CO2. The cytotoxicity was determined with
a XTT assay following the ISO/EN 10993 part 5 protocol: Cells
(L929 and HepG2) were seeded in 96-well plates at a density of
1  104 cells per well and grown as monolayer cultures for 24 h.
The cells were then incubated separately with diﬀerent polymer
concentrations (from 0.01 to 10.00 mg mL1 (n ¼ 6)) for 24 h.
Control cells were incubated with fresh culture medium. Aer
incubation, 50 mL of a XTT solution prepared according to the
manufacturer's instructions were added to each well. Aer 4 h
at 37 C, 100 mL of each solution were transferred to a new
microtiter plate and the optical density (OD) was measured
photometrically. The negative control was standardized as 0%
of metabolism inhibition and referred as 100% viability.
Experiments were run in sextuplicate.
In addition, the viability of the cells aer exposure to the
polymers was examined microscopically using a modied
uorescein diacetate (FDA)/propidium iodide (PI) viability
assay.67
Hemolysis of erythrocytes
For testing the hemolytic activity of the polymer solutions,
blood from three unmedicated and healthy donors was
collected (Institute for Transfusion Medicine, Friedrich Schiller
University Jena) and stabilized by sodium citrate. Aer centri-
fugation at 4.500  g for 5 min, the pellet was washed three
times with cold 1.5 mM phosphate buﬀered saline pH 7.4 (PBS).
Aer dilution with PBS in a ratio of 1 : 7 (number of erythrocytes
approx. 2  106 mL1), aliquots of the erythrocyte suspension
were mixed 1 : 1 with the polymer solutions (nal polymer
concentrations in the erythrocyte suspension of 10 mg mL1,
5 mg mL1 and 1 mg mL1) and incubated in a water bath at
37 C for 60 min. Aer centrifugation at 2400g for 5 min the
hemoglobin release into the supernatant was determined
spectrophotometrically using a microplate reader at 544 nm
wavelength. Complete hemolysis was achieved using 1% Triton
X-100 reecting the 100% value. PBS served as negative control.
Less than 5% hemolysis rate were taken as non-hemolytic.
Experiments were run in triplicate and were repeated once.
Erythrocyte aggregation
Erythrocyte aggregation induced by the polymers were tested
using a photometric and microscopic method according to
literature.68 Erythrocytes were isolated as described above.
Erythrocyte suspensions (100 mL) containing 2 Mio erythrocytes
per mL were mixed with the same volume of polymer solutions
(20, 10 and 2 mg mL1 diluted in PBS buﬀer) in a clear at
bottomed 96-well plate. The cells were incubated under
vigorous shaking at 37 C for 2 h, and the absorbance was
measured at 645 nm in a microplate reader. 25 kDa bPEI (50 mg
mL1) was used as positive control. As negative controls, cells
were only treated with PBS. Blank values were determined with
PBS and subtracted from the sample values. Absorbance values
of the test solutions lower than the negative control were
regarded as aggregation. Experiments were run in triplicate and
were repeated once.
Additionally, erythrocyte aggregation was evaluated by
microscopic observations using 10 diluted samples from the
above described photometric determinations.
Blood viscosity
The inuence of the polymers on blood viscosity was tested
according to a formerly published setup.31 The pooled blood of
three unmedicated and healthy donors was collected (Institute
for Transfusion Medicine, Friedrich Schiller University Jena)
and stabilized by sodium citrate. Within 4 hours aer collec-
tion, 200 mL of PBS or polymer solution (50 mg mL1, 10 mg
mL1 and 5 mg mL1 to obtain nal polymer concentrations in
the whole blood of 10 mg mL1, 5 mg mL1 and 1 mg mL1)
were added to 800 mL of whole blood and incubated for 30 min
at 37 C. In a parallel setup, PBS was used instead of the whole
blood sample to measure the dynamic viscosity of PBS and the
corresponding polymer solutions. Viscosity measurements were
conducted at 20 C using an AMVn (Anton Paar, Graz, Austria)
rolling ball viscometer at three inclination angles (50/70/85)
of the capillary. For normalization, the dynamic viscosity values
of the polymers diluted in whole blood or phosphate buﬀered
saline were divided by the viscosity value of the pure blood or
PBS, respectively, and results are expressed as relative dynamic
viscosity.
Platelet activation
The blood of three unmedicated and healthy donors was
collected (Institute for Transfusion medicine, Friedrich Schiller
University Jena) and stabilized by sodium citrate. The platelet
rich plasma (PRP) was isolated by centrifugation, pooled, and
used immediately. To 240 mL of PRP 60 mL of PBS or polymer
solution (50 mg mL1, 10 mg mL1 and 5 mg mL1 to obtain
nal polymer concentrations in the PRP of 10 mg mL1, 5 mg
mL1 and 1 mg mL1) were added and incubated for 10 min or
30 min at 37 C. To activate platelets 0.5 U mL1 of bovine
thrombin (Sigma, Tauirchen, Germany) were added to the
positive control instead of the polymer solution. Aliquots
containing 50 mL of the incubated mixture were removed and
xed for 10 min at room temperature using 4% para-
formaldehyde in PBS. Aer washing and centrifugation a
double immuno-staining was performed using 20 mL of FITC
labeled monoclonal antibody directed against CD42 and 20 mL
of phycoerythrin (PE) labeled monoclonal antibody directed
This journal is © The Royal Society of Chemistry 2014 Polym. Chem., 2014, 5, 5751–5764 | 5761
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against CD62P. Isotype controls were incubated with mouse
IgG antibodies conjugated with uorescein isothiocyanate
(FITC) or PE dye, respectively (all antibodies were purchased
from BD Biosciences, Heidelberg, Germany). Aer 30 min
incubation at room temperature the activation state of the
platelets was determined using uorescence ow cytometry.
Expression of the platelet activation marker CD62P and the
constitutively present platelet marker CD42 were detected
using a Beckmann Coulter Cytomics FC-500 equipped with
Uniphase Argon ion laser, 488 nm, 20 mW output. Overall
100 000 platelets were measured per sample and analyzed with
the Cytomics CXP soware. The experiment was repeated three
times.
Complement activation
The complement activation was measured on the basis of C3a
anaphylatoxins with the appropriate ELISA kit (Quidel, San
Diego, USA). The blood of three unmedicated and healthy
donors was collected (Institute for Transfusion Medicine,
Friedrich Schiller University Jena) and stabilized by sodium
citrate. The plasma was isolated by centrifugation, pooled, and
used immediately. 40 mL of plasma were mixed with 10 mL PBS
or polymer solution (50 mg mL1, 10 mg mL1 and 5 mg
mL1 to obtain nal polymer concentrations in the plasma of
10 mg mL1, 5 mg mL1 and 1 mg mL1) and incubated for
10, 30, and 60 min. Subsequently, samples, standards, and
controls were diluted in the ratio 1 : 200 with sample buﬀer
provided by the supplier and applied to a 96 well plate pre-
coated with an antibody directed against C3a epitopes.
Further incubation steps were performed according to the
instructions of the supplier. The C3a concentrations were
measured as absorption (at 450 nm) of the chromogenic
substrate added during performance of the assay. Experiments
were run in triplicate.
Blood coagulation
The blood of three unmedicated and healthy donors was
collected (Institute for Transfusion Medicine, Friedrich Schiller
University Jena) and stabilized by sodium citrate. The plasma
was isolated by centrifugation at 4000g for 3 min at room
temperature and used within 3 hours. The prothrombin time
(PT) and the activated partial thromboplastin time (APTT) were
spectroscopically determined with the clinical coagulation
analyzer BCS XP 1.1 (Siemens Healthcare Diagnostics, Mar-
burg, Germany). To 240 mL of plasma 60 mL of PBS or polymer
solution (50 mg mL1, 10 mg mL1 and 5 mg mL1 to obtain
nal polymer concentrations in the plasma of 10 mg mL1,
5 mg mL1 and 1 mg mL1) were added and incubated for
5 min. Experiments were run in triplicate. For the APTT
determination, the intrinsic and common coagulation path-
ways were activated by adding 100 mL Pathrombin SL activator
(Siemens Healthcare Diagnostics, Marburg, Germany) to
100 mL of the probe. Aer 2 min incubation at 37 C, the
coagulation was triggered by calcium chloride addition
(100 mL, 0.025 M) and followed spectroscopically for up to 240 s
at 671 nm. Additional samples were treated identically but with
100 mL of SyntASiL activator (Instrumentation Laboratory,
Kirchheim, Germany) instead of Pathrombin SL activator. The
PT was determined by addition of 100 mL of Dade Innovin
activator (Siemens Healthcare Diagnostics, Marburg, Germany)
to 50 mL of the plasma-polymer. The coagulation reaction was
followed spectroscopically for 120 s at 671 nm. Each experi-
ment was repeated three times.
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Figure S1. A) First-order kinetic plots of the copolymerization of EtOx (square) and ButEnOx 
(circle) at 140 °C with a total monomer concentration of 1 M and a [EtOx]:[ButEnOx]:[MeOTs] 
ratio of 16:4:1. B) SEC curves kinetic study after different times.
Table S1. Data of the kinetic study.
Time Conversion of EtOx:ButEnOx (%)a) Mn (g/mol)b) PDIb)
30 47:51 900 1.22
60 61:63 1,115 1.25
120 76:78 1,590 1.22
180 88:88 1,850 1.23
240 90:90 1,980 1.23
300 96:95 2,020 1.24
390 98:100 2,250 1.23
a)Determined by GC. b)Determined by SEC (chloroform/TEA/2-propanol 94:4:2, calibration against PS).
3Figure S2. 1H NMR spectra of (top) phthalimide end-capped and (bottom) amine end-
functionalized polymer (300 MHz, CD3OD).
Table S2. SEC data of the different polymers.
DMAc + 0.21% LiCl CHCl3 + TEA + iPrOH (94:4:2)Compound
Mn (g/mol)b) PDIb) Mn (g/mol)b) PDIb)
1 6,860 1.16 4,590 1.16
2 6,980 1.19 3,920 1.16
3 7,740 1.20 4,820 1.18
4 7,860 1.24 4,720 1.19
5 8,200 1.35 -a) -a)
6 8,150 1.59 3,640 1.27
PEtOx 6,600 1.21 4,830 1.15
a) Insoluble in the solvent. b) Calibration against PS.
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Figure S3. SEC curves of the different polymers. SEC running with A) DMAc + 0.21% LiCl, and 
B) CHCl3 + TEA + iPrOH (94:4:2).
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ABSTRACT: We report the synthesis of glyco(poly(2-oxazoline)s)
functionalized with Pt(II) units for targeted tumor applications.
To this end, poly(2-ethyl-2-oxazoline-block-2-(3-butenyl)-2-oxa-
zoline) is modified with thiol-modified acetyl protected glucose
and galactose, respectively, and terpyridine (tpy) units using
thiol-ene photoaddition. Deprotection of the sugars with
sodium methoxide and treatment with Pt(COD)Cl2 applying a
mild synthesis route yields polymers with monosaccharide tar-
geting moieties and cytotoxic Pt(II) units. The polymers and
intermediates are characterized by 1H nuclear magnetic reso-
nance spectroscopy and size exclusion chromatography. Sub-
sequently, the hemolytic activity, induction of erythrocyte
aggregation as well as the cytotoxicity against mouse fibro-
blast L929 cells, human embryonic kidney cells HEK 293, and
human hepatocytes HepG2 are studied. The comparison to cis-
platin, the standard for cancer therapy, demonstrates the
potential of the presented system. VC 2014 Wiley Periodicals,
Inc. J. Polym. Sci., Part A: Polym. Chem. 2014, 52, 2703–2714
KEYWORDS: biological applications of polymers; cationic poly-
merization, copolymerization; functionalization of polymers;
glycopolymer; poly(2-oxazoline); ring-opening polymerization
INTRODUCTION Platinum-based drugs are of high interest
for anticancer applications. The most prominent example is
cis-[PtCl2(NH3)2] (cisplatin), a chemotherapeutic drug that
induces apoptosis, that is, programmed cell death, by inter-
and intrastrand DNA-crosslinking processes.1–3 However,
severe side effects such as renal toxicity, gastrointestinal tox-
icity, and neurotoxicity as well as acquired and intrinsic cis-
platin resistance of various cancer types have led to the
search for alternatives.2–5 Modern drugs aim for selective
transport to the cancer cells by active and passive target-
ing.1–3,5–10 The latter can be achieved by exploiting the so
called enhanced permeability and retention (EPR) effect, that
is the preferred accumulation of molecules of a certain size
in tumor tissue. Such molecules can be, for example, drug-
loaded nanoparticles, nanospheres, liposomes, carbon nano-
tubes, and polymeric dendrimers or micelles. Particularly,
polymer-based systems are of high interest.2,3,9,10 Their
broad diversity makes them ideal materials for drug com-
plexation or encapsulation. In this context, an often used
material is oligo- or poly(ethylene glycol) (PEG), since it is
nontoxic, water soluble, and shows the so called “stealth
effect.”11 However, to not only rely on a possible EPR effect
and to increase the drug selectivity, active targeting has pre-
viously attracted increasing interest. Since certain receptors
are often overexpressed in tumor cells, this can be achieved
by functionalization with bioactive substances such as pro-
teins (e.g., transferrin), hormones (e.g., estrogen), amino
acids, folic acid, and saccharides.5,6,9,12 In particular the lat-
ter are interesting, as cancer cells commonly display an
altered sugar metabolism, for example, a high glucose con-
sumption for energy production.5 Moreover, they possess
specific saccharide receptors exclusively expressed by certain
cancers. It was shown by Stenzel et al. that micellar gold-
glycopolymer complexes display a high activity against
OVCAR-3 human ovarian carcinoma cells.13 Recently, Wild
et al. reported, a poly(pentafluorostyrene)-based glycopoly-
mer, carrying galactose as targeting unit and a terpyridine
(tpy) complexed Pt(II) species as active agent, which
revealed a higher activity against cisplatin-resistant Nalm-6
leukemia cells than cisplatin.14 Hence, it showed a higher
*Present address: Department of Chemical and Biomolecular Engineering, The University of Melbourne, Victoria 3010, Australia
Additional Supporting Information may be found in the online version of this article.
VC 2014 Wiley Periodicals, Inc.
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apoptotic activity, even in cells resistant to common chemo-
therapeutic agents. The mechanism of action, which causes
apoptosis, is most probably the DNA-intercalation and is well
known for square-planar tpy-Pt(II) complexes.15–17 Although
the chosen synthesis method by thiol-p-fluorine “click”
allowed the synthesis of tailor-made polymers with the pos-
sibility to tune the amount of sugar and platinum, the use of
PPFS as backbone resulted in poor water solubility. This
problem can be overcome by using poly(2-oxazoline)s (POx),
a versatile class of polymers, which can be prepared with a
narrow molar mass distribution by the living cationic ring-
opening polymerization (CROP) of 2-oxazolines. Moreover,
the broad variety of initiators, terminating agents, and mono-
mers enable the preparation of tailor-made polymers whose
functional groups can be exploited for post-polymerization
reactions. The most prominent examples are the water solu-
ble poly(2-methyl-2-oxazoline) and poly(2-ethyl-2-oxazoline)
(PEtOx). They are investigated as PEG alternatives, since
they not only show similar positive properties as PEG (e.g.,
“stealth effect,”18,19 “antifouling” properties20,21) but also
exhibit some advantageous features such as higher stabil-
ity,22 lower viscosity,18,23 and a less demanding synthesis.
The copolymerization with other 2-oxazolines, namely 2-(3-
butenyl)-2-oxazoline (ButEnOx) and 2-(9-decenyl)-2-oxazo-
line), enables the post-polymerization functionalization or
hydrogel formation via thiol-ene photoaddition.24–31 Applying
this approach, it is possible to attach sugar units as targeting
moieties.25,26,28–30 In the same manner, it is possible to
incorporate anticancer active units by photoaddition of tpy-
thiols (tpy-SH) and subsequent platinum complexation. Tpy-
thiols are described in literature but have not been attached
to POx so far.32,33 Here we describe the synthesis of Pt(II)
containing, water soluble, 2-oxazoline based glycopolymers.
To this end, a copolymer of EtOx and ButEnOx was synthe-
sized and partially functionalized with tpy via thiol-ene pho-
toaddition. In a next step acetyl protected galactose (Ac4Gal)
and glucose (Ac4Glc), respectively, were attached using the
same approach. After deprotection of the sugars, the active
anticancer agent was formed by complexation of the plati-
num under mild conditions. The resulting polymer architec-
ture is advantageous, since the covalent binding of the tpy-Pt
complex prevents its uncontrolled release. All polymers were
characterized structurally and their in vivo activity has been
investigated.
EXPERIMENTAL
Chemicals and Instrumentation
Dry acetonitrile, dry methanol, EtOx, and methyl tosylate
(MeOTs) were purchased from Acros Organics. ButEnOx was
prepared as described earlier.28 EtOx, ButEnOx, and MeOTs
were distilled to dryness over barium oxide (BaO), and
stored under nitrogen. Dichloro(1,5-cyclooctadiene)platinu-
m(II) (Pt(COD)Cl2), sodium methoxide in methanol (0.5 M),
and 2,2-dimethoxy-2-phenylacetophenone (DMPA) were
obtained from Sigma Aldrich. 2,3,4,6-Tetra-O-acetyl-b-D-1-thi-
oglucopyranoside (Ac4GlcSH) and 2,3,4,6-tetra-O-acetyl-b-D-1-
thioglacatopyranoside (Ac4GalSH) were prepared according
to the literature.34 6-([2,20:60,200’-Terpyridin]-40-yloxy)hexane-
1-thiol was synthesized analogically to other known terpyri-
dine thiols (Supporting Information).35
For the polymerizations, an Initiator Sixty single-mode
microwave synthesizer from Biotage, equipped with a nonin-
vasive IR sensor (accuracy: 62%) was used. 1H nuclear mag-
netic resonance (NMR) spectra were recorded on a Bruker
AC 300 and 250 MHz at 298 K. Chemical shifts are reported
in parts per million (ppm, d scale) relative to the residual
signal of the deuterated solvent.
Size exclusion chromatographies (SEC) of the polymers were
measured on an Agilent Technologies 1200 Series gel perme-
ation chromatography system equipped with a G1329A auto-
sampler, a G131A isocratic pump, a G1362A refractive index
detector, and both a PSS Gram 30 and a PSS Gram 1000 col-
umn placed in series. As eluent a 0.21% LiCl solution in N,N-
dimethylacetamide (DMAc) was used at 1 mL min21 flow
rate and a column oven temperature of 40 C. Molar masses
were calculated against poly(styrene).
Synthesis of Phthalimide End-Functionalized
P(EtOx30-stat-ButEnOx10) (1)
Prior to the reaction the kinetics of the copolymerization of
EtOx and ButEnOx have been investigated (see Supporting
Information).
A solution of initiator (MeOTs), solvent (acetonitrile), and
monomers (EtOx, ButEnOx) was prepared with a [EtOx]/
[ButEnOx]/[I] ratio of 30:10:1 and a total monomer concen-
tration of 3 M. The solution was heated at 140 C in a micro-
wave synthesizer for a predetermined time. After cooling to
room temperature a twofold excess of potassium phthalimide
was added and the reaction mixture was stirred at 70 C
overnight. The reaction mixture was filtered and the solvent
was removed under reduced pressure. Subsequently, the res-
idue was dissolved in dichloromethane and washed with
water, a saturated aqueous solution of NaHCO3, and brine.
The organic phase was dried over sodium sulfate, filtered,
and concentrated. After precipitation into ice-cold diethyl
ether, the polymer was dried at 40 C.
1H NMR (300 MHz, CDCl3, d): 7.59–7.94 (br, CH of phthalim-
ide), 5.55–5.99 (m, CH@CH2), 4.64–5.19 (br, CH@CH2), 3.07–
4.02 (br, CH2 backbone), 2.81–3.07 (m, initial CH3), 1.98–
2.68 (br, CH2 side chains), 0.68–1.39 (br, CH3 side chain).
Synthesis of Amine End-Functionalized
P(EtOx30-stat-ButEnOx10) (2)
Phthalimide end-capped P(EtOx30-stat-ButEnOx10) was dis-
solved in ethanol, a 10-fold excess of hydrazine monohydrate
was added, and the reaction mixture was refluxed overnight.
After cooling to room temperature, concentrated HCl was
added up to pH5 2–3. The precipitate was removed by fil-
tration. The ethanol was evaporated and the residue was dis-
solved in water. Aqueous NaOH was added up to pH5 9–10
and the aqueous solution was extracted thrice with
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chloroform. The combined organic layers were dried over
sodium sulfate, concentrated, and precipitated into ice-cold
diethyl ether. The white precipitate was filtered off and dried
at 40 C under reduced pressure.
1H NMR (300 MHz, CDCl3, d): 5.65–5.97 (m, CH@CH2), 4.81–
5.18 (br, CH@CH2), 3.06–4.17 (br, CH2 backbone), 2.75–3.05
(m, initial CH3), 1.87–2.65 (br, CH2 side chains), 0.54–1.43
(br, CH3 side chain).
Thiol-ene Functionalization of P(EtOx30-stat-ButEnOx10)
with 6-([2,20:60,200-terpyridin]-40-yloxy)hexane-1-thiol (3)
To a 5 mass% solution of 2 in THF/methanol (1:0.2) the
photocatalyst DMPA (0.04 equiv. per double bond) and tpy-
SH (0.4 equiv. per double bond) were added. After degassing
with nitrogen for 30 min, the reaction mixture was exposed
to UV light (365 nm) overnight. The solvent was evaporated,
the residue dissolved in chloroform, and washed twice with
a 0.1 M EDTA solution, followed by washing with a saturated
aqueous solution of NaHCO3 and brine. The organic layer
was dried over sodium sulfate, concentrated, and precipi-
tated into ice-cold diethyl ether. The polymer was filtered off
and dried under reduced pressure at 40 C.
1H NMR (300 MHz, CDCl3, d): 8.47–8.79 (CH of tpy), 7.72–
7.91 (CH of typ), 7.17–7.48 (CH of typ), 5.64–5.97 (m,
CH@CH2), 4.87–5.17 (br, CH@CH2), 4.12–4.34 (ACH2AOA
typ), 3.09–4.10 (br, CH2 backbone), 2.83–3.09 (m, initial
CH3), 2.64–2.83 (br, ACH2ASACH2A), 2.01–2.64 (br, CH2
side chains), 1.40–2.00 (br, CH2 side chains), 0.73–1.39 (br,
CH3 side chain).
Thiol-ene Functionalization with Ac4GlcSH (4) and
Ac4GalSH (5)
To a 5 mass% solution P(EtOx30-stat-ButEnOx6-stat-tpyBu-
tOx4) (3) in THF the photocatalyst DMPA (0.1 equiv. per dou-
ble bond), and Ac4GlcSH or Ac4GalSH (4 equiv. per double
bond), respectively, were added. After degassing with nitro-
gen for 30 min, the reaction mixture was exposed to UV light
(365 nm) overnight. The solvent was concentrated in vacuo
and the polymer was isolated by preparative SEC (Bio-
BeadsV
R
S-X1, THF). The solvent was evaporated and the poly-
mer was dried at 40 C under reduced pressure.
4 (Glc): 1H NMR (300 MHz, CD3OD, d): 8.52–8.79 (CH of
tpy), 7.81–8.12 (CH of typ), 7.35–7.61 (CH of typ), 4.62–5.54
(m, sugar), 3.77–4.45 (m, sugar), 3.69–3.76 (m, CH2AOAtpy),
3.20–3.69 (br, CH2 backbone), 2.94–3.15 (m, initial CH3),
2.60–2.93 (br, ACH2ASA), 2.14–2.59 (br, CH2 side chains),
1.91–2.12 (AOAc), 1.45–1.91 (br, CH2 side chains), 0.80–1.45
(br, CH3 side chain).
5 (Gal): 1H NMR (300 MHz, CD3OD, d): 8.50–8.83 (CH of
tpy), 7.80–8.13 (CH of typ), 7.35–7.61 (CH of typ), 4.47–5.64
(m, sugar), 3.79–4.44 (m, sugar), 3.70–3.78 (m, CH2AOAtpy),
3.19–3.78 (br, CH2 backbone), 2.94–3.18 (m, initial CH3),
2.62–2.94 (br, ACH2ASA), 2.24–2.61 (br, CH2 side chains),
1.91–2.23 (AOAc), 1.45–1.90 (br, CH2 side chains), 0.81–1.45
(br, CH3 side chain).
Deprotection of Glucose and Galactose (6, 7)
The respective sugar functionalized polymer was dissolved
in dry methanol. A 0.5 M solution of sodium methoxide (1
equiv. per sugar) in methanol was added and the reaction
mixture was stirred at room temperature for 1 h. The sol-
vent was removed and the residue was dissolved in water.
Subsequently, the polymer was purified by dialysis against
water. The water was evaporated and the product was dried
under reduced pressure at 40 C.
6 (Glc): 1H NMR (300 MHz, CD3OD, d): 8.49–8.74 (CH of
tpy), 7.81–8.08 (CH of typ), 7.29–7.55 (CH of typ), 4.15–4.49
(m, CH sugar), 3.80–3.98 (m, CH sugar), 3.25–3.79 (br, CH2
backbone), 3.13–3.25 (m, CH sugar), 3.02–3.13 (m, initial
CH3), 2.61–3.01 (br, ACH2ASA), 2.10–2.62 (br, CH2 side
chains), 1.45–2.10 (br, CH2 side chains), 0.79–1.44 (br, CH3
side chain).
7 (Gal): 1H NMR (300 MHz, CD3OD, d): 8.51–8.75 (CH of
tpy), 7.82–8.07 (CH of typ), 7.34–7.59 (CH of typ), 4.13–4.45
(br, CH sugar), 3.83–3.98 (br, CH sugar), 3.66–3.81 (m,
ACH2AOAtpy), 3.17–3.66 (br, CH2 backbone), 3.01–3.13 (m,
initial CH3), 2.62–2.98 (br, ACH2ASA), 2.06–2.62 (br, CH2
side chains), 1.45–2.02 (br, CH2 side chains), 0.79–1.44 (br,
CH3 side chain).
Complexation with Platinum (8, 9)
The deprotected polymer was dissolved in water. After addi-
tion of Pt(COD)Cl2 (1 equiv. per tpy unit) the reaction mix-
ture was heated at 70 C until all Pt compound was
dissolved (35–40 min). A color change to yellow could be
observed. Subsequently, the water phase was washed five
times with diethyl ether. The water was evaporated and the
yellow product was dried at 40 C under reduced pressure.
8 (Glc): 1H NMR (300 MHz, CD3OD, d): 7.32–8.87 (CH of
tpy), 3.81–4.75 (m, CH sugar), 3.25–3.80 (br, CH2 backbone),
3.14–3.26 (m, CH sugar), 3.03–3.14 (m, initial CH3), 2.64–
3.03 (br, ACH2ASA), 2.10–2.62 (br, CH2 side chains), 1.47–
2.10 (br, CH2 side chains), 0.82–1.47 (br, CH3 side chain).
9 (Glc): 1H NMR (300 MHz, CD3OD, d): 7.35–8.89 (CH of
tpy), 3.81–4.65 (m, CH sugar), 3.67–3.81 (m, CH2AOAtpy),
3.15–3.67 (br, CH2 backbone), 3.00–3.15 (m, initial CH3),
2.65–3.00 (br, ACH2ASA), 2.10–2.65 (br, CH2 side chains),
1.45–2.10 (br, CH2 side chains), 0.71–1.45 (br, CH3 side
chain).
Polymer Cytotoxicity
For the cytotoxicity screening, the mouse fibroblast cell line
L929, the human embryonic kidney cell line HEK 293, and
the human hepatocyte cell line HepG2 were purchased from
a commercial cell bank (Cell line service, Eppelheim, Ger-
many). The cells were routinely cultured as follows: Cell cul-
ture media [Dulbecco’s modified eagle’s medium (DMEM) for
L929 cells, Eagle’s Minimum Essential Medium (EMEM) for
HEK 293 cells, and DMEM/F-12 for HepG2 cells] were sup-
plemented with 10% fetal calf serum, 100 U mL21 penicillin,
and 100 lg mL21 streptomycin (all components from
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Biochrom, Berlin, Germany) at 37 C in a humidified atmos-
phere with 5% (v/v) CO2. The cytotoxicity was determined
with a XTT assay following the ISO/EN 10993 part 5 proto-
col: Cells (L929, HEK 293, and HepG2) were seeded in 96-
well plates at a density of 1 3 104 cells/well and grown as
monolayer cultures for 24 h. The cells were then incubated
separately with different concentrations of the glycopolymers
(from 0.0012 to 1.256 mM) or cisplatin (from 0.005 to
4.833 mM) for 24 h. The chosen glycopolymer and cisplatin
concentrations were comparable in terms of an equimolar
concentration of platinum moieties in the final solutions.
Control cells were incubated with fresh culture medium.
After incubation, 50 lL of a XTT solution prepared according
to the manufacturer’s instructions were added to each well.
After 4 h at 37 C, 100 lL of each solution were transferred
to a new microtiter plate and the optical density (OD) was
measured photometrically. The negative control was standar-
dized as 0% of metabolism inhibition and referred as 100%
viability. Experiments were run in sextuplicate.
In addition, the viability of the cells after exposure to the
polymers was examined microscopically using a modified
fluorescein diacetate (FDA)/propidium iodide (PI) viability
assay.36
Hemolysis of Erythrocytes
For testing the hemolytic activity of the glycopolymer and
cisplatin solutions, blood from three unmedicated and
healthy donors was collected (Institute for Transfusion Medi-
cine, Friedrich Schiller University Jena) and stabilized by
sodium citrate. After centrifugation at 4500 g for 5 min, the
pellet was washed three times with cold 1.5 mM phosphate
buffered saline pH 7.4 [phosphate buffered saline (PBS)].
After dilution with PBS in a ratio of 1:7 (number of erythro-
cytes 2 3 106 mL21), aliquots of the erythrocyte suspen-
sion were mixed 1:1 with the glycopolymer or cisplatin
solutions (final concentrations in the erythrocyte suspension:
1.25628, 0.62814, 0.25126, 0.12563, and 0.01256 for both
glycopolymers and 4.83372, 2.41686, 0.96674, 0.48337, and
0.04834 mM for cisplatin) and incubated in a water bath at
37 C for 60 min. After centrifugation at 2400 g for 5 min
the hemoglobin release into the supernatant was determined
spectrophotometrically using a microplate reader at 544 nm
wavelength. Complete hemolysis was achieved using 1% Tri-
ton X-100 reflecting the 100% value. PBS served as negative
control. Less than 5% hemolysis rate were taken as non-
hemolytic. Experiments were run in triplicates and were
repeated once.
Erythrocyte Aggregation
Erythrocyte aggregation induced by the polymers was tested
according to literature using a photometric and a micro-
scopic method.37 Erythrocytes were isolated as described
above. Erythrocyte suspensions (100 lL) containing 2 3 106
erythrocytes per mL were mixed with the same volume of
polymer solutions (final concentrations in the erythrocyte
suspension: 1.25628, 0.62814, 0.25126, 0.12563, and
0.01256 for both glycopolymers and 4.83372, 2.41686,
0.96674, 0.48337, and 0.04834 mM for cisplatin) in a clear
flat bottomed 96-well plate. The cells were incubated under
vigorous shaking at 37 C for 2 h. A 25 kDa bPEI (50 lg
mL21) was used as a positive control. As negative controls,
cells were only treated with PBS. The erythrocyte aggrega-
tion was evaluated by microscopic observations using 10-
times diluted samples. Experiments were run in triplicates
and were repeated once.
RESULTS AND DISCUSSION
Synthesis of Amine End-Functionalized P(EtOx30-stat-
ButEnOx10)
The synthesis of P(EtOx-stat-ButEnOx) was previously
described in literature.28 The methyl triflate initiated copoly-
merization at 70 C showed first-order kinetic behavior. The
same behavior was found when methyl tosylate was used as
initiator and the reaction was performed at 140 C in aceto-
nitrile (Supporting Information Fig. S1A). However, due to
the higher temperature, the polymerization proceeded much
faster with polymerization constants of kp(EtOx)5 0.206 L
mol21 s21 and kp(ButEnOx)5 0.188 L mol
21 s21. The simi-
lar conversions of both monomers are a reliable indication
of the formation of a random copolymer. Investigations by
SEC showed an increasing molar mass with increasing time
(Supporting Information Fig. S1B and Table S1).
The data obtained from the kinetic investigations were used
to synthesize amine end-functionalized P(EtOx30-stat-ButE-
nOx10) (2), a multifunctional copolymer, which enables post-
polymerization modifications, for example, labeling with
dyes. The living cationic species of the polymerization reac-
tion was quenched with potassium phthalimide (1,
Scheme 1).
The quantitative end-capping with phthalimide was proven
by 1H NMR spectroscopy. Subsequent reaction with hydra-
zine yielded the free amine end-group (2) as can be seen by
the disappearance of the phthalimide signal at 7.8 ppm (Fig.
1). The ButEnOx double bonds remained intact under these
reaction conditions with no changes in the integral inten-
sities in the 1H NMR spectrum. Consequently, the double
bonds were exploited for thiol-ene photoadditions to intro-
duce tpy and monosaccharides. Characterization by SEC
revealed a narrow molar mass distribution for both, phthal-
imide and amine end-functionalized, polymers with no or
only a minor change of the polydispersity index (PDI) after
hydrazinolysis, depending on the used SEC system (Fig. 2
and Table 1; Supporting Information Table S2).
Thiol-ene Functionalization of P(EtOx30-stat-ButEnOx10)
with Monosaccharides and Terpyridine Moieties as well
as Platinum Complexation
In order to incorporate platinum complexing ligands into
copolymer 2, four of the ButEnOx side chains of P(EtOx30-
stat-ButEnOx10) were functionalized with 6-([2,20:60,200-ter-
pyridin]-40-yloxy)hexane-1-thiol (tpy-SH) by thiol-ene photo-
addition (3, Scheme 1). The success of the reaction was
shown by 1H NMR spectroscopy (Fig. 1). Peaks for the tpy
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units appeared between 7 and 9 ppm. The signals of the hex-
amethylene linker can be found between 1.5 and 2 ppm. Fur-
ther evidence for the successful photoaddition of the tpy
units was provided by SEC (Table 1 and Fig. 2; Supporting
Information Table S2). A growing molar mass compared with
the starting material P(EtOx30-stat-ButEnOx10) was observed,
SCHEME 1 Schematic representation of the synthesis of platinum and sugar functionalized POx.
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while the PDI changed only slightly. Moreover, absorption of
the tpy unit can be detected in the UV detector of the SEC,
which is congruent with the RI signal of the polymer (Sup-
porting Information Fig. S2). In addition, no SEC signal of
unreacted tpy-SH was detected. The slight shoulder at lower
elution volume, that is, higher molar mass, might derive
from polymer–polymer coupling and could not be removed
by preparative SEC.
FIGURE 1 1H NMR spectra of (top) phthalimide (1) and (middle) amine (2) end-functionalized P(EtOx30-stat-ButEnOx10) as well as
(bottom) P(EtOx30-stat-ButEnOx6-stat-typButOx4) (3) (300 MHz, CDCl3).
FIGURE 2 SEC curves of the different polymers: (A) Starting material and glucose functionalized polymers, (B) starting material
and galactose functionalized polymers. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.
com.]
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In the next step the targeting sugar units were attached to
the polymer backbone by a second thiol-ene photoaddition
(Scheme 1). To this end, the remaining ButEnOx were
reacted with acetyl protected thioglucose (Ac4GlcSH) and thi-
ogalactose (Ac4GalSH), respectively. To ensure a full function-
alization of the ButEnOx units an excess of thio-sugar was
used and removed after reaction by preparative SEC. Charac-
terization by 1H NMR spectroscopy revealed the quantitative
consumption of the double bond and the appearance of sig-
nals typical for acetylated sugars (Fig. 3; Supporting Infor-
mation Fig. S3). The obtained spectra resemble spectra of
other sugar functionalized POx.38,39 SEC analysis revealed an
increasing molar mass with no change of the PDI value in
case of Glc and an insignificant change for Gal (Fig. 2 and
Table 1). In addition, no traces of unreacted sugar could be
detected by SEC.
Deprotection of the sugar moieties was achieved by treat-
ment with sodium methoxide (Scheme 1). After deprotection,
a shift of the sugar signals in the 1H NMR spectrum was
observed as already described for other sugar bearing POx
(Fig. 3; Supporting Information Fig. S3).38,39 In particular, the
peaks at around 5 ppm are shifted to lower ppm. However,
the most obvious change is the disappearance of the peaks
of the acetyl protecting groups at around 2 ppm. The tpy sig-
nals remained unchanged. Another proof for the successful
deprotection is the disappearance of the C@O band of the
acetyl protecting groups at 1747 cm21 (Glc) and 1745 cm21
(Gal), respectively, in the Fourier transform infrared (FT-IR)
spectra (Supporting Information Fig. S4). SEC characteriza-
tion revealed a change in molar mass (Table 1 and Fig. 2).
Although the theoretical molar masses are lower after the
deprotection reaction, a shift to higher molar masses was
observed. This finding was reported earlier for other sugar
TABLE 1 SEC Data of the Different Polymers
Compound Mn (g mol
21)a PDIa
1 6,860 1.16
2 6,980 1.19
3 8,000 1.21
4 9,340 1.21
5 9,360 1.23
6 11,980 1.22
7 11,800 1.23
8 11,560 1.23
9 12,370 1.29
a Determined by SEC: DMAc1 0.21% LiCl, calibration against PS.
FIGURE 3 1H NMR spectra of (top) P(EtOx30-stat-(Ac4GlcButOx)6-stat-tpyButOx4) (4), (middle) P(EtOx30-stat-GlcButOx6-stat-tpy-
ButOx4) (6), and (bottom) P(EtOx30-stat-GlcButOx-stat-PtButOx4) (8) (300 MHz, CD3OD).
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decorated POx and is ascribed to the increasing hydrody-
namic volume in DMAc.39 However, PDI values remained low
with no significant change in the shape of the SEC curves,
which confirms that the rest of the polymer, for example, the
tpy units, is not affected by the deprotection.
To obtain an active agent, which can induce cell death, the
tpy moieties were complexed with platinum. For this pur-
pose, the very efficient and mild route, using Pt(COD)Cl2 in
water, of Annibale et al. was applied.14,40 Since Pt(COD)Cl2 is
insoluble in water and only dissolves upon complexation of
the Pt, the reaction progress can be monitored easily. A color
change to orange/yellow, known from other tpy complexa-
tion reactions,14,40,41 was observed. When an excess of plati-
num compound was used, as reported by Wild et al.,14 a
black compound, insoluble in common organic solvents and
water, was obtained. Hence, a tpy:Pt ratio of 1:1 was chosen.
The side product cylco-octadiene was removed by washing
the aqueous phase with diethyl ether.
Characterization by 1H NMR spectroscopy showed a broad-
ening of the tpy signals, indicating the successful complexa-
tion (Fig. 3; Supporting Information Fig. S3). SEC analysis
after complexation revealed a shoulder at lower elution vol-
umes, that is, higher molar mass, for glucose (8) but to a
higher extent for the galactose functionalized polymer (9)
(Table 1 and Fig. 2). Consequently, the PDI values are
increasing, but do not exceed 1.3 (Table 1). This finding
might be ascribed to polymer–polymer coupling.
Although having hydrophilic and hydrophobic domains, the
polymers showed no self-assembly in water even at a con-
centration of 2 mg mL21. Dynamic light scattering (DLS)
measurements gave only hydrodynamic radii of about 3–
4 nm belonging to the free polymer chain (Supporting Infor-
mation Fig. S5).
In vitro Cytotoxicity
The potential of the platinum modified glycopoly(2-oxazo-
line)s as anticancer agents was examined in vitro against
mouse fibroblast L929 cells, human embryonic kidney cells
HEK 293, and human hepatocytes HepG2. The in vitro cyto-
toxicity was evaluated following a standardized XTT assay
protocol, in which a reduction of cell viability below 70% is
defining the tested substance as cytotoxic. The cells were
incubated with different polymer concentrations for 24 h. A
significant reduction of the metabolic activity was already
observed at glycopolymer concentrations in the range of
0.502 and 0.753 mM, depending on the analyzed cell type
[Fig. 4(A)]. HEK 293 and L929 cells tended to be slightly
more sensitive to the cytotoxic moieties of the glycopolymers
than HepG2 cells. However, a specific effect of the type of
conjugated sugar on the cytotoxicity could not be observed,
since for both, glucose and galactose functionalized poly-
mers, the viability rates of the particular cell types were in
most cases on similar levels. The absence of an enhanced
effectiveness of galactose functionalized polymers in HepG2
cells is unexpected since literature reports a galactose-
mediated targeting of polymeric substances to liver cells via
the asialoglycoprotein receptors.42,43 Possibly, the uptake of
the platinum containing glycopolymers was accomplished
preferentially via non-receptor–mediated endocytosis. Thus,
the role of the type of sugar conjugated was not evident.
Compared with free cisplatin, the glycopolymers exhibited
lower activities at same molar concentrations of platinum,
e.g. cisplatin is clearly cytotoxic at 0.483 mM, whereas the
glycopolymers, having four active platinum units per mole-
cule, are still cytocompatible at an equimolar platinum con-
tent (cPolymer5 0.125 mM).
A detailed live/dead microscopy study of the glycopolymer
and cisplatin treated cells confirmed the dose dependent
cytotoxic potential. At relatively low concentrations (0.005–
0.048 mM for cisplatin and 0.001–0.251 mM for both glyco-
polymers), an excellent cell viability (strong green fluores-
cence of FDA in cytoplasm) and the integrity of the cell
membranes (exclusion of red fluorescent PI from cell nuclei)
could be observed, proving the absence of cytotoxic effects
of the substances. In contrast, at higher concentrations (from
0.483 mM for cisplatin and from 0.502 mM for both glyco-
polymers), all cells were killed by both the platinum contain-
ing glycopolymers and the cisplatin reference [Fig. 4(B);
Supporting Information Figs. S6–S8].
The lower in vitro cytotoxic activity of the glycopolymers
when compared with cisplatin at equimolar amounts of plati-
num can be ascribed to the molecular structure of the com-
ponents. While cisplatin with a relatively low molar mass of
300 g mol21 is considered to enter the cell mostly by pas-
sive diffusion,44 the uptake of the macromolecular glycopoly-
meric platinum complexes might be retarded due to their
high molar mass of around 8000 g mol21. Hence, the inter-
nalization of the glycopolymers is rather accomplished by
endocytosis as well as receptor-mediated endocytosis pro-
moted by the attached sugar targeting moieties.
Even though the in vitro experiments revealed a higher effi-
ciency of cisplatin compared with the glycopolymer conju-
gated platinum, it is very likely that in vivo the latter is more
efficient and shows less side effects. As cisplatin is character-
ized by a relatively low molar mass, the better part of the
drug is excreted from the body within short time (elimina-
tion half-life of 43 min).45,46 Hence, the higher antitumor
activity of cisplatin cannot be fully exploited in vivo. This
provokes the need of an increased dosage of cisplatin, lead-
ing to more serious side effects for the patient. In contrast,
for both investigated glycopolymers, excretion from the body
might be decelerated due to their high molar mass and the
“stealth effect” of the PEtOx units. A prolonged blood circula-
tion time would be beneficial for the accumulation in cancer-
ous tissue (EPR effect). Moreover, the attached sugars might
support the specific uptake by neoplastic cells since they
exhibit overexpressed sugar receptors on their cell sur-
face.47,48 These effects could argue for a more cytotoxic
potential of the glycopolymers in vivo than observed in vitro
and could, in turn, decrease the overall drug dosage neces-
sary for disease treatment. The mode of action of platinum
based anticancer agents is based on the electrophilic
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properties of platinum and implies the crosslinking of DNA
strands, induction of DNA mutations as well as the suppres-
sion of DNA repair mechanisms. Hence, another possible rea-
son for the attenuated effectiveness of the glycopolymers
compared with cisplatin could be a hindered accessibility of
the active platinum species within the polymeric backbone
or an altered or shielded electrophilic capacity of the plati-
num complexes.
Hemolysis and Erythrocyte Aggregation
As blood is the first contact partner within the human body
during intravenous administration, the platinum conjugated
FIGURE 4 (A) Cell viability of L929 mouse fibroblasts, human embryonic kidney cells HEK 293, and human hepatocytes HepG2
after incubation with glycopolymers Glc-Pt(II) (8)/Gal-Pt(II) (9) and cisplatin at different concentrations for 24 h. Cells incubated
only with culture medium served as control. The cell viability was determined by XTT assay according to ISO 10993-5. Data are
expressed as mean6SD of six determinations. (B) Representative light field and fluorescence micrographs of Hoechst 33342/FDA/
PI stained L929 mouse fibroblast cells cultured for 24 h in the presence of high and low concentrations of Glc-Pt(II) (identical
results for Gal-Pt(II) and cisplatin). (1) Bright field image, (2) blue fluorescent Hoechst 33342 dye labels nuclei of all cells present,
(3) green fluorescent FDA dye indicates cytoplasm of vital cells, (4) red fluorescent PI signals tag nuclei of dead cells, and (5) over-
lay of Hoechst 33342 dye fluorescence and green fluorescence of the FDA dye. Scale bar5100 lm. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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glycopolymers as well as the cisplatin reference were tested
for their interaction with human blood.
In detail, adverse side reactions with red blood cells were
evaluated in terms of erythrocyte aggregation and hemolysis
upon glycopolymer and cisplatin incubation. To assess their
influence on the red blood cell membrane, the hemolytic
activity was measured photometrically by means of hemoglo-
bin release after potential damage of the erythrocyte mem-
brane (Fig. 5). The test substances were investigated at
different concentrations (both glycopolymers: 1.25628,
0.62814, 0.25126, 0.12563, and 0.01256 mM; cisplatin:
4.83372, 2.41686, 0.96674, 0.48337, and 0.04834 mM) in
comparison to PBS as negative and Triton-X100 as positive
control. A hemoglobin release of greater than 5% of the total
release was classified as hemolytic according to the ASTM
F756-08 standard.49
At low concentrations (between 0.01256 to 0.12563 mM for
glycopolymers and 0.04834 to 0.4834 mM for cisplatin),
both glycopolymers and cisplatin induced only a slight and
negligible hemoglobin release. It has to be mentioned, that
these glycopolymer concentrations are not within the cyto-
toxic range, as assessed in vitro using the XTT assay. Never-
theless, the required dosage for in vivo effectiveness was not
evaluated within this study.
Increasing the concentrations of glycopolymers (0.25126–
1.25628 mM) and cisplatin (0.96674–4.83372 mM) led to a
dose dependent damage of the erythrocyte membrane with a
remarkable release of hemoglobin from the cell plasma.
Interestingly, this effect was more pronounced in cisplatin
treated blood cells, indicating a higher hemolytic activity of
cisplatin than glycopolymer conjugated platinum. A major
difference between the glucose and galactose functionalized
polymers could not be observed.
FIGURE 5 Photometric determination of the hemolytic activity
of cisplatin and the glycopolymers Glc-Pt(II) (8) and Gal-Pt(II)
(9) after incubation for 1 h at 37 C. Triton X-100 (1%) served
as positive and PBS as negative control. Experiments were run
in triplicates and were repeated once; data are presented as
the mean percentage6SD of hemolytic activity compared with
the positive control set as 100%. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 6 Representative micrographs of red blood cells after 2 h incubation at 37 C with cisplatin, and the glycopolymers Glc-
Pt(II) (8) and Gal-Pt(II) (9). PBS served as negative and 25 kDa bPEI (50 lg mL21) as positive control. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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In addition, the induction of erythrocyte aggregation was
investigated microscopically. The formation of aggregates,
which could lead to an impeded blood flow, was analyzed
for different test substance concentrations (both glycopoly-
mers: 1.25628, 0.62814, 0.25126, 0.12563, and 0.01256 mM;
cisplatin: 4.83372, 2.41686, 0.96674, 0.48337, and
0.04834 mM) in comparison to PBS as negative and
branched poly(ethylene imine) (bPEI) as positive control.
Microscopic analysis revealed that no clear cell cluster for-
mation occurred with exception of the positive control
(bPEI). In contrast, it could be shown that a partial lysis of
erythrocytes occurred at the highest concentrations of cispla-
tin and both glycopolymers visible in a reduction of the total
cell density (Fig. 6). This assumption is supported by the
measurement of the hemolytic activity of both glycopolymers
and cisplatin shown before.
To conclude, adverse hemolytic side reactions with red blood
cells, representing the major cellular compartment of the
blood, were observed in a concentration dependent manner
for the two glycopolymeric platinum complexes but also for
the cisplatin reference, which is in clinical application for
many years. Interpreting these results, one has to keep in
mind that after intravenous injection the local drug concen-
tration in the blood stream of the patient is usually an order
of magnitude lower (for cisplatin maximum 2 mg L21 which
equates to 0.013 mM)50 than tested in our in vitro experi-
ments (for cisplatin between 7 and 1450 mg L21/0.48–
4.83 mM; for glycopolymers between 1000 and 10,000 mg
L21/0.012–1.256 mM). Due to this, the potential hemolytic
activity of the glycopolymers at high concentrations is not of
clinical relevance since such high concentration levels will
not be reached in the circulating human blood in vivo when
the anticancer drug is administered in a highly diluted
solution.
CONCLUSIONS
We herein describe for the first time the synthesis of plati-
num containing 2-oxazoline-based glycopolymers which were
obtained by attaching terpyridine (tpy) as well as acetyl pro-
tected glucose and galactose, respectively, to poly(2-ethyl-2-
oxazoline-block-2-(3-butenyl)-2-oxazoline) using thiol-ene
photoaddition. Subsequent deprotection of the sugars with
sodium methanolate and treatment with Pt(COD)Cl2 applying
a mild synthetic route in water, yielded polymers with both,
sugar units for active tumor targeting as well as cytotoxic
Pt(II) units. This synthetic approach allows the variation of
the sugar/platinum content and with it the fine-tuning of the
polymer properties.
To investigate the potential of the platinum containing glyco-
polymer as anticancer drug, their in vitro cytotoxicity and
influence on blood integrity has been studied and the results
have been compared with cisplatin as reference.
The cytotoxicity was examined against mouse fibroblast
L929 cells, human embryonic kidney cells HEK 293, and
human hepatocytes HepG2. For both, cisplatin and the two
glycopolymers, a dose dependent cytotoxicity was observed,
with a higher activity of cisplatin at equimolar platinum
amounts. However, the overexpression of sugar receptors on
neoplastic cells and the possible EPR effect, often observed
for hydrophilic polymers, might lead to a better in vivo per-
formance of the glycopolymers.
In conclusion, we demonstrated a straightforward route for
the synthesis of platinum containing 2-oxazoline-based glyco-
polymers as promising candidates for anticancer therapy,
whose potential will be exploited in our upcoming work.
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FIGURE S1 A) First-order kinetic plots of the copolymerization of EtOx (square) and ButEnOx (circle) at 
140 °C with a total monomer concentration of 1 M and a [EtOx]:[ButEnOx]:[MeOTs] ratio of 16:4:1. 
B) SEC curves kinetic study after different times. 
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TABLE S1. Data of the kinetic study. 
Time (s) Conversion of EtOx:ButEnOx (%)a) Mn (g mol-1)b) PDIb) 
30 47:51 900 1.22 
60 61:63 1,115 1.25 
120 76:78 1,590 1.22 
180 88:88 1,850 1.23 
240 90:90 1,980 1.23 
300 96:95 2,020 1.24 
390 98:100 2,250 1.23 
a)Determined by GC. b)Determined by SEC (chloroform/TEA/2-propanol 94:4:2, calibration against PS). 
 
TABLE S2. SEC data of the different polymers. 
Compund Mn (g mol-1)a) PDIa) 
1 4,590 1.16 
2 3,920 1.16 
3 7,590 1.14 
a)Determined by SEC (chloroform/TEA/2-propanol 94:4:2, calibration against PS). 
 
 
FIGURE S2. Overlay of the SEC curves of polymer 3 measured with an UV (280 nm and 405 nm) and an RI 
detector, respectively. 
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FIGURE S3 1H NMR spectra of P(EtOx30-stat-(Ac4GalButOx)6-stat-tpyButOx4), P(EtOx30-stat-GalButOx6-
stat-tpyButOx4), and P(EtOx30-stat-GalButOx-stat-PtButOx4) (300 MHz, CD3OD). 
 
 
FIGURE S4 ATR-FT-IR spectra of A) glucose and B) fructose functionalized glycopolymers before (4, 5) and 
after (6, 7) deprotection. 
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FIGURE S5 Dynamic light scattering (DLS) plot of the glycopolymers 8 and 9. 
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SCHEME S1. Schematic representation of the synthesis of 6-([2,2':6',2''-terpyridin]-4'-yloxy)hexane-1-
thiol. The shown reaction pathway is known in literature for other terpyridine thiols and was applied for 
a C6-linker between the terpyridine moiety and the thiol function.1-3 
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FIGURE S6 Microscopy study on the cell viability of L929 mouse fibroblasts after incubation with cisplatin 
at different concentrations for 24 hours. Cells incubated only with culture medium served as control. 
Representative bright field images and fluorescence micrographs from different channels: The blue 
fluorescent Hoechst 33342 dye labels nuclei of all cells present, the green fluorescent FDA dye indicates 
cytoplasm of vital cells, and the red fluorescent PI signals tag nuclei of dead cells. Identical results were 
obtained for human embryonic kidney cells HEK293 and human hepatocytes HepG2 (not shown). Scale 
bar = 100 μm. 
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FIGURE S7 Microscopy study on the cell viability of L929 mouse fibroblasts after incubation with Glc-
Pt(II) (8) at different concentrations for 24 hours. Cells incubated only with culture medium served as 
control. Representative bright field images and fluorescence micrographs from different channels: The 
blue fluorescent Hoechst 33342 dye labels nuclei of all cells present, the green fluorescent FDA dye 
indicates cytoplasm of vital cells, and the red fluorescent PI signals tag nuclei of dead cells. Identical 
results were obtained for human embryonic kidney cells HEK293 and human hepatocytes HepG2 (not 
shown). Scale bar = 100 μm. 
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FIGURE S8 Microscopy study on the cell viability of L929 mouse fibroblasts after incubation with Gal-
Pt(II) (9) at different concentrations for 24 hours. Cells incubated only with culture medium served as 
control. Representative bright field images and fluorescence micrographs from different channels: The 
blue fluorescent Hoechst 33342 dye labels nuclei of all cells present, the green fluorescent FDA dye 
indicates cytoplasm of vital cells, and the red fluorescent PI signals tag nuclei of dead cells. Identical 
results were obtained for human embryonic kidney cells HEK293 and human hepatocytes HepG2 (not 
shown). Scale bar = 100 μm. 
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EXPERIMENTAL 
Chemicals and instrumentation 
THF was dried and distilled over sodium, aceton over calcium chloride. Size exclusion chromatography 
(SEC) investigations of the kinetic study were measured on a Shimadzu system equipped with a SCL-10A 
VP system controller, a DGU-14A degasser, a LC-10AD VP pump, a RID-10A refractive index detector and 
a PSS SDV column running with chloroform, triethylamine (TEA), and 2-propanol (94 : 4 : 2) as eluent. 
The Techlab column oven was set to 50 °C. Molar masses were calculated against polystyrene (PS) 
standards. Gas chromatography (GC) measurements of the kinetic study were performed on a Shimadzu 
GC2010 equipped with a Restek Rtx-5 column (30 m length, 0.25 mm ID, 0.25 μm film thickness [5% 
diphenyl, 95% dimethyl polysiloxane] (carrier gas: helium) and a FID detector (carrier gases: H2, 
combustion: air). ATR-FT-IR spectra were measured on a Nicolet Avatar 370 DTGS from Thermo Electron 
Corporation. Dynamic light scattering (DLS) was performed on a Zetasizer Nano ZS (Malvern Instruments, 
Herrenberg, Germany).  After an equilibration time (25°C) of 180 s, 3 x 30 runs were carried out at 25°C 
???????????????????????????????????????????????????????????????????????????????????????? ???????ach 
measurement was performed in triplicate. Apparent hydrodynamic radii, Rh, were calculated according 
to the Stokes–Einstein equation. 
 
S-(6-Bromohexyl) ethanethioate2,3 
Under nitrogen atmosphere 1.7 mL dibromohexane (11.22 mmol) were dissolved in 20 mL 
dichloromethane. A solution of 760 mg potassium thioacetate (6.66 mmol) in 25 mL ethanol was added 
dropwise to the reaction mixture and a white precipitate formed. Subsequently the reaction mixture was 
stirred at room temperature for 16 hours. 
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After this the solvents were evaporated and the residue was dissolved in dichloromethane. The solution 
was washed with deionized water and the organic phase was dried over Na2SO4. The solution was 
concentrated and the compound purified by a silica gel chromatography (n-hexane/chloroform 2:1). 
Yield: 1.046 g of a yellow liquid, 66% 
1H NMR (250 MHz, CDCl3): ? = 1.25 – 1.64 (m, 6H, H-alkyl), 1.85 (q, J = 6.75 Hz, 2H, CH2-CH2Br), 2.32 (s, 
3H, -CH3), 2.86 (t, J = 7.25 Hz, 2H, CH2-S), 3.41 (t, J = 6.75 Hz, 2H, CH2-Br) ppm. 
13C NMR (62.5 MHz, CDCl3): ? = 27.6 (C?), 27.9 (C?), 28.9 (C?), 29.3 (C?), 30.6 (CH2-S), 32.6(-CH3), 33.7 (CH2-
Br), 195.9 (C=O) ppm. 
ESI-TOF MS (HR): m/z = [C8H15OSBr+Na]+: calcd.: 260.9919; found: 260,9923; error: 1.6 ppm 
 
S-(6-([2,2':6',2''-Terpyridin]-4'-yloxy)-hexyl) ethanethioate 
510 mg S-(6-Bromohexyl) ethanethioate (2.13 mmol), 810 mg potassium carbonate, and 525 mg 2,6-bis-
(pyrid-2-yl)-4-pyridone (2.11 mmol) were dissolved in 60 mL dry acetone. The solution was stirred under 
reflux for 6 hours. After this the mixture was stirred at 45 °C for 18 hours.  
Subsequently, the solvent was evaporated and the residue was dissolved in dichloromethane. After 
washing with water (300 mL) the organic layer was dried over Na2SO4 and concentrated. The product 
was obtained by silica gel chromatography (CHCl3). 
Yield: 763 mg of a white solid, 89% 
1H NMR (250 MHz, CDCl3): ? = 1.45 – 1.65 (m, 6H, H?????), 1.86 (q, J = 7.00 Hz, 2H, CH2-CH2S), 2.33 (s, 3H, -
CH3), 2.90 (t, J = 7.00 Hz, 2H, CH2-S), 4.22 (t, J = 6.25 Hz, 2H, O-CH2), 7.33 (dd, J = 4.75 Hz, J = 1.50 Hz , 2H, 
H?????), 7.85 (td, J = 8.00 Hz, J = 1.50 Hz, 2H, H?????), 8.01 (s, 2H, H?????), 8.62 (d, J = 8.00 Hz, 2H, H?????), 8.69 (d, 
J = 4.75 Hz, 2H, H?????) ppm. 
13C NMR (62.5 MHz, CDCl3): ? = 25.5 (C?), 28.4 (C?), 28.9 (C?), 29.0 (C?), 29.4 (CH2-S), 30.6 (-CH3), 68.0 (O-
CH2), 107.4 (C?????), 121.3 (C?????), 123.8 (C?????), 136.8 (C?????), 148.9 (C?????), 156.1 (C?????), 157.0 (C?????), 167.3 
(C??), 195.9 (C=O) ppm. 
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Elemental analysis:  
C23H25N3O2S calcd.: C 67.79% H 6.18% N 10.31% S 7.86% 
(407.518) found: C 67.84% H 6.14% N 10.20% S 7.54% 
 
6-([2,2':6',2''-Terpyridin]-4'-yloxy)hexane-1-thiol (tpy-SH) 
In a three neck flask 503 mg of 6a (1.23 mmol) were dissolved in 40 mL dry THF. The solution was 
degassed with nitrogen for 30 minutes and then 6 mL of a 0.5 M solution of sodium methoxide in 
methanol was slowly added. The reaction mixture was stirred for 4 hours at room temperature. 
Subsequently, the reaction was quenched by the addition of 60 mL of a saturated aqueous ammonium 
chloride solution. The solvents were evaporated and the residue was dissolved in water and 
dichloromethane. The aqueous phase was extracted with dichloromethane (300 mL) and the combined 
organic phases were dried over Na2SO4. The solvent was evaporated and the product was used without 
further purification. 
Yield: 440 mg of a white solid, 98% 
1H NMR (250 MHz, CDCl3): ? = 1.26 – 1.64 (m, 9H, -SH, H???????), 2.53 (t, J = 7.25 Hz, 2H, H?), 4.23 (t, J = 6.25 
Hz, 2H, H?), 7.33 (dd, J = 2.00 Hz, 4.75 Hz , 2H, H?????), 7.85 (td, J = 2.00 Hz, 8.00 Hz, 2H, H?????), 8.01 (s, 2H, 
H?????), 8.62 (d, J = 8.00 Hz, 2H, H?????), 8.79 (d, J = 4.75 Hz, 2H, H?????) ppm. 
13C NMR (62.5 MHz, CDCl3): ? = 24.5 (C?), 25.6 (C?), 28.0 (C?), 28.9(C?), 33.9 (C?), 68.0 (C?), 107.4 (C?????), 
121.4 (C?????), 123.8 (C?????), 136.8 (C?????), 149.0 (C?????), 156.1 (C?????), 157.0 (C?????), 167.3 (C??) ppm. 
ESI-TOF MS (HR): m/z = [M+Na]+: calcd.: 388.1460; found: 388.1456; error: 1.03 ppm 
[M+H]+:   calcd.: 366.1640; found: 366.1634; error: 1.64 ppm 
 
Kinetic study of the copolymerization of EtOx and ButEnOx 
For the kinetic studies, a stock solution containing methyl tosylate (initiator), acetonitrile (solvent) EtOx 
and ButEnOx was prepared. The total monomer concentration was adjusted to 1 M with a 
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[EtOx]/[ButEnOx]/[I] ratio of 16:4:1. The stock solution was divided over seven microwave vials and 
capped under nitrogen. To calculate the conversion, t0 samples were taken. The vials were heated to 140 
°C for different times in the microwave synthesizer. After cooling to room temperature, the reaction was 
quenched, and the conversion of the monomers was determined by GC. As internal standard the 
polymerization solvent was used. 
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Abstract 
To receive a more profound insight on the impact of the number and the density of protonable 
amines on the performance of polycations as non-viral vectors, a series of linear poly(ethylene 
imine)s (LPEIs) with different numbers of ethylene imine (EI) units was compared to partially 
hydrolyzed poly(2-ethyl-2-oxazoline)s (PHPEtOxs) with corresponding numbers of EI-units 
but with varying densities. PHPEtOxs synthesized from 20 kDa PEtOx with hydrolysis 
degrees between 21 and 86% as well as the corresponding LPEIs were able to form 
polyplexes with DNA and their cyto- and hemotoxicity increased with increasing numbers of 
EI units. Since PHEtOxs were only slightly better tolerated it was considered that the total 
number of EI units per polymer had a higher impact on the biocompatibility than the density 
of EI units. In addition it could be shown that the transfection efficiency of PHPEtOxs was 
much lower than that of their corresponding LPEIs leading to the assumption that the 
presence of high numbers of EI numbers in close juxtaposition to each other is a key 
parameter for the high transfection rate of LPEI and that the reduction of the EI density is 
a modification technique which should, with regard to the cost-benefit ratio, be critically 
scrutinized. 
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Abbreviations: 
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; BCA, bicinchoninic 
acid; BSA, bovine serum albumin; CHO-K1, Chinese hamster ovary cells; CROP, cationic 
ring opening polymerization; DH, degree of hydrolysis; DP, degree of polymerization; EI, 
ethylene imine; FBS, fetal bovine serum; HFIP, hexafluoroisopropanol; LPEI, linear 
poly(ethylene imine); PHPEtOx, partially hydrolyzed poly(2-ethyl-2-oxazoline); PBS, 
phosphate buffered saline; pDNA, plasmid DNA; PEtOx, poly(2-ethyl-2-oxazoline); POx, 
poly(2-oxazoline); PMeOx, poly(2-methyl-2-oxazoline); PS, poly(styrene); PDI, 
polydispersity index; RLU, relative light unit; RPMI 1640, Roswell Park Memorial Institute 
1640; SEC, Size exclusion chromatography; SI, supporting information; Tris, 
tris(hydroxymethyl)aminomethane. 
 
1. Introduction 
 The use of DNA and RNA is a promising approach in therapy, especially for 
applications aiming at the treatment of acquired and hereditary genetic defects, chronic heart 
insufficiency as well as infectious, neurological, and tumor diseases.[1] More and more 
nucleic acid formulations move from the preclinical development to the clinical trials, and 
several gene therapies are or will soon be in late-stage human trials.[2] Polycationic polymers 
are successful non-viral vectors, and a plethora of agents is already available for in vitro 
applications.[3] However, only a limited number of such polymers made their way to the 
clinical testing.[2] Limited efficacies as well as biocompatibility and safety issues are the 
most challenging reasons that hamper their therapeutic use so far.[4] 
 To improve their benefit-to-risk ratio, many studies to understand structure-property 
relationships have been performed.[5-8] Molar mass, three-dimensional architecture and 
molecular flexibility as well as type, number and density of cationic charges were identified 
as relevant parameters.[6, 9-10] High molar masses, number and density of the cationic 
residues were found to allow a more efficient electrostatic interaction with the nucleic acids, 
resulting in the formation of small sized and enzymatically stable polyplexes with enhanced 
cell uptake and transfection efficacy.[11] However, electrostatic interactions with negatively 
charged cell membranes caused membrane damaging effects, metabolic impairments, and 
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hemotoxic effects.[6, 12] This so called charge dilemma forced various strategies to reduce 
the number and density of charges. For poly(ethylene imine) (PEI), the most successful non-
viral vector polymer, several approaches to address these shortcomings were investigated 
such as using low molar mass PEIs, [13-14] PEI copolymers with “stealth effect” to mask the 
surface charge, [15] biodegradable [16] and zwitterionic PEIs.[17] While for branched PEI 
the importance of the structural parameters was already shown in extenso, [11, 18-20] for 
linear PEIs (LPEI) the data base is comparatively limited. 
 LPEIs can be obtained by the complete hydrolysis of poly(2-oxazoline)s (POxs) that 
are synthesized by cationic ring opening polymerization (CROP).[21] An increasing time of 
hydrolysis directly correlates with a higher number of ethylene imine units and cationic 
charges. High transfection efficacy and cytotoxicity were shown to be mediated by an 
increasing degree of hydrolysis (DH).[22] Preferentially, a DH between 70-88 % was 
identified as suitable due to moderate cytotoxicity and acceptable transfection rates.[22-23] 
The molar mass of the starting POx material defines the number of EI units of the resulting 
LPEI. Using partially hydrolyzed high molar mass poly(2-ethyl-2-oxazoline)s (PEtOxs, 50 
and 200 kDa) Jeong et al. suggested that beside the charge density a high molar mass also 
seems to play a critical role for high transfection.[22] Fernandes et al. [23] used lower molar 
mass 10 kDa PEtOx, forming polyplexes with comparably lower zeta potentials and siRNA 
transfection rates. In these studies, the performance of the polymers was compared to PEIs 
with a totally different structure such as 25 kDa branched PEI [22] or only to one fully 
hydrolyzed LPEI.[23] 
 In the present study, five PHPEtOxs were synthesized from a 20 kDa PEtOx with a 
wide range of degrees of hydrolysis between 21% and 86% resulting in a series of polymers 
with different numbers of EI units separated by randomly distributed 2-ethyl-2-oxazoline 
groups. In contrast to previous studies, a 20 kDa PEtOx was selected as starting material 
forming hydrolyzed polymers with molar masses that demonstrated in previous studies to be 
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the most relevant size range for efficacy as non-viral vector.[13-14] The PHPEtOxs were 
compared to six fully hydrolyzed LPEIs with a comparable number of EI units to be able to 
clearly identify the different importance of the number and the density of EI units. The 
influence of the different polymer structures on DNA binding, enzymatic polyplex stability, 
cyto- and hemotoxicity as well as transfection efficacy was investigated  
 
2. Material and methods 
2.1 Synthesis of linear poly(ethylene imine) and partially hydrolyzed poly(2-ethyl-2-
oxazoline)  
 The synthesis and characterization of the LPEIs has been reported in detail 
elsewhere.[21, 24-25] PHPEtOx synthesis was performed as follows: Twenty kDa PEtOx 
(4 g) were dissolved in 6 M HCl (12 mL). The mixture was heated in an Initiator Sixty single-
mode microwave synthesizer (Biotage, Uppsala, Sweden) equipped with a non-invasive 
infrared sensor (accuracy: ±2), at 100 °C for different times. The solvent was removed under 
reduced pressure, and the residue was dissolved in water. Further purification was performed 
using two different approaches. For the DH below 75% (21, 41, 56%), the solution was 
neutralized to pH 7 with 3 M NaOH solution and dialyzed against water. After dialysis, the 
water was removed under reduced pressure. For a DH of 75% and higher, 3 M NaOH solution 
was added until a white precipitate occurred. The precipitate was filtered off and re-
crystallized from water. All polymers were dried at 40 °C for 5 days under vacuum. 
 
2.2 Characterization of the polymers 
 1H NMR spectra were recorded on a Bruker AC 300 MHz spectrometer (Bruker 
BioSpin GmbH, Rheinstetten, Germany) at room temperature. As solvent deuterated methanol 
was used. The chemical shifts were given in ppm relative to the signal from residual non-
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deuterated solvent. The degree of hydrolysis (DH) was calculated by correlating the methyl 
proton signal of the uncleaved side chain (1.13 ppm) and the protons of the LPEI backbone 
(2.73 ppm). Size exclusion chromatography (SEC) of the LPEIs and the PHPEtOxs was 
measured at 40 °C on a system equipped with a Shimadzu LC-10AD pump (Shimadzu Europe 
GmbH, Duisburg, Germany), a Waters 2414 refractive index detector (35 °C), a Spark 
Holland MIDAS injector (Spark Holland, Emmen, the Netherlands) a Polymer Standards 
Service GmbH (PSS) PFG guard column, and two PFG-linear-??? ??? ???? ?? ?? ???? ????
columns placed in series (PSS, Mainz, Germany). As eluent hexafluoroisopropanol (HFIP, 
Apollo Scientific Limited, Stockport, United Kingdom) with potassium trifluoroacetate 
(3 g/L) was used at a flow rate of 0.8 mL/min. In all cases, the molar masses were calculated 
against poly(styrene) standards. 
 
2.3 Formation of polyplexes 
 Polymer stock solutions were prepared with a PEI content of 0.9 mg/mL in highly 
purified water at pH 7.4. After sterile filtration (0.2 μm, VWR International, Darmstadt, 
Germany), the PEI concentration was determined spectrophotometrically by Cu2+ chelation 
according to Perrine et al.[26] using a microplate reader (Fluostar OPTIMA, BMG Labtech, 
Offenburg, Germany) at a wavelength of 645 nm. Only the stock solutions for the 
hemocompatibility experiments required a maximum concentration of 3 mg/mL and were 
prepared in 1.5 mM phosphate buffered saline pH 7.4 (PBS). Polyplexes were prepared as 
described previously[14] with different N/P ratios (polymer nitrogen (N)) per DNA phosphate 
(P)). The required volumes of polymer stock solution (0.9 mg/mL) and 5 μg DNA were each 
diluted in 150 mM NaCl (Roth, Karlsruhe, Germany) solution (pH 7.4) to a total volume of 
125 μL, vortexed for 10 seconds and incubated for 10 minutes at room temperature. 
Afterwards, the polymer solution was pipetted to the DNA solution, vortexed for 10 seconds 
and incubated for further 10 minutes before use. Dependent on the experiment, herring testis 
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DNA (1 mg/mL tris(hydroxymethyl)aminomethane (Tris) buffered stock solution, type XIV, 
Sigma Aldrich, Deisenhofen, Germany) or plasmid DNA (pDNA) (pGL3, Promega, Madison, 
WI, USA) were used. Amplification of the pGL3 plasmid encoding the luciferase reporter 
gene was performed in competent E. coli TG1 (Hans-Knoell Institute, Jena, Germany) 
followed by isolation with a standard kit according to the manufacturer’s protocol (Plasmid 
Maxi Kit E.Z.N.A®, OMEGA bio-tek, Norcross, GA, USA).  
 
2.4 Horizontal gel retardation assay 
 Fifty μL aliquots of the polyplex solutions containing 1 μg herring testis DNA were 
?????? ????? ?? ??? ???????? ??????? ???? ??? ?????? ???? ?????? ????????? ????? ?? ??? ?????
(ethylenediaminetetraacetic acid), pH 7.4, all from Roth) and applied on a 1% agarose gel 
(peqGold Universal Agarose, Peqlab Biotechnology GmbH, Erlangen, Germany) loaded with 
ethidium bromide. Free DNA and free polymer solutions were used as controls. 
Bromphenolblue was applied in a separate pocket as running control. Electrophoretic 
separation was carried out in an electrophoresis chamber (Biometra, Goettingen, Germany) at 
80 V for 1 h with TAE running buffer (40 mM Tris, 1% acetic acid, 1 mM EDTA, all from 
Roth). Gels were photographed under UV transillumination (Intas GmbH, Goettingen 
Germany) at 312 nm with a gel documentation system (Digit Store UNO, Intas GmbH). 
 
2.5 Laser light scattering experiments 
 Hydrodynamic diameter and zeta potential of pGL3 polyplexes were measured with 
the Zetasizer nano ZS (4 mW HeNe Laser, 633 nm) (Malvern Instruments, Worcestershire, 
United Kingdom) in 50 mM NaCl solution. The hydrodynamic diameter was determined by 
photon correlation spectroscopy in six measurement cycles in a ZEN 0112 low volume sizing 
cuvette (Brand, Wertheim, Germany) at a scattering angle of -173° at 25 °C. For data analysis 
the refractive index (1.33) and the viscosity (0.88 mPa·s) of distilled water at 25 °C were 
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used. Results were calculated with the CONTIN algorithm using the Malvern Zetasizer 
software 6.20. Zeta potential was determined by measuring the electrophoretic mobility at 
25 °C in DTS1060 capillary cells (Malvern) in five measurement cycles. Results were 
calculated by the Malvern software 6.20. All experiments were repeated once. 
 
2.6 Stability testing of polyplexes 
 ???????????????????????????????????????????????????????????????????????with 10 μL 
DNase I (5 Kunitz units/μg plasmid), diluted in 150 mM NaCl solution supplemented with 20 
mM MgCl2 solution, pH 7.4 (Amersham Biosciences, Piscataway, USA), at 37 °C for 45 
minutes. Afterwards the enzyme was inactivated by heating of the samples to 70 °C for 35 
minutes. To release pDNA from the polyplexes, 50 μL dextran sulfate solution (10 mg/mL) (5 
kDa, Leuconostoc species pluralis, Sigma) were added at 37 °C for 20 minutes. Untreated 
free pDNA and free pDNA equally treated as the polyplexes, but without the addition of 
DNase I represented the negative controls. Non-complexed pDNA treated with DNase I was 
used as positive control. Separation by gel electrophoresis was performed as described in the 
section above. 
 
2.7 In vitro transfection of eukaryotic cells 
 Transfection efficiency was tested on CHO-K1 (Chinese hamster ovary cells, German 
Collection of Microorganisms and Cell Cultures, DSMZ, Braunschweig, Germany) cells 
cultured in Ham’s F12 medium (PAA, Pasching, Austria) containing 1 mM L-glutamine and 
10% fetal bovine serum Gold (FBS Gold, PAA) at 37 °C, 5% CO2 and 95% relative humidity. 
Polyplexes were freshly prepared before each experiment as described above in 150 mM 
NaCl containing 4 μg pGL3 plasmid in a total volume of 200 μL. Cells (50.000/well) were 
seeded in 12-well plates (Greiner bio one) with each well containing 2 mL medium. After 
24 h medium was changed, and polyplexes or controls were added in serum-containing 
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medium. Cells only treated with 200 μL physiological saline served as negative control while 
polyplexes formed with a commercial LPEI (2.5 kDa, Polysciences Europe GmbH, 
Eppelheim, Germany) at N/P 25 were used as positive control. Additionally, the minimum 
transfection rate was determined by the use of non-complexed plasmid DNA. After 4 h 
incubation medium was changed again, and the cells were incubated for further 44 h. 
Afterwards cells were lysed, and luciferase activity was determined using a commercial kit 
(Luciferase assay system, Promega) according to the manufacturer’s protocol using an 
onboard dispensing system for the direct application of the assay reagent on the samples in the 
microplate reader (Fluostar OPTIMA microplate reader, BMG Labtech, Offenburg, 
Germany). The protein content of the samples was quantified with a standard bicinchoninic 
acid (BCA) assay kit (Thermo Scientific, Rockford, USA) as instructed by the manufacturer 
with minor changes. To inactivate dithiothreitol of the lysis reagent, 25 μL cell lysate were 
treated with 10 μL 0.05 M iodacetamide solution (Applichem, Darmstadt, Germany) at 37 °C 
for 20 min. Afterwards, 200 μL BCA assay reagent were added and incubated at 37 °C for 40 
minutes. Absorption was measured using a microplate reader at a wavelength of 570 nm and 
compared to a bovine serum albumin (BSA) standard curve. The transfection efficiency is 
presented as relative light units (RLUs)/?g protein.  
 
2.8 Biocompatibility assays 
 To investigate the cytotoxicity of the polyplexes the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) assay was performed as described before [27] using 
L929 mouse fibroblasts (DSMZ) grown in clear flat bottomed 96-well plates (Greiner bio 
one) in Roswell Park Memorial Institute 1640 culture medium (RPMI 1640, PAA) 
supplemented with 10% FBS Gold and 2 mM L-glutamine at 37 °C, 5% CO2 and 95% 
relative humidity. To obtain the same polyplex to cell ratios as used in the transfection 
experiments polyplexes at N/P 25 and 50 were formed by mixing 3.2 μg DNA and the 
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required polymer stock solution each diluted with 150 mM physiological saline to a total 
volume of 60.5 μL as described in the section above. Afterwards, the polyplex solutions were 
diluted with 1089 μL medium. Aliquots of 110 μL were added to the cells and incubated for 
4 h. Polyplex solutions were replaced by 200 μL RPMI 1640 medium, and cells were 
incubated for further 20 h. Experiments were run in seven parallel experiments and repeated 
once.  
Hemocompatibility testing of non-complexed LPEIs and PHPEtOxs was performed by 
erythrocyte aggregation and hemolysis assays. The collection of sheep erythrocytes and the 
assay procedures were described in detail by Bauer et al.[27] For light microscopic 
determination of erythrocyte aggregation, polymer dilutions with five different concentrations 
up to a minimum concentration of 1.875 μg/mL were prepared. As negative and positive 
controls erythrocytes were treated with PBS or 25 kDa branched poly(ethylene imine) (30 
μg/mL, kind gift of BASF corporation, Ludwigshafen, Germany). Test polymers as well as 
controls were incubated with erythrocytes for 2 h followed by the evaluation of the 
erythrocyte aggregating potential with a three staged classification system as described 
in [27].  
For hemolysis experiments five different polymer concentrations were investigated ranging 
from 0.1875 to 3 mg/mL compared to the negative control consisting of PBS. Positive control 
(100%) was achieved by treatment of red blood cells with a 1% Triton X-100 solution (Ferak, 
Berlin, Germany). Polymer solutions as well as controls were mixed with the erythrocyte 
suspension at ratio 1:1, and incubated at 37 °C for 1 h. Measurements and evaluation were 
described in detail elsewhere.[27]  
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3. Results and discussion 
3.1 Synthesis and structural characterization of the polymers 
 LPEIs (Fig. 1 a) with molar masses from 1.76 to 8.65 kDa (corresponding to 40–200 
repeating units) have been synthesized (Table 1) by acidic hydrolysis of both poly(2-methyl-
2-oxazoline) (PMeOx) and PEtOx. The starting poly(2-oxazoline)s were obtained by 
CROP.[24, 27] For the synthesis of the PHPEtOx (Fig 1 b) with different amounts of ethylene 
imine units, the 20 kDa PEtOx [polydispersity index (PDI) = 1.35, Mn (SEC) = 12,000 Da] 
was partially hydrolyzed under acidic conditions. With increasing hydrolysis time, the DH 
increased from 21, 41, 56 and 75 to 86% (corresponding to 42, 82, 112, 150, and 172 ethylene 
imine repeating units) (Table 2). Analysis of the LPEIs and PHPEtOxs by means of 1H NMR 
spectroscopy confirmed their purity and identity. The DHs of the PHEtOxs were calculated by 
correlating the methyl proton signal of the uncleaved side chain (1.13 ppm) and the protons of 
the LPEI backbone (2.73 ppm). Size exclusion chromatography revealed that the LPEIs were 
synthesized with a narrow molar mass distribution (Table 1). The high PDI values of some 
PHPEtOx (Table 2) can be ascribed to the statistical character of the hydrolysis, resulting in 
polymer chains with different amounts of positively charged ethylene imine units and slightly 
varying molar masses and, hence, different interactions with the used SEC column. The 
differences between the calculated molar masses and the measured values can be explained 
with the usage of the neutral PS as calibration standard, while the LPEIs and PHPEtOx are 
positively charged, varying with the amount of ethylene imine units. All polymer stock 
solutions could be spectrophotometrically quantified by copper chelate complex formation. 
Preliminary experiments using polymer concentrations up to 2 mg/mL confirmed that the 
presence of 2-oxazoline units did not interfere with the quantification of the ethylene imine 
units (data not shown). 
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3.2 Determination of DNA binding by agarose gel electrophoresis 
 A qualitative insight into the DNA binding capacity of LPEIs and PHPEtOxs resulting 
from electrostatic interactions between the oppositely charged binding partners was obtained 
by agarose gel electrophoresis. Based on previous experiments with LPEIs, N/P ratios from 
0.25 to 9 were selected to form polyplexes.[13] DNA was classified as complexed when its 
movement in the electric field was completely inhibited either by increase in size due to the 
formation of nanoassemblies and/or by masking its anionic charge. Free herring testes DNA 
that was used as model DNA [28], migrated into the gel without any hindrance and showed a 
broad fluorescent band corresponding to its broad molar mass distribution (Fig. 1 SI and 2 SI, 
“untreated”). Free polymers were used as controls to exclude unspecific polymer/dye 
interactions and exhibited no signals (Fig. 1 SI and 2 SI, “free polymer”).  
Although all cationic polymers spontaneously formed polyplexes with herring testes DNA 
(Fig. 1 SI and 2 SI, “N/P 0.25-9”), differences between LPEIs and PHPEtOx were obvious. 
For the LPEIs a molar mass dependent binding profile could be observed in accordance to 
earlier reports [13], resulting from the increase of EI units. While for LPEIs with 
? 60 monomer units (Table 1, Fig. 1 SI d-h) a complete retardation of DNA was apparent 
already at N/P 1 representing charge balance, for LPEIs with lower molar masses higher N/P 
ratios of 2 or 3 were necessary, indicating a weaker DNA binding capacity (Fig. 1 SI a-c).  
 The formation of interpolyelectrolyte polyplexes of the PHPEtOxs was found to be 
dependent on the degree of hydrolysis. Only PHPEtOx-86 (Table 2, Fig. 2 SI e) was able to 
fully complex DNA at N/P ratio 1 whereas all other partially hydrolyzed polymers started to 
form polyplexes at N/P ratio 2 (Table 2, Fig. 1 SI a - d). Comparable data were reported by 
others [22-23, 29] showing a more efficient neutralization of DNA phosphate groups with 
increasing DH. The direct comparison of LPEIs and PHPEtOxs revealed that despite having 
the same number of ethylene imine units, a higher N/P ratio was necessary for the PHPEtOxs 
to fully retard DNA which might be related to the lower density of ethylene imine units of the 
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PHPEtOx, the protein repellent character of the PEtOx units, and a possible steric hindrance 
caused by the 2-ethyl-2-oxazoline side chains.  
 
3.3 Polyplex stability against enzymatic treatment 
 The formation of stable polymer/DNA nanoassemblies by electrostatic interactions is 
not only a prerequisite to facilitate cell uptake but also for the protection of DNA against 
enzymatic digestion in the blood stream and the endosome. The enzymatic stability of 
plasmid DNA was tested by agarose gel electrophoresis with a DNase I concentration of 
96.2 U mL-1 which is approximately 270-times higher than the normal level in human 
blood [30], representing a worst case scenario. Afterwards, the enzyme was inactivated by 
heat treatment and the DNA released by dissociation of the polyplexes with dextran sulfate. 
For the experiments two different N/P ratios (25 and 100) were selected that represent 
conditions with fully condensed DNA based on preliminary experiments (data not shown) and 
reports.[13-14] 
 Untreated DNA showed two characteristic bands for the supercoiled and the open 
circular form (Fig. 2 a-d, lane 1, “untreated"). The same pattern was obtained for plasmid 
treated according to the same procedure as the complexed DNA but without enzyme (Fig. 2 a-
d, lane 2, “treated”). It was found to be stable and served as control to exclude non-specific 
degradation. DNase treated free plasmid was highly prone to enzymatic degradation to low 
molar mass products with higher mobility, and the bands disappeared (Fig. 2 a-d, lane 3, 
“DNase I”). 
 The DNA protection by the polyplexes was found to be strongly dependent on the 
physicochemical characteristics of the polymers and the polyplex composition that correlated 
well with the observations of the binding studies described above. After interaction with the 
LPEIs, plasmid was stabilized not only with increasing polyplex N/P ratios but also an 
increasing number of the ethylene imine units per polymer. While at N/P ratio 25 (Fig. 2 a, 
 14 
lane 10) 150 monomers were necessary to stabilize the DNA, at N/P ratio 100 already 50 units 
(Fig. 2 b, lane 6) were found to be effective. PHPEtOxs started to form stable polyplexes at a 
degrees of hydrolysis of 86% and 75% at N/P ratios 25 (Fig. 2 c, lane 8) and 100 (Fig. 2 d, 
lane 7), respectively. The direct comparison of LPEIs and PHPEtOxs with the same number 
of EI units revealed an increased stability against the degradative mechanisms by the fully 
cleaved LPEIs that might reflect the stronger intermolecular associations and a more effective 
shielding of DNA described in the section before. Changes in the topology of the plasmids 
were observed in some cases as reported earlier.[28, 31] For the following experiments only 
the PHPEtOxs and LPEIs with a comparable number of ethylene imine monomers were 
selected and tested. 
 
3.4 Size and zeta potential of the polyplexes 
 Measurements of the hydrodynamic radius (Fig. 3 a) und the zeta potential (Fig. 3 b) 
were performed with plasmid DNA polyplexes at N/P ratios 25 and 100. Polyplexes 
consisting of plasmid and commercial 2.5 kDa LPEI at N/P ratio 25 were used as control 
since they showed a high transfection efficiency and an acceptable toxicity in preliminary 
experiments (data not shown). They were characterized by a particle size of 169 nm and a zeta 
potential of 35.4 mV. 
None of the polymers with 40 EI units was able to form small sized (hydrodynamic 
radius > 1000 nm) monodisperse particles (Fig. 3 a). For the LPEIs from 40 to 150 EI units a 
decrease of particle size from 1340 nm to 153 nm, respectively, could be detected with 
increasing polymer chain length at N/P 25 (Fig. 3 a), whereas LPEI-150 to LPEI-200 gave 
comparable results. The decrease was found to be more pronounced at N/P 100 where already 
the lower molar mass LPEIs with 80 and 100 EI units formed polyplexes ? 264 nm. The 
tendency of the PDIs and the monomodality of the LPEI polyplexes were found to be directly 
correlated with the hydrodynamic diameters. Comparable data were obtained by 
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characterization of the LPEIs using ultracentrifugation.[32] The influence of the density of EI 
units on particle size was found to be comparatively lower as demonstrated by the PHPEtOx 
polyplexes. With exception of the PHPEtOx-21, all polyplexes were found to be in a size 
range from 112 to 299 nm. Not only the hydrodynamic diameters but also the PDIs and the 
monomodality were widely independent of the N/P ratio and the degree of hydrolysis. 
 Due to the excess of the cationic polymer at N/P ratios 25 and 100, all polyplexes were 
positively charged with zeta potentials between 19.5 and 47.3 mV (Fig. 3 b). The large 
hydrodynamic diameter and the strong tendency to aggregate of the 40 EI unit polyplexes 
with both types of polymers were related to the lowest surface charges and, thus, minimal 
charge-charge repulsion. A comparison of fully and partially cleaved polymers revealed 
higher cationic zeta potentials for LPEIs compared to PHPEtOxs despite a comparable 
amount of EI units. The LPEIs with 80 ethylene imine units already reached the maximum 
zeta potentials with minor changes at higher N/P ratios or more monomer units. For the 
PHEtOxs structure dependent changes were detectable. At N/P 25 the zeta potential increased 
from 19.5 mV for 21% to 41.1 mV for 86% whereas at N/P 100 the increase was only 
detectable from 21% to 56% followed by a plateau phase for higher degrees of hydrolysis.  
 The physicochemical characteristics of the polyplexes were reasonably consistent with 
the earlier findings reporting a dependency of both parameters on the number of EI units. 
Jeong et al. compacted pDNA by 88% hydrolyzed PHPEtOx to about 150 nm with a zeta 
potential of 28.4 mV.[22] Fernandes et al. also reported a correlation of size and surface 
charge with the degree of hydrolysis, the formation of PHPEtOx/DNA polyplexes with 
comparable particle sizes but only moderate cationic zeta potential.[23] This might be related 
to the lower molar masses of 10 kDa used for the synthesis of PHPEtOx. 
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3.5 In vitro cyto- and hemotoxicity testing 
 To evaluate the influence of the polymer characteristics on the cell viability, a MTT 
assay (Fig. 4) was performed after 24 h incubation using L929 mouse fibroblasts according to 
the recommendations of different standard organizations.[33-35] To be able to directly 
compare the results with the transfection experiments the same N/P ratios, incubation times, 
and polyplex/cell ratios were used. Positive control cells treated with a 0.02% thiomersal 
solution showed a reduced cell viability of 2.8% mean. 
 Although at N/P 25 a slight trend to a reduced cell viability with an increase in the 
number of EI units could be observed (Fig. 4 a), all polyplexes could be classified as non-
toxic based on the recommendations of the DIN ISO 10993-5 that categorizes cell viabilities 
higher than 70% as non-toxic.[35] The comparison of partially and fully cleaved compounds 
up to 175 EI units did not reveal relevant differences, indicating that the ethylene imine 
density had no substantial impact on cytotoxicity of the polyplexes at N/P 25. Increasing the 
N/P ratio from 25 to 50 elicited in a decline of the metabolic activity of the cells that might be 
related to the larger amount of unbound polymer in the polyplexes (Fig. 4 b). Cell viabilities 
below 70% could be obs????????????????????????????????????????????????????????????????????
The increase of the N/P ratio was found to be associated with larger differences of 
cytotoxicity between both types of polymers with PHPEtOxs being slightly better tolerated 
than their fully cleaved counterparts (Fig. 4 b).  
 Since the polyplexes are intended for systemic administration a high 
hemocompatibility is essential. Therefore, aggregation and hemolysis of sheep erythrocytes 
were analyzed after treatment with LPEIs and PHPEtOxs at different concentrations. To 
simulate a worst case scenario possibly caused by polyplex dissociation, overdosing or 
general wrong use, the polymers were investigated in the free form. In the screenings of the 
red blood cell aggregation, the negative control was represented by erythrocytes only treated 
with PBS, classified as stage 1 (data not shown). In contrast, strong rouleau and cluster 
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formation could be observed for the positive control cells incubated with 25 kDa BPEI (30 
μg/mL) that was classified as stage 3 (data not shown).  
 None of the polymers induced changes (stage 1) of the red blood cells at the lowest 
concentration (1.875 μg/mL) tested (Fig. 5). This was also valid for PHPEtOx-21 and -41 as 
well as for LPEI-40 up to the highest concentration of 30 μg/mL. In contrast, 
LEI ? 150 ethylene imine units and PHEtOx-86 already formed clusters (stage 3) at 3.75 
μg/mL. All polymers in between demonstrated an increased aggregation of the erythrocytes 
with increasing polymer concentration. A direct comparison of LPEI and PHPEtOx with 
comparable number of ethylene imine units demonstrated a more pronounced effect on red 
blood cells for LPEIs than for PHPEtOxs indicating a more important role of the number than 
of the density of the ethylene imine units. 
 To exclude any influence of the polymers on the membrane integrity of erythrocytes 
under the chosen conditions the hemoglobin release was spectrophotometically quantified. 
Completely lysed erythrocytes treated with 1% Triton X-100 solution represented 100% 
hemolysis, while negative controls incubated in PBS reached values of about 0.6%. Limits for 
the evaluation of hemolysis were taken from ASTM F756-13 that describes a relative 
hemolysis below 2% as non-hemolytic. [36] Neither LPEIS nor PHPEtOxs caused hemolysis 
higher than 1.9%, demonstrating the low membrane damaging potential of both types of 
polymers under the chosen conditions (data not shown). 
 As mentioned above in the discussion of the so called charge dilemma, the cationic 
charge of the polymers is not only the key parameter for the electrostatic interaction with the 
DNA, but also responsible for the electrostatic attachment of the polymers to negatively 
charged cell membranes, plasma proteins and connective tissues, leading to unwanted side 
effects or rapid elimination from the blood.[37] In accordance to our observations, with an 
increasing number of cationic charges, the deposition of LPEIs on the cell surface was found 
to be increased impairing the plasma membrane functions and leading to cell death.[12] In 
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accordance, for HEEI-copolymers higher ratios of EI in the copolymers correlated with 
increasing degree of protonation, allowing more efficient interactions with membranes.[11] In 
agreement with previous outcomes, the cytotoxic effects of the LPEI polyplexes were 
comparably lower than that of the non-complexed polymers.[6] 
 Additionally, a reduced charge density was identified as advantageous for the 
biocompatibility of cationic polymers.[6, 22] In accordance to our results, for PHEtOxs the 
cell viability was described to decline as the DH increased.[22-23] However, Fernandes et al. 
reported a 70% hydrolyzed PHPEtOx still to be low toxic which might be related to the lower 
molar mass of their starting materials.[23] The biocompatibility of PEtOx itself has been 
widely studied in in vitro experiments showing that this polymer is well tolerated by mouse 
fibroblasts and red blood cells.[27] 
When comparing the influence of the number and density of the EI units on the 
biocompatibility, the number of EI units seems to have a slightly higher impact on the 
cytotoxicity of polyplexes than their density. In red blood cell experiments, for LPEIs and 
PHPEtOxs ????????????????????????????????????????????????????ts both parameters cannot be 
ranked since the minimum or maximum of toxicity has been reached. For polymers with 
numbers of EI units in between can be suggested that the total amount of EI units has a more 
profound effect on the aggregation of red blood cells than their density. Differences to former 
investigations are possibly related to different study designs using free polymers for 
cytotoxicity test, only small ranges or numbers of hydrolyzed polymers or missing fully 
cleaved counterparts with comparable EI units.[22-23, 38]  
 
3.6 In vitro transfection efficiency  
 For the quantification of the transfection efficacy, CHO-K1 cells were transfected with 
polyplexes containing pGL3 pDNA that encodes the luciferase gene driven by a SV40 
promoter. Reporter gene expression efficiency was presented as relative light units (RLUs)/μg 
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protein and calculated by dividing the total RLUs determined by bioluminescence 
measurements by the total protein mass. Based on preliminary experiments, N/P ratios 25 
(Fig. 6 a) and 50 (Fig. 6 b) of the polyplexes were found to be suitable and were selected for 
the following experiments. Non-complexed DNA and untreated cells served as controls and 
failed to produce detectable levels of transgene expression (Fig. 6).  
 LPEI/DNA polyplexes mediated an increase of the transgene expression with a higher 
number of EI units and increasing N/P ratios. A minimum of 80 and 40 EI units at N/P ratio 
25 and 50 were necessary to achieve detectable transfections. LPEI-175 and LPEI-200 
reached transfection efficiencies higher than the commercial 2.5 kDa LPEI at both N/P ratios 
tested, presumably due to their higher molar mass. The slightly lower transfection rate of the 
LPEI-200 compared to LPEI-175 might be related to its higher cytotoxicity as observed by 
BCA assay which showed a reduced protein content (data not shown). 
 The PHEtOxs were able to transfect the CHO-K1 cells, but with a comparably lower 
rate of expression compared to the LPEIs. A trend to higher transfection with increasing N/P 
ratios and higher degrees of hydrolysis could be observed. While at N/P ratio 25 PHPEtOx-86 
was found to be the most efficient partially hydrolyzed polymer, at N/P 50 no difference 
could be observed between PHPEtOx-75 and PHPEtOx-86 that correlated with a reduced 
protein content. Accordingly, PHPEtOx polymers with DHs between 70 and 85% were 
reported to be the most efficient PHPEtOx.[22-23, 38] However, only PHPEtOx hydrolyzed 
from PEtOx with a higher molar mass of 50 kDa reached efficacies comparable to 22 kDa 
LPEI [38] and 25 kDa branched PEI.[22]  
 Generally/In general, for both types of polymer low transfection rates correlated well 
with large polyplex sizes, the formation of aggregates and low zeta potentials which was 
reported before for many classes of polycations.[39] The lower gene transfer of PHPEtOx 
compared to LPEI, although having a similar number of EI units could not be explained by an 
impaired endosomal release since the addition of the lysosomotropic agent chloroquine did 
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not improve the transfection efficacy (data not shown). PHPEtOx polyplexes performed less 
efficient in transfection, although they exhibited smaller or even comparable polyplex 
diameters, similar zeta potentials and similar or even preferred biocompatibility profiles 
compared to the LPEI polyplexes under the chosen conditions. Excluding all these parameters 
as explanation, the weaker DNA binding and lower protective effect of PHPEtOxs against 
enzymatic degradation of pDNA, as shown in the gel electrophoresis experiments, seem to be 
the conclusive reason for the poorer performance. Since all transfection experiments were 
performed in serum containing culture medium, DNA degradation could be partially caused 
by heat resistant DNases that are present in fetal bovine serum.[40]  
 
4. Conclusion 
Partially hydrolyzed poly(2-ethyl-2-oxazoline)s (PHPEtOxs) with a degree of polymerization 
of 200 and different degrees of hydrolysis (21 to 86%) have been prepared by acidic 
hydrolysis. They have been compared to LPEIs with an equivalent number of EI units 
regarding the physicochemical and biological characteristics of their polyplexes with DNA. 
PHPEtOxs revealed a lower DNA binding capacity and enzymatic polyplex stability leading 
conclusively, to a reduced transfection efficacy compared to LPEIs. The biocompatibility 
profile was found to be more preferred only for the free polymers, but comparable for the 
polyplexes. The direct comparison of both polymer types revealed that the total amount of EI 
units is not the most important parameter but their density within the polymer backbone. The 
LPEIs with EI units in close juxtaposition with each other demonstrated a dramatically higher 
increase in transfection with increasing number of EI units compared to the PHPEtOx with a 
lower density of protonable amines in the backbone. Conclusively, the reduction of EI density 
to generate more biocompatible polyplexes has to be carefully discussed since the effect on 
toxicity is dramatically lower than the loss of transfection capability.  
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Figures 
 
Fig 1. Schematic drawing of linear PEI (a) and partially hydrolyzed PEtOx (b) 
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Fig. 2. Stability of LPEI (a, b) and PHPEtOx (c, d) polyplexes with plasmid DNA against 
enzymatic degradation by DNase I at N/P ratios 25 (a, c) and 100 (b, d). Controls: lane 1: 
untreated free plasmid; lane 2: free plasmid treated in the same way as polyplexes but without 
enzyme; lane 3: free plasmid treated with enzyme. 
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Fig. 3. Hydrodynamic diameter (a) and zetapotential (b) of polyplexes formed at N/P ratio 25 
and 100. Results are shown as the mean of at least 5 measurements ± SD. 
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Fig. 4. Cytotoxicity of PHPEtOx and LPEI polyplexes with herring testes DNA at N/P 25 (a) 
and N/P 50 (b) as a function of the number of ethylene imine monomers. Tests were 
performed with L929 mouse fibroblasts using the MTT assay after 24 h incubation. 
According to ISO 10993-5 values below 70% viability (see plotted line) were regarded as 
cytotoxic. Each data point represented the mean ± SD of seven determinations. 
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Fig. 5. Dependency of the erythrocyte aggregation of PHPEtOx and LPEI polymers on 
polymer concentration, number of EI units, and degree of hydrolysis, Aggregation was 
classified from stage 1 (no aggregation) over stage 2 (slight rouleau formation) to stage 3 
(strong aggregation with cluster formation). Each bar shows the mean value of three 
determinations. 
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Fig. 6. Transfection efficiency of polyplexes tested on CHO-K1 cells with a luciferase assay. 
Polyplexes were formed with pGL3 at N/P 25 (a) and N/P 50 (b). Luciferase reporter gene 
expression is shown as relative light units/μg. Polyplexes with commercial 2.5 kDa LPEI at 
N/P 25 were used as positive control. Cells treated with 150 mM NaCl solution or non-
complexed DNA represented controls. The inserts give a more detailed view on the results of 
the negative controls and PHPEtOxs. 
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Tables 
 
Table 1 Physicochemical and DNA-binding characteristics of LPEIs 
Polymer LPEI-20 
LPEI-
40 
LPEI-
50 
LPEI-
60 
LPEI-
80 
LPEI-
100 
LPEI-
150 
LPEI-
175 
LPEI-
200 
DP 20 40 50 60 80 100 150 175 200 
Mw, 
calculated 
(Da)a) 
877 1,755 2,186 2,616 3,478 4,339 6,493 7,569 8,646 
Mn (Da)b) 6,800 10,900 13,900 15,200 16,800 21,100 27,400 19,340 17,450 
PDIb) 1.09 1.12 1.12 1.15 1.22 1.16 1.27 1.33 1.57 
N/P ratio 
of DNA 
complexat
ionc) 
3 2 2 1 1 1 1 1 1 
a)calculated for CH3-(C2H5N)n-OH;  
b)determined by SEC (eluent: hexafluoroisopropanol (HFIP); calibration against 
poly(styrene) (PS) standards);  
c)determined by horizontal gel electrophoresis. 
 
Table 2 Physicochemical and DNA-binding characteristics of PHPEtOx. 
PHPEtOx PHPEtOx-21 
PHPEtOx-
41 
PHPEtOx-
56 
PHPEtOx-
75 
PHPEtOx-
86 
Degree of hydrolysis (%)a) 21 41 56 75 86 
Corresponding number of 
ethylene imine units 42 82 112 150 172 
Mw (calculated) (Da)b) 17,503 15,261 13,579 11,449 10,216 
Mn (SEC) (Da)c) 33,010 26,160 19,290 11,100 13,810 
PDI (SEC)b) 1.38 1.54 1.73 1.85 1.64 
N/P ratio of DNA 
complexationd) 2 2 2 2 1 
a)determined by 1H NMR spectroscopy;  
b)calculated for CH3-[(C5H9NO)m-stat-(C2H5N)k]-OH;  
c)determined by SEC (eluent: HFIP; calibration against PS standards);  
d)determined by horizontal gel electrophoresis. 
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ABSTRACT: The synthesis of poly(2-ethyl-2-oxazoline)-b-linear
poly(ethylenimine) (PEtOx-b-LPEI) copolymers by selective ba-
sic hydrolysis of PEtOx-b-poly(2-H-2-oxazoline) (PEtOx-b-PHOx)
is described. For this purpose, an easy method for the prepara-
tion of the 2-H-2-oxazoline (HOx) monomer was developed.
Based on the microwave-assisted polymerization kinetics for
this monomer, PEtOx-b-PHOx copolymers were prepared. Sub-
sequently, the block copolymers were selectively hydrolyzed to
PEtOx-b-LPEI under basic conditions. The success of the poly-
merizations and subsequent post-polymerization reactions was
demonstrated by 1H NMR spectroscopy and MALDI-TOF-MS
investigations of the obtained polymers. VC 2012 Wiley Periodi-
cals, Inc. J Polym Sci Part A: Polym Chem 50: 4516–4523, 2012
KEYWORDS: block copolymer; cationic polymerization; linear poly-
(ethylenimine); poly(2-H-2-oxazoline); ring-opening polymerization
INTRODUCTION Linear poly(ethylenimine)s (LPEIs) are of
high interest in pharmaceutical research. As they can interact
with negatively charged macromolecules like DNA, RNA, and
si-RNA they are investigated as polymeric vectors for gene
delivery.1 However, their in vivo and clinical administrations
are limited due to cytotoxic effects and a low hemocompati-
bility.2 To overcome these drawbacks as well as the poor
water solubility of LPEI, chemical modifications with biocom-
patible compounds have been performed. In this context,
poly(ethylene glycol) (PEG) represents a suitable polymer
with beneficial properties. It has good water solubility and
exhibits the so-called ‘‘stealth effect.’’3 A large number of
PEG-LPEI copolymers are already described in literature.4–6
They can be synthesized, for example, by grafting acryl ter-
minated-PEG to LPEI via Michael addition5 or using tosylated
PEG as initiator for the cationic ring-opening polymerization
(CROP) of poly(2-oxazoline)s (POxs), which are subsequently
hydrolyzed to LPEI.6 As a promising alternative to PEG,
POxs,7–12 particularly poly(2-ethyl-2-oxazoline) (PEtOx)13,14
and poly(2-methyl-2-oxazoline) (PMeOx),15,16 have shown
comparable features like PEG, but have additional advanta-
geous properties such as low viscosity and high stability in
the therapeutically relevant dose. Jeong et al.17 could show
that statistical copolymers of LPEI and PEtOx, obtained by
partial hydrolysis of PEtOx, have a reduced cytotoxicity and
a transfection efficiency similar to branched poly(ethylen-
imine). Hsiue et al.18 reported the synthesis of PEtOx-b-LPEI
by coupling PEtOx with LPEI in a thiol-disulfide exchange
reaction between sulfhydryl and pyridyl disulfide terminated
groups. These polymers also showed a low cytotoxicity and
high transfection efficiency. However, the block copolymer
synthesis via thiol-disulfide exchange includes multiple reac-
tion steps and is rather time-consuming. Conversely, statisti-
cal copolymers of LPEI and PEtOx suffer from the problem
that they are not well-defined, since only an overall degree
of hydrolysis can be determined, but not the exact lengths of
the LPEI blocks. Moreover, some free nitrogens of the LPEI
units might not be usable for DNA complexation, since the
LPEI units are either too short or sterically blocked by the
adjacent ethyl side chains. Hence, well-defined block copoly-
mers of PEtOx and LPEI are of interest for pharmaceutical
research. Unfortunately, the synthesis of well-defined POx-
LPEI block copolymers is demanding. As LPEI is prepared by
acid19–21 or basic22,23 hydrolysis of POx, usually statistical
cleaved copolymers of LPEI and POx are obtained, when POx
homo- or copolymers are hydrolyzed. However, it is known
that the sterical hindrance, and therefore, the type of the
side chain significantly influence the rate of hydrolysis.19,24
The more bulky the rest is the slower the POx side chain is
cleaved. This leads to the following order for the rate of hy-
drolysis: H > Me > Et > Ph. The selective hydrolysis of
PMeOx-b-PPhOx to LPEI-b-PPhOx is already reported.24 Basic
VC 2012 Wiley Periodicals, Inc.
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hydrolysis conditions were found to have a much slower hy-
drolysis rate, but also a higher selectivity, so that the poly(2-
phenyl-2-oxazoline) (PPhOx) block remained almost unhy-
drolyzed. Litt et al.25 described the selective hydrolysis of
poly[2-(4-t-butylbenzoyl)-2-oxazoline]-b-PEtOx, where only
the PEtOx block is hydrolyzed to LPEI with the help of meth-
anesulfonic acid. A similar behavior is expected for block
copolymers of 2-H-2-oxazoline (HOx) and 2-ethyl-2-oxazoline
(EtOx). Saegusa et al.23 reported that LPEI can be prepared
by basic hydrolysis of PHOx within 3 h at 98 C, whereas the
basic hydrolysis of PEtOx proceeds much slower. Only 12%
of the side chains are cleaved after 2 h at 130 C.21
Here, we report the preparation of PEtOx-b-LPEI based on a
significant improved and straightforward method for the
large scale synthesis of the HOx monomer. Most of the prep-
aration methods described so far suffer from problems like
low overall yields due to instable intermediates and multiple
reaction steps, or they use expensive or highly toxic starting
material. Moreover, polymerization kinetics of HOx, the syn-
thesis of PEtOx-b-PHOx and its subsequent hydrolysis to
PEtOx-b-LPEI were performed. All polymers were character-
ized by in detail by 1H NMR spectroscopy and MALDI-TOF-
MS investigations.
RESULTS AND DISCUSSION
Synthesis of HOx
For the detailed kinetic studies, the preparation of different
PEtOx-b-PHOx copolymers, as well as for the subsequent hy-
drolysis, larger amounts of HOx are required. HOx was first
synthesized by Wenker in 1938.26 With minor changes,
Wenker’s way is the most common method to obtain HOx.
Starting from N-(2-hydroxyethyl)formamide, N-(2-chloro-
ethyl)formamide is prepared by chlorination with thionyl chlo-
ride. Subsequent addition of a base, for example, KOH,23,26–30
NaHCO3,
29 or NaH,27,31 leads to the formation of the oxazoline
ring. However, the intermediate N-(2-chloroethyl)formamide is
very unstable and tends to decompose to carbon monoxide
and chloroethylamine, resulting in a low overall yield and a
contaminated product. By performing the reactions under
inert condition with prepurified educts, and using solvents
such as 1-methyl-2-porrolidone,27,31 triglyme,27 and tertiary
amines or amides,23,27 the yield could be improved. Another
drawback of the ‘‘Wenker method’’ is the ring closure by
means of a base/water system, which increases the chance of
uncontrolled polymerization or the decomposition of the reac-
tive HOx, and therefore decreases the yield.
Other methods to synthesize HOx either use highly toxic
and expensive compounds, like AgCN32 and t-butyl
isocyanide,32,33 or they suffer from bad overall yields.34–38
Therefore, they are not suitable for a large scale synthesis.
However, HOx can also be prepared by dehydration of
N-(2-hydroxyethyl)formamide, heating it with a Lewis acid
under reduced pressure. When Al2O3 and Fe2O3 are used
as catalyst the product yield is low, due to decomposition
to 2-ethanolamine.39 However, when zinc chloride is used
as catalyst the decomposition does not occur, and the
product can be obtained in a high yield accompanied by
the formation of water.40 This method was used for the
synthesis of HOx in multigram scale (Scheme 1). Before
the polymerization the water had to be removed. As HOx
tends to autopolymerize when heated, and has also a high
fugacity, water could not be removed by fractionized distil-
lation under heating as stated by the Kaiser.40 However,
Saegusa described a method to dry the HOx, obtained
from the instable N-(2-chloroethyl)formamide, by distilla-
tion over crushed KOH under reduced pressure into a
cooling trap.23 This procedure turned out to be the most
suitable drying method, since no heating or extraction is
needed, and hence, no autopolymerization or the presence
of impurities from extraction solvents are observed. Also,
the fugacity could be overcome, since the product is col-
lected in a cooling trap. Additional distillation over BaO
gave dry HOx in an excellent purity and good yield (67%),
suitable for the subsequent application in the CROP. By
combining the ZnCl2 catalyzed dehydration method with
Saegusa’s drying method, it is possible to obtain HOx in
only two reaction steps with a high purity. Moreover, the
observed overall yield (67%) starting from N-(2-hydroxy-
ethyl)formamide is much higher than for other synthesis
approaches, for example, 42% for Saegusa’s approach, and
the reaction can be easily upscaled to synthesize multiple
grams of HOx. No instable, expensive, smelly, or toxic
compounds have to be used. The intermediate N-(2-
hydroxyethyl)formamide can be easily prepared by heating
2-ethanolamine with methyl formate, followed by fraction-
ized distillation. It can be stored in a freezer without
decomposition for more than a year.
Polymerization and Characterization of HOx
The CROP of HOx, its polymerization kinetics and polymer-
ization mechanism, was first studied by Saegusa et al. in the
beginning of the 1970s.23,41–44 The polymerization kinetics
were only recorded at 24, 31, and 40 C, respectively, and
polymerizations were performed in general for 5 h at 80 C.
However, no polymerization kinetic for that temperature was
reported. Since Saegusa et al. already showed that methyl
tosylate (MeOTs) is the most suitable initiator, and that
N,N-dimethylformamide (DMF) and acetonitrile are the best
solvents for the CROP of HOx, the polymerization kinetics
have been studied in acetonitrile with MeOTs as initiator.
The polymerization was performed in a microwave synthesizer
at 80 C, with a [M]/[I] ratio of 20 and a monomer
SCHEME 1 Schematic representation of the synthesis of HOx.
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concentration of 4 M; the monomer conversion was deter-
mined by GC. The linearity of the first order kinetic plots
shows the living character of the polymerization (Fig. 1). A
polymerization rate of kp ¼ 0.0193 L mol1 s1 was calcu-
lated. As expected, the reactions proceeds much faster com-
pared to Saegusa’s results for 24, 31, and 40 C.43 In every
case, the product precipitated during the polymerization, as
was already noted by Saegusa. This behavior is ascribed to
the formation of strong hydrogen bonds between the poly-
mer molecules, due to interactions of the oxygen and hydro-
gen of the formyl side chains. A broad band at 3400 cm1,
typical for hydrogen bonds, can be found in the IR spectrum
(Fig. 2). The obtained PHOx is soluble only in water at room
temperature and dimethyl sulfoxide (DMSO) at temperatures
above 120 C. In DMSO, unfortunately no polymerization
could be observed. To overcome the drawback, different
polar ionic liquids have been investigated as solvent, for
example, 1-ethyl-3-methylimidazolium chloride, 1-butyl-3-
methylimidazolium chloride, and 1-allyl-3-methylimidazo-
lium chloride. Some dissolved the PHOx, but they were too
hygroscopic to be used as polymerization solvent. Because of
dissolution problems and unsuitable columns, on which the
polymer adhered, size exclusion chromatography (SEC) char-
acterization of the samples from the kinetic study could not
be performed.
The PHOx was characterized by MALDI-TOF- and ESI-Q-TOF-
MS (Fig. 3), showing similar results. This is the first report
of PHOx mass spectra. Distributions for hydroxyl and ethyle-
nimine-terminated species can be found. The two different
end groups originate from the varying possible ring-opening
reactions when the reaction is quenched with water
(Scheme 2). Either a hydroxyl group or a formyl ester is
formed and subsequently hydrolyzed. The ester formation
also occurs for other POxs.45,46
Synthesis of PEtOx-b-PHOx
PEtOx-b-PHOx was prepared by the sequential monomer
addition method (Scheme 3). The concentration of EtOx in
the solvent acetonitrile was adjusted to 4 M and MeOTs was
used as initiator. As reference, always an aliquote of the
stock solution was polymerized under the same conditions,
but without addition of the second monomer. Three block
copolymers with EtOx/HOx ratios of 20/5 (1b, 2b) and 40/
10 (3b) were synthesized using this approach (Table 1).
FIGURE 1 First order polymerization kinetics for the micro-
wave-assisted polymerization of HOx in acetonitrile at 80C
using MeOTs as initiator.
FIGURE 2 ATR-FT-IR spectrum of PHOx.
FIGURE 3 Expanded region of the MALDI- (top) and the ESI-
TOF-MS (bottom) spectra as well as structural assignments for
the different distributions of PHOx.
SCHEME 2 Schematic representation of the different ring-
opening possibilities leading to different end groups of PHOx.
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Characterization by SEC revealed the growth of the polymer
chain and therewith the increase of the molar mass. Com-
pared to the reference PEtOx homopolymer, the SEC curve is
shifted to higher molar masses after the addition of the sec-
ond monomer (HOx, Fig. 4). Furthermore, in the 1H NMR
spectra an additional peak at d ¼ 8.02 ppm, deriving from
the formyl side chain, can be found (Fig. 5). Similar as for
pure PHOx the polymer precipitated during the polymeriza-
tion of the second block. When the PHOx block becomes too
long, the copolymer is only soluble in water. A good ratio for
EtOx and HOx was found to be n/m ¼ 4/1. For this ratio,
the polymer is still soluble in polar solvents like methanol,
DMSO, and N,N-dimethylacetamide.
Characterization by MALDI-TOF-MS revealed a PEtOx with
one HOx unit (PEtOxn-b-PHOx1) as main distribution. Also,
other distributions were found, but they were hardly visible.
This is ascribed to a mass discrimination effect, which often
occurs in MALDI-TOF-MS measurements. Hence, the copoly-
mer was fractionated by preparative SEC using a Sepahdex
LH20 column with methanol as eluent. The obtained frac-
tions showed a complex pattern of overlapping peaks in the
expected molar mass region, but allowed a detailed interpre-
tation. In all fractions, both monomers were incorporated,
but with different ratios and chain lengths. An example
MALDI-TOF-MS spectrum and the assignment of all the peaks
is shown below (Fig. 6). Based on the results of 1H NMR
spectroscopy, this fraction contains an EtOx/HOx ratio of
4/1. The difference between the ratio calculated from 1H
NMR spectroscopy and the ratio in the MALDI-TOF mass
spectrum can also be explained with the mass discrimination
occurring in MALDI-TOF-MS.
Hydrolysis of PHOx, PEtOx, and PEtOx-b-PHOx Under
Basic Conditions
As already reported by Saegusa, PHOx can be easily hydro-
lyzed under basic conditions at 98 C within 3 h.23 When the
hydrolysis of PHOx with 3 M NaOH was performed at 100 C
in a microwave synthesizer, the degree of hydrolysis was 93%
after 1 min, and 99% after 5 min as determined by 1H NMR
spectroscopy. After 10 min full hydrolysis was observed. This
shows that the formyl side chain can be very easily cleaved off.
Under the same conditions, PEtOx was only hydrolyzed for 2%
after 1 min, 6% after 5 min, and 8% after 10 min, respectively.
When the reaction time was increased to 4 h the degree of hy-
drolysis was about 12%. As the PHOx can be hydrolyzed much
easier and faster than the PEtOx, it is assumed that PEtOx-b-
PHOx can be selectively hydrolyzed to PEtOx-b-LPEI. For the
investigation of the hydrolysis conditions, 25 mg of PEtOx-b-
PHOx were heated with 1 mL of 3 M NaOH in a microwave
synthesizer at 100 C for different times. The solvent was
removed under vacuum. The degree of hydrolysis was deter-
mined by 1H NMR spectroscopy by correlating the proton sig-
nal of the uncleaved PHOx side chain (d ¼ 8.02 ppm) and the
SCHEME 3 Schematic representation of the synthesis of
PEtOx-b-LPEI.
TABLE 1 SEC Data for the Different PEtOx-b-PHOx Copolymers and Reference PEtOx Homopolymers
DMAc þ 2.1% LiCl
(PEG calibration)
Water þ 0.1% TFA þ 0.05 M NaCl
(PEG calibration)
Sample EtOx:HOx Mn (g mol
1) Mw (g mol
1) PDI Mn (g mol
1) Mw (g mol
1) PDI
1a 20:0 1,950 2,180 1.12 1,870 2,170 1.16
1b 20:5 3,100 3,950 1.27 1,980 2,440 1.23
2a 20:0 1,780 1,970 1.11 1,730 2,020 1.17
2b 20:5 2,280 2,680 1.17 1,850 2,390 1.29
3a 40:0 3,240 3,750 1.16 2,240 3,080 1.37
3b 40:10 4,660 5,850 1.26 2,420 3,380 1.40
FIGURE 4 Comparison of the SEC curves of the PEtOx-b-PHOx
3b (dashed) and the reference PEtOx homopolymer 3a
(straight) (SEC eluent: DMAc þ 0.21% LiCl).
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resulting formiate (d ¼ 8.53 ppm). The determination of the
degree of hydrolysis of the PEtOx block by 1H NMR spectros-
copy was challenging since the broad signals of LPEI (d ¼ 2.76
ppm) and CH2 group of PEtOx (d ¼ 2.42 ppm) overlap. Also,
the signals of the CH2 group of the resulting propionate (d ¼
2.20 ppm) and CH2 groups of PEtOx were not clearly sepa-
rated. Nevertheless, reproducible results could be obtained.
The degree of hydrolysis of PEtOx is about 5% for n/m ¼ 40/
10 and 14% for n/m ¼ 20/5 when full cleavage of the PHOx
side chain is achieved. This is in good agreement with the
degree of hydrolysis for the basic hydrolysis of the reference
PEtOx homopolymers. It was found that the copolymer with
n/m ¼ 20/5 hydrolyzed much faster than the copolymer with
doubled block lengths; however, the block copolymer with n/
m ¼ 40/10 is hydrolyzed more selectively (Fig. 7).
Unlike LPEI, the PEtOx-b-LPEI copolymer with a m/n ratio of
4/1 is soluble in chloroform and dichloromethane. This
allows the purification of the copolymer, since it can be
easily extracted from the salt residues (NaOH, formiate) after
removal of the solvent. The comparison of the 1H NMR spec-
tra before and after the hydrolysis shows that the peak of
the formiate side chain of the PHOx block totally disap-
peared (Fig. 5). Instead a new peak for LPEI can be found at
2.76 ppm. Moreover, no signals for formiate or propionate
can be found anymore, showing that extracting the block co-
polymer with dichloromethane represents a suitable purifica-
tion method. SEC was measured on a PSS SUPREMA-MAX
column, which is applicable for cationic polymers and does
not only separate by size, but also by charge. Consequently,
the SEC curve of the PEtOx-b-LPEI is shifted to a lower elu-
tion volume although the molar mass is lower compared to
the starting material PEtOx-b-PHOx (Fig. 8), confirming that
the PHOx block is hydrolyzed and the cationic LPEI is
formed. Unfortunately, there are no suitable available stand-
ards for the determination of the molar masses and PDI
values of the PEtOx-b-LPEI.
The MALDI-TOF mass spectrum showed a complex pattern
of overlapping peaks, making the interpretation nearly
FIGURE 6 Expanded region of the MALDI-TOF mass spectrum
of PEtOx-b-PHOx 1b and assignments of the different distribu-
tions (matrix: DHB).
FIGURE 5 1H NMR spectra of the reference PEtOx 2a (top),
PEtOx-b-PHOx 2b (middle), and PEtOx-b-LPEI (bottom) (solvent:
CD3OD).
FIGURE 7 Degree of hydrolysis of 2b (circle) and 3b (square)
against hydrolysis time as determined by 1H MNR
spectroscopy.
FIGURE 8 SEC curve of PEtOx-b-PHOx 3b before (straight) and
after hydrolysis (dashed) (SEC eluent: water þ 0.1% TFA þ 0.05
M NaCl).
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impossible. Therefore, analog to the PEtOx-b-PHOx, the copol-
ymer was fractionated by preparative SEC using a Sephadex
LH20 column (eluent methanol). After fractionation, fractions
with different EtOx and EI chain lengths and ratios, but inter-
pretable MALDI-TOF mass spectra were obtained. Both EtOx
and EI repeating units can be assigned, demonstrating that
the PHOx block is successfully hydrolyzed to LPEI (Fig. 9).
EXPERIMENTAL SECTION
Chemicals and Instrumentation
Dry acetonitrile and methyl formate were purchased from
Acros Organics and 2-ethanolamine from Sigma Aldrich. EtOx
and MeOTs were obtained from Acros Organics, distilled to
dryness over barium oxide (BaO), and stored under argon.
The Initiator Sixty single-mode microwave synthesizer from
Biotage, equipped with a noninvasive IR sensor (accuracy:
62%), was used for polymerizations and hydrolyses under
microwave irradiation. Before usage, the microwave vials
were heated to 110 C overnight and allowed to cool down
to room temperature under an argon atmosphere. Proton
(1H) and carbon (13C) nuclear magnetic resonance (NMR)
spectra were recorded on a Bruker AC 300 MHz at 298 K.
Chemical shifts are reported in parts per million (ppm, d
scale) relative to the residual signal of the deuterated sol-
vent. SEC of PEtOx and PEtOx-b-PHOx was measured on an
Agilent Technologies 1200 Series gel permeation chromato-
graphy system equipped with a G131A isocratic pump, a
G1329A autosampler, a G1362A refractive index detector,
and both a PSS Gram 30 and a PSS Gram 1000 column
placed in series. A 0.21% LiCl solution in N,N-dimethylaceta-
mide (DMAc) was used as eluent at 1 mL min1 flow rate
and a column oven temperature of 40 C. Molar masses
were calculated against PEG. SECs of PEtOx-b-PHOx and
PEtOx-b-LPEI were measured on a Jasco SEC system
equipped with a PU-980 pump, a AS-1555 autosampler, a
DG-980-50 degasser, a RI930 refractive index detector, and a
PSS SUPREMA-MAX column. As eluent, a solution of 0.1%
trifluoroacetic acid (TFA) and 0.05 M NaCl in water, running
at a flow rate of 1 mL min1 and a column oven tempera-
ture of 30 C, was used. Molar masses were calculated
against PEG. The MALDI-TOF-MS spectra were recorded
using an Ultraflex III TOF/TOF (Bruker Daltonics GmbH, Bre-
men, Germany), equipped with a frequency-tripled Nd:YAG
laser, operating at a wavelength of 355 nm. All spectra were
measured in the positive reflector mode using 2,5-dihydroxy-
benzoic acid (DHB) as matrix. ESI-Q-TOF-MS measurements
were performed with a micrOTOF Q-II (Bruker Daltonics)
mass spectrometer. The ESI-Q-TOF mass spectrometer was
operating at 4.5 kV at a desolvation temperature of 180 C.
The mass spectrometer was operating in the positive ion
mode. As solvent methanol/water mixtures were used. The
ESI-Q-TOF-MS instrument was calibrated in the m/z range of
50–3000 using an internal calibration standard (Tunemix so-
lution), which was supplied from Agilent. The electron
impact MS spectra were measured with a Finnigan MAT
SSQ710 spectrometer. The IR spectra were recorded on a FT-
IR spectrometer IRAffinity-1 (Shimadzu).
Synthesis of N-(2-Hydroxyethyl)formamide
Methyl formate (107 mL, 1.72 mol) was heated with a 25%
excess 2-ethanolamine (130 mL, 2.15 mol) for 8 h under
reflux. The resulting methanol was removed by distillation at
normal pressure and the residue was purified by vacuum
distillation. A colorless liquid was obtained (bp. 110–112 C,
0.01 mbar). Yield: 132.93 g (87%).
1H NMR (300 MHz, CD3OD, d, ppm): 8.09 (s, trans, 1H), 8.01
(s, cis, 1H), 3.57–3.64 (m, 2H), 3.28–3.37 (m, 2H). 13C NMR
(300 MHz, CD3OD, d, ppm): 166.36 (cis), 162.68 (trans),
61.60 (cis), 60.00 (trans), 43.94 (cis), 40.11 (trans). IR (ATR-
FT-IT, cm1): 3278 (OH/NH), 2877 (CH), 1651 (C¼O), 1531
(NH), 1060 (CAO).
Synthesis of the HOx Monomer
A flask equipped with a Claisen condenser was charged with
ZnCl2 (1.412 g, 10 mmol) and N-(2-hydroxyethyl)formamide
(10.026 g, 112 mmol). The reaction mixture was heated at
180 C and 30 mbar. The product was collected in a cooling
trap together with the resulting water. Crushed KOH (8.38 g)
was added and the crude product was distilled into a cooling
trap at 30 mbar. To the distillate, crushed KOH (6.24 g) was
added, and the product was distilled again under reduced
pressure (30 mbar) into a cooling trap. Repeated addition of
KOH (3.22 g) was followed by distillation under reduced
pressure (30 mbar) into a cooling trap. At last, the product
was distilled over BaOH under reduced pressure (30 mbar)
into a cooling trap. The product was stored under argon
over mol sieve 4 Å. Yield: 5.38 g (67%).
1H NMR (300 MHz, CD3OD, d, ppm): 6.71 (s, 1H), 4.08 (t,
3J ¼ 9.71 Hz, 2H), 3.71 (td, 3J ¼ 9.71 Hz, 4J ¼ 1.88 Hz, 2H).
13C NMR (300 MHz, CDCl3, d, ppm): 155.16 (CH), 65.39
(CH2), 53.37 (CH2). (ATR-FT-IT, cm
1): 2978 (CH), 1627
(C¼N), 1080 (CAOAC), 918 (¼CH). MS (EI, m/z, %): 71 (41)
[Mþ], 41 (45) [MACH2O]
þ, 40 (12) [MAC2H3N]
þ, 32 (100).
Kinetic Investigation of the Polymerization of HOx
For the kinetic studies, a stock solution containing MeOTs
(initiator), HOx (monomer), and acetonitrile (solvent) was
FIGURE 9 Expanded region of the MALDI-TOF mass spectrum
of PEtOx-b-LPEI and assignments of the different distributions
(matrix: DHB).
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prepared. The monomer concentration was adjusted to 4 M,
and a monomer to initiator ratio ([M]/[I]) of 20 was used.
The stock solution was divided over six microwave vials that
were capped under argon. For the calculation of the conver-
sion, t0 samples were taken. The vials were heated to 80 C
for different times in the microwave synthesizer. After cool-
ing, the reaction was quenched and GC samples were
prepared to determine the monomer conversion. The poly-
merization solvent was used as internal standard.
1H NMR (300 MHz, D2O, d, ppm): 7.90 (m, NACHO), 3.42
(m, NACH2), 2.84 (m, CH3AN). IR (ATR-FT-IR, cm
1): 2939
(CH), 2870 (CH), 1651 (C¼O), 1427 (CH2/CH3), 1400 (CH2/
CH3), 1153 (CAOAC), 1053 (CAOAC).
Synthesis of the PEtOx-b-PHOx Copolymers
A stock solution containing MeOTs (initiator), 2-ethyl-2-oxa-
zoline (monomer), and acetonitrile (solvent) was prepared.
The EtOx concentration was adjusted to 4 M, with a mono-
mer to initiator ration of [M]/[I] ¼ 20 and [M]/[I] ¼ 40,
respectively. An aliquot of the stock solution was taken and
polymerized as reference for the PEtOx block. Both, the
remaining stock solution and reference sample were heated
in a microwave synthesizer at 140 C for a predetermined
time. After cooling to room temperature, the second mono-
mer (HOx) was added to the polymerization mixture through
the septum with a syringe and heated in a microwave syn-
thesizer at 80 C for a predetermined time. The reaction mix-
ture was cooled to room temperature. The precipitate was
dissolved in methanol, precipitated in ice-cold diethyl ether
and dried under reduced pressure at 40 C.
1H NMR (300 MHz, CD3OD, d, ppm): 8.02 (m, NACHO), 3.54
(m, NACH2), 3.08 (m, CH3AN), 2.42 (m, CACH2AC), 1.11
(m, CACH3).
Kinetic Investigations of the Basic Hydrolysis of PHOx
and PEtOx
PHOx and PEtOx (40 6 1 mg), respectively, were dissolved
in 3 M NaOH (2 mL) in a microwave vial. The reaction mix-
ture was heated at 100 C for different times in a microwave
synthesizer. After cooling to room temperature, the solvent
was removed under reduced pressure. The residue was dis-
solved in deuterated methanol and the degree of hydrolysis
was determined by 1H NMR spectroscopy.
Kinetic Investigations of the Basic Hydrolysis of
PEtOx-b-PHOx
PEtOx-b-PHOx (2b, 3b) (25 6 1 mg) was dissolved in 3 M
NaOH (1 mL). The reaction mixture was heated in a micro-
wave synthesizer for different times at 100 C. After cooling
to room temperature, the solvent was removed under
reduced pressure. The residue was dissolved in deuterated
methanol, and the degree of hydrolysis was determined by
1H NMR spectroscopy.
Synthesis of PEtOx-b-LPEI
PEtOx-b-PHOx 2b (216 mg) was heated in 3 M NaOH (4 mL)
at 100 C for 4 h in a microwave synthesizer. The solvent
was removed under reduced pressure, and the residue was
extracted with dichloromethane. After filtration the solvent
was removed, and the resulting polymer was dried under
reduced pressure at 40 C.
1H NMR (300 MHz, CD3OD, d, ppm): 3.54 (m, NACH2), 3.08
(m, CH3AN), 2.76 (NHACH2), 2.42 (m, CACH2AC), 1.11 (m,
CACH3).
CONCLUSION
A cheap and easy method for the synthesis of the monomer
HOx was developed, and its polymerization kinetics were
investigated. The obtained PHOx was characterized by 1H
NMR, MALDI-TOF-MS, and ESI-Q-TOF-MS. The monomer
(HOx) was further used to synthesize PEtOx-b-PHOx copoly-
mers in a sequential monomer addition approach. During the
reaction, the polymer precipitated, due to hydrogen bond
formation between the formyl side chains. If the HOx block
became too long the polymer was only soluble in water,
making the characterization challenging. However, if an
EtOx/HOx ratio of 4:1 is used, the copolymer was soluble in
polar solvents like methanol, DMF, and DMAc. Block copoly-
mers with two different block lengths and an EtOx/HOx ratio
of 4:1 were synthesized and characterized by 1H NMR spec-
troscopy, SEC, and MALDI-TOF MS, proving that the block
copolymer was formed. Subsequently, the basic hydrolysis to
PEtOx-b-LPEI was performed. 1H NMR spectroscopy and
MALDI-TOF-MS demonstrated that the HOx block was suc-
cessfully hydrolyzed to LPEI, and SEC indicated the forma-
tion of a cationic species, due to a different column interac-
tion of the product and educt. The obtained PEtOx-b-LPEI
copolymers represent interesting materials for pharmaceuti-
cal studies, with promising features for a high transfection
efficiency and a ‘‘stealth effect.’’ Their potential is currently
under investigation.
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a b  s  t  r  a c t
Low  molar mass  linear  poly(ethylene  imine)s (lPEI) were grafted  onto  dextran  via  different  synthesis
routes aiming  at  the  elucidation  of  structure-property  relationships  of  dextran-graft-linear  poly(ethylene
imine) (dex-g-lPEI)  conjugates for gene  delivery  applications.  Beside  the  molar mass of well-deﬁned  lPEIs
and the  linker  unit, also the  amount of  lPEI  in  the polymeric vectors  was  varied.  The synthesized  dextran
modiﬁcations were  characterized  regarding their  chemical  structure and  showed enhanced  complexa-
tion and stabilization  of  DNA  against enzymatic  degradation.  The  transfection  efﬁciency  of  dex-g-lPEIs
was increased  compared  to unmodiﬁed  lPEI and  revealed  a dependency  of  the used  linking  strategy.
All complexes  of  DNA  and dex-g-lPEIs  were  found  to be nontoxic,  but  the synthesis  route showed  a
strong inﬂuence on the  aggregation  of red blood  cells.  In  conclusion,  the linking  strategy  of  lPEI  to  dex-
tran has a signiﬁcant impact  on the  physicochemical  characteristics  of  DNA/polymer  complexes, the
biocompatibility as well  as  the  transfection efﬁciency.
© 2014 Elsevier  Ltd. All rights reserved.
1. Introduction
Dextran, a natural hydrophilic, biodegradable polysaccharide
mainly based on -1-6-linked d-glucose units, has been widely
used in medical, pharmaceutical, and drug delivery applications
(Varshosaz, 2012). More than 50 years of clinical use provided an
impressive proof of its safety in parenteral and oral administration,
e.g.  as lubricant in ophthalmic solutions, creams, and ointments
or as coating material for diagnostic nanoparticles(Heinze, Liebert,
Heublein, & Hornig, 2006; Mehvar, 2000). Additionally, several
modern drug delivery systems containing dextran are under
∗ Corresponding authors at: D. Fischer Department of Pharmaceutical Technology,
Institute of Pharmacy, Friedrich Schiller University Jena, Otto-Schott-Str. 41, 07745
Jena, Germany. Tel.: +49 3641 949940/+49 3641 948200;
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2 Present address: Department of Chemical and Biomolecular Engineering, The
University of Melbourne, Parkville 3010, VIC, Australia.
preclinical development, for instance nanoparticles, hydrogels or
microspheres (Vlugt-Wensink et al., 2007).  In the ﬁeld of gene
therapy, series of attempts have been made to selectively modify
dextran with cationic moieties such as diethylaminoethyl (Eshita
et  al., 2009),  spermine (Abdullah et  al., 2010; Azzam et al., 2002;
Cohen et al., 2011),  protamine (Thomas, Rekha, &  Sharma, 2010b),
poly(l-lysine) (Maruyama et al.,  1998),  poly(ethylene imine) (PEI)
(Jiang &  Salem, 2012; Sun et al.,  2011; Sun, Xiao, Cheng, Zhang,
&  Zhuo, 2008a; Sun, Zhang, Cheng, Cheng, & Zhuo, 2008b; Tseng
& Jong, 2003),  or  2,3-epoxypropyl-trimethylammonium chloride
(Thomas, Rekha, & Sharma, 2010a) in order to make them suitable
as non-viral vector system. PEI was thereby one of the most favored
cationic polymers applied for conjugation to dextran owing to its
excellent transfection efﬁciency.
Several studies have evaluated dextran-graft-poly(ethylene
imine) (dex-g-PEI) conjugates as promising gene delivery systems
in recent years. Three different strategies for conjugation were fol-
lowed:
(i) Low molar mass dextran was covalently grafted onto high
molar mass branched PEIs (bPEIs) or  linear PEIs (lPEIs) to
decrease its cytotoxicity, to enhance the complex stability and
to  decrease the charge effects of salts and proteins present
http://dx.doi.org/10.1016/j.carbpol.2014.07.048
0144-8617/© 2014 Elsevier Ltd. All rights reserved.
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in the extracellular environment as also observed for stealth
polymers like poly(ethylene glycol) (Knop, Hoogenboom,
Fischer, & Schubert, 2010; Petersen et al., 2002; Tseng &  Jong,
2003; Tseng, Tang, &  Fang, 2004). Depending on the molar mass
of dextran and the degree of grafting, transfection efﬁciencies
of  dex-g-PEI were reported to be comparable or  lower than
that  of the unmodiﬁed PEI. This ﬁnding was ascribed to a  steric
hindrance of the PEI protonation causing a decreased buffering
capacity dependent on the molar mass of the dextran (Tseng,
Fang, Su, & Tang, 2005).
(ii)  The grafting of low molar mass bPEI onto large dextran back-
bones was investigated. The cytotoxicity of the conjugate was
lower compared to high molar mass bPEI. In addition, the
transfection could be enhanced by increasing the degree of
substitution (DS) of low molar mass bPEI conjugated to dextran
or  increasing the N/P ratio of  DNA/dextran-g-bPEI complexes
or by using serum containing media (Jiang & Salem, 2012; Sun
et  al., 2008a; Sun et al., 2008b). First in vivo studies with pEGFP
were already performed in mice using in vivo ﬂuorescent imag-
ing  (Chu et al., 2013).
(iii) Dextran nanoparticles were formed by crosslinking of dex-
tran and grafted in different extents with bPEI by reductive
amination. In this way, the steric hindrance of the dextran
molecules to form stable complexes of PEI  and plasmid could
be decreased and the transgene expression as well as the
cell  viability were enhanced compared to unconjugated bPEI
(Tripathi, Goyal, &  Gupta, 2011).
Several linking strategies have been reported to covalently
bind bPEI to dextran by commonly exploiting the primary amine
groups. Reductive amination of oxidized dextran with bPEI results
in improved complex stability, lower cytotoxicity, and higher or
comparable transfection efﬁciency than the respective unmodi-
ﬁed PEI dependent on the degree of grafting (Jiang &  Salem, 2012;
Tseng et al., 2004). The oxidation followed by conjugation repre-
sents a convenient method to form irreversible linkages in aqueous
solution, but also yields adverse products with undeﬁned chemical
structures due to the occurrence of various chain scission reactions
during the oxidation reaction of dextran. In another approach, dex-
tran was functionalized with hexamethylene diisocyanate (HMDI)
for  subsequent reaction with PEI (Sun et al., 2008a; Xiao et al.,
2010). The HMDI linkage was found to be advantageous since
the functionalization reaction could be conducted fast and effec-
tively without addition of any catalyst and by maintaining the
original dextran backbone structure. However, crosslinking is an
important parameter both inter- and intramolecular, which might
result in non-deﬁned structures, higher molar masses, and unde-
sired  solution properties. The  functionalization of  dextran with
carboxymethyl groups and the subsequent amidation might also
inﬂuence the original properties signiﬁcantly due to the introduc-
tion of negatively charged carboxyl groups (Sun et al., 2008b).
So  far, the inﬂuence of the different linker strategies has only
received little attention, but might have a  signiﬁcant inﬂuence on
the  biocompatibility, transgene expression and DNA binding char-
acteristics. Most studies also lack in systematic analysis of polymer
characteristics such as molar mass, copolymer composition, but
also the purity and structure of the original polymers. To gain a
better insight into the structure-property relationships, a  direct
comparison of the effects of various linking strategies was per-
formed. To this end, only well-deﬁned and in depth characterized
polymers were used. In contrast to previously published studies
using bPEI, linear PEI (lPEI) was chosen because it can be synthe-
sized in a controlled manner with narrow molar mass distributions
and well-deﬁned structures such as tailored end groups (Altuntas¸
et al., 2012; Tauhardt et al., 2011). Consequently, no  intra- and
intermolecular crosslinking can be expected in contrast to bPEI.
lPEI with 20 (lPEI20) and 40 repeating units (lPEI40) were pre-
pared and subsequently grafted onto different dextran-precursors,
namely dextran aldehyde (CHO-dex), carboxymethylated dextran
(CM-dex), and  4-nitrophenyl carbonate-substituted dextran (NPC-
dex). The degree of the functional groups (CHO, COOH, NPC) per
anhydroglucose unit (AGU) of dextran as well as the degree of sub-
stitution (DS) and the molar mass of conjugated lPEI were varied.
Finally, the inﬂuence of the linker, the DS, and  the molar mass of
lPEI  of the various dex-g-PEI conjugates were examined regarding
the interaction with DNA, the complex formation, and the cell- and
hemocompatibility as well as transgene expression.
2. Materials and methods
See supporting information.
3. Results and discussion
3.1. Synthesis of  dextran-graft-poly(ethylene imine) polymers
Well-deﬁned, proton initiated poly(2-ethyl-2-oxazoline)s
(PEtOx) were initially synthesized and subsequently hydrolyzed
to  lPEI under acidic conditions (Scheme S1). LPEI with a  theoret-
ical  molar mass of Mn = 860 g mol−1 (20 repeating units, lPEI20)
and 1720 g mol−1 (40 repeating units, lPEI40) were obtained,
which both carried an active -primary amine end group for
the subsequent conjugation to dextran (Table S1, Scheme S1). A
detailed characterization of the utilized lPEI is  published else-
where (Altuntas¸ et al., 2012; Tauhardt et al., 2011). To evaluate
the inﬂuence of the linker unit, but also of the DS and molar
mass  of lPEI, various lPEIs were allowed to react with different
ratios with dextran-precursors. To this end, a  library of various
dextran-graft-linear poly(ethylene imine)s (dex-g-lPEI), was  syn-
thesized applying different dextran-precursors and degrees of
functional groups. In detail, three synthesis strategies were uti-
lized to graft lPEI to dextran: (i) reductive amination of aldehyde
functionalized dextran (CHO-dex), (ii) EDC promoted coupling of
lPEI to carboxymethylated dextran (CM-dex), and (iii) carbamate
formation via activation of dextran to 4-nitrophenyl carbonate-
substituted dextran (NPC-dex) followed by reaction with lPEI
(Scheme 1) (Azzam et al., 2002; Sun et al., 2008b; Vandoorne,
Bruneel, Vercauteren, &  Schacht, 1991). In preliminary studies
(data not shown), these synthesis routes were examined to enable
a straightforward reaction of the primary amino functionality of
lPEI with the respective active groups introduced to dextran. It
was found that the reductive amination and the EDC coupling
are  well-suited techniques for the synthesis of various dex-g-lPEI.
In contrast, the carbamate formation method was not  qualiﬁed
because signiﬁcant crosslinking occurred during reaction of 4-
nitrophenyl carbonate-activated dextran with lPEI, resulting in
insoluble products for higher DS values (data not shown).
3.2. Reductive amination
Pharmaceutical grade dextran from Leuconostoc mesenteroides
(Mw =  65,900 g mol−1, supplier information 60,000 g mol−1) was
oxidized in a low level with potassium periodate (KIO4).  This
dextran sample is  frequently applied in preclinical and clinical
applications (Mehvar, 2000; Sun et al., 2008b). For the oxidation,
two different ratios of  KIO4 per anhydroglucose unit (AGU) (1:3 and
1:10) were chosen to react with dextran. The ﬁnal degree of oxi-
dation (degree of aldehyde groups per AGU) of the products was
found to be 0.51 (CHO-dex0.5) and 1.09 (CHO-dex1.0), as exam-
ined by hydroxylamine chloride titration, and correlates directly to
the amount of KIO4 applied per AGU (Table S2) (Zhao & Heindel,
1991).  Further investigations by size exclusion chromatography
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Scheme 1. Schematic representation of the functionalization of dextran by oxidation and carboxymethylation with subsequent reaction with lPEIs via reductive amination
(CHO-dex-g-lPEI) and EDC  coupling (CM-dex-g-lPEI), respectively.
(SEC) exhibited, as expected, a slight decrease in the molar mass
due  to chain degradation with increasing KIO4-ratio (CHO-dex0.5:
Mw = 55,100 g mol−1, CHO-dex1.1: Mw = 52,500 g mol−1,  Table S2).
The ﬁnal products were further characterized by elemental analy-
sis  (EA) and 1H NMR  spectroscopy (Table S2, Fig. S3). In the 1H NMR
spectra, the signals at 3.4 ppm to 4.1 ppm can be assigned to the pro-
tons of the AGU, and the peak at 5.2 ppm to 5.3 ppm is attributed
to  the anomeric proton (Fig. S3). Additionally, the 1H NMR  spec-
tra showed several distinctive signals in the region of 4.0 ppm to
6.0 ppm that were not  present in the original dextran and give hints
for  different C C bond breaking reactions as well as the formation
of  various hemiacetals (Jeanes & Wilham, 1950; Kent, 1949; Rankin
&  Jeanes, 1954).
Subsequently, the two dextran precursors were each converted
with lPEI20 and lPEI40 by reductive amination in water at  60 ◦C
(Scheme 1A). To reduce aminolysis side reactions caused by a fast
conjugation rate, the pH value of the lPEI solution was  adjusted to
pH 6, which additionally improved the solubility of the lPEI. The
DS of conjugated lPEIs per AGU was aimed to be highest 0.5, thus,
the molar ratio of NH2-lPEI to CHO was set to 1:2 for CHO-dex1.0
and 1:1 for CHO-dex0.5.  After subsequent reduction with NaBH4, all
dex-g-lPEIs (CHO-dex-g-lPEIs) were puriﬁed by extensive dialysis
against water at 60 ◦C (for enhanced lPEI solubility), lyophilized,
and investigated by 1H NMR  spectroscopy, EA as well as SEC mea-
surements (Table S3, Fig. S4). In the 1H NMR  spectra, the signals
of  the CHO-dex samples are still detectable (AGU: 3.4 to 4.1 ppm;
anomeric proton: 5.2 to 5.3 ppm). The  additional peaks at 3.1 to
3.3 ppm correspond to the protons of the lPEI backbone and con-
ﬁrm the successful covalent conjugation of lPEI to CHO-dex. Various
DS of lPEI per AGU were obtained (DS = 0.13 to 0.38) as calculated
from the nitrogen content determined by EA (Table 1).  The molar
masses increase with DS from Mw = 24,000 g mol−1 for CHO0.5-dex-
g-lPEI20 to Mw = 36,500 g mol−1 for the CHO1.0-dex-g-lPEI40 (Table
S3). However, these results are not absolute values due to the fact
that a dramatic rise in charge density of the polymers leads to a
considerable change in the elution behavior from the column.
3.3.  EDC coupling
For the second synthetic strategy, carboxylic moieties, which
are able to react with the primary amino groups of the lPEIs, were
introduced to the dextran backbone by carboxymethylation using
monochloroacetic acid (MCA) under basic conditions (Sun et  al.,
2008b; Wotschadlo et al., 2009). The ratios of  the reagents (dextran-
AGU:MCA:NaOH =  2.2:1:1 or 1:5:10) as well as the reaction times
(90  or 300 min) were altered in order to obtain different CM-dex
precursors with varying DS. The lyophilized samples were charac-
terized with regard to their content of the carboxymethyl groups
according to a HPLC procedure (Heinze, Erler, Nehls, & Klemm,
1994; Liebert &  Heinze, 1998).  Three degrees of carboxymethyl
functionalization per AGU were found, namely 0.32 (CM0.3-dex),
0.54  (CM0.5-dex), and 1.60 (CM1.6-dex) (Table S4). The 1H NMR
spectra  (600 MHz, D2O) showed the expected methylene peak of
the carboxymethyl group in the CM-dex at  4.1 to 4.3 ppm, and
the proton signals of the AGU (3.4 to 4.1 ppm) as well as the
anomeric proton peak at 5.2 to 5.3 ppm (Fig. S5). SEC data revealed
increasing molar masses with increasing attachment of the car-
boxymethyl groups, ranging from Mw =  51,100 g mol−1 (CM0.3-dex)
up to 60,100 g mol−1 (CM1.6-dex, Table S4).
The subsequent grafting of lPEI20 and lPEI40 to the vari-
ous CM-dex samples was performed in water in the presence
of  N-hydroxysulfosuccinimide (sulfo-NHS) and 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) (Sun et  al., 2008b).
Both  CM-dex0.3 and CM-dex0.5 were allowed to react with a  slight
excess  of lPEI (COOH:NH2 =  1:1.2), whereas the COOH:NH2 ratio
was reduced to 3:1 for CM-dex1.6.  After extensive puriﬁcation and
lyophilization, the products (CM-dex-g-lPEIs) were characterized
by 1H NMR  spectroscopy, SEC, and EA (Table S5). The chemical shifts
of the protons of the lPEI backbone are detected at  3.1 to 3.3 ppm
conﬁrming the successful binding of the lPEIs to the CM-dextrans
(Table S6) (Park et al.,  2005; Sun et al., 2008b). The resulting DS
of lPEI per AGU was again calculated from the nitrogen content
obtained by EA and found to be in the range of 0.06 to 0.18 (Table 1).
Furthermore, SEC analysis also revealed an increase of molar mass
due to attachment of the lPEI to the CM-dex.
By comparing the strategies applied for the grafting of lPEI to
dextran, it is  apparent that both ways enabled the synthesis of
various dex-g-lPEIs with different DS of lPEI in a straightforward
manner. Although the reductive amination method reached consid-
erably higher DS values, this technique has the drawback that the
required oxidization of dextran led to ring opening reactions of the
glucose, chain degradation, and other adverse side-reactions, which
resulted in hardly predictable chemical structures and biophysico-
chemical characteristics. In contrast, during dextran activation via
carboxymethylation the glucose units of the dextran kept their ring
structure and no chain degradation occurred. However, dex-g-lPEIs
prepared by EDC coupling additionally contained carboxylic acid
functionalities (COOH) in the dextran backbone, which resulted
in  polyelectrolyte structures including both cationic and anionic
charges that might inﬂuence the physicochemical and the biologi-
cal  properties as well.
3.4. Binding and protection of DNA
Nanoassemblies can be formed spontaneously by masking the
anionic  charge of the DNA based on electrostatic interactions
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Table 1
Overview about the DS and nitrogen content of all synthesized dex-g-lPEI samples.
dex-g-lPEIs CHO/COOH: NH2 [mol] DS [lPEI/AGU] N [%] Cationic charge/MMonomera Anionic charge/MMonomerb
Reductive amination (CHO-dex-g-lPEI)
CHO0.5-dex-g-lPEI20 1:0.5 0.18 15.78 0.0114 –
CHO0.5-dex-g-lPEI40 1:0.5  0.13 19.12 0.0135 –
CHO1.0-dex-g-lPEI20 1:0.5  0.38 21.45 0.0156 –
CHO1.0-dex-g-lPEI40 1:0.5  0.19 21.73 0.0156 –
EDC coupling (CM-dex-g-lPEI)
CM0.3-dex-g-lPEI20 1:1.2 0.06 6.73 0.0052 0.0013
CM0.3-dex-g-lPEI40 1:1.2 0.07 12.80 0.0093 0.0010
CM0.5-dex-g-lPEI20 1:1.2 0.07 7.96 0.0056 0.0020
CM0.5-dex-g-lPEI40 1:1.2 0.10 14.83 0.0110 0.0014
CM1.6-dex-g-lPEI20 3:1 0.11 8.16 0.0063 0.0046
CM1.6-dex-g-lPEI40 3:1 0.18 18.38 0.0127 0.0028
a Calculated cationic charge/molar mass of monomer unit.
b Calculated anionic charge/molar mass of monomer unit.
between the cationic carrier material and the anionic DNA. Com-
plexes of lPEI modiﬁed dextran were formed with herring testes
DNA as model DNA (Fischer, Dautzenberg, Kunath, & Kissel, 2004)
applying different N/P ratios (0.5 to 40) and analyzed by agarose
gel  electrophoresis (Fig. S7 for N/P 0.5–10, for N/P ratio >10 to 40
data not shown). The complex parameters (N/P ratio) as well as
the polymer characteristics (molar mass lPEI, DS and type of linker
technology) were tested in a  systematically modiﬁed way  as they
were expected to inﬂuence the interaction with DNA.
Depending on the N/P ratio, all cationic dextrans spontaneously
formed interpolyelectrolyte complexes with the DNA as a result
of  cooperative electrostatic interactions. With increasing cationic
dextran concentration, the amount of DNA migrating into the gel
decreased indicating that the complexes were larger in size and/or
less  negatively charged than free DNA. It was explored that all CHO-
dex-g-lPEIs fully complexed herring testes DNA already at  an N/P
ratio of 1 (Fig. S7) indicating charge balance. The complexation was
found to be slightly increased with higher molar mass of lPEI cou-
pled to CHO-dex. Other studies also showed that an increase of the
molar mass of bPEI resulted in a  higher binding capacity indepen-
dent of the degree of  grafting (Jiang &  Salem, 2012).  For comparison,
both  linear PEIs (20 and 40 monomers) also fully retarded the DNA
at a N/P ratio 1 (Lungwitz, Breunig, Liebl, Blunk, &  Goepferich, 2008).
Furthermore, CM-dex-g-lPEIs were found to completely retard DNA
migration into the gel at an N/P ratio ﬁrstly at 2, which indicates a
weaker complexation ability compared to free lPEI and CHO-dex-g-
lPEI  samples. This may  be attributed to the presence of the anionic
charges that could interfere with lPEI and decrease the interaction
with DNA. This assumption is  supported by polymer CM1.6-dex-g-
lPEI20, which contained the highest number of anionic charges and
demonstrated the lowest interaction with DNA with a  total com-
plexation earliest at N/P ratio 5. The negative “charge effect” on
DNA binding can be balanced by a higher DS and molar mass of
lPEI  grafted on the CM-dex backbone as demonstrated for sample
CM1.6-dex-g-lPEI40 (complexation at  N/P ratio 1). A slight trend to
higher compaction with increasing molar mass of lPEI can be found
as already observed for dextran copolymers with bPEI (Sun et al.,
2008b).
Compaction of plasmid DNA (pDNA) by cationized dextrans
should substantially hinder the access of enzymes to the pDNA by
physical or electrostatic barriers and, thus, increase the stability
(Tripathi et al., 2011). To study the integrity of pDNA after enzy-
matic treatment by gel electrophoresis (Fig. 1),  pDNA/cationized
dextran complexes of different N/P ratios were treated with DNase
I  for 45 min. After inactivation of the enzyme by heating and release
of  the plasmid by dissociation of the complex using dextran sulfate,
free  pDNA was detected on agarose gels. Intact plasmid revealed
two major ﬂuorescent bands corresponding to the supercoiled and
open circular form (Fig. 1a–c, lane 1, “untreated”). Free plasmid
Fig. 1. Stability of dex-g-lPEI/plasmid complexes against enzymatic degradation
(DNase I, 37 ◦C, 45 min) at  N/P ratio 25 and 50: (a) C; (b) and (c) dex-g-lPEIs by
EDC-coupling, (c) lPEIs. Controls: lane 1: untreated free plasmid; lane 2: free plas-
mid  treated in the  same way as complexes but without enzyme; lane 3: free plasmid
treated with enzyme.
was rapidly degraded after DNase I incubation at 37 ◦C already after
5  min  (data not shown). Thus, the characteristic bands disappeared
due to degradation to lower molar mass products (Fig. 1a–c, lane
3,  “DNase I”). Plasmid treated by the same procedure but without
enzyme remained stable and served as control to exclude nonspe-
ciﬁc  degradation (Fig. 1a–c, lane 2,  “treated”).
Since in the binding studies a high N/P ratio, high molar lPEI mass
and DS as well as a  low number of COOH residues were identiﬁed
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as parameters for an efﬁcient interaction with DNA, they were
suggested to correlate with a high enzymatic stability of the com-
plexes. Although a  full pDNA complexation by cationic dextrans
already occurred at low N/P ratios, higher N/P ratios were selected
for physicochemical analysis according to later transfection results.
The results of the stability assay indicated that the efﬁciency to sta-
bilize DNA was increased with increasing N/P ratio, higher molar
masses of lPEI, and DS with lPEI independent of the type of linker.
For free lPEI, a molar mass dependent interaction with pDNA could
be observed (Fig. 1c, lanes 8 and 10). The higher the molar mass of
free  lPEI, the more efﬁcient was the stabilizing effect of the complex.
This effect could also be observed for the dex-g-lPEIs and was more
pronounced for these than for the free lPEI. In particular, at  N/P ratio
25 of dex-g-lPEI the stability increased with higher molar mass,
which might be related to the increase in charge density within the
macromolecules.
For  CHO-dex-g-lPEIs, the stabilization effect was  most obvious.
CHO-dex-g-lPEI20 polymers revealed at  N/P ratio 25 a  different pat-
tern of DNA bands compared to the CHO-dex-g-lPEI40 complexes.
Changes in the topology of the plasmids are common as reported
in  many other studies (Fischer et al., 2004; Gebhart et al., 2002).
CHO0.5-dex-g-lPEI40 and CHO0.1-dex-g-lPEI40 protected the plas-
mid  better than their lPEI20 counterparts, since at N/P ratio 25
no degradation product was visible and just a  weak ﬂuorescent
band between the expected supercoiled and the open circular band
appeared (Fig. 1a  lanes 8  and 10). At N/P ratio 50 for both conju-
gates even a low ﬂuorescent supercoiled plasmid band is still visible
(Fig. 1a, lanes 9 and 11).
Likewise all CM-dex-g-lPEI20 conjugates were not able to
protect the pDNA as good as their lPEI40 counterparts. CM0.3-dex-g-
lPEI20 with the lowest DS of lPEI demonstrated at N/P ratio 25 a  high
plasmid damaging effect. In contrast, for CM0.3-dex-g-lPEI40 and
CM0.5-dex-g-lPEI40,  a  certain amount of supercoiled plasmid could
be conserved. In accordance with the low DNA binding efﬁciency
described above, CM1.6-dex-g-lPEI20 was not able to stabilize plas-
mid  DNA even at N/P ratio 50.
In  summary, it could be demonstrated that improved binding
and protection of  DNA is  basically reached with increased N/P ratio.
Furthermore, the higher the molar mass of lPEI and DS with lPEIs
the better the stabilization of pDNA by the conjugates due to the
increase of positive charge. Thus, it is  not surprising that in contrast
to the CHO-dex-g-lPEIs, the CM-dex-g-lPEIs showed weaker DNA
binding and less stabilization characteristics. Theses polymers are
characterized by lower DS with lPEI and also by negative charges
originating from the carboxymethyl (CM) functionalities within the
polymer backbone that might decrease the interaction with nega-
tively charged pDNA due to electrostatic repulsion.
3.5.  Size and zeta potential of  complexes
The efﬁciency of the dex-g-lPEI-mediated cellular DNA deliv-
ery  will also be determined by the size and the surface charge of
the complexes formed. A  positive surface charge represents a pre-
requisite to stabilize the included nucleic acid against enzymatic
degradation in small sized complexes, which are able to interact
with the negatively charged cell membrane for an effective endo-
cytosis into cellular compartments (Grund, Bauer, &  Fischer, 2011).
Complexes were prepared with two different N/P ratios (25 and 50)
in  bidistilled water to avoid any inﬂuence of the ionic strength of
the  solvent and were studied by light scattering with regard to the
ﬁnal size and surface charge. Based on  the electrophoresis experi-
ments, it was hypothesized that (i) all copolymers should be able
to  form small, positively charged nanoassemblies with DNA with
(ii) CHO-dex-g-lPEIs being more effective than CM-dex-g-lPEIs.
In detail, all dex-g-lPEI/pDNA assemblies revealed sizes in
the range of 70 to 113 nm with monomodal size distributions
Fig. 2. (a) Hydrodynamic diameter and (b) zeta potential of dex-g-lPEI and lPEI
complexes with plasmid DNA at N/P ratio 25 and 50  measured in water. Results are
shown as mean of six  measurements ± SD.
(polydispersity indices (PDI) 0.13 to 0.31, data not shown), which
were  comparable to the sizes obtained for the DNA complexes with
lPEI20 and lPEI40 (Fig. 2a).  Since an excess of polymer was used, no
major differences could be observed between N/P ratio 25 and 50.
For polymer CM1.6-dex-g-lPEI20,  a relatively high hydrodynamic
diameter of 113 nm was measured at  N/P ratio 50. The insufﬁcient
DNA binding and stabilization of DNA by  CM1.6-dex-g-lPEI20 cor-
relates with a  lower DNA compaction and, consequently, a larger
complex size. A  similar trend was observed for CM0.3-dex-g-lPEI20
at  N/P ratio 25 (hydrodynamic diameter 110 nm). All complexes
were positively charged with zeta potentials between +17 and
+37 mV with comparable results for N/P ratios 25 and 50 due to
the  excess of the cationic component (Fig. 2b).
Additionally, complexes were prepared in 50 mM NaCl solution
at  pH 7.4 (data not shown). All complexes of CHO-dex-g-lPEIs pre-
pared with N/P ratio 25 aggregated immediately. In contrast, by
trend smaller sized complexes were obtained at N/P ratio 50 with
diameters of about 170 to 320 nm due a more intense compaction of
the plasmid by the modiﬁed dextrans, but again with a tendency to
602 S. Ochrimenko et  al. /  Carbohydrate Polymers 113 (2014) 597–606
(a)
C
H
O
0.
5-
de
x-
g-
lP
E
I 2
0
C
H
O
0.
5-
de
x-
g-
lP
E
I 4
0
C
H
O
1.
0-
de
x-
g -
lP
E
I 2
0
C
H
O
1.
0-
de
x-
g -
lP
E
I 4
0
C
M
0.
3-
de
x-
g-
lP
E
I 2
0
C
M
0.
3-
de
x-
g-
lP
E
I 4
0
C
M
0.
5-
de
x-
g-
lP
E
I 2
0
C
M
0.
5-
de
x-
g-
lP
E
I 4
0
C
M
1.
6-
de
x-
g-
lP
E
I 2
0
C
M
1.
6-
de
x-
g-
lP
E
I 4
0
lP
E
I 2
0
lP
E
I 4
0
P
os
iti
ve
 c
on
tro
l
D
N
A
0.00
2.50x105
5.00x105
7.50x105
1.00x106
1.25x106
1.50x106
1.75x106
2.00x106
2.25x106
2.50x106
2.75x106
3.00x106
Lu
m
in
es
ce
nc
e 
[R
LU
/μ
g 
pr
ot
ei
n]
Polymer
 N/P 25 (b)
C
H
O
0.
5-
de
x-
g-
lP
E
I 2
0
C
H
O
0.
5-
de
x-
g-
lP
E
I 4
0
C
H
O
1.
0-
de
x-
g-
lP
E
I 2
0
C
H
O
1.
0-
de
x-
g-
lP
E
I 4
0
C
M
0.
3-
de
x-
g-
lP
E
I 2
0
C
M
0.
3-
de
x-
g-
lP
E
I 4
0
C
M
0.
5-
de
x-
g-
lP
E
I 2
0
C
M
0.
5-
de
x-
g -
lP
E
I 4
0
C
M
1.
6-
de
x-
g -
lP
E
I 2
0
C
M
1.
6-
de
x-
g-
lP
E
I 4
0
lP
E
I 2
0
lP
E
I 4
0
P
os
iti
ve
 c
on
tro
l
D
N
A
0.00
2.50x105
5.00x105
7.50x105
1.00x106
1.25x106
1.50x106
1.75x106
2.00x106
2.25x106
2.50x106
2.75x106
3.00x106
Lu
m
in
es
ce
nc
e 
[R
LU
/μ
g 
pr
ot
ei
n]
Polymer
 N/P 50
Fig. 3. Transfection efﬁciency of dex-g-lPEIs and free lPEIs complexed with plasmid pGL3 at  (a) N/P ratio 25 and (b) N/P ratio 50 in  CHO-K1 cells determined by luciferase
assay; in comparison to the  positive control 2.5 kDa lPEI at  N/P ratio 25 and naked plasmid (DNA).
slowly agglomerate over time. Measurements of complexes of the
CM-dex-g-lPEIs with pDNA in 50 mM NaCl did not lead to evaluable
results due to strong aggregation, forming complexes larger than
1  m with multimodal size distributions.
It is known that the complex formation can be strongly inﬂu-
enced by the medium used for preparation, since complexation
is driven by electrostatic forces (van Gaal et al., 2011).  Usually,
the higher the ionic strength of the media the higher the impact
on  the complexation and the resulting complex size (Rinkenauer
et  al., 2013). 150 mM  NaCl as iso-osmotic solution is  often used for
transfections, but can lead to a fast complex aggregation (Petersen
et  al., 2002). To reveal relevant information about the complex
size for product characterization, many authors described therefore
useful measurements under salt-free conditions (Cavallaro et al.,
2008; Ogris, Brunner, Schuller, Kircheis, & Wagner, 1999; Ogris
et al., 2003). Measurements of complexes in cell culture medium
and  serum supplemented cell culture medium are often mislead-
ing, since the proteins itself prevent a  proper characterization by
DLS. Several authors have mentioned this effect, and  formation
of complexes and their measurements under low salt conditions
have been therefore widely described (van Gaal et al., 2011).  Fur-
thermore, in serum containing media the process of aggregation
could often be avoided due to the stabilization of the complexes
by the formation of a  surrounding protein corona. For transfec-
tion experiments it  has to be taken into consideration that possible
aggregation is a  time-dependent process. Consequently, complexes
were freshly prepared before each biological experiment and used
within 10 min. Ogris et al. (1998) hypothesized that the transfec-
tion efﬁcacy in vitro might increase with larger complex sizes due
to  their faster sedimentation. Although we  also observed aggre-
gation for the pDNA complexes prepared from CHO-dex-g-lPEIs,
they  revealed a decrease in complex size demonstrating a positive
impact of dextran on the complex formation in comparison to free
lPEI20/40.
However, the inﬂuence of complex aggregation on transfection,
cytotoxicity and hemolysis results was  not in the focus of this study
and therefore, not further addressed. For future studies, a  low ionic
strength medium supplemented e.g. with glucose at  iso-osmotic
concentrations might be beneﬁcial since it tolerates the character-
ization as well as the transfection (van Gaal et al., 2011).
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3.6. Transfection mediated by pDNA/dex-g-lPEI complexes
CHO-K1 cells were transfected with complexes of the cationized
dextrans and the plasmid pGL3 at  different N/P ratios for 4  h. Based
on preliminary experiments, N/P ratios 25 and 50 were found to be
suitable for the following experiments. Luciferase expression was
presented by normalizing the measured relative light units (RLU)
to  the total protein mass of the cells per culture well. For all tested
samples, cytotoxicity-related effects as the reason for the declining
transfection efﬁciencies were unlikely, since the protein concen-
trations in cell lysates (an indicator for cell growth, determined by
a  BCA assay) were very similar (data not shown). Free plasmid itself
revealed only a limited ability to transfect cells. Unmodiﬁed dex-
tran  was tested in concentrations up to 25 g g−1 pGL3 plasmid
in  a preliminary study and failed to produce any detectable level
of  transgene expression (data not shown). Also lPEI20 and lPEI40,
were characterized by a low transgene expression.
The transfection experiments for the copolymers were designed
to  evaluate the importance of the structural polymer characteristics
identiﬁed above, for the delivery of genes in  vitro. Besides increasing
N/P ratios, especially molar mass of  lPEI and  DS with lPEIs leading
to  smaller and more stable complexes, were found to be impor-
tant factors for efﬁcient DNA transfer. Furthermore, the inﬂuence of
the  carboxy groups of the CM-dex-g-lPEIs, which seemed to cause
reduced interactions with DNA, on cellular processing of DNA has
to be elucidated.
Interestingly, the transfection efﬁciency obtained for the CHO-
dex-g-lPEIs was only slightly higher than for the corresponding
free lPEIs, but cationized dextrans with negatively charged groups,
prepared by EDC coupling, demonstrated a  high activity (Fig. 3).
For CM-dex-g-lPEIs, the transgene expression increased with
higher molar mass of the lPEIs and N/P ratio, as already expected
from the available physicochemical characterization data. For
the  CM-dex-g-lPEIs, the transfection rate increased in the range
CM0.3-dex-g-lPEI20,  CM0.3-dex-g-lPEI40,  CM0.5-dex-g-lPEI20 at
N/P  ratio 25, whereas for CM0.5-dex-g-lPEI40 a  decrease could
be observed (Fig. 3a). It has to be highlighted that CM0.3-dex-g-
lPEI20, CM0.5-dex-g-lPEI20 and CM0.5-dex-g-lPEI40 at  N/P ratio 50
(1.8 to 2.3 × 106 RLU g−1 protein, Fig. 3b) showed transfection
efﬁciencies comparable to that of a  commercially available lin-
ear  2,500 g mol−1 lPEI at  N/P ratio 25 (2.55 × 106 RLU g−1 protein,
Fig. 3b). A similar effect could be observed earlier for CM-dex-PEIs
(Sun et al., 2008b). CM0.3-dex-g-lPEI40 and CM0.5-dex-g-lPEI40
were expected to induce higher transfection rates than CM0.3-dex-
g-lPEI20 and CM0.5-dex-g-lPEI20, as it is known from the higher
molar mass dex-g-bPEI conjugates(Jiang & Salem, 2012) and was
also observed for the CHO-dex-g-lPEIs. However, a contrary effect
was revealed for CM0.5-dex-g-lPEI40 at N/P ratio 25 and CM0.3-
dex-g-lPEI40 at N/P ratio 50, since an approximately 1/3 lower
transfection compared to their lPEI20 counterparts was found. This
is ascribed to stronger interactions between the longer lPEI chain
with COOH groups of the CM-dex than with the pDNA.
In conclusion, CM0.5-dex-g-lPEI20 provides the best gene deliv-
ery properties in this study at both N/P ratios, what might be related
to  the ratio of cationic charges to anionic charges per monomer
(Table 1). Additionally, the low efﬁciency of the CHO-dex-g-lPEIs
may  be attributed to the higher DNA complexation efﬁciency of
the  polymer and, therefore, lower ability to release pDNA from
the complexes compared to the polymers of the CM-dex-g-lPEIs
as shown by the electrophoresis assays. Dissociation of  DNA from
the complexes is one of the critical steps in the biological process,
since only released and intact DNA can be transcribed. The observed
trends are in accordance with the results of the physicochemical
experiments: As uptake of complexes into cells imposes certain size
and  stability requirements on the endocytosed material, it is nec-
essary for a successful gene transfer that the cation in polyplexes
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Fig. 4. Viability of L929 mouse ﬁbroblasts treated with dex-g-lPEI/DNA and
lPEI/DNA complexes at N/P ratio 25 and 50 for 24 h, determined by MTT assay. Com-
plexes were formed with herring testes DNA as model DNA. Results are shown as
mean of seven values ± SD.
not only binds DNA, but also compacts it. Since the condensation
of DNA is also known to protect the genetic material from enzy-
matic degradation (Godbey, Barry, Saggau, Wu,  & Mikos, 2000),
the  decrease of transfection ability of the complexes formed by
polymers CM1.6-dex-g-lPEI20 and CM1.6-dex-g-lPEI40 may  result
from the insufﬁcient interactions with pDNA based on the highest
number of anionic charges.
3.7.  In vitro biocompatibility testing
Biocompatibility testing has been performed with respect
to  cyto- and hemotoxicity. The in vitro cytotoxicity of the
non-viral vectors was evaluated by the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay representing the
metabolic activity of cells (Fig. 4).  The same conditions as in the
transfection experiments were used. Independent of the N/P ratio,
complexes with the two  lPEIs did not cause any cytotoxic effect,
which is supported by  results from earlier studies demonstrating
the low cytotoxicity of complexes formed with low molar mass
lPEIs (Breunig et al., 2005; Thomas, Ge, Lu, Chen, & Klibanov, 2005;
Yu  et al., 2009).  Taking the DIN ISO 10993-5 guideline (2009) into
consideration which deﬁnes a reduction of cell viability lower than
70% as nontoxic, all tested dex-g-lPEI/DNA complexes were found
to  be highly compatible (84 to 110%) at  N/P ratios 25 and 50. The
compatibility was  thereby independent of the linker technique, the
DS and the selected N/P ratios (Fig. 4). For comparison, the positive
control thiomersal solution (0.02%) reduced the mean cell viability
to  0.6% (data not shown). The results of the MTT  assay correlated
well with the observation of the BCA assay (data not shown) in the
transfection experiments. Similar results were reported in earlier
studies as well (Jiang &  Salem, 2012; Sun et al., 2008b).
Furthermore, the compatibility of non-viral vectors with blood
indicates their suitability for administration directly into the sys-
temic circulation. The hemolytic behavior of the free polymers
was tested as worst case scenario and classiﬁed according to the
ASTM F756-08 standard (data not shown) (2008).  According to this
standard, neither free lPEIs nor dex-g-lPEIs did  show any detectable
disturbance of the red blood cell membranes (hemolysis <2%) up
to 1 mg  mL−1.  The observed behavior can be attributed to the low
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Fig. 5. Aggregation of sheep red  blood cells after treatment with free dex-g-lPEI and lPEI polymers incubated at  37 ◦C for 2 h. (a) Representative pictures of microscopic obser-
vation at 50 g mL−1 (negative control = PBS;  positive control = 15 g mL−1 bPEI 25,000 g mol−1) with magniﬁcation 200×.  (b) Stages of sheep blood erythrocyte aggregation
of  dex-g-lPEIs and lPEIs at concentrations up to  50 g mL−1. Classiﬁcation: 1 = no aggregation of erythrocytes, 2 = moderate aggregation with rouleau formation, 3  = strong
aggregation with cluster formation. (c)  Absmax of polymers. The RBC aggregation experiments were performed with n = 2  and repeated once (mean ± SD).
DS and the low molar mass of the cationic polymers (Moreau,
Domurado, Chapon, Vert, & Domurado, 2002). For comparison, dex-
tran itself showed no erythrocyte membrane disturbance up to
16  mg  mL−1 with 0.2% hemolytic activity (Yang et al., 2012).
To  avoid clinical complications like thrombosis and embolism
by  systemic use of the dextran-based vectors, their potential to
aggregate red blood cells was investigated by qualitative light
microscopy (Fig. 5a and b) and  classiﬁed into three stages (Fig. 5b)
as  well as quantitatively by UV–vis spectroscopy (Fig. 5c). Both
methods gave comparable results and displayed a  concentration-
dependent red blood cell aggregation behavior of the polymers up
to  50 g mL−1. In microscopic experiments, the negative control
did not show any signs of cluster formation (stage 1), whereas
the  positive control (25,000 g mol−1 bPEI, 15 g mL−1) caused
the  formation of large aggregates (stage 3)  as described before
(Fig. 5a) (Bauer et al., 2012). Additionally, the Absmax value was
introduced, meaning the difference of the reduction in absorbance
to the negative control absorbance. In  contrast to the positive
control (Absmax = 0.12), lPEI20 was  well tolerated and classiﬁed
as stage 1  (Absmax =  0.026), whereas an  increase in molar mass
(lPEI40) initiated rouleaux formation only at  the highest tested con-
centration of 50 g mL−1 (stage 2, Absmax = 0.04). The molar mass
and concentration dependent effects of PEIs on red blood cell aggre-
gation were described by several authors (Jeon, Yang, Lee, & Kim,
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2008; Petersen et al., 2002). Correlated to the increasing number
of  charges with size, the interactions with negatively charged cell
membranes increase as well.
In  accordance to the results obtained for the free lPEIs, also for
the dex-g-lPEIs an increase of red blood cell aggregation could be
observed with higher molar mass of lPEI (Fig. 5).  For the CHO-
dex-g-lPEIs erythrocyte aggregation could be observed starting at
concentrations of 6.25 and 25 mg  mL−1 for CHO1.0-dex-g-lPEI20,
CHO1.0-dex-g-lPEI40, and CHO0.5-dex-g-lPEI40,  respectively. In
contrast, CHO0.5-dex-g-lPEI20 did not show any signs of interac-
tion up to the highest tested concentration of 50 g mL−1 (Fig. 5b).
Therefore, interactions with negatively charged cell membranes of
the red blood cells were found to increase with the molar mass
of  lPEI; this observation correlated well with the nitrogen content
of  the CHO-dex-g-lPEIs.  In general, the conjugates synthesized by
reductive amination demonstrated a higher red blood cell aggre-
gation potential compared to the modiﬁed dextrans prepared by
EDC-coupling. CM0.3-dex-g-lPEI40,  CM0.5-dex-g-lPEI20,  and CM0.5-
dex-g-lPEI40 reached only stage 2  with maximum Absmax values of
0.06, even at the highest concentration of 50 g mL−1.  Again, for the
lPEI40-containing polymers CM0.3-dex-g-lPEI40 and CM0.5-dex-
g-lPEI40 the aggregation effects were more pronounced than for
the  lPEI20-based polymers (CM0.3-dex-g-lPEI20 and CM0.5-dex-g-
lPEI20). The higher compatibility of the CM-dex-g-lPEIs compared
to  the CHO-dex-g-lPEIs may  be ascribed to the polyelectrolyte
nature of the CM-dex-g-lPEIs since they contain both positive
and negative charges. This was particularly demonstrated by the
polymer CM1.6-dex-g-lPEI40,  that possesses a  higher number of
anionic charges and revealed the lowest effects on red blood cells
(stage 1 at 50 g mL−1,  Absmax =  0.02). Hence, the high number of
anionic charges within the CM-dex-g-lPEI polymers seems to inter-
fere with the electrostatic interactions between the anionic cell
membranes and the cationic polymers resulting in a  decreased cell
aggregation. De facto, for polyelectrolytes (e.g. zwitterionic poly-
mers) a higher resistance to non-speciﬁc protein adsorption and
blood cell interactions, which lead to a  prolonged half life time in
blood circulation, has been shown (Jiang &  Cao, 2010).
4.  Conclusion
With the objective to evaluate the inﬂuence of the linking strat-
egy of lPEI to dextran, several dextran-g-lPEIs were prepared. For
this purpose, different low molar mass lPEIs were synthesized and
conjugated to dextran via two routes, namely reductive amination
and EDC coupling. These linking strategies were already used in the
past but mainly lack on a  detailed characterization of the result-
ing molecules and a  direct comparison of the different linking
strategies (Jiang &  Salem, 2012; Sun et al., 2008b). For a  detailed
comparative study of structure-activity relationships, the content
of  functional groups (CHO, COOH) within the dextran precursors
and  the DS with lPEI were varied as well. Subsequently, the ﬁnal
dex-g-lPEI samples were characterized in detail and investigated
with regard to their physicochemical properties (DNA binding
and  stabilization, complex size and surface charge), transfection
efﬁciency as well as biocompatibility. The investigations were per-
formed in terms of dependency on the linking strategy, the molar
mass of conjugated lPEIs, and the N/P ratio of the formed DNA/dex-
g-lPEI complexes. Independent from the linking strategy, DS and
molar mass of lPEI, it was observed that almost all conjugates
formed with DNA were in the range of 100 nm (in water), sta-
ble  against enzymatic degradation, and revealed a  positive surface
charge. Differences between the types of conjugation were visible
when lPEI was conjugated with CM1.6-dex (CM1.6-dex-g-lPEI20):
The binding capacity was reduced, as well as the stability and the
zeta potential, which was attributed to the higher content of COOH
groups along the dextran backbone. Moreover, cell viability studies
revealed a  good cytocompatibility of the resulting dex-g-lPEI/DNA
complexes with no crucial inﬂuence of the synthesis route or the
DS and molar mass of  lPEI. Instead, a  remarkable effect of these
parameters was  observed regarding transfection efﬁciency, since
the cationic dextrans prepared by EDC coupling showed a more
than one order of magnitude increased transgene expression com-
pared to the CHO-dex-g-lPEIs despite much lower lPEI content. For
comparison, free lPEIs formed complexes that showed almost no
transgene expression. The additional integration of COOH-groups
seems to accomplish a  positive to negative charge ratio within the
CM-dex-g-lPEI conjugates that is advantageous for DNA release
and transfection efﬁciency. Their transfection rates were found to
be  comparable with the positive control 2.5 kDa lPEI. It was also
discovered that both polymer series induced higher red blood cell
aggregation compared to unconjugated lPEIs, with CM-dex-g-lPEI
showing a  lower erythrocyte aggregation activity than CHO-dex-
g-lPEI. This was  again ascribed to the polyelectrolyte nature of the
CM-dex-g-lPEI.
In conclusion, the variation of the linking strategy of cationic
polymers to dextran affects the biological properties signiﬁ-
cantly, while the physicochemical properties were only marginally
affected. The EDC coupling was more suitable as linking strat-
egy  compared to the polymers obtained by reductive amination,
since the conjugates showed improved hemocompatibility and
enhanced performance in the transfection experiments.
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Material and Methods 
 
1. Instrumentation 
 
Size exclusion chromatograms (SEC) of poly(2-ethyloxazoline) were measured on an 
Agilent Technologies 1200 Series gel permeation chromatography system equipped with a 
G1310A isocratic pump, a G1329A autosampler, a G1362A refractive index detector, and 
both a PSS Gram 30 and a PSS Gram 1000 column placed in series. A 0.21% lithium chloride 
(LiCl, ACROS Organic, New Jersey, USA) solution in N,N-dimethylacetamide (DMA, 
HiPerSolv CHROMANORM, VWR Prolabo, Darmstadt, Germany) was used as eluent at 
1 mL ? min-1 flow rate and a column oven temperature of 40 °C. The molar masses were 
calculated against poly(ethylene glycol) (PEG, Polymer Standards Service, Mainz, Germany).  
The dextran aldehyde and carboxymethylated dextran were investigated on a Jasco SEC 
system composed of a DG-2080-53 degasser, a PU-980 pump and a RI-930 refractive index 
detector running in dimethyl sulfoxide (DMSO, ROTIPURAN 99.8%, Carl-Roth GmbH, 
Karlsruhe, Germany) containing 0.5% lithium bromide (LiBr, Riedel-de Haën, Seelze, 
Germany) at 0.5 mL ? min-1 at 65 °C. The samples were separated on PSS NOVEMA 3000 
and 300 Å columns and their molar masses calculated against narrow distributed dextran 
standards (Polymer Standards Service, Mainz, Germany). 
Moreover, all dextran-graft-linear poly(ethylene imine)s were measured on a Jasco SEC 
system equipped with a PU-980 pump, a AS-1555 autosampler, a DG-980-50 degasser, a RI-
930 refractive index detector, and a PSS SUPREMA-MAX column. As eluent, a solution of 
0.1% trifluoroacetic acid (TFA, Uvasol, MERCK, Darmstadt, Germany) and 
0.05 M NaCl (Sigma Aldrich, Deisenhofen, Germany) in water (pH 2), running at a flow rate 
of 1 mL ? min-1 and a column oven temperature of 60 °C, was used. The molar masses were 
calculated against pullulan (Polymer Standards Service, Mainz, Germany). 
 
1H NMR and 13C NMR spectra were recorded in deuterated water (D2O, Eurisotop, Gif sur 
Yvette Cedex, France) or deuterated dichlormethane (CD2Cl2, Eurisotop, Gif sur Yvette 
Cedex, France) on a Bruker Avance 250 MHz or 300 MHz spectrometer. Chemical shifts are 
given in ppm relative to signals from the NMR solvents. Conversions were calculated from 
1H spectra using anisole as an internal standard. 
 
Elemental analysis (EA) was carried using an Elementaranalysator Vario EL III CHNS from 
Elementar Analysensysteme GmbH, Hanau.  
 
2. Synthesis 
 
Synthesis of poly(2-oxazolines) 
The poly(2-ethyl-2-oxazoline)s (pEtOx) used in this study as starting materials for the 
preparation of linear poly(ethylene imine)s (lPEIs) were synthesized according to literature 
procedures.(Hoogenboom, Paulus, Pilotti & Schubert, 2006; Tauhardt et al., 2011) Briefly, 
pEtOx with monomer-to-initiator ratios of 20 and 40 were synthesized under microwave 
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irradiation. In order to obtain solely proton initiated chains p-toluene sulfonic acid (Sigma 
Aldrich) was used as initiator for the cationic ring-opening polymerization (Scheme S1). 
Polymerization kinetics revealed a linear increase of ln([M]0/[M]t) with time demonstrating a 
constant concentration of propagating species indicative of a living polymerization 
mechanism. The resulting first-order kinetic plot is shown in Figure S1, left. The linear 
increase in the molar mass with conversion as well as low polydispersity index (PDI) values 
(< 1.3) further support the living character of the polymerization (Figure S1, right). Based on 
these results two large batches of pEtOx20 and pEtOx40 were synthesized. The molar mass 
determined by 1H NMR spectroscopy was in accordance with the feed ratio (pEtOx20: 
2,000 g ? mol-1, pEtOx40: 4,000 g ? mol-1) and SEC measurements revealed reasonable molar 
mass distributions with low PDI values (PEtOx20: 3,530 g ? mol-1, PDI = 1.14; PEtOx40: 
5,900 g ? mol-1, PDI = 1.2) (Figure S2). 
 
Synthesis of linear poly(ethylene imines) 
The lPEI synthesis was performed according to a modified procedure described in 
literature.(Tauhardt et al., 2011) Briefly, corresponding pEtOx (30 g) was dissolved in 
6 M HCl (400 mL, Sigma Aldrich) and heated for 24 h at 150 °C. The solvent was removed 
under reduced pressure. The residue was dissolved in water (500 mL) and 3 M NaOH (Sigma 
Aldrich) was added until precipitation occurred. The precipitate was filtered off and 
recrystallized from water (600 mL). After filtration the lPEI was dissolved in methanol 
(200 mL, Mineralöl Albert, Jena, Germany) and precipitated into ice-cold diethyl ether 
(1,300 mL, Mineralöl Albert). The white precipitate was filtered off and dried under reduced 
pressure at 40 °C for 5 d. The purity and degree of hydrolysis of the resulting lPEI were 
determined by 1H NMR spectroscopy.(?????????????????????; Tauhardt et al., 2011) 
 
Table S1. Analytical data of pEtOx and the resulting lPEIs. 
 Mna [g ? mol-1] PDI 
PEtOx20 3,550 a 1.14 a 
PEtOx40 5,900 a 1.20 a 
lPEI20 860b - 
lPEI40 1,720b - 
a SEC were performed in DMA containing 0.21% LiCl using PEG as standard. 
b Theoretical values calculated from the pEtOx precursor. 
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Scheme S1. Schematic representation of the cationic ring-opening polymerization of pEtOxs followed 
by the subsequent acidic hydrolysis to lPEI. 
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Figure S1. Kinetics of the cationic ring-opening polymerization of pEtOx: Resulting first-order 
kinetic plot of ln([M]0/[M]t) (left) linear increase in the molar mass with conversion as well as low 
polydispersity index (PDI) values (right). 
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Figure S2. SEC traces of pEtOx20 and pEtOx40 using DMA as eluent. 
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Synthesis of dextran aldehyde (CHO-dex) 
Pharmaceutical grade dextran with an average molar mass of 65,900 g ? mol-1 
(Pharmacosmos, Holbaek, Denmark) (5 g, 0.0136 mol per anhydroglucose unit (AGU)) was 
dissolved in 20 mL distilled water, and the adequate amount (0.0045 or 0.00136 mol) of 
potassium periodate (KIO4, Sigma Aldrich) was added. After stirring in the dark at room 
temperature for 24 h, the products were dialyzed for 5 days (10 times exchange of water) and 
were transferred into tare glass vials and lyophilized in an Alpha 1-2/LD Plus freeze dryer 
(Martin Christ, Osterode Germany) at a pressure of 0.006 mbar for 72 h (yield 90%). The 
final CHO-dextrans were characterized by elemental analysis, SEC (Table S2) as well as 
1H NMR spectroscopy (Figure S3). The degree of oxidation in the CHO-dex was determined 
according to the hydroxylamine chloride titration after Zhao et al. in distilled water.(Zhao & 
Heindel, 1991) CHO-dex samples (100 mg) were dissolved in 25 mL of 0.25 M 
hydroxylamine hydrochloride solution (Sigma Aldrich). After 2 h incubation at room 
temperature, the solution was titrated against 1 N NaOH solution. Thereby, the degree of 
substitution (DS) of CHO was calculated based on the sample weights (formula) and 
subscripted as CHOX-dex. 
 
?? [???? ? ???] =
??? × 10??(?)  ×  ????? (??? ×  ???)
???? (?)
????(? ×  ?????)
 
 
Table S2. Overview of analytical data of the oxidation of dextran with KIO4. 
 
 
KIO4:AGU 
[mol] [CHO/AGU]
a Mw
  
[g ? mol-1]b PDI
b C [%] 
H 
[%] 
N 
[%] 
Dextran - - 65,900 1.86 40.49 6.79 - 
CHO0.5-dex 1:10 0.51 55,100 2.51 42.34 6.39 - 
CHO1.0-dex 1:3 1.09 52,500 2.35 41.43 6.25 - 
a Determined by hydroxylamine chloride titration. 
b SEC were performed in DMSO containing 0.5 % LiBr using pullulan as standard.  
 
a) b) c) 
Figure S3. 1H NMR spectra of (a) dextran, (b) CHO0.5-dex and (c) CHO1.0-dex prepared by oxidation 
with KIO4. The 1H NMR spectra were measured at 25 °C in D2O.  
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Synthesis of CHO-dex-g-lPEI 
For the synthesis of various dextran conjugated lPEIs, 200 mg (0.0012 mol AGU) CHO0.5-dex 
and CHO1.0-dex as well as the desired amount of lPEI (CHO:NH2-PEI ratio = 1:1 or 1:0.5) 
were dissolved in water at 60 °C. After mixing both solutions, the color turned to yellow 
indicating an imine bond formation. The mixture was stirred for 24 h at 60 °C following the 
slow addition of a 5 times excess of sodium borohydride (NaBH4, Sigma Aldrich). The 
solutions became colorless due to the reduction of the imine bond to an amine formation and 
were stirred for 2 days at room temperature. Subsequently, the product was purified from 
uncoupled lPEI and NaBH4 residues by extensive dialysis against water at 60 °C. The water 
was exchanged at least 10 times within 5 days until the pH of the dialysis water was neutral 
(pH 6-7). The product was lyophilized in an Alpha 1-2/LD Plus freeze dryer (Martin Christ) 
at a pressure of 0.006 mbar for 72 h reaching 30 to 40% overall yield. The absence of 
unbound lPEI was proven by 1H NMR measurement (600 MHz, D2O, 60 °C) of the collected 
dialysis water and the final DS of lPEI was calculated by the nitrogen content obtained from 
elemental analysis (Table S3). The polymers were further characterized by SEC 
measurements (in H2O, 0.1% TFA) and 1H NMR spectroscopy (600 MHz, D2O, 60 °C) 
(Figure S4).  
 
Table S3. Overview of analytical data of the CHO-dex-g-lPEI samples obtained by reductive 
amination. 
Products 
CHO: 
NH2-lPEI 
[mol] 
DSa 
[lPEI/ AGU] 
C 
[%] 
H 
[%] 
N 
[%] 
Mw 
[g ? mol-1]b PDI
b 
CHO0.5-dex-g-lPEI20 1:1 0.18 41.95 9.75 15.78 24,000 1.21 
CHO0.5-dex-g-lPEI40 1:1 0.13 43.00 10.38 19.12 27,600 1.26 
CHO1.0-dex-g-lPEI20 2:1 0.38 43.74 10.58 21.45 31,300 1.20 
CHO1.0-dex-g-lPEI40 2:1 0.19 43.62 10.45 21.73 36,500 1.20 
a Calculated from the nitrogen content N [%] of the elemental analysis. 
b SEC measurements were performed in H2O containing 0.1% TFA and 0.05 M NaCl (pH 2) using 
pullulan as standard.  
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a) b) 
  
c) d) 
  
 
Figure S4. 1H NMR spectra of dex-g-lPEI samples obtained by reductive amination. The 1H NMR 
spectra were measured at 60 °C in D2O. (a) CHO0.5-dex-g-lPEI20, (b) CHO0.5-dex-g-lPEI40 (c) CHO1.0-
dex-g-lPEI20, (d) CHO1.0-dex-g-lPEI40. 
 
 
Synthesis of carboxymethyl dextran (CM-dex) 
Pharmaceutical grade dextran with an average molar mass (Mn)of 65,900 g ? mol-1 
(Pharmacosmos) (5 g, 0.0136 mol per AGU) was dissolved in 50 mL water and stirred for 
20 minutes at room temperature. The desired amount of 15 M NaOH was added dropwise, 
and the reaction mixture stirred for further 60 minutes. Subsequently, the desired amount of 
monochloracetic acid (Sigma Aldrich) was added dropwise and the temperature was increased 
to 60 °C. The reaction was stopped after 90 minutes or 300 minutes by neutralization with 
acetic acid (pH 6-7, Sigma Aldrich). After precipitation in 1.5 L of cold methanol (Mineralöl 
Albert), the solid product was filtered off over a G3 frit and washed (at least 3 times) with 
methanol. After dialysis (5 times exchange of water, 3 days) the products were obtained in 
80% yield by lyophilization in an Alpha 1-2/LD Plus freeze dryer (Martin Christ) at a 
pressure of 0.006 mbar for 72 h. The DS of carboxymethyl groups was determined according 
to the HPLC procedure described by Wotschadlo et al.(Wotschadlo et al., 2009) Furthermore, 
the products were characterized by 1H NMR spectroscopy (600 MHz, D2O), SEC (in DMSO) 
and EA measurements (Table S4).  
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Table S4. Overview of analytical data of the CM-dex samples obtained by carboxymethylation. 
 AGU:ClCH2COOH 
:NaOH [mol] 
DSa [CH2COOH 
/AGU] 
Mw 
[g ? mol-1]b 
PDIb 
CM0.3-dex 2.2:1:1 (90 minutes) 0.32 51,100 2.36 
CM0.5-dex 2.2:1:1 (300 minutes) 0.54 54,400 2.37 
CM1.6-dex 1:5:10 (300 minutes) 1.6 60,100 2.04 
a Determined by HPLC measurement. 
b SEC were performed in DMSO containing 0.5% LiBr using pullulan as standard. 
 
 
a) b) c) 
   
Figure S5. 1H NMR spectra of (a) CM0.3-dex, (b) CM0.5-dex and (c) CM1.6-dex obtained by 
carboxymethylation with monochloroacetic acid. The 1H NMR spectra were measured at 25 °C in 
D2O. 
 
 
Synthesis of CM-dex-g-lPEI 
The reactions of the CM-dex with the lPEIs were performed using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, Sigma-Aldrich) as coupling reagent. Firstly, 
300 mg of each CM-dex and the desired amount of lPEI (NH2:COOH = 1.2:1) were dissolved 
in distilled water at 60 °C to ensure complete dissolution of the lPEIs. Subsequently, the 
pH value of the solution was adjusted to 6.0 by 1 M HCl solution. After 20 minutes stirring at 
60 °C EDC (COOH:EDC = 1:1) and N-hydroxysulfosuccinimide (sulfo-NHS, Sigma Aldrich) 
(EDC:sulfo-NHS = 1:1) were added. The reaction mixture was stirred for 24 h at 60 °C, and 
the product was purified by extensive dialysis (at least 10 times exchange of water within 
5 days) at 60 °C. The products were obtained by lyophilization (Alpha 1-2/LD Plus freeze 
dryer, Martin Christ) at a pressure of 0.006 mbar for 72 h in 30 to 40% overall yield. The 
absence of free unbound lPEI was proven by 1H NMR (600 MHz, D2O) measurement of the 
collected dialysis water. Furthermore, SEC analyses (in H2O, 0.1% TFA) as well as 1H NMR 
spectroscopy (600 MHz, D2O, 60 °C) and elemental analysis investigations of the products 
were performed. The final DS of lPEI was calculated by the nitrogen content obtained from 
elemental analysis (Table S5). 
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Table S5. Overview of analytical data of the dex-g-lPEI samples obtained by EDC coupling. 
Products COOH:EDC:NH2-lPEI 
DSa 
[lPEI 
/AGU]b 
Mw 
[g ? mol-1]b PDI
b C [%] 
H 
[%] 
N 
[%] 
CM0.3-dex-g-lPEI20 1:1.2 0.06 22,900 1.06 40.91 7.35 6.73 
CM0.3-dex-g-lPEI40 1:1.2 0.07 36,500 1.09 38.91 8.07 12.80 
CM0.5-dex-g-lPEI20 1:1.2 0.07 25,000 1.07 40.55 7.11 7.96 
CM0.5-dex-g-lPEI40 1:1.2 0.1 36,000 1.09 37.89 8.51 14.83 
CM1.6-dex-g-lPEI20 3:1 0.11 15,600 1.14 43.29 7.09 8.16 
CM1.6-dex-g-lPEI40 3:1 0.18 17,200 1.18 33.91 8.57 18.38 
a Calculated from the nitrogen content N [%] of the elemental analysis.  
b SEC measurements were performed in H2O containing 0.1% TFA and 0.05 M NaCl (pH 2) using 
pullulan as standard. 
 
 
a) b) 
  
c) d) 
  
 
Figure S6. Representative 1H NMR spectra of dex-g-PEI samples obtained by EDC coupling of CM-
dex and lPEI: (a)  CM0.3-dex-g-lPEI20 (b) CM0.3-dex-g-lPEI40 (c) CM0.5-dex-g-lPEI20 (d) CM0.5-dex-g-
lPEI40. The 1H NMR spectra were measured at 60 °C in D2O. 
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3. Biological studies 
 
DNA preparation 
Luciferase reporter gene encoding plasmid pGL3 (Promega, Madison, WI, USA) was 
transferred to competent E. coli TG1 (kind gift of Hans-Knoell-Institute, Jena) and isolated 
with the plasmid Maxi kit according to manufacturer’s protocol (E.Z.N.A®, OMEGA bio-tek, 
Norcross, GA, USA). Herring testes DNA Type XIV (Sigma Aldrich) was used as model 
DNA. 
 
Preparation of polymer/DNA complexes 
Stock solutions of dextran derivatives and lPEIs were prepared in highly purified water at a 
concentration of 1 mg ? mL-1, and the pH was adjusted to 7.4. The solutions were sterile 
filtered (0.2 μm, VWR international, Darmstadt, Germany). Polymer concentrations after 
filtration were quantified as copper(II) (Cu2+) complexes according to Perrine et al.(Perrine & 
Landis, 1967) by measurement of the absorbance at 645 nm in 96-well plates (Greiner Bio-
One, Frickenhausen, Germany) with a microplate reader (Fluostar OPTIMA, BMG Labtech, 
Offenburg, Germany) using a calibration curve of the corresponding derivatives. The 
complexes were formed according to Fischer et al. (Fischer, Bieber, Li, Elsasser & Kissel, 
1999) and Tseng et al.(Tseng & Jong, 2003) The N/P ratio was calculated by the molar ratio 
of the nitrogen (N) (determined by elemental analyses) of each dex-g-lPEI sample to 
phosphorus (P) in the DNA. Five μg DNA and the appropriate amount of polymer solution 
were each diluted in 125 μL 150 mM NaCl (Roth, Karlsruhe, Germany) pH 7.4 and vortexed 
for 10 minutes. Afterwards, the polymer solution was added to the DNA solution, vortexed 
for 10 seconds and incubated at room temperature for 10 minutes. 
 
Horizontal gel retardation assay 
A 50 μL aliquot (containing 1 μg herring testes DNA type XIV) of the complex dilution was 
????????????????????????????????????M Tris, 50% (v/v) glycerol 85%, 1 mM EDTA, pH 7.4, 
all from Roth). Subsequently, 5 μL dilution was applied on a 1% agarose gel (PeqGold 
Universal agarose, Peqlab Biotechnology GmbH, Erlangen, Germany). Electrophoretic 
separation was carried out in TAE running buffer (40 mM Tris, 1% acetic acid, 
1 mM EDTA, all from Roth) in a horizontal electrophoresis chamber (Biometra, Goettingen, 
Germany) at 80 V for 1 h. For DNA detection, the fluorescence of intercalated ethidium 
bromide (Roth) was determined using a UV transilluminator (Intas GmbH, Goettingen, 
Germany) at 312 nm. Photographs were taken with a gel documentation system (Digit Store 
UNO, Intas GmbH). 
The analysis of the free DNA as control (left lane of each gel), which was detected by 
ethidium bromide intercalation, revealed a broad fluorescent band corresponding to its broad 
molar mass distribution. Free polymers were used as controls (data not shown) to 
exclude unspecific interactions between polymer and dye and exhibited no signal. 
Free 60,000 g · mol-1 dextran was not able to interact with DNA due to the missing charge 
since the bands showed the same signal as the DNA control (data not shown). 
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Figure S7. DNA binding capacity of lPEI20/40 and dex-g-lPEIs at different N/P ratios in comparison to free 
DNA, determined by agarose gel electrophoresis. 
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Complex stability against enzymatic degradation 
Complexes were prepared as described above with 4 μg pGL3 plasmid in a total volume of 
200 μL 150 mM NaCl solution. DNase I (2.5 Kunitz units/μL, Applichem, Darmstadt, 
Germany) diluted in 150 mM NaCl and 20 mM MgCl2 pH 7.4 with an activity of 
1.5 Kunitz units/μg plasmid was added to the complex solution, gently mixed and incubated 
for 45 minutes in a water bath at 37 °C. The enzyme was inactivated in a water bath at 70 °C 
for 30 minutes. Subsequently, plasmid was released from the complexes by incubation with 
10 μL dextran sulfate solution (5,000 g ? mol-1, 10 mg ? mL-1, Sigma) per μg plasmid at 37 °C 
for 20 minutes. Naked plasmid treated with DNase I, untreated plasmid, as well as plasmid 
incubated in the same way like complexes but without enzyme were used as controls. An 
aliquot of 50 μL complex solution (containing 1 μg plasmid) of each sample were mixed with 
5 μL TAE loading buffer and electrophoresed as described above.  
 
Complex size measurement and zeta potential 
Size and zeta potential of complexes with N/P ratios of 25 and 50 with 2 μg plasmid were 
measured with the Zetasizer Nano ZS (Malvern Instruments, Herrenberg, Germany) in 
50 mM NaCl and highly purified water. Photon correlation spectroscopy was carried out in a 
minimal volume cuvette ZEN 0040 (BRAND GmbH, Wertheim, Germany) with a laser beam 
at 633 nm and a scattering angle of 173° at 25 °C. The viscosity (0.89 mPa ? s) and refractive 
index (1.33) of purified water at 25 °C were used for data analysis. Results are shown as the 
mean of Z-average of 6 runs ± standard deviation (SD) and calculated with the “General 
purpose” (normal resolution) algorithm using the Malvern software 6.20. Zeta potential of the 
complexes was performed in a zetasizer cuvette (DTS1060, Malvern Instruments) by 
measuring the electrophoretic mobility at 25 °C. The results were calculated with the Malvern 
software 6.20 and shown as the mean of 6 runs ± SD. All measurements were repeated once. 
 
Cell culture 
L929 mouse fibroblasts (German Collection of Microorganisms and Cell Cultures, DSMZ, 
Braunschweig, Germany) were cultured in Roswell Park Memorial Institute 1640 
(RPMI 1640) culture medium supplemented with 2 mM L-glutamine and 10% fetal bovine 
serum gold (FBS) (all PAA, Pasching, Austria). CHO-K1 (Chinese hamster ovary cells, 
DSMZ) cells were cultured in Ham’s F12 (PAA) supplemented with 1 mM L-alanyl-L-
glutamine and 10% FBS (PAA). Cells were subcultured once a week and incubated at 37 °C, 
5% CO2 and 95% relative humidity. To test the absence of squirrel monkey retrovirus, DNA 
of the cells was isolated (QIAamp® DNA Mini kit, Qiagen, Hilden, Germany) and regularly 
screened by PCR (polymerase chain reaction). Absence of mycoplasma in the cells was 
periodically tested with a standard test kit (Venor® GeM, Minerva Biolabs, Berlin, Germany). 
 
Cytotoxicity of complexes 
In vitro cytotoxicity of complexes was tested by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay as described by Mosman(Mosmann, 1983) and 
Fischer et al..(Fischer, Li, Ahlemeyer, Krieglstein & Kissel, 2003) Briefly, complexes were 
prepared as described above with 3.2 μg herring testes DNA (in 10 mM Tris buffer) and the 
appropriate amount of polymer to receive N/P ratios of 25 and 50. Afterwards, RPMI 1640 
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culture medium was added to each complex solution up to 1,210 μL. L929 mouse fibroblasts 
were selected since they were recommended as target cells for in vitro toxicity testing by 
many standard institutions.(2009) The cells (8500/well) were seeded in 96-well plates 
(Greiner Bio-One, Frickenhausen, Germany) and incubated for 24 h. The culture medium was 
then replaced by 110 μL complex dilution/well. Cells were incubated with the complexes for 
4 h. Afterwards, the test solution was removed and replaced by 200 μL RPMI 1640 medium 
followed by incubation for further 20 h. The following MTT assay procedure was performed 
as described before. Absorbance (A) of the samples was measured in a microplate reader 
(Fluostar OPTIMA) at 570 nm. As blank control culture medium without cells was used. 
Negative control (100% viability) was determined using cells treated only with culture 
medium. The positive control (0% viability) was obtained by treatment of the cells with 
0.02% thiomersal solution (Synopharm, Barsbüttel, Germany). Relative cell viability was 
calculated as follows: 
 
???????? ????????? [%] = ??????? ? ??????????????? ??????? ? ??????  ×  100 
 
Relative cell viability < 70% was regarded as cytotoxic according to DIN ISO 10993-5.(2009) 
All experiments were run with n = 7 and repeated once. 
 
Aggregation of erythrocytes 
To investigate the erythrocyte aggregation of the polymers a modified method of Ogris et 
al.(Ogris, Brunner, Schuller, Kircheis & Wagner, 1999) was applied. Polymers were tested in 
phosphate buffered saline (PBS) [8 mM disodium hydrogen phosphate, 1.5 mM potassium 
dihydrogen phosphate, 137 mM sodium chloride and 2.7 mM potassium chloride (all from 
Roth)] pH 7.4 at concentrations of 0.024 to 50 μg ? mL-1. Sheep blood was collected in 
heparinized tubes and the serum was removed by centrifugation at 2,880 g for 7 minutes 
(Eppendorf Centrifuge 5804R, Eppendorf, Hamburg, Germany). The pellet was washed three 
times with PBS by centrifugation at 2,880 g for 7 minutes and was resuspended in PBS to the 
initial volume. The red blood cell suspensions were used within 24 h after collection. 
Erythrocyte suspension (100 μL) containing 20 × 106 erythrocytes/mL was mixed with 
100 μL test compound in a 96-well plate (Greiner Bio-One). The plates were incubated under 
vigorous shaking at 37 °C for 2 h. Afterwards, erythrocyte aggregation was evaluated by 
microscopic observations (Leica DM IL, Achromat 10/0.20 Phaco 1a objective, 200fold 
magnifications, Wetzlar, Germany) and the results were classified in three stages. In stage 1 
the erythrocytes stay discrete in suspension, no aggregation is detectable. At stage 2 the 
majority of red blood cells stays separate and shows only a moderate aggregation with rouleau 
formation. In stage 3 almost all erythrocytes are aggregated in clusters. As negative control 
for the determination of stage 1, erythrocytes were treated with PBS. As stage 3 (positive 
control), erythrocytes were treated with a 15 μg ? mL-1 solution of 25,000 g ? mol-1 branched 
poly(ethylene imine) (bPEI, a kind gift of BASF corporation, Ludwigshafen, Germany). 
Additionally, the aggregation of erythrocytes was analyzed by quantitative measurement of 
total absorbance at 645 nm with a microplate reader (Fluostar OPTIMA) according to Bauer 
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et al.(Bauer, Lautenschlaeger, Kempe, Tauhardt, Schubert & Fischer, 2012) To quantify the 
???????????? ???????????? ???? ???????????? ??? ????max was established by using the following 
equation according to Florian Schlenk (personal communication): 
 
??????? = ?????????? ??????? ? ??????? ? (??????? ??? ? ??????) 
 
The experiments were run in duplicate and repeated once. The results are shown as the mean 
of two experiments (n = 4) ± SD. 
 
Hemolysis of erythrocytes 
According to Bauer et al.(Bauer, Lautenschlaeger, Kempe, Tauhardt, Schubert & Fischer, 
2012) the hemolytic activity of the dex-g-lPEIs was determined. The erythrocytes were 
isolated as described in the previous section. Polymers were tested in PBS buffer with 
concentrations of 0.125 to 1 mg ? mL-1. They were mixed with the erythrocyte dilution and 
incubated on a shaker (Heidolph Instruments Titrimax 100, Schwabach, Germany) at 450 rpm 
at 37 °C for 1 h. Hemoglobin release was determined by spectrophotometric analysis of 
100 μL supernatant at 544 nm with a microplate reader (Infinite® M200 PRO, Tecan, 
Maennedorf, Switzerland) after centrifugation at 2,250g for 5 min (Eppendorf Centrifuge 
5804R). As positive control 0.05% Triton X-100 solution (Ferak, Berlin, Germany) was used. 
Erythrocytes treated with PBS provided the negative control. Percentage hemolysis was 
calculated according to the following equation:  
 
????????? [%] = (??????? ? ??????) ? (????????? ??????? ? ??????)????????? ??????? ? ??????  ×  100 
 
Hemolytic activity of the polymers was evaluated with the limit values of the ASTM F756-08 
standard.(2008) A hemoglobin release of 0% to 2%, 2% to 5%, or >5% of the total 
hemoglobin release was classified as non-hemolytic, slightly hemolytic, or hemolytic, 
respectively. Experiments were run in duplicate and repeated once. The results are shown as 
the mean of the two experiments ± SD. 
 
Transfection 
CHO-K1 cells (50,000/well) were seeded in 12-well plates (Greiner bio one) and incubated 
for 24 h. Afterwards, culture medium and complex solution (200 μL/well) prepared as 
described above containing 4 μg pGL3 plasmid at N/P ratios 25 and 50 were added to the 
wells. Cells were incubated with complexes for 4 h. As controls were used cells treated 
with 200 μL physiological saline, free plasmid as well as complexes formed with 
2,500 g ? mol-1 lPEI (Polysciences Europe GmbH, Eppelheim, Germany) N/P 25. Culture 
medium was changed, and the cells were incubated for further 44 h. Cells were washed twice 
with PBS buffer. Lysis of cells and luciferase assay were carried out according to 
manufacturer’s protocol (Luciferase assay system, Promega). Protein mass was quantified 
with a standard BCA assay kit (Thermo Scientific, Rockford, USA) according to 
manufacturer’s protocol with minor modifications: cell lysate (25 μL) was incubated with 
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10 μL 0.05 M iodacetamide solution (Applichem) to inactivate dithiothreitol (DTT) of the 
lysis reagent at 37 ????????????????????????????????????????????????????????????????????????
protein and presented as the mean of a duplicate testing ± SD. The experiment was repeated 
twice. 
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ABSTRACT. To date, cationic polymers with high transfection efficiencies often have a high 
cytotoxicity. By screening an 18-membered library of cationic polymers based on 2-methyl-2-
oxazoline and 2-(9-decenyl)-2-oxazoline or 2-(3-butenyl)-2-oxazoline, respectively, a polymer 
could be identified that is superior to linear poly(ethylene imine), since it has a similar 
transfection efficiency but no detectable cytotoxicity at the investigated concentrations. The 
library was investigated regarding the influence of different polymer parameters, namely the 
polymer side chain hydrophobicity and the type and content of amino groups, on the pDNA 
condensation, the transfection efficiency, the cytotoxicity, and cellular membrane interaction as 
well as the size, charge and stability of the polyplexes. First structure-property relationships 
revealing that for the presented polymer class, primary amines and an amine content of at least 
40% were required for an efficient polyplex formation. While short hydrophobic polymer side 
chains were non-toxic up to an amine content of 40%, long hydrophobic side chains revealed a 
high cytotoxicity.  
Introduction 
Nanomaterials and their applications are of great interest for scientists of different disciplines 
such as biology, pharmacy, chemistry, biotechnology, physics, and medicine.[1] Within the field 
of nanomedicine, non-viral gene delivery has a high potential for the treatment of a large variety 
of diseases.[2, 3] Although many problems have been solved during the last three decades, the 
ideal delivery agent, i.e. vector, still has to be found.[4] To design successful non-viral vectors for 
genetic materials, several bottlenecks have to be overcome.[5, 6] 
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Non-viral vectors, in particular synthetic polymers, offer the advantage of being tailor-made 
systems, which can be produced in large scale and stored without further complications. Due to 
their good interaction with negatively charged genetic material such as plasmid DNA (pDNA) or 
small interfering RNA (siRNA), cationic polymers play an important role within the field of gene 
delivery.[1, 7-12] Prominent examples of this polymer class are poly(ethylene imine) (PEI),[13-16] 
poly(L-lysine) (PLL),[17] and poly(methacrylate)s (e.g. PDMAEMA)[18-20] in which PEI represent 
the “gold standard” for in vitro transfections. Previous studies on structure-property relationships 
revealed the influence of molar mass, pKa value, polymer end groups, side chain substitution and 
polyplex size on the transfection efficiency (TE).[21-23] However, comprehensive structure-
property relationships are rare[24] and the results of the different studies often cannot be 
transferred to other polymer classes leading to the necessity to perform detailed analyses for 
every material. 
The main requirement for transfection agents is an efficient delivery, combined with a low 
cytotoxicity. However, most cationic polymers are either efficient in delivering the genetic 
material but cytotoxic or they are non-toxic and fail in their delivery potential.[25, 26] An often 
used method to overcome this drawback is the functionalization with non-toxic and 
biocompatible compounds such as carbohydrates or non-ionic polymers, e.g. poly(ethylene 
glycol) (PEG) and poly(2-oxazoline)s (POx).[27-35] Due to the so called “stealth effect”, the 
polymers reduce the nonspecific interactions with blood components, e.g. by shielding of positive 
charges. Moreover, a prolonged blood circulation time leading to an enhanced permeability and 
retention (EPR) effect as well as a reduced cytotoxicity can be observed and the water solubility 
is increased.[31] POx, in particular poly(2-ethyl-2-oxazoline) (PEtOx) and poly(2-methyl-2-
oxazoline) (PMeOx), have been intensively investigated as PEG alternative.[36-46] Compared to 
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PEG, the synthesis of POx by a living cationic ring-opening polymerization (CROP) is rather 
undemanding, but also leads to well-defined polymers.[47-50] The preparation of cationic PEtOx 
copolymers with primary amine units,[51] and their usage in DNA binding hydrogels has been 
reported earlier.[52] However, the 2-(4-aminobutyl)-2-oxazoline/EtOx copolymers showed no 
transfection efficiencies (TE) (unpublished data). In addition, it was reported that partially 
hydrolyzed POxs, i.e. P(Ox-stat-EI), show less cytotoxicity but also less TE with increasing POx 
concentrations.[32, 34] Further studies described a correlation between the polyplex stability and 
the amount of positive charges. Often, a decrease of the positive charge goes along with a 
reduction of the polyplex stability and, hence, leads to an inefficient cellular uptake and 
endosomal release. Moreover, the functionalization with PEG or hydrophilic POx (e.g. PMeOx, 
PEtOx) can result in an inefficient delivery, due to a reduced interaction with the genetic material 
and the cellular membranes caused by the cell- and protein-repellent character of the polymers, 
the so called PEG dilemma.[53-58] To solve this problem, additional polymer features have to be 
considered. Besides modifying polycations with “stealth” polymers,[31, 37] the introduction of 
more neutral or hydrophobic characteristics have been discussed for gene delivery 
applications.[59, 60] It is known from the development of antimicrobial POx that the introduction of 
long alkyl spacers leads to an enhanced membrane interaction.[61] Hence, it is assumed that the 
cellular uptake of modified cationic polymers, which is often reduced to the “stealth effect”, can 
be improved by introducing hydrophobic moieties. 
In this study, the influence of hydrophobicity, type of amine, and amine content of 2-oxazoline 
based polymers on the transfection behavior was systematically investigated. In detail, 
copolymers of alkene containing 2-oxazolines, namely 2-(9-decenyl)-2-oxazoline (DecEnOx) or 
2-(3-butenyl)-2-oxazoline (ButEnOx), and 2-methyl-2-oxazoline (MeOx) were synthesized and 
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further functionalized by thiol-ene photoaddition.[62-66] MeOx was chosen as comonomer to 
improve the water-solubility which is limited for P(EtOx-co-ButEnOx) and P(EtOx-co-
DecEnOx) due to the LCST behavior of PEtOx.[67] These copolymers were further systematically 
investigated with regard to: 1) their ability to interact with pDNA and the cellular membrane, 2) 
their cellular uptake, 3) cytotoxicity, and 4) the transfection efficiency.  
 
Experimental Part 
See supporting information. 
 
Results and discussion 
Synthesis of a cationic poly(2-oxazoline) library 
To investigate the influence of the type of amine (primary or tertiary), the amine content, and 
the side chain hydrophobicity, a library of 18 new cationic POx copolymers has been synthesized 
(Scheme 1). Starting from MeOx and ButEnOx as well as DecEnOx, a series of copolymers 
containing up to 50 mol% of the double bond bearing comonomer has been prepared. In a 
straightforward approach these double bonds have been functionalized with different amines 
(primary or tertiary) using the thiol-ene photoaddition procedure. For clarity, the final products 
have been labeled according to the following pattern: s, for all copolymers based on a “short” 
side chain of ButEnOx; l, for all polymers based on a “long” side chain of DecEnOx; the amine 
content is given as number in mol%; p or t, characterize the type of amine, namely primary (p) or 
tertiary amine (t) (Scheme 1). If not stated otherwise, there is a C2H4 spacer between the sulfur 
and the final amine group. In case of a hexamethylene spacer the term h is added to the 
compound abbreviation. 
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Scheme 1. Schematic representation of the synthesis of cationic poly(2-oxazoline)s. Reaction 
conditions: a) 140 °C, microwave reactor, acetonitrile, b) room temperature, overnight, methanol, 
catalyst: 0.1 mol% 2,2-dimethoxy-2-phenylacetophenone with respect to contained double bonds, 
c) room temperature, overnight, dichloromethane/trifluroacetic acid. Product terms: s = short 
butyl side chain, l = long decenyl side chain, N = amine content in mol%, h = hexamethylene 
spacer, p = primary amine, t = tertiary amine. 
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Synthesis of P(MeOx-co-ButEnOx) and P(MeOx-co-DecEnOx) 
In order to synthesize well-defined P(MeOx-co-ButEnOx), a kinetic study was performed for 
this copolymer system. The linearity of the first-order kinetic plots shows the living character of 
the copolymerization (Figure S1). Having a higher polymerization rate, MeOx (kp = 0.097 L mol-
1 s-1) is incorporated faster into the polymer chain than ButEnOx (kp = 0.052 L mol-1 s-1) 
indicative for the formation of a gradient copolymer. Characterization by size exclusion 
chromatography (SEC) showed an increasing molar mass with increasing conversion (Table S1). 
Similar results were obtained for P(MeOx-co-DecEnOx), as reported elsewhere.[68] 
To achieve a sufficient binding with the genetic material and a low cytotoxicity, an overall 
degree of polymerization (DP) of 200 was chosen. The ButEnOx/DecEnOx content was varied 
between 10, 20, 30, and 40 mol%. Full conversion of the monomers was proven by 1H NMR 
investigations. Copolymers with dispersity (ÐM) values between 1.43 and 1.63 (Table S2) were 
obtained. The rather high ÐM values for a living cationic polymerization can be attributed to two 
aspects: 1) The different hydrodynamic volumes and column interactions of the polymers 
compared to the used poly(styrene) standard and 2) the occurrence of chain-transfer,[69, 70] 
commonly observed for PMeOx systems with DP values higher than 100.[50] Due to the 
monomodality of the obtained SEC curves (exemplarily shown for the P(MeOx-co-ButEnOx) 
copolymer in Figure S2), it is assumed that no chain coupling or “long chain branching”[70] 
reactions occurred, since those would lead to a shoulder at lower elution volumes, i.e. higher 
molar masses. Instead tailing of the SEC curves is observed, indicating the existence of low 
molar mass polymer chains, originating from chain-transfer and termination reactions. The extent 
of chain transfer reactions might have been reduced using EtOx as comonomer (more controlled 
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reaction up to a DP of 200). However, to avoid low critical solution temperature (LCST) behavior 
known of PEtOx containing copolymers, MeOx was chosen as comonomer.[62, 67, 71] 
The 1H NMR spectra showed that both monomers are incorporated (Figure 1, Figure S3). In 
each case, two signals for the double bonds are visible around 5.86 and 5.00 ppm. The polymer 
backbone signal is found around 3.52 ppm. The signals of the side chain protons occur between 
1.00 and 2.60 ppm. By correlating the proton signal of the double bond at 5.86 ppm with the 
backbone signal, the monomer ratios within the polymer could be calculated. They were found to 
be in agreement with the ratios aimed for.  
In general two different end groups are possible, namely a hydroxyl or an ester end group.[72] 
Unfortunately, the end group analysis, e.g. by ESI- or MALDI-TOF-MS, is not possible due to 
the high DP. However, at this high molar mass the influence of the end group should be only 
marginal or even negligible. 
 
Thiol-ene functionalization of P(MeOx-co-ButEnOx) and P(MeOx-co-DecEnOx) with 
different amines 
To obtain a cationic character, required for DNA-binding, primary and tertiary amino groups 
were introduced into the copolymers by thiol-ene photoaddition reaction (Scheme 1). The 
primary amines were obtained by reaction of the copolymers with 2-(boc-amino)ethanethiol 
?????? ??? ???????????? ??? ?? ???? ???? and subsequent deprotection with trifluoroacetic acid. 
Characterization by 1H NMR spectrometry showed that for both copolymer types (3 and 4) the 
double bond signals of the starting materials at 5.86 and 5.00 ppm disappeared after the 
photoaddition, indicating the complete functionalization with the thiol (Figure 1, Figure S3). 
Moreover, a singlet of the boc protecting group at 1.44 ppm was obtained. For both 3 and 4, the 
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signals of the CH2 next to the boc protected nitrogen can be found around 3.21 ppm. The protons 
signals at 2.60 ppm can be assigned to the CH2 groups adjacent to the sulfur atom. After 
treatment with TFA and precipitation into ice-cold diethyl ether, the singlet of the boc protecting 
group disappeared, indicating the successful deprotection. SEC characterization of the 
MeOx/ButEnOx systems revealed a growing molar mass (lower elution volume) after the 
photoaddition of 2-(boc-amino)ethanethiol (Figure 2, Table S2). After deprotection, the molar 
mass decreases further. For the MeOx/DecEnOx systems, SEC measurements were performed for 
the starting materials 2and the final products lNp. A growing molar mass of the end products lNp 
compared to the starting materials 2 was observed. This is in accordance with the 
MeOx/ButEnOx systems. In all cases the ÐM  values changed only slightly. 
 
Figure 1. 1H NMR spectra of 1d (bottom), 3d (middle), s40p (top) (250 MHz, solvent: CD3OD). 
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In addition, copolymers with a tertiary amino group were prepared form 1 and 2 by UV-
initiated thiol-ene reaction with dimethylaminoethanethiol hydrochloride. The 1H NMR spectra 
of sNt and lNt showed a broad peak around 2.92 ppm belonging to the two CH3 groups of the 
amino thiol (Figure S3). The double bond signals of the starting materials disappeared, indicating 
a complete conversion. Although in theory the molar mass should increase after thiol-addition, 
analysis by SEC revealed lower molar masses of the cationic sNt polymers compared to the 
neutral starting material (Table S2). Depending on the particular compound the lNt polymers 
showed both increasing and decreasing molar masses. This is ascribed to the different 
hydrodynamic volumes of the cationic polymers in DMAc, but also to the different column 
interactions compared to the neutral PS standards used for calibration. It also explains the large 
variation in the molar masses and ÐM values, e.g. of s40p (Mn = 29,100 g/mol, ÐM = 1.52) and 
s40t (Mn = 20,180, ÐM = 1.35), which are both synthesized from the same starting material and 
only differ by the type of amine. 
 
Figure 2. SEC curves of the copolymers 1d (straight), 3d (dashed), and s40p (dotted) (eluent: 
DMAc + 0.21% LiCl; calibration: PS). 
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Binding of genetic material  
An essential requirement for non-viral vectors is their interaction with negatively charged 
nucleic acids, resulting in the formation of interelectrolyte complexes, also known as polyplexes. 
The resulting plasmid DNA (pDNA) condensation caused by the interaction with the polymers 
was analyzed using the ethidium bromide quenching assay (EBA). Due to electrostatic and 
hydrophobic interactions between polymer and pDNA, ethidium bromide (EB) is excluded from 
a preformed pDNA/EB complex and the decrease in the EB fluorescence intensity can be 
detected. All 16 polymers (sNp, sNt, lNp, lNt) led to a decrease in the fluorescence intensity of 
EB and, thus, showed interaction with the pDNA (Figure S6). As positive control, linear PEI 
(lPEI) with a DP of 200 was used, decreasing the fluorescence intensity to 44.9 ± 3.1% (Figure 
S7). Higher relative fluorescence intensities of 65 to 80% were observed for the sNp polymers 
without significant differences concerning their amine content.  
 
A) B) 
 
 
Figure 3. Ethidium bromide quenching assay of all 16 polymers with pDNA measured at 
physiological pH via EBA. A) Comparison at N/P ratio 40. B) Comparison of 40 mol% amine 
content (N/P 40) polymers. Values represent the mean ± S.D (n=3); # represents a significant 
difference (p < 0.05) to l40p. 
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For the investigated copolymers three tendencies can be observed: 1) In the case of the 
polymers with long side chains, primary amines bind better than tertiary, 2) the amine content 
correlates with the pDNA condensation, and 3) the pDNA condensation increases with the side 
chain length (Figure 3A and B). The latter can be probably ascribed to stronger hydrophobic 
interaction with the pDNA, caused by the higher number of CH2 groups in the side chains.49 
However, based on the obtained data it is evident that the influence of the type of alky side chain 
(long vs. short) is more pronounced. In detail, up to 30% difference in the relative fluorescence 
intensity of s40p and l40p compared to 10% of l40p and l40t were found (Figure 3 B). This 
observation emphasizes the importance of understanding the physicochemical interactions 
between the polymer and the genetic material, and not only the influence of electrostatic 
interactions for the polyplex formation mainly discussed in literature.[73, 74]  
Transfection efficiency 
Since an interaction with the pDNA could be observed, the polymer library was analyzed 
regarding the transfection efficiency. To this end, human embryonic kidney cells (HEK) and 
pDNA, encoding the reporter gene EGFP, were used. As transfection outcome, the percentage of 
cells successfully expressing EGFP was identified using flow cytometry. Interestingly, one 
polymer, the s40p, showed a TE (30.5 ± 7.6%) comparable to that of lPEI (31.2 ± 1.7%) (Figure 
4, S18 and Table S3, S6), whereas all other polymers showed lower TEs (below 10%). The 
comparable TE of s40p and lPEI is surprising, since the same DP was used and, hence, s40p 
exhibits a much lower amine content (only 80 of 200 repeating units bear an amino group).  
The observed differences in TE of 2-oxazoline-based polymers lead to the assumption that 
primary amino groups in the side chain in combination with small spacers to the backbone are 
beneficial. These results were not expected and highlight the influence of the polymer 
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constitution for the biological properties. Only slight changes in the amine type, the amine 
content, or the side chain length can have a great impact on the TE. To gain a deeper insight into 
the structure-property relationship and find an answer to the question, why the other comparable 
polymers are less efficient, further investigations were performed. Subsequently, the polymers 
were studied concerning their polyplex properties, their cytotoxicity, and their membrane 
interaction. 
 
 
Figure 4. Transfection efficiency of all polymers with short side chains (sNp and sNt) and 
lPEI200 for adherent HEK cells in serum reduced media at different N/P ratios. Values represent 
the mean (n=3), SD can be found in the Supporting Information.
 
Size and charge of polyplexes 
For a fast and efficient internalization by endocytosis, polyplexe sizes between 100 and 200 nm 
and positive surface charge are beneficial.[6, 75] It was found that all polymers, except s10p, form 
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polyplexes with diameters below 200 nm (Table 1). Moreover, with increasing amine content a 
tendency to form smaller polyplexes was observed. The polyplexes prepared from the four 10 
mol% amine containing polymers exhibited a negative zeta potential, indicating an insufficient 
polyplex formation and, thus, explaining the insufficient TE (Figure 4). All other polymers 
formed polyplexes with a positive zeta potential (Table 1). 
 
Table 1: Polyplex properties and hemolysis assay: Polyplexes of indicated polymers and pDNA 
were formed at N/P ratio 20 in HBG buffer at pH 7.4 (PDIP see Figure S8). Hemolysis assay of 
the whole polymer library using blood of three different donors (n=3). 1% Triton X-100 was used 
as positive control and values were set to 100% hemolysis. Values represent the mean (n=3) (SD 
can be found in the Supporting Information). 
      Polyplex properties     Hemolysis / % 
    
zeta potential          diameter / nm 
       / mV 
 
concentration 
      10 μg/mL 50 μg/mL 100 μg/mL 
Sh
or
t h
yd
ro
ph
ob
ic
 si
de
 c
ha
in
 
pr
im
ar
y 
am
in
es
 s10p -4.3 ± 2.1 255 ± 57 0.09 0.05 0.2 
s20p 22 ± 2.7 178 ± 2.6 0.4 1.5 2.6 
s30p 40 ± 1.6 110 ± 11 0.09 0.2 0.2 
s40p 23 ± 2.7 94 ± 3.4 0.6 1.6 2.9 
te
ria
ry
 a
m
in
es
 
s10t -5.5 ± 2.5 151 ± 14.7 0.5 0.6 0.7 
s20t 19 ± 1.7 158 ± 0.4 0.8 0.6 0.5 
s30t 29 ± 4.7 124 ± 3.5 0.6 0.6 0.7 
s40t 29 ± 1.7 105 ± 1.2 0.8 0.7 0.8 
Lo
ng
 h
yd
ro
ph
ob
ic
 si
de
 c
ha
in
 
pr
im
ar
y 
am
in
es
 l10p -17 ± 1.1 152 ± 3.1 0.9 18 17 
l20p 28 ± 1.8 105 ± 3.2 83 107 107 
l30p 29 ± 1.3 84 ± 0.5 105 124 102 
l40p 34 ± 1 97 ± 3 106 104 108 
te
ria
ry
 a
m
in
es
 
l10t -9 ± 1.2 152 ± 3.5 0.7 0.6 0.7 
l20t 26 ± 0.7 113 ± 3.6 10 50 86 
l30t 30 ± 2.7 84 ± 0.5 62 101 95 
l40t 27 ± 3 67 ± 1.8 102 100 100 
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Furthermore, neither the hydrophobicity of the side chain nor the amine type showed an 
influence on the size and zeta potential of the investigated polyplexes. In conclusion, a critical 
amine content of 20 mol% is necessary for an efficient polyplex formation, indicated by a 
positive zeta potential. 
Cytotoxicity of polymers and interaction with cellular membranes  
In a next step, the biocompatibility of the polymers was investigated. To study the interactions 
between polymers and cellular membranes a hemolysis assay was performed. It was found that 
the polymers with short side chains (sNp and sNt) exhibit a hemolysis below 3%, indicative of no 
hemolytic activity (Table 1). In contrast, the polymers with long side chains (lNp and lNt) 
showed high hemolytic activity even at low concentrations (Table 1). This finding can be 
ascribed to strong membrane interaction of the more hydrophobic side chain leading to 
membrane destruction, as also reported elsewhere.[61] Moreover, the lNp polymers are more 
hemolytic compared to lNt, which also indicates an enhanced interaction of primary amines with 
the negative cellular membrane or their proteins. Due to their low amine chain content and 
insufficient polyplex formation, l10p and l10t did not cause any hemolytic effect (1.8%) (Table 
1). The results show that the interaction between the polymers and membranes is much more 
influenced by the hydrophobic nature of the polymers than by the amine type and content. This is 
in accordance with the results of the pDNA condensation (EBA) study (Figure 3). 
Besides the hemolytic activity, the cytotoxicity was investigated. It is a well-known problem 
that cationic polymers, such as high molar mass PEI or PDMAEMA, lead to low cell 
viabilities.[19, 76] Both, PMeOx and PEtOx were postulated to decrease the cytotoxicity. Hence, 
the cytotoxicity of the 16 PMeOx containing copolymers was analyzed using the AlamarBlue 
assay (Figure 5). This assay is based on a non-fluorescent indicator dye (resazurin) that is 
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converted into a fluorescent dye by metabolically active cells. While the sNp and sNt polymers 
caused no cytotoxicity at concentrations up to 200 μg mL-1 (Figure 5 A), lPEI showed an IC50 
(concentration where 50% of cells are viable) at 3.6 μg mL-1 (data not shown). In this context, it 
has to be noted that s40p shows the same TE as lPEI but without any cytotoxic effects. In 
contrast, higher cytotoxicities were observed for polymers with long side chains (lNp and lNt), 
showing furthermore a dependency on the amine content, amine type, and the used concentration 
(Figure 5 B). IC50 values of 4 to 14 μg mL-1 were obtained, meaning they have a cytotoxicity 
comparable to lPEI. In contrast to the lNp polymers, where l40p showed a lower cytotoxicity 
than l30p, an increasing cytotoxicity with increasing amine content was observed for the lNt 
polymers. The decreased toxicity of l40p might be caused by (electrostatic) interactions with 
serum components and will be investigated in further studies. In summary, the alkyl content and 
the hydrophobicity of the side chains showed again a high impact on the interaction of the 
polymers with cellular membranes. 
To further investigate the reason for the different cytotoxicity of the polymers, in particular s40p 
and s40t or l40p, a lactate dehydrogenase (LDH) assay was performed with all four 40 mol% 
amine containing polymers (Figure 6). Due to the possibility to determine the released cellular 
LDH in a sensitive way, the LDH assay is used to detect membrane destruction.[77] 
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A) 
 
B) 
 
 
Figure 5. Cytotoxicity of indicated polymers (A, short side chains; B, long side chains) using 
AlamarBlue and L929 cells. A, Cells treated with sNp polymers and sNt polymers. B, Cells 
treated with lNp polymers and with lNp polymers. Arrow represents the increased cytotoxicity of 
lNp polymers. Values represent the mean (n=3), SD can be found in the Supporting Information. 
  
18
In contrast to the hemolysis assay, the LDH assay can be performed with HEK cells which are 
also used for transfection studies. Consequently, the membrane destruction ability of both, the 
polymers and the polyplexes, can be analyzed. It was observed that the polymers s40p and s40t 
as well as their polyplexes showed no membrane destruction, at an N/P ratio of 20. In case of 
l40p the polyplex is less toxic than the corresponding polymer, which was also observed for PEI. 
This was already reported in literature and was ascribed to the shielding of the cationic charges of 
PEI by interactions with the genetic material.[78] It is assumed that this is also valid for l40p, since 
this polymer strongly interacts with the pDNA (Figure 3). Interestingly, the polyplexes of l40t 
showed a slightly higher membrane destruction activity compared to the non-complexed 
polymers. A possible explanation can be an enhanced internalization of polyplexes compared to 
the polymers resulting in high intracellular cytotoxicity. 
 
 
 
Figure 6. LDH assay of HEK cell. Cells were incubated with polyplexes of indicated polymers 
for 1 h at N/P 20. Values represent the mean (n=3), SD can be found in the Supporting 
Information; # represents a significant difference (p < 0.05) compared to l40t.  
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A possible reason for the higher cytotoxicity of l40t compared to l40p is the more hydrophobic 
character of the tertiary amine compared to the primary counterpart. In addition, the sterically 
demanding methyl groups of the tertiary amine possibly reduce the pDNA binding (Figure 3) and 
shield the cationic charges, as observed for l40t Thus, the LDH assay confirms the assumption 
that an increased side chain hydrophobicity enhances the interaction with the membrane. In the 
case of s40p an optimum between the amount of “stealth” (MeOx) units for high 
biocompatibility, the amount and type of cationic groups for pDNA interaction, and the ideal 
length of the hydrophobic segment for membrane interactions was found, making s40p the best 
performing polymer. 
Uptake of polyplexes 
Hitherto, the performed experiments could not explain the differences between the good 
performer s40p and the bad performer s40t regarding its transfection mechanism. Therefore, the 
uptake behavior was investigated using YOYO-1 labeled pDNA. The uptake of the fluorescent 
polyplexes was determined by flow cytometry.[79] To focus on the influence of amine type and 
hydrophobicity, only the 40 mol% polymers were studied (Figure 7). Polyplexes based on l40p 
showed a time dependent uptake, similar to that of lPEI. Compared to this, the s40p based 
polyplexes, which showed the highest TE, were taken up much faster and more efficiently. 70% 
of the HEK cells internalized s40p polyplexes already after one hour of incubation (LPEI: 34%). 
In contrast to the s40p polyplexes, its corresponding polymer with tertiary amines (s40t) showed 
the lowest polyplex internalization. Only 60% of the cells internalized polyplexes, even after 4 h. 
For l40t polyplexes, no analysis was possible since the cytotoxicity was too high to obtain any 
reliable data, as also observed by the AlamarBlue and the LDH assay (Figure 5 and Figure 6). 
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The reduced uptake of polymers with tertiary amine side chains (s40t) and/or their high 
cytotoxicity (l40t) can explain their insufficient TE, compared to s40p. The bad TE of polymers 
with tertiary amines coupled to long hydrophobic side chains is in contrast to the poly(amine-co-
ester) terpolymers systems reported by Zhou et al., where polymers with long hydrophobic 
domains and tertiary amines in the main chain revealed an excellent transfection behavior and 
low cytotoxicity.[80] This once more highlights the importance of the polymer hydrophobicity for 
gene delivery applications. However, it also shows that results from different studies cannot 
easily be transferred to other polymer classes. Therefore, it is necessary to perform detailed 
analyses for each compound. 
 
 
Figure 7. Uptake study: Amount of cells transfected with YOYO-1 labeled pDNA for indicated 
time points using the polymers with 40 mol % amine content and pDNA and lPEI200 (NP ratio 
20) as controls. Values represent the mean (n=3), SD can be found in the Supporting Information. 
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Polyplex stability 
To understand, why some polymers perform better than others, different bottlenecks were 
analyzed, starting from the polyplex itself to the cellular mechanisms. Another critical parameter 
is the polyplex stability. On one hand the pDNA has to be protected against digestion, on the 
other hand it has to be released inside cells. Hence, an optimum between strong and weak binding 
has to be found. The polyplex stability was analyzed using the heparin assay, in which negatively 
charged heparin competes with the pDNA. In Figure 8 the heparin concentration necessary for 
complete polyplex dissociation is presented (Data of all compound see Figure S9). Compared to 
the polyplexes formed from polymers with short side chains (sNp and sNt), the ones of long side 
chain (lNp and lNt) are more stable, as indicated by higher heparin concentrations required to 
release the pDNA. This is particularly the case for l40p, where 50 U mL-1 heparin are required 
for the polyplex dissociation, which is in good correlation with the strong pDNA condensation 
(Figure 3). In contrast, the s40p polyplexes release the pDNA already at heparin concentration of 
10 U mL-1. This indicates a stronger binding of l40p and could result in an inefficient release of 
pDNA in the cytoplasm and, hence, a low TE (Figure 4 and Figure 7). For the sNt and lNt 
polyplexes only a small amount of heparin leads to dissociation. This is another indication that 
tertiary amines interact less strongly with genetic material and, hence, are not able to protect the 
pDNA at physiological pH 7 (Figure 3). As a consequence, the pDNA could be degraded due to 
the polyplex instability during the incubation in the transfection media or inside the cell (pH 7). 
The latter could also explain their inefficient uptake and the low amount of internalized pDNA.  
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Figure 8. Polyplex stability: Dissociation assay of polyplexes formed at N/P 20. The bars 
represent the heparin concentration at which the polyplexes are dissociated. 
 
Influence of the thioether position and higher amine content 
The type of polymer side chain showed a high impact on the cytotoxicity and the TE. To test 
whether the location of the sulfur within the side chain has an influence on the properties another 
polymer (s40hp, Scheme 1), having a hexamethylene spacer between the sulfur and the amine, 
was prepared by thiol-ene photoaddition. The polymer exhibits the same total number of CH2 
groups in the side chain but a different position of the thioether group. Analysis of the TE (data 
not shown) and the cytotoxicity (Figure 9 A) yielded similar results as for the analogous l40p 
polymer. In detail, no TE and high cytotoxicity was observed. This proves that the cytotoxicity 
and TE is influenced by the side chain length and not by the location of the thioether group in the 
side chain. 
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Figure 9. (A) Cytotoxicity of indicated polymers (s50p and s40hp) using AlamarBlue and L929 
cells (n=3) and (B) transfection efficiency of indicated polymers for adherent HEK cells in serum 
reduced media at different N/P ratios.  
Another question that arises is, if a higher amine content will lead to a further increased TE. 
Thus, a polymer with a short side chain and 50 mol% of primary amines was synthesized (s50p) 
according to the procedure described for the other sNp polymers (Scheme 1). Again, the TE and 
the cytotoxicity were investigated. For this polymer (s50p), the TE was slightly lower but showed 
no significant differences to the s40p polymer (Figure 9 B). However, it was cytotoxic at higher 
concentration (Figure 9 A), whereas for s40p no cytotoxicity was observed up to N/P ratio 700 
(Figure 5 A). Since a higher amine content showed no advantage for the transfection process and 
an increased cytotoxity, the s50p was not investigated further. Obviously, the polymer s40p 
represents an optimal combination of cationic charges, hydrophobicity and biocompatible 
monomers for enhanced cellular interaction and transfection efficiency as well as reduced 
cytotoxicity. 
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Conclusion 
Understanding the interplay between different parameters represents an important prerequisite 
for the development of non-toxic cationic polymers used as non-viral vectors in gene delivery 
applications. Here, we presented the synthesis and biological screening of an 18-membered 2-
oxazoline-based copolymer library. Different parameters, such as the polymer side chain 
hydrophobicity, the type and content of amine groups were systematically varied. 2-Methyl-2-
oxazoline as biocompatible “stealth” comonomer and 2-(9-decenyl)-2-oxazoline or 2-(3-butenyl)-
2-oxazoline, respectively, have been copolymerized with varying ratios. Subsequent 
functionalization of the double bonds by thiol-ene photoaddition yielded cationic polymers with 
primary and tertiary amine groups. The influence of the different parameters on the pDNA 
condensation, the transfection efficiency, the cytotoxicity and cellular membrane interaction as 
well as the size, charge and stability of the polyplexes was investigated (Table 1).  
It was found that independent of the amine content, long hydrophobic side chains enhance the 
pDNA condensation to the genetic material but interrupt the cellular membranes, leading to a 
higher cytotoxicity, hemolysis, and LDH release. Poly(2-oxazoline)s with short side chains and 
an amine content below 50 mol% were found to be biocompatible at all studied concentrations.  
In addition, it was observed that primary amines are more suitable for an efficient binding and 
protection of pDNA. Here, an amine content of at least 40 mol% is necessary, since lower amine 
mol% revealed a decreased pDNA condensation. In case of tertiary amines the binding with 
pDNA was too weak for all investigated polymers. Hence, the pDNA was released into the 
transfection media or inside the endosomes, which resulted in a reduced TE. 
In the end, we could identify one polymer, namely s40p, which showed superior properties 
over lPEI. High transfection efficiencies similar to that of lPEI and a faster internalization were 
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found. Most importantly, no cytotoxicity was observed in the tested concentration range. The 
presented study demonstrates the high potential of cationic poly(2-oxazoline)s for gene delivery 
and shows that it is possible to design cationic polymers having a high transfection efficiency 
while being non-toxic. Further investigations will be executed, in particular on the best 
performing polymer, to gain a deeper insight into the transfection mechanism. 
 
Table 2. Overview of all polymers regarding their characteristics and bottlenecks for the 
transfection process. Probable reasons for transfection failure or drawbacks are described as 
comments. Toxicity (AlamarBlue), hemolysis and LDH were classified with 0 for no effect, 0.5 
for middle occurrence, and 1 for high occurrence.  
 
 
Supporting Information. Includes synthetic details, mass spectrometric and NMR 
characterization data of polymers, experimental descriptions, mean value and standard deviations 
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of the presented values. Supporting Information is available from the Wiley Online Library or 
from the author. 
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Results Section 
 
 
 
Figure S1. First-order kinetic plots of the copolymerization of MeOx and ButEnOx in 
acetonitrile at 140 °C for A) MeOx : ButEnOx = 90 : 10(kpMeOx = 0.095 L mol-1 s-1; kpButEnOx 
= 0.052 L mol-1 s-1) and for B) MeOx : ButEnOx = 180 : 20 (kpMeOx = 0.097 L mol-1 s-1; 
kpButEnOx = 0.052 L mol-1 s-1). The conversion was determined by gas chromatography. 
 
Table S1. Kinetic and SEC Data for the copolymerization of MeOx and ButEnOx. 
MeOx90-co-ButEnOx10 MeOx180-co-ButEnOx20 
Time MeOx : 
ButEnOx 
Mn ÐMb) Time MeOx : 
ButEnOx 
Mn ÐMb) 
[s] [%]a) [g mol-1]b)  [s] [%]a) [g mol-1]b)  
60 13 : 5 2,200 1.10 1 1 : 0 - - 
300 48 : 24 5,780 1.11 300 27 : 14 6,510 1.20 
600 72 : 46 7,400 1.13 600 44 : 24 8,690 1.28 
900 82 : 59 8,310 1.14 1200 67 : 43 11,560 1.34 
1500 95 : 80 9,190 1.15 2400 90 : 70 14,690 1.39 
1800 96 : 82 9,470 1.16 3600 96 : 84 15,650 1.43 
2400 99 : 92 9,550 1.16 4200 98 : 89 16,470 1.43 
    4800 99 : 91 16,140 1.40 
a)Conversion determined by gas chromatography. b)Determined by SEC. 
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Table S2. SEC Data of the different copolymers. 
MeOx-co-ButEnOx  MeOx-co-DecEnOx 
Sample 
MeOx : 
ButEnOx 
Mn 
(g/mol) 
ÐM  Sample 
MeOx : 
DecEnOx 
Mn 
(g/mol) 
ÐM 
1a 180 : 20 22,800 1.43  2a 180 : 20 19,800 1.47 
1b 160 : 40 23,300 1.46  2b 160 : 40 25,500 1.47 
1c 140 : 60 23,300 1.49  2c 140 : 60 19,800 1.45 
1d 120 : 80 22,200 1.56  2d 120 : 80 22,900 1.63 
1e 100 : 100 20,300 1.48      
3a 180 : 20 26,000 1.43  4a 180 : 20 - - 
3b 160 : 40 29,000 1.46  4b 160 : 40 - - 
3c 140 : 60 29,500 1.47  4c 140 : 60 - - 
3d 120 : 80 32,000 1.50  4d 120 : 80 - - 
3e 100 : 100 27,700 1.47      
s10p 180 : 20 24,100 1.44  l10p 180 : 20 23,600 1.51 
s20p 160 : 40 23,200 1.40  l20p 160 : 40 31,600 1.43 
s30p 140 : 60 27,400 1.40  l30p 140 : 60 30,500 1.54 
s40p 120 : 80 29,100 1.52  l40p 120 : 80 38,100 1.62 
s50p 100 : 100 28,500 1.26      
s10t 180 : 20 20,440 1.43  l10t 180 : 20 20,300 1.49 
s20t 160 : 40 19,560 1.43  l20t 160 : 40 28,100 1.47 
s30t 140 : 60 18,120 1.45  l30t 140 : 60 23,900 1.37 
s40t 120 : 80 20,180 1.35  l40t 120 : 80 30,300 1.57 
s40hp 120 : 80 34,200 1.31      
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Figure S2. SEC curves of the P(MeOx-grad-ButEnOx). 
 
 
Figure S3. 1H NMR spectra of 2d (bottom), 4d (middle), and l40p (top) (250 MHz, solvent: 
CD3OD). 
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Figure S4. 1H NMR spectra of s40t (bottom) and l40t (top) (250 MHz, solvent: CD3OD). 
 
 
Figure S5. 1H NMR spectrum of s40hp (300 MHz, solvent: CD3OD). 
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Ethidium bromide binding assay 
A) B) 
 
C) D)
Figure S6. pDNA condensation of all 16 polymers with pDNA measured at physiological pH 
via EBA at indicated N/P ratios (n = 3). 
 
Figure S7. pDNA condensation of lPEI (DP = 200) with pDNA measured at physiological 
pH via EBA (n = 3). 
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Transfection efficiency 
Table S3. Transfection efficiency: Raw data and standard derivation of all polymer at the 
indicated N/P ratio (n = 3).  
N/P 
ratio Sample 
TE / 
% SD Sample 
TE /  
% SD Sample 
TE / 
% SD Sample 
TE / 
% SD 
10 s10p 0.33 0.57 s10t 1.15 1.63 l10p 0 0 l10t 0.33 0.58 
20 0.67 0.57 0.85 1.2 0 0 0 0 
30 0.67 0.57 0.5 0.71 0 0 0.17 0.29 
40 0 0 0 0 0 0 0.77 0.40 
10 s20p 4.73 3.59 s20t 2.65 3.75 l20p 3.65 3.89 l20t 0.43 0.35 
20 8.7 8.16 7.8 0.99 4.2 4.53 2.1 1.51 
30 5.27 2.34 2.55 0.07 3.75 0.21 1.37 0.49 
40 5.33 1.38 1 0 6.1 0 2.52 1.35 
10 s30p 3.4 0.2 s30t 5.15 4.31 l30p 2.4 2.26 l30t 6.48 3.76 
20 2.73 1.16 2.35 1.91 3.95 3.04 2.98 2.4 
30 5.33 2.97 2.05 1.77 2.65 1.63 1 0 
40 5.77 2.91 0.5 0 2.7 2.97 1 0 
10 s40p 30.5 7.64 s40t 2.25 1.77 l40p 2.7 0.85 l40t 1.33 0.58 
20 26.77 3.30 3.2 1.56 5.85 3.89 1 0 
30 27.17 7.51 3.05 2.19 7.4 3.25 0.67 0.58 
40 19.93 2.15 2.8 0 8.8 5.52 0.33 0.58 
10 s50p 22.1 3.55 lPEI200 31.27 1.75 
20 24.07 2.54 25.23 8.81 
30 23.63 2.17 12.17 11.6 
40 21.6 2.63 4.57 6.18 
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Polyplex properties PDIP 
Besides size and zeta potential, also the PDIP was measured.   
A) B) 
  
Figure S8. PDIs of the polyplexes prepared at NP ratio of 20. 
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Cytotoxicity and hemolysis assay 
Table S4. Raw data with standard derivation for cytotoxicity (IC50) and hemolysis assay at 
the indicated polymer concentration. 
      Toxicity Hemolysis 
  
IC50 
  
STAB 
  
  raw data   STAB   
      10 
μg/mL 
50 
μg/mL 
100 
μg/mL 
10 
μg/mL 
50 
μg/mL 
100 
μg/mL 
Sh
or
t h
yd
ro
ph
ob
ic
 si
de
 c
ha
in
 
pr
im
ar
y 
am
in
es
 
10 0 - 0.0999 0.0544 0.1872 0.0269 0.0059 0.0642 
20 0 - 0.402 1.5459 2.5634 0.144 0.2172 0.4657 
30 0 - 0.0938 0.1925 0.188 0.0143 0.0291 0.0539 
40 0 - 0.5647 1.6672 2.8517 0.1148 0.0924 0.3764 
50 1 - - - - - - - 
te
ria
ry
 a
m
in
es
 10 0 - 0.47 0.57 0.71 3E-05 1E-07 3E-07 
20 0 - 0.76 0.56 0.47 4E-07 2E-07 7E-08 
30 0 - 0.55 0.57 0.69 0.5488 0.572 0.6938 
40 0 - 0.80 0.68 0.80 0.7989 0.6844 0.796 
Lo
ng
 h
yd
ro
ph
ob
ic
 si
de
 c
ha
in
 
pr
im
ar
y 
am
in
es
 10 0 0 0.8589 1.802 1.6973 0.1767 0.544 0.6171 
20 5 0.0794 83.206 107.42 107.07 27.032 44.606 45.089 
30 4.7127 0.0157 105 124.21 102.13 40.686 43.969 41.632 
40 34.853 0.0619 106.8 104.16 108.75 44.857 43.014 43.779 
te
ria
ry
 a
m
in
es
 10 0 0 0.6555 0.6133 0.7276 0.0616 0.0185 0.045 
20 13.795 0.059 10.204 50.688 85.833 0.4399 3.4895 3.3771 
30 13.795 0.0393 62.046 101.21 94.963 5.8019 5.557 17.997 
40 4.5983 0.1263 102.47 100.68 99.833 1.0602 3.8171 2.8269 
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Uptake studies 
Table S5. Raw data and standard derivation of time dependent uptake kinetic. 
  1 h 2 h 3 h 4 h 
  
amount of 
cells / % STAB 
amount 
of cells / 
% STAB 
amount 
of cells / 
% STAB 
amount of 
cells / % STAB 
pDNA 0.3 0.2646 0.25 0.2121 0.65 0.495 0.4666667 0.1155 
s40p 81.233333 7.9223 70 19 74.2 4.3841 73.4 3.2512 
s40t 37.85 2.6163 38.9 0 48.05 16.9 53.7 4.1328 
l40p 24.666667 6.8712 41.25 6.1518 69.65 16.051 74 14.47 
l40t 0 0 0 0 0 0 0 0 
lPEI200 33.8 0.8485 47.45 0.2121 81.85 13.647 88.033333 6.3058 
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Dissociation assay 
A) 
 
B) 
 
Figure S9. Dissociation assay with the indicated heparin concentration. 
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Experimental Section 
Chemicals and instrumentation 
Dry acetonitrile, MeOx and methyl tosylate (MeOTs) were obtained from Acros Organics. 
ButEnOx[1] and DecEnOx[2] were prepared according to literature procedure. All compounds 
were distilled to dryness over barium oxide (BaO), and stored under nitrogen. 2-(Boc-
amino)ethanethiol and 2-dimethylaminoethanethiol hydrochloride were purchased from 
Sigma Aldrich.  
Ethidium bromide solution 1% was purchased from Carl Roth (Karlsruhe, Germany). 
AlamarBlue and YOYO-1 was obtained from Life Technologies (Darmstadt, Germany). If not 
stated otherwise, cell culture materials, cell culture media, and solutions were obtained from 
PAA (Pasching, Austria). Plasmid pEGFP-N1 (4.7 kb, Clontech, USA) was isolated using 
Qiagen Giga plasmid Kit (Hilden, Germany). The CytoTox-One homogenous membrane 
integrity assay (LDH) was purchased from Promega (Mannheim, Germany) All other 
chemicals were purchased from Sigma Aldrich (Steinhausen, Germany) and are of analytical 
grade or better and used without further purification.  
The Initiator Sixty single-mode microwave synthesizer from Biotage, equipped with a 
noninvasive IR sensor (accuracy: ±2%), was used for polymerizations microwave irradiation. 
Prior to use, the microwave vials were heated to 110 °C overnight and allowed to cool to 
room temperature under a nitrogen atmosphere. Proton (1H) nuclear magnetic resonance 
(NMR) spectra were recorded on a Bruker AC 250 MHz at 298 K. Chemical shifts are 
????????? ??? ?????? ???????????? ?????? ?? ??????? ????????? ??? ???? ????????? ??????? ??? ???? ???????????
solvent. Size exclusion chromatographies (SEC) were measured on an Agilent Technologies 
1200 Series gel permeation chromatography system equipped with a G1329A autosampler, a 
G131A isocratic pump, a G1362A refractive index detector, and both a PSS Gram 30 and a 
PSS Gram 1000 column placed in series. As eluent a 0.21% LiCl solution in N,N-
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dimethylacetamide (DMAc) was used at 1 mL min-1 flow rate and a column oven 
temperature of 40 °C. Molar masses were calculated against poly(styrene). 
Gas chromatography (GC) was measured on a Shimadzu GC-2010 VP equipped with an 
AOC-20s autosampler, an AOC-20i injector, a FID detector, a Restek Rtx-5 column (30 m 
length, 0.25 mm inner diameter, 0.25 μm film thickness, stationary phase: 5% diphenyl/95% 
dimethyl polysiloxane), and chloroform as solvent. 
Kinetic investigation of the synthesis of P(MeOx-co-ButEnOx) 
For the kinetic studies, a stock solution containing initiator (MeOTs), monomer (MeOx and 
ButEnOx), and solvent (acetonitrile) was prepared. The total monomer concentration was 
adjusted to 2 M with a total monomer to initiator ratio ([M]/[I]) = 100 with 10 mol% of 
ButEnOx. The stock solution was divided over seven microwave vials and capped under 
argon. For the calculation of the conversion a t0 samples was taken. The vials were heated in 
the microwave synthesizer at 140 °C for different times. After cooling, the reaction was 
quenched. The monomer conversion was determined GC using the polymerization solvent as 
internal standard. 
Synthesis of P(MeOx-co-ButEnOx) (1a-d) and P(MeOx-co-DecEnOx) (2a-d) 
A solution of initiator (MeOTs), monomers (MeOx, and ButEnOx or DecEnOx), and 
solvent (acetonitrile) was prepared. The total monomer to initiator ratio was [M]/[I] = 200, 
with a ButEnOx/DecEnOx amount of 10, 20, 30, and 40 mol%, respectively (corresponding to 
20, 40, 60, and 80 repeating units). For MeOx/ButEnOx also a 50 mol% solution was 
prepared (corresponding to 100 ButEnOx repeating units). The total monomer concentration 
was adjusted to of 4 M. The solution was heated in a microwave synthesizer for a 
predetermined time at 140 °C. After cooling to room temperature a sample was taken and the 
conversion was determined by 1H NMR. The solvent was removed under reduced pressure. 
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The residue was dissolved in dichloromethane and precipitated into ice-cold diethyl ether. 
After filtration the polymer was dried at 40 °C for 3 days under reduced pressure. 
Thiol-ene functionalization of P(MeOx-co-ButEnOx) with 2-(boc-amino)ethanethiol (3a-
d) 
A 5% solution of P(MeOx-stat-ButEnOx), 0.1 mol% 2,2-dimethoxy-2-phenylacetophenone 
(DMPA) per double bond, and a 10-fold excess per double bond of 2-(boc-amino)ethanethiol 
in ethanol was prepared. After degassing with nitrogen for 30 min, the reaction mixture was 
stirred in ??????????????????????????????night, and the polymer was precipitated in ice-cold 
diethyl ether. After filtration the polymer was dried under reduced pressure for 3 days at 
40 °C. 
Thiol-ene funtionalization of P(MeOx-co-DecEnOx) with 2-(boc-amino)ethanethiol 
(4a-d) 
A 5% solution of P(MeOx-stat-DecEnOx), 0.1 mol% 2,2-dimethoxy-2-phenylacetophenone 
(DMPA) per double bond, and a 10-fold excess per double bond of 2-(boc-amino)ethanethiol 
in tetrahydrofurane was prepared. After degassing with nitrogen for 30 min, the reaction 
mixture was stirred in ?? ??? ???????? ??? ?? ???? ???? ????night, and the polymer was 
precipitated in ice-cold diethyl ether. After filtration the polymer was dried under reduced 
pressure for 3 days at 40 °C. 
Deprotection of P(MeOx-co-bocAmButEnOx) (sNp) and P(MeOx-co-bocAmDecEnOx) 
(lNp) 
The polymer dissolved in dichloromethane (3 mL). Trifluoracetic acid was added (5 mL) 
and the reaction mixture was stirred overnight at room temperature. After the addition of 
methanol, the polymer was precipitated in ice-cold diethyl ether. The precipitate was filtered, 
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dissolved in methanol and stirred over night with Amberlyst® A21 (free base). The solvent 
was removed and polymer dried at 40 °C under reduced pressure for 3 days.  
Thiol-ene funtionalization of P(MeOx-co-ButEnOx) (sNt) and P(MeOx-co-DecEnOx) 
(lNt) with 2-dimethylaminoethanethiol hydrochloride 
A 5% solution of P(MeOx-stat-ButEnOx) or P(MeOx-stat-DecEnOx), respectively, 0.1 
mol% 2,2-dimethoxy-2-phenylacetophenone (DMPA) per double bond, and a 10-fold excess 
per double bond of 2-dimethylaminoethanethiol hydrochloride in methanol was prepared. 
After degassing with nitrogen for 30 min, the reaction mixture was stirred in a UV chamber 
?? = 365 nm) overnight. The reaction mixture was concentrated and purified by size exclusion 
chromatography using Sephadex® LH-20 running with methanol. The product was dried at 
40 °C for 3 days. 
Thiol-ene funtionalization of P(MeOx-co-ButEnOx) with 6-amino-1-hexanethiol 
hydrochloride (s40hp) 
A 5% solution of P(MeOx-stat-ButEnOx) (1d), 0.1 mol% 2,2-dimethoxy-2-
phenylacetophenone (DMPA) per double bond, and a 2-fold excess per double bond in 
methanol was prepared. After degassing with nitrogen for 30 min, the reaction mixture was 
stirred in ??????????????????????????????night. The reaction mixture was concentrated and 
purified by size exclusion chromatography using Sephadex® LH-20 running with methanol. 
The product was dried at 40 °C for 3 days. 
Polyplex preparation  
Polyplexes of pDNA and polymers were prepared by mixing stock solutions of pDNA and 
polymers at a certain N/P ratio (nitrogen of polymer to phosphate of pDNA ratio) with 15 μg 
mL-1 pDNA solution in HBG buffer (20 mM 4-(2-hydroxethyl) piperazine-1-ethanesulfonic 
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acid (HEPES) and 5% (w/v) glucose, pH 7.2). Subsequently, the solutions were vortexed for 
10 sec at maximal speed, and incubated at room temperature for 20 min.  
Ethidium bromide quenching assay 
The polyplex formation of pDNA and polymers was detected by quenching of the ethidium 
bromide (EB) fluorescence as described previously.[3] Briefly, 15 μg mL-1 pDNA in a total 
volume of 100 μL HBG (hepes buffered glucose) were incubated with EB (0.4 μg mL-1) for 
10 min at room temperature. Then, polyplexes with increasing amounts of indicated polymers 
were prepared in black 96-well plates (Nunc, Langenselbold, Germany). The samples were 
equilibrated for 10 min before the fluorescence was measured using a Tecan Genios Pro 
fluorescence microplate reader (Tecan, Crailsheim, Germany); the excitation and emission 
wavelength were 525 and 605 nm, respectively. A sample containing only pDNA and EB was 
used to calibrate the device to 100% fluorescence against a background of 0.4 μg mL-1 of EB 
in HBG solution. The percentage of dye displaced upon polyplex formation was calculated 
using equation (1): 
    
Here, RFU is the relative fluorescence and Fsample, F0, and FpDNA are the fluorescence 
intensities of a given sample, the EB in HBG alone, and the EB intercalated into pDNA alone. 
Cytotoxicity 
The cytotoxicity was tested with L929 cells, as this sensitive cell line is recommended by 
ISO10993-5. In detail, cells were seeded at 104 cells per well in a 96-well plate and incubated 
for 24 h. No cells were seeded in the outer wells. After exchanging the media with fresh one 
and 30 min incubation, polymers at the indicated end concentrations were added, and the cells 
(1) 
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were incubated at 37 °C for further 24 h. Subsequently, the medium was replaced by fresh 
media and AlamarBlue as recommended by the supplier. After incubation for 4 h, the 
fluorescence was measured at Ex 570/Em 610 nm, with untreated cells on the same well plate 
serving as controls. The experiments were performed independently three times. 
Dynamic and electrophoretic light scattering 
Dynamic light scattering (DLS) was performed on an ALV-CGS-3 system (ALV, Langen, 
Germany) equipped with a He-??????????????????????????????????????? = 633 nm. The counts 
were detected at an angle of 90°. All measurements were carried out at 25 °C after an 
equilibration time of 120 sec. For analyzing the autocorrelation function (ACF), the CONTIN 
algorithm[4] was applied. Apparent hydrodynamic radii were calculated according to the 
Stokes–Einstein equation. 
Electrophoretic light scattering was used to measure the electrokinetic potential, also 
known as zeta potential. The measurements were performed on a Zetasizer Nano ZS (Malvern 
Instruments, Herrenberg, Germany) by applying laser Doppler velocimetry.[5] For each 
measurement, 20 runs were carried out using the slow-field reversal and fast-field reversal 
mode at 150 V. Each experiment was performed in triplicate at 25 ???????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
coefficient f(ka) was calculated according to Oshima.[6] 
Transfection of adherent cells 
HEK-293 cells (CRL-1573, ATCC) cells were maintained in RPMI 1640 culture medium, 
L929 cells (CCL-1, ATCC) in DMEM culture medium. Both media were supplemented with 
10% fetal calf serum (FCS), 100 μg mL-1 streptomycin, 100 IU mL-1 penicillin, and 2 mM L-
glutamine. Cells were cultivated at 37 °C in a humidified 5% CO2 atmosphere.  
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For transfection of the adherent cell lines, cells were seeded at a density of 104 cells per 
well in 24-well plates one day before transfection. One hour prior to transfection, cells were 
rinsed with PBS and supplemented with 1 mL OptiMEM (Life Technologies) or fresh serum 
containing growth media (without antibiotics). After polyplexes formation (as described 
above “polyplexes formation”), the polyplexes (100 μL) were added to the cells and the plates 
were incubated for 4 h in the incubator. Afterwards, the supernatant was replaced by1 mL of 
fresh growth medium, and the cells were further incubated for 20 h. For analysis, adherent 
cells were harvested by trypsinization. 
 For determination of the viability during flow cytometry, dead cells were identified via 
counterstaining with propidium iodide. The relative expression of EGFP fluorescence of 104 
cells was quantified via flow cytometry using a Cytomics FC 500 (Beckman Coulter). For 
determination of the transfection efficiency viable cells expressing EGFP were gated. The 
experiments were performed independently three times.  
Hemolysis assay 
The membrane damaging properties of the polymers were quantified by analyzing the 
release of hemoglobin from human erythrocytes. The hemolysis assay was performed as 
described before.[7] Briefly, blood from sheep was centrifuged at 4.500 × g for 5 min and the 
pellet was washed three times with cold DPBS. The stock solutions were diluted in HBG of 
indicated pH, and polymer solutions were prepared in HBG buffer as well. 100 μL of each 
solution were mixed and further incubated for 60 min at 37 °C. The release of hemoglobin in 
the supernatant was determined at 580 nm after centrifugation (2,400 g for 5 min). The 
absorbance was measured using a plate reader (Genios Pro, Tecan, Germany). For 
comparison, collected erythrocytes were washed with DPBS and either lysed with 1% Triton 
X-100 yielding the 100% lysis control value (A100) or resuspended in DPBS as reference (A0). 
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The analysis was repeated with blood from at least six independent donors. The hemolytic 
activity of the polycations was calculated as follow (2): 
 
    (2) 
 
Here, Asample, A0, and A100 are the absorbance intensities of a given sample, erythrocytes 
incubated with DPBS, and erythrocytes lysed with Titon X-100. 
Lactate dehydrogenase (LDH) assay 
For the LDH assay the CytoTox-ONE homogenouse membrane integrity assay was used. The 
assay was performed as recommended by the supplier. The samples (polymer as well as 
polyplexes) were incubated for 1 h with adHEK cells. 
Plasmid DNA labeling 
For labeling of a 1 μg pDNA, 0.026 μL of 1M YOYO-1 solution was mixed with pDNA in 
20 μL of pure water. The solution was incubated for 1 h at room temperature protected from 
light, before HBG was added to the used pDNA concentration described before. Polymers 
were added at the indicated N/P ratio, and the polyplex solution was treated as described 
before and added to the cells. After the indicated time points of incubation, the cells were 
harvested and 10% trypan blue was added to quench the outer fluorescence of cells and 
identify only those cells, which have taken up the genetic material. To determine the relative 
uptake of NPs, 10,000 cells were measured by flow cytometry and the amount of viable cells 
showing YOYO-1 signal were gated. For measuring the mean fluorescence intensity, all 
viable cells were measured. 
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Heparin dissociation assay 
To investigate the release of pDNA from polyplexes, the heparin dissociation assay was 
used. For this purpose, 15 μg mL-1 pDNA were incubated for 10 min with EB (0.4 μg mL-1) in 
a total volume of 100 μL HBG before polyplexes at N/P 20 were formed. After 15 min in the 
dark the polyplexes were transferred into black 96-well plates, and heparin was added at the 
indicated concentrations. The solution was mixed and incubated for further 30 min at 37 °C in 
the dark. The fluorescence of EB (Ex 525 nm / Em 605 nm) was measured, and the 
percentage of intercalated EB was calculated as described before (1). 
 
Statistical analysis 
The values represent the mean ± SD. For the calculation of the standard derivation of two 
different groups the two sample t-test (student’s t-test) was used. Statistical significant was 
defined with p-values of < 0,05. 
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Figure S10. Overlay of the 1H NMR spectra of 1a (blue), 1b (red), 1c (green), 1d (purple), 
and 1e (orange). The signal intensities of the spectra were normalized to the peak of the 
polymer backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S11. Overlay of the 1H NMR spectra of 3a (blue), 3b (red), 3c (green), 3d (purple), 
and 3e (orange). The signal intensities of the spectra were normalized to the peak of the 
polymer backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S12. Overlay of the 1H NMR spectra of s10p (blue), s20p (red), s30p (green), s40p 
(purple), and s50p (orange). The signal intensities of the spectra were normalized to the peak 
of the polymer backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S13. Overlay of the 1H NMR spectra of s10t (blue), s20tp (red), s30t (green), and s40t 
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S14. Overlay of the 1H NMR spectra of 2a (blue), 2b (red), 2c (green), and 2d 
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S15. Overlay of the 1H NMR spectra of 4a (blue), 4b (red), 2c (green), and 4d 
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S16. Overlay of the 1H NMR spectra of l10p (blue), l20p (red), l30p (green), and l40p 
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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Figure S17. Overlay of the 1H NMR spectra of l10t (blue), l20t (red), l30t (green), and l40t 
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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control s40p transfected cells 
A) B) 
  
C) D) 
  
E) F) 
  
Figure S18. Histograms of non-transfected cells (A, C, E) and the corresponding HEK cell 
transfected with s40p (B, D, F) (NP 20). FL1 represents green fluorescence by EGFP 
expression.  
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Table S6. Mean fluorescence intensities (MFI) of non-transfected cells (control cells) and 
corresponding HEK cells transfected with s40p or lPEI (NP20). The values represent the MFI 
of the gated EGFP positive area (s. figure S18).  
 MFI control cells MFI transfected cells 
s40p 
MFI transfected cells 
lPEI 
Sample A, B  0,682 381 389 
Sample C, D 4,37 317 297 
Sample D, E  11,3 226 257 
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ABSTRACT: In recent years, “high-throughput” (HT) has turned
into a keyword in polymer research. In this study, we present a novel
HT workﬂow for the investigation of cationic polymers for gene
delivery applications. For this purpose, various poly(ethylene imine)s
(PEI) were used as representative vectors and investigated via HT-
assays in a 96-well plate format, starting from polyplex preparation up
to the examination of the transfection process. In detail, automated
polyplex preparation, complex size determination, DNA binding
aﬃnity, polyplex stability, cytotoxicity, and transfection eﬃciency
were performed in the well plate format. With standard techniques,
investigation of the biological properties of polymers is quite time-
consuming, so only a limited number of materials and conditions
(such as pH, buﬀer composition, and concentration) can be
examined. The approach described here allows many diﬀerent polymers and parameters to be tested for transfection properties
and cytotoxicity, giving faster insights into structure−activity relationships for biological activity.
KEYWORDS: high-throughput screening, transfection, nonviral gene delivery, polyplex stability, poly(ethylene imine), heparin,
combinatorial workﬂow
■ INTRODUCTION
Nonviral gene delivery (transfection) methods are of great
interest for research and clinical applications. The use of
cationic polymers as nonviral vectors to form complexes
(polyplexes) with negatively charged plasmid DNA (pDNA)
has long been explored as a safer and more controllable
alternative to the use of possible infectious viral vectors.1,2 For
the evaluation of polymers as transfection agents, two main
aspects must be considered: the eﬃciency of gene delivery with
subsequent reporter gene expression and cytotoxicity.3
Biophysical properties, such as polyplex size, surface charge,
and binding aﬃnity between the polymer and the genetic
material play crucial roles in the required cellular uptake.4,5 The
binding within the interelectrolyte complex of polymer and
pDNA has to be strong enough to protect the pDNA but must
be reversible to release the pDNA inside the cells.6,7 While
much progress has been made, there is still an insuﬃcient
knowledge of how polymers should be constructed to be highly
eﬃcient and safe gene delivery vectors.8,9
This lack of predictability results in part from the great
diversity of polymer classes and methods reported in the
literature, which are diﬃcult to compare to each other. For
instance, transfection protocols diﬀer notably for diﬀerent cells
and media, and diﬀerent polymer solutions and buﬀers are used
in the preparation of polyplexes.10,11 While some examples have
been used for in vitro applications and biotechnology research
for decades, no polymer-based transfection agent has been
approved for clinical use.12−14
The development of robotic techniques for the preparation
of polymeric materials provides an opportunity for the high-
throughput (HT) synthesis and characterization of cationic
polymers in this context.15−20 Using this synthetic approach,
polymer properties such as molar mass, functional groups,
architecture, and the combination of diﬀerent monomers in
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statistic or block copolymers can be altered, yielding systematic
polymer libraries, which enable the elucidation of structure−
property relationships.15−23 Unfortunately, rapid methods for
biological evaluation have not been hyphenated with eﬃcient
automated synthesis to construct a combinatorial HT work-
ﬂow.24−27 For example, binding aﬃnity and polyplex stability
have commonly been assessed by agarose gel electrophoresis,
which is not well suited to HT screening. The use of an
intercalating dye to establish binding aﬃnities can provide an
alternative compatible with a microtiter plate format.28
Transfection and cytotoxicity assays can be similarly performed
in multiwell plates with repeating samples to reduce measure-
ment mistakes. Pioneers in this type of HT screening of a wide
range of polymers as transfection agents have been Langer and
co-workers (synthesis and transfection eﬃciency)29 and
Massing and co-workers (lipofection transfection eﬃciency
and toxicity).30
We describe here a simple and powerful combinatorial high-
throughput workﬂow that combines polyplex formation and
biological screening (Scheme 1). It starts with the automated
polyplex preparation via pipetting robots and continues with a
parallel and HT analysis of analytical and biological properties
of size, binding aﬃnity, stability, transfection eﬃciency, and
toxicity. We show that the novel workﬂow is applicable to a
variety of polymer systems and conditions, allowing for fast and
eﬃcient screening of important vector parameters, such as
polyplex formation, pDNA release, cytotoxicity, and trans-
fection.
■ RESULTS AND DISCUSSION
Poly(ethylene imine) (PEI), the most prominent cationic
polymer and most eﬃcient transfection agent for pDNA in
vitro, was used to validate the method.31,14 Linear PEI (LPEI),
obtained from poly(2-ethyl-2-oxazoline)s of diﬀerent molar
masses, was prepared.32,33 By application of automated
microwave synthesizers, poly(2-ethyl-2-oxazoline)s can be
obtained within 10 min and converted into PEI within 1 h
by acidic hydrolysis.32 These cationic PEI polymers oﬀer the
advantage to be molecularly designed in a highly reproducible
manner for speciﬁc applications in pharmacy or biotechnology.
Commercially available branched PEI (BPEI) materials were
also used in this study.
Evaluation of an Appropriate Buﬀer System. The
formation of polyplexes from cationic polymers and anionic
genetic material is driven by electrostatic interactions and a gain
of entropy.34 Thus, ionic strength, pH, and the ﬁnal polyplex
concentration have a major impact on the complexation
behavior and the resulting polyplex size.35,36 For the ex cellular
characterization, polyplexes are often prepared in high ionic
strength buﬀers, such as 150 mM sodium chloride (NaCl) or
buﬀer systems using phosphate (PBS) or TRIS (TBS). Such
high ionic strength media can have a negative impact on
particle size and stability and lead to fast polyplex
aggregation.36,37 Thus, a low ionic strength 20 mM HEPES
buﬀer with 5% glucose for physiological osmolarity (HBG
buﬀer) was examined for polyplex preparation in a HT manner,
as has been previously done for transfection.37 Preliminary
studies with linear PEI600 revealed that smaller polyplexes were
formed in HBG.35 A lower tendency to aggregate over time
compared to physiological salt solutions (150 mM NaCl) was
observed if the polyplexes were prepared in HBG.38−40 Our
measurements showed LPEI600 polyplexes to exhibit no
aggregation over 2 h in HBG (see Supporting Information),
no aggregation or particle growth before and after the addition
to serum containing culture media.36−38 Furthermore, HBG
buﬀer can be used for zeta potential measurements41 in this
concentration range as well as for electron microscopic
evaluations, where salts cause electrophoresis or artifacts,
respectively. Consequently, HBG was selected as most
appropriate buﬀer system for HT studies and was used here
for all polyplex preparations and analytical investigations.
Polyplex Preparation Using Pipetting Robots. A
standard liquid handling robot was used for automated
preparation of polyplexes from cationic polymers and DNA,
similar to reports of robotic production of polymeric
nanoparticles.42 The beneﬁt of such pipetting systems is the
ability to systematically alter diﬀerent parameters, such as
polymer concentration, pH, or buﬀer composition.43 Auto-
mated deposition of a buﬀered pDNA solution into wells
containing various buﬀered cationic polymer solutions at
desired concentrations was performed. While the reverse
Scheme 1. Workﬂow of the High-Throughput Transfection Studies for Structure−Property Evaluations Concerning Molar
Ratio, Size, Polyplex Formation, Polyplex Stability, Release, Transfection Eﬃciency, and Cytotoxicity
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addition (pipetting polymer to DNA solution, vortexing after
polymer addition) is the more conventional method,1 giving
better transfection results,44 we observed similar outcomes in
preliminary experiments using LPEI600 and BPEI600 (see
Supporting Information) and in scattered tests of the HT
method (data not shown). This may be due to more reversible
interelectrolyte formation in the low ionic strength HBG buﬀer
compared to high ionic strength buﬀers used previously.
To evaluate the dependence of polyplex properties on the
nature of the polymers and preparation conditions, various
cationic LPEI and BEI with varied degree of polymerization
(DP = 20, 200, and 600) were used to form polyplexes with
pDNA. Besides the molar mass and architecture, several
nitrogen (polymer) to phosphate (DNA) ratios (N/P = 2.5,
5, 10, and 20) were applied. To this end, pDNA solution was
added to a dilution series of polymer solutions, and the
resulting suspensions were directly mixed by repetitive suction
and release. After polyplex formation, the prepared suspensions
were distributed automatically into diﬀerent well plates for
parallel analysis studies.
Investigation of Polyplex Size and Stability. The
polyplex size allows a ﬁrst hint of the polymer’s capability to
be used as a transfection agent, since polyplexes larger than
500 nm are known to show relatively poor uptake.45 For this
purpose, the polyplexes were ﬁrst analyzed on a dynamic light
scattering (DLS) plate reader.46 As shown in Figure 1, all
polyplexes exhibited an average radius of less than 270 nm, with
materials mixed at N/P ratios above 5 showing smaller radii.
The smallest size (70 nm radius) was obtained for BPEI200. It
should be noted that the HT-DLS analysis data tended to
report larger radii than measurements performed with a single-
beam DLS instrument (see Supporting Information). HT-DLS
results should be always considered with care, and we consider
them informative only in a relative sense, to establish the
potential of polymers to form nanoscaled polyplexes and gain
information about their stability in comparison to standard
polymer controls. Our data revealed three tendencies, also
described in the literature: (i) increasing N/P ratios gave rise to
smaller polyplexes, (ii) BPEI with higher DPs showed a
stronger size dependency compared to LPEI, and (iii) BPEI
condensed DNA into smaller particles compared to LPEI.31
Interestingly, no systematic inﬂuence of the degree of
polymerization or the molar mass on polyplex size was
observed under the chosen conditions.
Fluorescence Displacement Assay. Considering the
interpretation of transfection results the determination of the
binding aﬃnity of the polymers to the genetic material is of
vital importance. As previously mentioned, the binding of a
polyplex is at its optimal state when having a strong and
reversible interaction. The required N/P ratio to form
polyplexes were either done by usage of gel retardation assays
or by ﬂuorescence measurement of intercalating dyes, such as
ethidium bromide (EB) or Pico Green. For an HT screening
application, the gel retardation method is not suitable in a 96-
well plate format, thus, the ﬂuorescence displacement assay
with EB (EBA) was chosen. Commonly, the binding of EB with
pure pDNA leads to a high ﬂuorescence signal. However,
provided that the pDNA forms interelectrolyte complexes with
the polymers, the displacement of dyes leads to a decrease of
ﬂuorescence signals. In Figure 2, the ﬂuorescence signals
(RFU) of all PEI polymers with increasing N/P ratio are
illustrated. It was found that BPEI200 and BPEI600 reached a
comparable RFU of around 30.5 ± 1.4% (p > 0.5) indicating a
strong DNA binding. Furthermore, the higher molar mass
LPEIs (LPEI200 and LPEI600) along with BPEI20 revealed
comparable RFUs in the range of 37.1 ± 6.2% (p > 0.1). The
weakest binding was obtained with LPEI20 also showing the
strong dependence of N/P. In particular, polyplexes formed at
N/P 20 revealed a mediate RFU of 48.7 ± 8% (p > 0.5) in
comparison to 73.8 ± 8.5% at N/P 5. The ﬁndings accredit that
the binding aﬃnity depends on the molar mass and the
architecture of the polymer as well as on the N/P ratio applied.
The relationship between the binding aﬃnity and the molar
mass of the polymer increases in a proportional manner. In
addition, a higher binding aﬃnity of branched structures
(BPEI) was detected in comparison to linear architectures.8,31
The literature47,48 reports similar trends and conﬁrms the
possible analysis of polyplexes by this HT assay. Moreover,
identical tendencies were obtained for this particular handmade
assay using polyplexes of linear PEIs (see Supporting
Information). At this point of the workﬂow, one should note
that after performing size measurements and binding aﬃnity
assays, it is possible to exclude nonsuitable polymers as
Figure 1. Hydrodynamic radii of polyplexes prepared using the
pipetting robot. The values represent the mean (n ≥ 3) of each
polymer at diﬀerent N/P ratios. PDIP values of 0.09 to 0.5 were found.
Figure 2. Fluorescence displacement assay using LPEI and BPEI with
varying DP. The RFU of pure pDNA represent 100% RFU. N/P ratios
of 2.5 up to 20 were studied using EB as intercalating agent. The
values represent the mean ± S.D., n ≥ 3, # indicate signiﬁcant
statistical diﬀerence (ANOVA, p < 0.05).
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transfection agents, which showed undesired interaction such as
aggregation or no polyplex formation.
DNA Release. Subsequent to the determination of binding
aﬃnity, the release of pDNA from the polyplexes was
investigated using the heparin assay. Heparin is a polyanion
and it was reported to be a good competitor to negatively
charged pDNA.48 As a result of the polymer-heparin
interaction, the pDNA is released and EB is repeatedly
intercalating into pDNA leading to increased ﬂuorescence
intensities. Studies using heparin are often quantiﬁed via gel
retardation assays or applying only one N/P ratio, which would
potentially lead to misinterpretations. In particular for in vitro
cultivations of adherent cells, the polyplex concentration at the
cell membrane at the beginning of the transfection and after
incubation diﬀers. The explanation for this behavior could be
justiﬁed by the polyplex sedimentation process.8,49,50 For a
more trustworthy outcome, all polyplex suspensions were
titrated automatically against two heparin stock solutions to
determine the critical heparin concentration at diﬀerent N/P
ratios. Using this approach, a wide range of heparin
concentrations (n = 20) could be tested for one sample. The
results obtained from the performed assay are displayed in
detail for LPEI600 (Figure 3A) and for all polymers and N/P
ratios in (Figure 3C). As expected, the release of pDNA
detected by RFU was dependent on the heparin concentration.
Moreover, it was explored that for the release of total pDNA at
higher N/P ratios, an increased amount of heparin was
required. This can be explained by the fact that the amount
of noncomplexed free polymer was increased at high N/P
ratios, whereas the amount of complexed polymer remained
constant.51 Thus, by the addition of heparin to polyplex
suspensions at high N/P ratios, ﬁrst the free polymers complex
with the heparin and no pDNA was released. Unless the critical
concentration of heparin was met, the pDNA was not released.
For an improved comparability, the inﬂection point of the
titration curves in Figure 3A and C was deﬁned as the critical
heparin concentration (HC50) and implemented as a
representative value of the concentration at which 50% of the
complexed pDNA was released (Figure 3B and D). The
correlation between the N/P ratio and the heparin concen-
tration was an apparent observation and conﬁrmed already
published trends.48 However, our ﬁndings underline the
relation between the architecture of PEI and the ability to
release pDNA.
Polyplexes prepared from BPEIs showed higher HC50 values
in comparison to the LPEIs (indicated by larger purple areas in
particular at N/P 2.5 and 5, Figure 3C and D). Furthermore,
the polyplexes prepared with the LPEI20 exhibited an early
release of the pDNA at low heparin concentration in contrast
to its branched analog (BPEI20) and the linear PEIs with higher
molar masses (LPEI200 and LPEI600). A ﬂagrant correlation
could be made of these with the weak binding aﬃnity (Figure
2).
Figure 3. pDNA release of polyplexes after titration with heparin. Release of pDNA was measured by incubation of polyplexes with increasing
heparin concentrations. (A) RFU of polyplexes prepared from LPEI600 at diﬀerent N/P ratios and increasing heparin concentrations. (B) Slope of
RFU of LPEI600 polyplexes at diﬀerent N/P ratios. (C) RFU of all polyplexes at diﬀerent N/P ratios and increasing heparin concentrations. Color
represents the RFU. (D) Slope of RFU of all polyplexes at diﬀerent N/P ratios. Color represents the slope. The values represent the mean ± S.D., n
≥ 3.
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Cytotoxicity. To study the cytotoxicity of the polyplexes,
HEK cells used as for transfection experiments, were seeded in
96-well plates and incubated for 24 h with the prepared
polyplex suspensions. Afterward, the viability of the cells was
detected by staining with Hoechst 33324. This dye crosses of
the cell membrane and stains the chromosomal DNA of
attached cells. Subsequently, the ﬂuorescence was measured
utilizing the ﬂuorescence plate reader. The obtained RFU
signals of Hoechst of all treated cells are presented in Figure 4.
No indication for cytotoxic eﬀects of the polyplexes was found
considering the fact that the obtained values were comparable
to nontreated cells (ANOVA, p > 0.05).
As the polyplexes exhibited a lower cytotoxicity than the
single polymers, due to neutralized cationic groups, the toxicity
of these polyplexes at N/P 20 would be a criterion for knock
out. However, for a comprehensive analysis, the polymers were
also screened with concentrations up to 72 μg mL−1,
correlating to N/P 500 (DP 20 and 600, see Supporting
Information). A relationship was elucidated between the
increasing DP of the cationic polymers and the higher
cytotoxicity level, which is in accordance to literature where
no signiﬁcant diﬀerence between linear and branched PEI was
observed.3,31 Interestingly, the polymers with the lowest DP
showed no cytotoxicity at all investigated concentrations (see
Supporting Information).
Transfection Eﬃciency. The transfection eﬃciency of the
polyplexes was quantiﬁed using EGFP as reporter protein. For
HT screening, the studies regarding the transfection eﬃciency
were performed with a ﬂuorescence plate reader by automatic
scanning of the bottom area of the wells and complemented by
Figure 4. Investigation of cytotoxicity. The viability of cells after incubation of the polyplexes up to N/P 20. Nontreated cells served as controls and
gave comparable results. The bottom of 96-well plates were measured at Em350/Ex461 (Hoechst 33324).
Figure 5. Transfection eﬃciency by microscopic evaluation and ﬂuorescence intensity measurements. (A) HEK cells transfected with EGFP coding
pDNA and LPEI600 at N/P 10. Cell nuclei were stained with Hoechst 33324 (blue). Scale bare indicates 500 μm. (B) Correlation of the microscopic
evaluation of EGFP content determined (RFUmicroscope) and bottom measurements using a plate reader (RFUplate reader). Three control wells, where
cells were not transfected, as well as cells only incubated with the polymer at concentrations correspond N/P 20 (N20) showed no RFU. (C)
Transfection eﬃciency and number of cells transfected with a pipetting robot in a 96-well plate. Values represent the mean ± S.D., n ≥ 3.
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microscope analysis. In Figure 5A, a representative overview of
the cells (blue) transfected with LPEI600 (green) is portrayed.
Microscopic analysis and, in particular, subsequent data
processing is not appropriate and eﬃcient enough for a rapid
HT screening, thus the quantiﬁcation of EGFP using a
ﬂuorescence plate reader were compared to the mean
ﬂuorescence in each picture (Figure 5B). Thereby, a good
correlation between the microscopic analysis and the
ﬂuorescence plate reader results was demonstrated, proving
the capability to screen the EGFP amount in a fast and facile
manner, in contrast to ﬂow cytometry or microscopy. In
general, it can be stated that there are some decent advantages
of a ﬂuorescence screening with a plate reader compared to
luciferase or galactose based assays, namely, (i) an easy and
cheap detection, (ii) the possibility to perform afterward single
cell analysis by ﬂow cytometry or microscopy of the same cells,
and (iii) the fact that EGFP is a stable reporter protein.
The EGFP expression for all investigated PEI polymers are
shown in Figure 5C. The polymers can be ranked from high to
low transfection eﬃciency: LPEI600 > LPEI200 > BPEI200 >
BPEI600 > BPEI20 > LPEI20, whereby the obvious increase in the
standard deviation compared to ﬂow cytometry measurements
(see Supporting Information) must be taken into account.
However, the HT investigation showed clear trends conﬁrming
a suitable approach to spot high potential candidates and to be
subsequently investigated in depth. Thus, LPEI20 revealed no
transfection eﬃciency, while LPEI600 shows the highest one,
also conﬁrmed by handmade polyplexes and the detection of
EGFP by ﬂow cytometry (see Supporting Information). This
observation further veriﬁes the potential of such a HT
screening using a ﬂuorescent plate reader for determination
of the transfection eﬃciencies of polymers.
■ CONCLUSION
Since HT synthesis and characterization of polymers could be
managed by synthetic robots and microwave synthesizers
combined with subsequent automated characterization of the
molecular properties, polymer libraries for biological applica-
tions can be prepared in a rapid manner.15−20 So far, an
eﬃcient and fast HT screening of these polymers for gene
delivery purposes regarding structure−property relationship
was not possible. Herein, a solution for the biological screening
for gene delivery applications has been presented. The
discussed HT workﬂow enables a rapid analysis of polymer
vectors in an automated way with respect to important polymer
characteristics, such as molar mass, architecture, and N/P ratio.
This supports the identiﬁcation and evaluation of polymers
with regard to their capability of eﬃcient complexation,
protection, and transfection eﬃciency. For instance, the
described heparin assay can be used for 23 polymers at four
diﬀerent N/P ratios resulting in 92 samples plus controls (n =
1). Furthermore, the HT approach was applied and
demonstrated the possible screening of the cytotoxicity and
the transfection eﬃciency of the polyplexes. As expected, the
study of the diﬀerent PEI model polymers revealed that linear
and branched PEI are noncytotoxic at the investigated
concentrations, but with rising molar mass and polymer
concentration the cytotoxic eﬀect was increasing.31 The
polymeric architecture itself showed thereby no inﬂuence on
the cell viability.3 As per literature, at low molar masses the
DNA binding aﬃnity is inﬂuenced by the polymeric
architecture, since BPEI20 revealed a stronger pDNA binding
than LPEI20.
15,26 The obtained results indicated that PEIs with
branched architectures and small molar masses have the highest
potential to be used as gene vectors in vitro, as they oﬀer the
advantage of low cytotoxicity combined with high pDNA
binding aﬃnity. Beyond, the best transfection results were
obtained for LPEI600 and the BPEI200.
In comparison with literature and handmade performances
proof was established that the developed workﬂow is applicable
for polymer systems. Furthermore, conditions enabling a fast
and eﬃcient screening in terms of important vector parameters,
such as polyplex formation, transfection, and release were
found. The possible screening of polymer libraries for the best
transfection candidate will help to elucidate main polymer
characteristics and to understand why some polymers are high
performers and others not. Thus, an enhanced development of
more eﬃcient polymers and polyplexes can be realized.
■ EXPERIMENTAL PROCEDURES
Material. Ethidium bromide solution 1% was purchased
from Carl Roth (Karlsruhe, Germany). AlamarBlue was
obtained from Life Technologies (Darmstadt, Germany). If
not otherwise stated, cell culture materials, cell culture media,
and solutions were obtained from PAA (Pasching, Austria).
Plasmid pEGFP-N1 (4.7 kb, Clontech, Mountain View, CA,
U.S.A.) was isolated using Qiagen Giga plasmid Kit (Hilden,
Germany). All other chemicals were purchased from Sigma
Aldrich (Steinhausen, Germany) and are of analytical grade or
better and used without further puriﬁcation. Linear PEI was
synthesized according to procedure described in literature.32
Polyplex Preparation Using Pipetting Robot. For an
automated polyplex preparation, 100 μL buﬀered DNA
solution (c = 15 μg mL−1) were injected into wells that
contain 300 μL of the desired polymer solution. As cationic
polymers, linear PEI with a DP of 20, 200, and 600, as well as
branched PEI with a DP of 20, 200, and 600 were applied. To
achieve diﬀerent polymer to DNA ratios (N/P ratios), a
dilution series in HBG of four diﬀerent polymer concentrations
(N/P ratio 2.5, 5, 10, 20) was prepared using a pipetting robot
from a polymer stock solution of c = 72 μg mL−1. After addition
of the DNA solution, the polyplex suspension was mixed ﬁve
times by suction and release using 200 μL tips and incubated at
least 20 min. Subsequently, 100 μL of each polyplex suspension
were transferred into three diﬀerent well plates for a detailed
analysis studies. The following assays were performed up to 2 h
after polyplex preparation.
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In  the ﬁeld  of  nanomedicine,  cationic  polymers  are  the  subject of  intensive  research  and  represent promis-
ing carriers  for genetic  material. The detailed  characterization  of  these carriers  is  essential  since  the
efﬁciency of  gene delivery  strongly  depends  on the  properties  of  the  used  polymer.  Common character-
ization methods such as size exclusion  chromatography  (SEC)  or  mass spectrometry  (MS)  suffer  from
problems, e.g.  missing standards,  or even failed  for cationic  polymers.  As an  alternative, asymmetrical
ﬂow ﬁeld-ﬂow  fractionation  (AF4)  was  investigated.  Additionally,  analytical  ultracentrifugation  (AUC)
and 1H  NMR  spectroscopy,  as well-established  techniques,  were applied to  evaluate  the  results  obtained
by AF4.  In this study, different polymers  of  molar masses between  10 and  120 kg  mol−1 with varying
amine functionalities  in  the side  chain  or  in  the  polymer  backbone  were  investigated.  To  this end, some
of the  most  successful  gene delivery  agents,  namely  linear poly(ethylene  imine)  (LPEI)  (only  secondary
amines in  the  backbone),  branched poly(ethylene  imine) (B-PEI) (secondary  and  tertiary  amino groups  in
the backbone,  primary  amine  end  groups),  and  poly(l-lysine)  (amide  backbone  and primary  amine  side
chains), were characterized. Moreover, poly(2-(dimethylamino)ethyl  methacrylate)  (PDMAEMA),  poly(2-
(amino)ethyl methacrylate)  (PAEMA),  and  poly(2-(tert-butylamino)ethyl  methacrylate)  (PtBAEMA)  as
polymers with primary,  secondary,  and tertiary  amines  in  the  side  chain,  have  been  investigated.  Reliable
results were  obtained for  all investigated  polymers  by  AF4.  In  addition,  important  factors for  all  meth-
ods were evaluated, e.g.  the  inﬂuence  of  different elution buffers and AF4  membranes.  Besides  this,  the
correct determination  of  the  partial  speciﬁc volume and  the  suppression  of  the  polyelectrolyte  effect  are
the most  critical issues  for AUC  investigations.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Polyelectrolytes, in particular cationic polymers, are a  highly
promising class of compounds in biological, pharmaceutical, and
medical research. They represent promising carriers for genetic
material like DNA or RNA into cells [1–3]. The efﬁciency of
gene delivery strongly depends on different parameters, such
as the molar mass and architecture of the used polymer, since
they  inﬂuence the cytotoxicity, the cellular uptake, and transfec-
tion efﬁciency, or  in the case of siRNA the protein knockdown.
To investigate these structure–property relationships, a detailed
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molecular characterization of the polymers with respect to their
physico-chemical properties is  essential. In particular, key param-
eters such as molar mass, radius, architecture, intermolecular
interactions, and conformation strongly inﬂuence the resulting
macroscopic properties. For the determination of the molar mass,
a  large range of techniques are available in modern analytical
and  bioanalytical chemistry. Unfortunately, common methods like
size exclusion chromatography (SEC) or  mass spectrometry (MS)
suffer problems or failed for polyelectrolytes, in particular for
cationic ones [4,5]. While results from MS (MALDI–TOF MS or
ESI–TOF MS)  are difﬁcult to achieve and the interpretation becomes
more complex due to the probable multiply charged species in
the polymer chain [6],  SEC results should be regarded carefully,
due to strong interactions of the polyelectrolytes with the col-
umn  material and the lack of  suitable standards for most of the
cationic polymers [7].  Here, the development of modern stationary
phases and the coupling of a  multi-angle light scattering (MALS)
0021-9673/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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detector to SEC can circumvent some of these limitations [8].  Other
methods like viscosimetry or  techniques based on colligative phe-
nomena are applicable, but suffer the drawback that the constants
in the Kuhn–Mark–Houwink–Sakurada equation are not  available
for  most of these polymers, moreover, the determination of the
degree of protonation of the polymer in water and the degree of dis-
sociation are problematic. As a  consequence, in solution the amount
of  species having counterions is  not known. Further, important
methods for characterization are NMR  spectroscopy, static light
scattering (SLS), and analytical ultracentrifugation (AUC). How-
ever, just average values and no or limited information about the
polydispersity index (PDI) of the sample can be obtained. Hav-
ing knowledge of  the PDI is  important from a  synthetical and
applicational point of view, particularly when structure–property
relationships are investigated.
Due to intrinsic limitations described for the other analytical
methods, asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) coupled
to  a UV/RI and a MALS detector was investigated in this study as an
alternative characterization method for cationic polyelectrolytes.
AF4 was ﬁrstly introduced in 1966 by J.  Calvin Giddings. It is  an
emerging technique and nowadays widely applied for colloids, e.g.
nanoparticles or proteins [9].  Although preferred for the analysis of
high molar mass samples, only rarely studies were performed using
synthetic macromolecules, in particular polyelectrolytes of lower
molar mass [10–13].  With AF4, the polymers are separated in a
trapezoidal channel without any porous packing material accord-
ing to their diffusion coefﬁcient [14]. The separation of the sample
is  achieved by application of a cross-ﬂow perpendicular to the
direction of the sample ﬂow through a semipermeable membrane
with a deﬁned molar mass cut-off (MWCO). A  detailed description
and theoretical consideration for the calculation of the diffusion
coefﬁcient based on the retention time was given by Wahlund
and Giddings [15].  In comparison to classic chromatography tech-
niques such as HPLC or SEC, AF4 contains no stationary phase,
which reduces disturbing interactions and adsorption effects in
the most cases. Moreover, the ﬂow is less tortuous for the sam-
ple, due to the decreased shear forces in an empty channel. This
is  advantageous for sensitive biological samples [16]. Nowadays,
in  most cases, a MALS detector is  used for the analysis after the
fractionation process [17].  The calculation of  molar mass or  radius
of  gyration is based on the same principle as classic static light
scattering. A common way to treat the data uses the well-known
Zimm-plot. In contrast to classical SLS, the second virial coefﬁcient
A2 can be neglected due to the high dilution during the fractionation
process.
In  contrast to AF4, analytical ultracentrifugation (AUC) and 1H
NMR  spectroscopy are well-established techniques, which are used
for  many years for the characterization of biological and synthetic
macromolecules [18–20]. It should be noted that both methods
yield different molar mass averages. While 1H  NMR  spectroscopy
gives the number average molar mass (Mn), in AUC the sedi-
mentation diffusion average molar mass (MsD) is  obtained from
sedimentation velocity experiments and the Svedberg equation (1).
These  methods can be used for the comparison of the results and
to  show the potentials and possible limitations of  AF4 with regard
to  the characterization of (cationic) polymers.
In this study, cationic polymers of different molar masses
with varying amine functionalities in the side chain or the
polymer backbone (Fig. 1) were investigated for the ﬁrst time
by AF4. As the most successful gene delivery agents, a  tailor-
made linear, and commercially available linear and branched
poly(ethylene imine)s (L-PEI, B-PEI) were characterized [21]. More-
over, poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA),
poly(2-(amino)ethyl methacrylate) (PAEMA), and poly(2-(tert-
butylamino)ethyl methacrylate) (PtBAEMA) as polymers with
primary, secondary, and tertiary amines in the side chain were
studied. Additionally, two samples of different molar masses
of commercially available poly(l-lysine) (PLL), a  prominent
polyamino acid in gene delivery research [22],  are analyzed by
AF4. As AF4-MALS is typically not applied to low molar mass
(M  < 100 kg mol−1) polymers, this study focuses on the evalua-
tion of AF4 as a  potential alternative for characterization of these
cationic polyelectrolytes. Therefore, the results obtained from the
synthesized methacrylate based cationic polymers are compared
to  well-established methods like 1H NMR  spectroscopy, SEC and
AUC. Beside the determination of the molar masses and the poly-
dispersity index values, different types of membranes and eluents
were evaluated to identify optimal conditions for the analysis. This
should also  reveal potential interactions with the membrane and
show how far it affects the retention behavior and the obtained
results. PDMAEMA was  studied in more detail by AF4 to gain deeper
insight into the conformation as well as the inﬂuence of ionic
strength and pH value on the retention behavior. This study shows
that AF4 allows fast and reliable characterization of cationic poly-
mers. Moreover, the limitations concerning molar mass limits and
membrane interactions for different classes of cationic polymers
are discussed in detail.
2. Experimental
2.1. Materials
Poly(l-lysine) (PLL) and branched poly(ethylene imine) (B-
PEIcom) were purchased from Sigma Aldrich (Steinhausen,
Germany). Linear poly(ethylene imine) (L-PEIcom) was  purchased
from Polysciences (Eppelheim, Germany). Methyl tosylate and
2-ethyl-2-oxazoline (EtOx) were purchased from Acros Organics
(Geel, Belgium), distilled to dryness over barium oxide (BaO), and
stored under argon. A second linear poly(ethylene imine) (L-PEI600)
was synthesized by acidic hydrolysis of poly(2-ethyl-2-oxazoline)
(PEtOx) in a microwave synthesizer (Biotage) as described recently
(see supporting info SI-I) [6].
2-(Dimethylamino)ethyl methacrylate (DMAEMA),
2-aminoethyl methacrylate hydrochloride (AEMA) and 2-(tert-
butylamino)ethyl methacrylate (tBAEMA) were purchased from
Sigma–Aldrich and puriﬁed by stirring in the presence of inhibitor-
remover for hydroquinone or  hydroquinone monomethyl
ether (Aldrich) for 30 min  prior to use. The initiators 4,4′-
azobis(4-cyanopentanoic acid) (ACVA), 1,1′-azobis(cyclohexane
carbonitrile) and 4-cyano-4-(phenylcarbonothioylthio)pentanoic
acid as well as 4-cyano-4-[(dodecylsulfanylthiocarbonyl) sul-
fanyl] pentanoic acid RAFT agents were purchased from
Fig. 1. Schematic representation of the  structure of the polymers used in  this study.
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Sigma–Aldrich. Poly(2-(dimethylamino)ethyl methacrylate)
(PDMAEMA), poly(2-(amino)ethyl methacrylate) (PAEMA), and
poly(2-(tert-butylamino)ethyl methacrylate) (PtBAEMA)  were syn-
thesized using the RAFT polymerization technique (see supporting
info  SI-II) [23,24].  All solvents, salts and other chemicals used in
this study were of analytical grade or better.
2.2. Analytical ultracentrifugation (AUC)
AUC was performed using a  Beckman XL-I analytical ultra-
centrifuge (ProteomeLab XLI Protein Characterization System).
Experiments were carried out in double-sector epon or aluminum
centerpieces, depending on the solvent, with optical path length of
12 mm in a four holes rotor setup. Each cell was  ﬁlled with 0.44 mL
of solvent and 0.42 mL  of sample. A  rotor speed of 40,000 rpm was
used for all samples. The system was equilibrated for 40 min  at  25 ◦C
in  the centrifuge. Sedimentation data were recorded by absorbance
optics. Data analysis was done by the Sedﬁt software [25].  For c(s)
analysis of sedimentation data, the partial speciﬁc volume of the
polymers was determined via AUC using the “density variation
method” as described by  Mächtle [26].  For calculating the molar
mass the Svedberg equation (1) was used:
MsD =
s0RT
D0(1 − ¯)
(1)
Here, R is the universal gas constant, T  is  the temperature, s0
is the sedimentation coefﬁcient, D0 is the translational diffusion
coefﬁcient, v¯ is the partial speciﬁc volume and  is  the density of
the solvent. Solvent density and viscosity measurements were per-
formed on a DMA  02 density meter (Anton Paar, Graz, Austria) and
an  AMVn falling sphere viscometer (Anton Paar). s0 was obtained
by measurement of at least three concentrations and extrapolation
to zero concentration using the Gralen relations [27].
2.3.  Dynamic light scattering
Dynamic light scattering (DLS) was performed using an ALV-
CGS-3 system (ALV, Langen, Germany) equipped with a  He–Ne laser
operating at a wavelength of   =  633 nm.  The counts were detected
at angles  of 30◦,  60◦,  90◦, 120◦,  and 150◦. All measurements
were carried out at  25 ◦C  after an equilibration time of 120 s. All
polymers were measured at three different concentrations. For ana-
lyzing the autocorrelation function, the CONTIN algorithm [28] was
applied. The diffusion coefﬁcient was obtained by linear extrapo-
lation of the apparent diffusion coefﬁcient to zero concentration
and  = 0◦. Hydrodynamic radii were calculated according to the
Stokes–Einstein equation (2):
RH =
kT
6D0
(2)
Here,  RH is the hydrodynamic radius, k  is the Boltzmann con-
stant, T is the absolute temperature,  is  the viscosity of the sample,
and D0 is the translational diffusion coefﬁcient.
2.4. Asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4)
Asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) was performed
on an AF2000 MT  System (Postnova Analytics, Landsberg, Germany)
coupled to an UV (PN3211, 260 nm), RI (PN3150) and MALS
(PN3070, 633 nm)  detector. The eluent is delivered by three dif-
ferent pumps (tip, focus, cross-ﬂow) and the sample is  injected
by  an autosampler (PN5300) into the channel. The channel has a
trapezoidal geometry and an overall area of 31.6 cm2. The nominal
height of the spacer was 500 m and a regenerated cellulose mem-
brane (Z-MEM-AQU-670, PostNova Analytics) with a MWCO  of
10  kg mol−1 was used as accumulation wall, if not stated otherwise.
All experiments were carried out at  25 ◦C. For each measurement
20 L of the sample were injected with an  injection ﬂow rate of
0.2 mL min−1 for 7  min. For PLL and L/B-PEI the detector ﬂow rate
was set to 0.6 mL min−1 and 0.8 mL  min−1 for PDMAEMA, PAEMA
and PtBAEMA. The cross-ﬂow rate was  set to 5  mL min−1 for PLL,
4.5  mL min−1 for L-PEI and 4  mL  min−1 for B-PEIcom as well as the
methacrylate based polymers. After the focusing step, the cross-
ﬂow rate was kept constant for 5 min  and then reduced under an
exponential gradient (0.5) within 20 min  to 0.1 mL min−1.  After-
wards,  the cross-ﬂow rate was  reduced under a linear gradient to
zero within 5 min  and then kept constant for 20 min  to ensure com-
plete elution. For calculation of the molar mass and the radius of
gyration from the MALS signal, the Zimm plot, according to Eq. (3),
was  used [29]. All measurements were repeated ﬁve times
Kc
R()
= 1
M
(
1 + 2
3!
〈R2g 〉
[
40

sin

2
]2)
(3)
K = (2n0(dn/dc))
2
4NA
(4)
Here, K is  a  constant factor according to Eq. (4), c is  the concen-
tration, R is the excess Rayleigh ratio, M is the molar mass, Rg is
the radius of gyration,   is the laser wavelength,  is the scattering
angle, n0 is  the refractive index of the solvent, NA is  the Avogadro’s
number and dn/dc is the refractive index increment.
2.5.  Refractive index increment
The refractive index increment of  the samples was measured by
manual injection of a known concentration directly into the AF4
channel without any focusing or cross-ﬂow. Integration of the RI
signal and comparison with the injected mass gives the dn/dc value.
All  measurements were repeated ﬁve times. To increase the accu-
racy,  all  polymers were dissolved in the eluent of the corresponding
AF4 run.
2.6. 1H  NMR spectroscopy
Proton nuclear magnetic resonance (1H NMR) spectra were
recorded on a  Bruker AC 300 (300 MHz) spectrometer at 298 K.
The chemical shifts are reported in parts per million (ppm, ı scale)
relative to the signals from the NMR  solvents. The standard devi-
ations  were calculated using the individual CH2 signals of the
polymer.
2.7.  Size-exclusion chromatography
Size-exclusion chromatography (SEC) of the PEtOx precursor,
PDMAEMA and PAEMA was  performed on a  system using an Agi-
lent1200 series system, a G1310A pump, G1329A autosampler, a
G1362A refractive index detector and both a PSS Gram 30 and a
PSS Gram 1000 column in series, whereby N,N-dimethylacetamide
(DMAc) with 50 mM lithium chloride was  used as an eluent at
1  mL min−1 ﬂow rate and the column oven was set to 40 ◦C. The
system was  calibrated against polystyrene (Mn from 374 g  mol−1
to 1,040,000 g mol−1) standards. Additional SEC experiments of
PtBAEMA were performed on a  JASCO system equipped with
a  PU-980 pump, a RI-930 refractive index detector and a  PSS
SUPREMA-MAX guard/300 A˚  column using water with 0.1% trichlo-
racetic acid (pH 2.3) and 0.05 M NaCl as eluent and the column oven
was set to 30 ◦C. A calibration with low PDI pullulan standards was
used.
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3. Results and discussion
In principle, AF4 coupled to a  UV/RI-MALS detector allows
a  detailed characterization of biological and synthetic macro-
molecules or nanoparticles by combination of a gentle separation
with the broad molar mass and size range of SLS. Nevertheless, AF4-
MALS was, to the best of our knowledge, never applied on these
kinds of polymers. Therefore, the results have to be compared to
already well-established methods. On the one hand, data from the
supplier were used for the commercially available polymers (PLL,
B-PEIcom, L-PEIcom) that are often obtained by classic light scat-
tering, SEC, or viscosity. On the other hand, polymers synthesized
in  our lab (polymethacrylates, L-PEI600) were characterized using
AUC, SEC, and end group analysis by 1H NMR.
3.1.  AF4 – choice of eluent and membrane
For AF4, several types of  membranes with different MWCOs
and  different eluents can be used to inﬂuence the retention of the
sample. Besides the limitations of the MALS detector, the MWCO
of the membrane predeﬁnes the lowest molar mass, which can
be  studied. All samples with a molar mass below the MWCO
will, in theory, pass through the membrane and, hence, cannot be
analyzed. Another important parameter, with regard to the used
solvent and the potential interactions between the sample and the
membrane surface, is  the chemical nature of the membrane. The
available membranes have different surface charges as well as vary-
ing  degrees of hydrophilicity and hydrophobicity. In  the case of
aqueous eluents, the interactions with the sample can be affected
by adjusting the pH, addition of surfactants or increasing the ionic
strength, e.g. for screening of  charges. Also the adsorption of  ions
or  the addition of chaotropic or kosmotropic agents, which inﬂu-
ence  the hydration of the sample, can alter the interactions and
the  resulting retention behavior [30].  Since the investigated poly-
mers show a high positive charge density and in the case of the
methacrylate based polymers a hydrophobic backbone, several elu-
ent compositions and three different membranes were evaluated,
namely: a regenerated cellulose (RC), a  cellulose triacetate (CTA),
and  a polyvinylidenediﬂuoride (PVDF) membrane. As eluents water
with different amounts of sodium chloride, sodium azide, sodium
hydroxide, and solutions containing urea as chaotropic agent were
investigated. Additionally, an acetate as well as an ammonia buffer
at different pH values and ionic strength were studied. On PVDF and
CTA  based membranes, strong sample interactions were observed,
leading to peak deformation and broadening (SI-III). This behav-
ior  was independent of the ionic strength, which was  varied
from 0 to 150 mM  NaCl. In particular, CTA membranes with a
MWCO  < 10 kg mol−1 and PVDF membranes (MWCO  30 kg mol−1)
showed large deviations between different batches. These ﬁndings
can probably be attributed to a  non-uniform pore size distribu-
tion. The best results were obtained using a  RC membrane with a
MWCO  of 10 kg mol−1 and water containing 0.02% NaN3,  to avoid
bacterial growth, as eluent. The isoeletric point of this membrane
is  around 3.4, so that it is negatively charged at pH > 3.4 and posi-
tively charged at pH <  3.4 [31].  At neutral pH, this causes attractive
Fig. 2. AF4  fractogram with the  corresponding cross-ﬂow rate  and molar masses of
B-PEIcom.
electrostatic interactions between the negative surface of the mem-
brane and the positive charges in the polymer, and consequently
leads to the adsorption of polymer chains onto the surface of a
fresh RC membrane after the ﬁrst injection. During further injec-
tions repulsive forces occur between the now positively charged
membrane surface and the sample, leading to reduced interactions
and fast retention [32].  Taking this into account, the polyelectrolyte
saturated RC membrane was used to determine the molar mass of
all polymers investigated in this study.
3.2. Poly(ethylene imine) (PEI)
PEI is a well-known cationic polymer and used in several appli-
cations, e.g. for waste water treatment [33],  as ﬂocculant in paper
industry [34],  and it is  of  high interest in the ﬁeld of gene deliv-
ery [35].  PEI is widely applied for the delivery of plasmid DNA as
well as mRNA or  siRNA [36–38]. Different architectures and molar
masses are available, but typically, linear or hyperbranched struc-
tures with molar masses of around 25 kg mol−1 were used [39,40].
Here, two  commercially available PEIs, a linear (L-PEIcom) and a
branched (B-PEIcom),  with a  given molar mass (Mw) of around
25 kg mol−1 as well as a  tailor-made linear PEI (L-PEI600) with a
theoretical molar mass (Mn) of around 26 kg mol−1 were charac-
terized. The results obtained by AF4-MALS and the Zimm-plot are
shown in Table 1.  A representative AF4 fractogram of B-PEIcom is
shown in Fig. 2 (for L-PEIs see SI-IV). In the case of B-PEIcom a com-
plete separation between the void peak and the main peak was
observed, whereas for both L-PEIs no full baseline separation was
possible. This was  also the case at higher cross-ﬂows (data not
shown). The measured values agree well to the data provided by
the manufacturers and the PDI values are in the known range for
hyperbranched and linear PEIs [6]. For B-PEIcom the Mn obtained by
AF4  (13.4 kg mol−1) is  higher compared to the value given by the
manufacturer (10 kg  mol−1). This deviation is  probably due to the
MWCO  of the RC membrane (10 kg mol−1), which can lead to a  loss
of  low molar mass species through the membrane. For the L-PEI600
the Mn (24.3 kg mol−1) obtained by AF4-MALS differs only slightly
Table 1
Molar masses given by  the manufacturers and values obtained by AF4 for PEI.
Sample Molar mass/kg mol−1 Mn (AF4)/kg mol−1 Mw (AF4)/kg mol−1 PDI (AF4)
B-PEIcom 10.0 (Mn)a, 25.0 (Mw)b 13.4 ± 1.4 25.4  ± 1.2 1.91
L-PEIcom 25.0 (Mw)b 19.9 ± 1.5 26.1  ± 1.3 1.31
L-PEI600 26.0 (theoretical Mn)c 24.3 ± 2.7 32.0 ± 2.7 1.32
a Obtained by SEC as speciﬁed by the  manufacturer.
b Obtained by light scattering as speciﬁed by the manufacturer.
c Calculated from the M/I  ratio used for the  synthesis of the  PEtOx precursor.
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Table 2
Molar masses given by the manufacturers and values obtained by AF4  of PLL.
Sample Molar mass/kg mol−1 Mn (AF4)/kg mol−1 Mw (AF4)/kg mol−1 PDI (AF4)
PLL-1 15–30 (M)a 16.8 ± 0.7 20.9 ± 0.8 1.25
PLL-2 30–70 (M)a 23.4 ± 1.86 30.8 ± 2.9 1.32
a Obtained by viscosity as speciﬁed by the  manufacturer.
from the theoretical Mn (26 kg mol−1), which is  calculated from
the monomer to initiator ratio (M/I) used for the synthesis of the
poly(2-ethyl-2-oxazoline) (PEtOx) precursor. This slight difference
probably derives from difﬁculties in adjusting the M/I  ratio. For high
molar masses only a  very small amount of initiator is required in
comparison to the monomer, which results in an increased weigh-
ing error. Taking the refractive index increment into account, the
studied PEIs reached the lower detection limit of the MALS detec-
tor  (low signal to noise ratio) for calculation of molar masses from
the Zimm plot. In particular, linear PEIs with lower molar masses
(<10 kg mol−1) did not show a  reliable light scattering signal, which
can  be distinguished from the baseline (data not  shown). A molar
mass of 15–20 kg mol−1 was found to be the acceptable minimum
for  L-PEI. For these low molar mass polymers the radius of  gyration
could not be obtained. Here, the minimum is around 8–10 nm [41].
3.3.  Poly(l-lysine) (PLL)
Another class of polymers with high importance for industrial
and  research applications is  the polyamino acid poly(l-lysine)
(PLL). It is widely used for the preparation of surfaces for cell
attachment, as preservative in food products, and also as polyplex
forming carrier in the ﬁeld of  gene delivery [3,42–44].  In this study,
PLLs of two different molar masses were investigated. The results
obtained by AF4-MALS are shown in Table 2.  Fractograms of PLL-1
and PLL-2 are shown in Fig. 3  and SI-V, respectively. While the
values obtained for PLL-1 are in accordance with the data provided
by the supplier (15–30 kg mol−1, measured by viscosity), the molar
masses by AF4 for PLL-2 are lower (Mn 23.4 kg mol−1),  compared
to the given speciﬁcation (30–70 kg mol−1,  measured by viscosity).
Two explanations are conceivable. First, the data obtained by
viscosity are limited to the accurate determination of the constants
in  the Kuhn-Mark–Houwink–Sakurada equation (5)  and, second,
some kind of polymer degradation could occur. It should also be
noted that the lower detection limit of the light scattering signal
for accurate measurement of the molar mass is  reached for PLL-1,
resulting in a low signal to noise ratio. However, the data show that
Fig. 3. AF4 fractogram with the corresponding cross-ﬂow rate and molar masses of
PLL-1.
AF4 is  still applicable for the analysis of this kind of biodegradable
polymers even if they have a  low molar mass.
3.4.  Methacrylate based polymers
The third class of polymers, investigated in this study, is  based
on  polymethacrylates. Within this class, polymers with primary,
secondary and tertiary amino groups in the side chain were inves-
tigated, namely PAEMA, PtBAEMA, and PDMAEMA (Fig. 1).  In
particular, PDMAEMA is  well-known for gene delivery applications
[45,46] and was, therefore, further investigated at  four different
molar masses. All methacrylate based polymers were successfully
characterized by AF4. A representative fractogram of PDMAEMA500
is  shown in Fig. 4 (for PAEMA, PtBAEMA and the other PDMAEMAs
see SI-VI). Reliable molar masses and, even more importantly, PDI
values were obtained (Table 3).  For comparison with traditional
chromatography methods, analysis was additionally performed on
a  common SEC-RI system with DMAc/LiCl as eluent and  polystyrene
as  calibration standard. It was  found that the obtained molar mass
(SI-II)  differs signiﬁcantly from the results obtained by AF4. This
ﬁnding is ascribed to the lack of a  suitable standard and the use
of a  MALS detector similar as for AF4 would circumvent this prob-
lem.  However, this does not solve the problem of polymer-column
interactions which can occur for this kind of polymers, as shown
for PtBAEMA170 in SI-VII. Since interactions were present at  both,
AF4  and SEC, the general statement that AF4 shows less interac-
tions than SEC cannot be abiden for these cationic polyelectrolytes.
To verify the AF4 data, 1H  NMR  and AUC were applied (Table 3).
As  a standard method to determine Mn, end group analysis by 1H
NMR  was performed by comparison of the integral, in this case
the aromatic RAFT end group and the integrals from the repeating
units  in the polymer. Unfortunately, this method is  limited to rela-
tively low molar masses, as the integral volumes of the end group
decreases with increasing degree of polymerization. A typical 1H
NMR  spectrum for PDMAEMA320 synthesized via RAFT is  shown in
SI-VIII. In addition to 1H NMR  spectroscopy, AUC was applied. It is  as
a  powerful technique for characterization of macromolecules and
Fig. 4. AF4  fractogram with the corresponding cross-ﬂow rate and molar masses of
PDMAEMA500.
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Table 3
Molar masses and PDI values of the methacrylate based cationic polymers obtained by 1H NMR  spectroscopy, AUC, and AF4.
Sample Mn (NMR)/kg mol−1  a MsD (AUC)/kg mol−1 Mn (AF4)/kg mol−1 Mw (AF4)/kg mol−1 PDI (AF4)
PDMAEMA90 14.5 ± 0.2 16.3  ± 0.3 14.7 ±  0.7 16.8 ± 0.4 1.14
PDMAEMA230 36.3 ± 3.3 42.5  ± 0.2 36.1 ±  0.61 41.1 ± 0.72 1.14
PDMAEMA320 42.6 ± 1.9 65.8  ± 1.7 51.2 ±  1.9 67.3 ± 1.2 1.31
PDMAEMA500 72.3 ± 1.6 112.0 ± 2.6 80.2 ±  2.1 113.1 ± 1.0 1.41
PAEMA150 25.0 ± 0.2 27.2  ± 1.4 24.9 ±  1.2 29.1 ± 1.2 1.17
PtBAEMA170 31.2 ± 2.8 36.0 ± 0.6 29.9 ±  2.3 37.3 ± 1.3 1.25
a Measured in CD2Cl2 or D2O.
nanomedicines, such as nanoparticles or  polyplexes [47].  The molar
mass (MsD), obtained by  sedimentation velocity experiments and
the Svedberg equation (1),  is a  weight-average molar mass compa-
rable  to Mw[48]. Here, the translational diffusion coefﬁcient, which
is  measured by DLS, is  required for calculations. For an accurate
determination of the molar mass by AUC the suppression of the
polyelectrolyte effect is  of the utmost importance [48]. Therefore,
an  aqueous solution of 150 mM NaCl and  1  mM NaOH was  used
to  guaranty that the polymers are in the unionized state [49]. For
PtBAEMA170, which is not soluble under these conditions, methanol
containing 1 mM NaOH was used as solvent. The suppression of
the polyelectrolyte effect can be proven by the measurement of
the reduced viscosity as shown exemplarily for PDMEAMA500 in
SI-IX.  A linear positive slope at low concentrations indicates the
absence of any polyelectrolyte speciﬁc behavior. An overview of
the molar mass obtained by AUC can be found in Table 3.  For
PAEMA150, PtBAEMA170, PDMAEMA90, and PDMAEMA230 the molar
masses obtained by AF4-MALS are in good accordance with the
molar masses from 1H NMR  spectroscopy, AUC, and the theoreti-
cal molar masses. For the two polymers with higher molar mass
(PDMAEMA320/500),  the results from AF4 correlate well to those
by  AUC, whereas larger deviations to the molar masses obtained
by 1H NMR  were observed. These differences are probably caused
by limitations of 1H NMR  spectroscopy for high molar mass poly-
mers, as the signal integral of the used RAFT agents decreases
with increasing molar mass (M/I), resulting in a  lower signal to
noise  ratio. This results in the calculation of lower molar masses.
In  case of the synthesis of high molar mass polymers by RAFT,
also the probability of side reactions, e.g. chain termination reac-
tion, increases, affecting the end group ﬁdelity (not each chain
has  the speciﬁc RAFT end group). Here, AF4-MALS is  more reli-
able since the accuracy in light scattering increases with increasing
size  and molar mass. An  advantage of AF4 over AUC is  the reduced
measurement time. Moreover, less material is  required for the mea-
surements and information about the polydispersity can easily be
obtained.
Since the molar masses of the investigated PDMAEMA polymers
ranges from around 15 to 80 kg mol−1, larger differences between
the retention times of the different polymers were expected, as
their diffusion coefﬁcients differ remarkably. However, this was
not the case. All polymers show similar retention times or just
slight changes (Fig. 4  and  SI-VI). This indicates that the elution is
highly inﬂuenced by other forces, than cross-ﬂow and  diffusion,
leading to a certain equilibrium height in the channel. Probably the
repulsive electrostatic forces between the positive charges on the
surface and the sample in solution govern the retention. This leads
to a larger equilibrium height of the polymer and results in a faster
elution due to the higher ﬂow velocity in the center of the chan-
nel. This assumption is supported by the observation that a  change
of  the cross-ﬂow rate (up to 6  mL  min−1) only slightly inﬂuenced
the  retention time (data not shown). To gain further informa-
tion on the interactions and the conformation of PDMAEMA,
the high molar mass PDMAEMA500 was investigated in more
detail.
3.5. Inﬂuence of  sample concentration and ionic strength
As  already mentioned, the choice of eluent and  its composition
essentially inﬂuences the retention behavior in AF4. In  particu-
lar, for charged samples, like polyelectrolytes, the ionic strength
of the solvent plays an important role for the interactions in the
separation channel. An  increase of ionic strength results in a reduc-
tion of the range of attractive or  repulsive electrostatic forces
(Debye length) and can, therefore, be used to adjust the interactions
between the polymer or colloid itself and the interactions between
the polymer and the membrane surface. To investigate this effect
on the retention behavior, PDMAEMA500 was  studied at different
concentrations of NaCl (5–150 mM) by AF4 (Fig. 5).  The applied sep-
aration method was the same as for molar mass determination of
all methacrylate based polymers. It was found that the retention
time is shifted to higher values with increasing concentration of
NaCl or ionic strength, respectively. The recovery rate increased
slightly from around 80% at  5 mM to 84% at 150 mM  NaCl. Addi-
tionally, a peak broadening with a shoulder in the beginning and
at  the end was  observed. At  salt concentrations higher than 50 mM
NaCl, the retention time and the peak shape does not change sig-
niﬁcantly, except small alterations of the shoulder at  the end. This
can probably be attributed to the switch-off of the cross-ﬂow at
25 min  and was a  general observation for different polymers and
methods. The molar masses obtained at different concentrations
of  NaCl are identical and show no deviations therefore, exclud-
ing the possibility of the degradation or alteration of the sample.
The shift in the retention time is a further indication of the domi-
nating effect of electrostatic interactions at low ionic strength. As
mentioned above (3.1), the fresh membrane surface is  saturated
with cationic PDMAEMA500 after the ﬁrst run, as indicated by a
lower recovery rate of 70% in contrast to around 80% for subsequent
runs. The repulsive long-ranged electrostatic interactions between
0 5 10 15 20 25 30 35 40 45 50
0.20
0.22
0.24
0.26
0.28
0.30
0.32
R
I S
ig
na
l /
 V
Time /mi n
PDMAEMA500, 340  μg
 5 mM Na Cl
 10  mM  Na Cl
 20 mM NaCl
 50  mM  Na Cl
 15 0 mM  NaC l
Fig. 5. AF4 fractograms (RI)  of PDMAEMA500 at different concentrations of NaCl
present in the  eluent.
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mer  mass.
the positive formulated surface and the cationic polymer lead to a
movement of the sample in a  certain distance to the membrane,
resulting in a faster elution, caused by a  higher ﬂow velocity in the
center of the channel compared to the accumulation wall. With
increasing ionic strength, the long-ranged electrostatic forces are
more shielded and the sample could move closer to the membrane
[50], facilitating other short-ranged interactions such as Van-der-
Waals or hydrophobic interactions. In particular, the hydrophobic
backbone of PDMAEMA chains on the membrane surface and in
the  sample, lead to attractive interactions and can explain the late
elution at high ionic strength and the peak broadening/tailing.
The  amount of the polymer sample was altered to evaluate in
detail the possible limitations of the determination of the molar
masses by AF4. It is  known that the volume injected into the
channel can inﬂuence the retention time and the peak shape, if
overloading occurs [4]. In general, the overloading depends on the
focusing of the sample zone. If the concentration of the sample in
the  zone becomes too high some molecules are excluded, which
leads to the broadening of peaks. Also intermolecular interactions
will increase and can start to affect the elution. In general, the over-
loading starts to take place at  a certain critical concentration which
decreases with increasing molar mass. Also for low molar mass
samples, where a  relative high amount of sample is necessary for
a  reliable light scattering signal, this effect has to be taken into
account. In general, it  could be observed that polyelectrolytes elute
earlier with increasing sample load, whereas neutral polymers in
aqueous solution show an increase of  retention time [4,51].  Addi-
tionally, a peak distortion and zone broadening is  widely described
in literature [14,52]. For polyelectrolytes, overloading is  mainly
inﬂuenced by electrostatic repulsion, both, inter/intra-molecular
and between sample and membrane. With increasing charge the
critical concentration is reduced and the sample is repelled from
the accumulation wall. Overloading is also inﬂuenced by the ionic
strength. An increase of the ionic strength suppresses electrostatic
forces and, therefore, reduces the excluded volume of the chains,
the  chain expansion, and the electrostatic repulsion from the mem-
brane. To see if any effect of the peak distortion was caused by
sample overloading [52], the AF4 experiment with PDMAEMA500
in 50 mM NaCl was repeated with different amounts of injected
polymer mass. As shown in Fig. 6, a  slightly higher retention time
was found for the lowest amount of PDMAEMA500,  which is  typi-
cally observed for charged polymers and in accordance with other
studies mentioned above. It also indicates that polyelectrolyte
effects are still present. This is in agreement with measurements
of reduced viscosity (SI-IX), showing the presence of such effects
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Fig. 7.  Mark–Houwink exponent of PDMAEMA500 at different concentrations of
NaCl obtained by AF4.
even at  150 mM NaCl. However, the peak shape does not depend
on  the injected amount of sample for the investigated range. The
recovery rate for all amounts of sample is  constant at 83%, a value,
which is also typically observed for polyelectrolytes [53].  Molar
masses obtained from the light scattering signal are similar for
all  amounts of injected masses. Taking all results into account,
overloading seems to be slightly present, but does not  affect the
characterization of the polymers.
3.6. Conformational investigations using AF4
It  was expected that not only the interactions between differ-
ent polymer chains (intermolecular) and between the polymer and
the  membrane, but also the intramolecular interactions vary with
the ionic strength and, therefore, inﬂuence the conformation of the
macromolecule [53].  The conformation of a  macromolecule can be
described by the exponent of the Kuhn–Mark–Houwink–Sakurada
equation or the so called power-law-relationships (5), where the
molar mass (M) is  combined, e.g. with the radius of gyration (Rg),
the sedimentation coefﬁcient (s0),  the diffusion coefﬁcient (D0) or
the intrinsic viscosity ().
X  =  KMv (5)
log X  =  log  K  + v  ∗  log M (6)
Here, X  =  Rg,  s0,  D0 or  []. In AF4-MALS, the exponent (v) is cal-
culated as the slope in a  log–log plot of the radius against the
molar  mass of each slice, as illustrated in SI-X for PDMAEMA500 in
150  mM NaCl. A slope of 0.56 was  found, which ﬁts well to the typ-
ical  range for a  linear chain (0.5–0.7). The dependency of the slope
(v), or  the conformation of the polymer chain is  related to the ionic
strength as shown in Fig. 7.  At  low ionic strength (5 mM)  a value of
around 0.91 is obtained, which decreases to 0.56 at  150 mM NaCl.
Moreover, it can be observed that even above a NaCl concentra-
tion  of 50 mM the conformation still changes. In contrast, the ionic
strength dependent fractograms (Fig. 5) showed a constant reten-
tion  time and peak shape above 50 mM NaCl. This indicates that
no  relevant (detectable) changes in hydrodynamic radius (RH) or
interactions with the membrane occurred. This observation clearly
illustrates the differences between inter/intra-molecular interac-
tions of the polymer chains and interactions with the membrane.
While an exponent v of 1  describes a rod like structure and a value
of 0.33 a sphere, a  value of 0.9 was  typically observed for elongated
structures [54,55]. It is assumed that this is caused by the
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Fig. 8. AF4 fractograms of PDMAEMA500 in different buffers: 50 mM  acetate, 50 mM
NaCl, pH 3.0, 50 mM NH3/NH4Cl, 50 mM NaCl, pH  11.0 and 50 mM  NaCl.
electrostatic repulsion of the positive charges present in the side
chain. With increasing ionic strength, the charges are screened and
the  range of the electrostatic forces is diminished. This reduces the
repulsion between the side chains and leads to a  conformation sim-
ilar  to a Gaussian chain, as indicated by an exponent of around
0.56.
The power-law-relationships were also applied to the data of
the  sedimentation and diffusion coefﬁcients for all  PDMAEMAs
(SI-XI). Here, a value of 0.39 for the sedimentation and value of
−0.62  for the diffusion coefﬁcient was obtained. Both exponents
are  in the limits for a  Gaussian chain (0.35–0.5 for s and −0.5
to −0.7 for D). Since the sedimentation velocity is more sensi-
tive to the polyelectrolyte effect (molar mass obtained by Eq.
(3)), the polymers should be in the unionized state [48].  For this
reason, the sedimentation velocity and dynamic light scattering
experiments were conducted in 150 mM NaCl +  1  mM NaOH. The
polyelectrolyte effect is  even present at neutral pH and 150 mM
NaCl, as shown by measurements of the reduced viscosity (SI-
IX). Fortunately, this does not  seem to affect the determination
of  the molar mass by  AF4-MALS. Moreover, a  separation before
the light scattering measurement has a  time-related advantage,
in particular for the characterization of polymers using AF4. Pro-
viding that the sample polydispersity is  not  too low, information
about the conformation of the macromolecule can be obtained from
a  single experiment. In contrast, traditional techniques (e.g. sedi-
mentation, diffusion or viscosity) to study the conformation require
synthesis and analysis of a  variety of polymers of different molar
masses.
3.7. Inﬂuence of the pH value
For charged colloids, e.g. proteins, with positive and nega-
tive charges or polyelectrolytes with just one type of charge,
the pH value of the solvent dramatically inﬂuences the structure
of the sample. The pH primarily affects the protonation of the
functional groups and, therefore, the appearance of charges, in a
synthetic or biological macromolecule. For the characterization of
PDMAEMA500 by AF4 two other pH regions, an  acidic and a  basic,
were investigated. First, a pH value of 3.0 was chosen (50 mM
acetic acid/sodium acetate and 50 mM NaCl). As the isoelectric
point (IEP) of a fresh RC membrane is  around 3.4, the cellulose is
expected to be positively charged at pH 3  [31].  The second region of
interest was pH 11, where PDMAEMA is  nearly unionized (50 mM
ammonia/ammonium chloride buffer and 50 mM NaCl). The results
obtained at pH 3.0 show a  molar mass distribution similar to pre-
vious results (Fig. 8).  In addition, a  small shift in the retention time
and a  peak deformation was  observed. By comparing both frac-
tograms (neutral pH and pH 3)  at 50 mM NaCl, it is  obvious that
the retention behavior seems not to be inﬂuenced by the pH value.
Probably the repulsive electrostatic forces at  this ionic strength are
shielded and short-ranged interactions, caused by  the hydrophobic
backbone or van-der-Waals interactions, dominate the retention,
even at pH 3.
The situation is more complex at pH  11, where PDMAEMA is in
the  unionized state. The retention time is slightly shifted to higher
values but the progression of molar mass shows an irregular behav-
ior  at 26 min  (Fig. 8).  This might be caused by massive interactions
of  the hydrophobic backbone with the membrane or the tubes of
the AF4 system, since the molecule is  uncharged at pH 11 and no
repulsive electrostatic interactions are present. An aminolysis of
the ester groups in the PDMAEMA polymer seems to be unlikely
for the applied NH3 concentration (50 mM)  and  temperature. From
a  practical point of view, the observed effect of decreasing molar
mass just appears at the end of the peak where the concentration
is rather low and does not inﬂuence the molar mass distribution
noticeably. Nevertheless, further experiments are necessary to elu-
cidate the origin of this effect and  to exclude that it is caused by
irregular changes of the membrane surface by the buffer used in
the experiment.
4. Conclusion
In  this study, the characterization of cationic polymers, which
are  of great interest for gene delivery and numerous indus-
trial applications, by asymmetric ﬂow ﬁeld-ﬂow fractionation
(AF4) was  presented for the ﬁrst time. It could be shown
that AF4 coupled to multi-angle light scattering enables a fast
and reliable determination of molar masses and PDI values of
polymers such as poly(ethylene imine), poly(l-lysine) and poly(2-
(dimethylamino)ethyl methacrylate) and its derivatives. For the
validation of the results, 1H NMR  spectroscopy and AUC  were
applied. It was  found that the lower molar mass limit, which yields
a  reliable light scattering signal, was around 15 kg mol−1, depend-
ing on the refractive index increment. For polymers with a  lower
molar mass 1H  NMR  spectroscopy or AUC is recommended. With
increasing molar mass the accuracy of AF4-MALS increases and
becomes more adequate, due to the fact that information about
polydispersity, different mass averages and conformation can be
obtained from a single measurement.
Furthermore, different membranes and eluents were evaluated
for AF4 and the inﬂuence of ionic strength, injected mass of the
analyte, and pH value was  investigated. It could be shown that the
retention behavior at  low ionic strength is  probably dominated by
repulsive electrostatic forces between the polymer, adsorbed on
the membrane surface, and the sample. In contrast, hydrophobic
or  other short-ranged interactions are important at higher ionic
strength. Both diminish the advantage of AF4 to show less inter-
action with the sample than column based techniques. Up to now,
no  ideal membrane material was found for these cationic polyelec-
trolytes. Additionally, the conformation of PDMAEMA was studied
by power-law-relationships in dependence of the ionic strength. It
was found that the exponent, v,  decreases from 0.91 at 5 mM NaCl
to  0.56 at 150 mM NaCl, which probably describes the conforma-
tional change from a stretched chain to a  linear Gaussian chain. The
recovery rate of around 80% was  in the typical range for cationic
polymers. In summary, we  could successfully present that AF4 is  a
well-suitable method for the characterization of cationic polymers,
with respect to their molar masses, PDI values, and conformational
information within short time and requiring only low amounts
of  samples. This enables a  more detailed investigation of  cationic
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polymers used for further applications, e.g. for the formation of
polyplexes in gene delivery.
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SI-I: Synthesis L-PEI600 
A solution of dry acetonitrile (Acros Organics, Geel Belgium), 2-ethyl-2-oxazoline (monomer), and 
methyl tosylate (initiator) was prepared with a total monomer concentration of 4 M and a total 
monomer-to-initiator ratio of 600 as recently published.[1] The mixture was heated in a microwave 
synthesizer at 140 °C for a pre-determined time. A sample was taken and full monomer conversion 
was confirmed by 1H NMR spectroscopy. Subsequently, the solvent was removed. The resulting 
PEtOx (Mn = 40.6 kg·mol-1, PDI = 1.79, 3.8 g) was dissolved in 6 M aqueous hydrochloric acid (15 
mL) and heated at 130 °C for 1 h in the microwave synthesizer. After removing the acid under reduced 
pressure, the residue was dissolved in water and 3 M aqueous NaOH was added until precipitation 
occurred. The precipitate was filtered off, recrystallized from water, filtered, dissolved in methanol, 
and precipitated into ice-cold diethyl ether. Subsequently, the L-PEI600 was dried for 3 day at 40 °C. 
The degree of hydrolysis was 99% as determined by 1H NMR spectroscopy. 
1H NMR (300 MHz, CD3??????????????????CH2-OH), 2.73 (br., N-CH2), 2.39 (s, CH3-N). 
SI-II: Synthesis PDMAEMA, PAEMA and PtBAEMA via RAFT 
In a typical polymerization experiment, 1.258 g of DMAEMA (8.0 × 10–3 mol), 2.8 mg of ????-
azobis(4-cyanopentanoic acid), ACVA, initiator (1.0 × 10–5 mol), 11.18 mg of 4-cyano-4-
(phenylcarbonothioylthio) pentanoic acid (used as a CTA) RAFT agent (4.0 × 10–5 mol) and 
ethanol/water (in total 50/50 vol%) were mixed together in a 10 mL glass vial as follows DMAEMA 
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monomer, followed by individual stock solutions of initiator and RAFT agent dissolved in ethanol and 
filled with water up to a ratio of 50/50 vol%. The ratio between [CTA] and [AIBN] was 1:0.25. Before 
closing the vial, the reaction solutions were degassed by sparging argon for at least 30 min prior to 
use. Subsequently, the reaction was performed in an oil bath at 70 °C for 12 h keeping a total 
monomer concentration of 2.0 M or 3.0 M. After the polymerization, acetone was added to the final 
mixtures, and the polymers were subsequently precipitated into cold diethyl ether. The utilized 
reaction conditions, monomer concentration and [M]/[CTA] ratios are summarize in Table 1. In the 
case of PDMAEMA-90 the 1,1'-azobis(cyclohexane carbonitrile) initiator and as RAFT agent the 4-
cyano-4-[(dodecylsulfanylthiocarbonyl) sulfanyl]pentanoic acid were used. 
Table 1: Overview of the selected reaction conditions and SEC data of methacrylate based polymers. 
Sample amine [M]/[CTA] c / M Mn (SEC) / kg·mol-1 PDI (SEC) 
PDMAEMA90 tert. 100/1 3.0 15.2[a] 1.21 
PDMAEMA230 tert. 200/1 2.0 25.7[a] 1.34 
PDMAEMA320 tert. 600/1 3.0 47.2[a] 1.35 
PDMAEMA500 tert. 1200/1 3.0 66.9[a] 1.37 
PAEMA150 prim. 200/1 2.0 77.8[b] 1.15 
PtBAEMA170 sec. 200/1 2.0 37.8[a] 1.25 
[a] Calculated from SEC (DMAc) using PS calibration. [b] Calculated from aqueous SEC (CF3COOH/NaCl/pH 2.3) using 
Pullulan calibration. 
 
SI-III: AF4 fractogram of PDMAEMA500 on a 10 kg·mol-1 CTA and 30 kg·mol-1 PVDF 
membrane and 150 mM NaCl as eluent. 
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SI-IV: AF4 fractograms with the corresponding cross-flow rates and molar masses of (A) 
L-PEIcom, and (B) L-PEI600. 
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SI-V: AF4 fractograms with the corresponding cross-flow rates and molar masses of PLL-2. 
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SI-VI: AF4 fractograms with the corresponding cross-flow rates and molar masses of (A) 
PAEMA150, (B) PtBAEMA170, (C) PDMAEMA90, (D) PDMAEMA230, and (E) PDMAEMA320. 
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SI-VII: SEC results of PtBAEAMA170 with DMAc/LiCl as eluent and polystyrene as calibration 
standard. 
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SI-IX: Measurement of reduced viscosity for PDMAEMA500 
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SI-X: Conformation plot of PDMAEMA500 in 150 mM NaCl obtained by AF4-MALS. 
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SI-XI: Log-log plots of (A) s0 and (B) D0 against the different molar masses of PDMAEMA in 
150 mM NaCl + 1 mM NaOH. 
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ABSTRACT: A series of copolymers containing both amine
groups of linear poly(ethylene imine) (LPEI) and double
bonds of poly(2-(3-butenyl)-2-oxazoline) (PButEnOx) was
prepared. To this end, a poly(2-ethyl-2-oxazoline) (PEtOx)
precursor was hydrolyzed to the respective LPEI and
functionalized in an amidation reaction with butenyl groups
resulting in the double bond containing poly(2-(3-butenyl-2-
oxazoline)-co-ethylene imine) (P(ButEnOx-co-EI)). Hydrogels
were obtained by cross-linking with dithiols under UV-
irradiation resulting in networks with diﬀerent properties in
dependence of the content of double bonds. The developed method allows the exact control of the amount of ethylene imine
units within the copolymer and, thus, within the resulting hydrogels. The gel structures were characterized by solid state NMR
and infrared spectroscopy. In addition the water uptake behavior from the liquid and the gas phase was investigated. It was shown
by an ethidium bromide assay (EBA) that the copolymers and the respective hydrogels were able to bind and release DNA.
Furthermore, the inﬂuence of the ethylene imine content on this interaction was investigated.
■ INTRODUCTION
The fast and eﬃcient detection of pathogenes is of tremendous
interest nowadays, ranging from applications in agriculture to
medicine. Each species of pathogen carries a unique set of DNA
and RNA sequences, which can be potentially detected by
hybridization with another DNA strand containing comple-
mentary nucleic acid sequences. This approach is exploited by
DNA biochips that consist of DNA sequences covalently
bound/attached to solid substrates like glass,1,2 silicon, gold,3 or
polymers such as poly(methyl methacrylate).4 However, an
essential prerequisite for a successful detection is the isolation
and puriﬁcation of nucleic acids from highly complex samples,
such as blood and feces.5 For this purpose, materials that can
speciﬁcally and reversibly bind genetic materials are of
signiﬁcant interest. In this context, the interaction between
DNA and cationic polymers has been investigated intensely. In
particular, poly(ethylene imine) (PEI) has been widely studied,
since its amine groups interact eﬀectively with the DNA/RNA
phosphate groups, forming a so-called polyplex.6−11
The major drawbacks of two-dimensional DNA chips are the
limited loading capacity of surface materials and the restricted
hybridization eﬃciency.12,13 An alternative approach, over-
coming these issues, is the reversible binding of genetic
materials within a three-dimensional network. In this way a
considerable increase of the loading capacity compared to a
two-dimensional system can be achieved.14,15 A special class of
three-dimensional networks are the so-called hydrogels.
Although insoluble in any solvents, they can incorporate
water up to a multitude of their own mass. This property allows
the encapsulation and rapid diﬀusion of DNA molecules inside
the network. The immobilization of DNA and other
biomolecules within hydrogel-like structures has been recently
the topic of intensive research.16−19
In this contribution we focus on the synthesis of three-
dimensional networks based on linear poly(ethylene imine)
(LPEI). The most common method for the formation of PEI-
based hydrogels is the cross-linking of the amine groups using
difunctional compounds like diglycidyl ethers or diisocya-
nates.20−26 However, due to the insolubility of the network, it is
not possible to determine the amount of amine groups that
remain after the cross-linking process. For the binding and
release of genetic material, it is essential to know the exact
amount of amine groups. Hence, it is desirable to perform the
cross-linking without decreasing the amine binding sides. To
this end, a second functionality needs to be incorporated into
the hydrogel precursor, which can be exploited for cross-
linking. Possible candidates could be partially hydrolyzed
double bond bearing poly(2-oxazoline)-based homo- and
copolymers.27 However, the double bonds of poly(2-(3-
butenyl)-2-oxazoline) (PButEnOx)28−30 and poly(2-(9-decen-
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yl)-2-oxazoline) (PDecEnOx)31−33 based polymers do not
stand the harsh hydrolysis conditions required to cleave of the
oxazoline side chains. To overcome this problem, the alkene
functionalities have to be introduced subsequently to
hydrolysis.
This report introduces a new route to obtain LPEI-hydrogels
with an adjustable amount of amine groups. To this end, we
have synthesized an eight-membered library of poly(2-(3-
butenyl)-2-oxazoline-co-ethylene imine) (P(ButEnOx-co-EI)
copolymers by reaction of LPEI with N-succinimidyl-4-
pentenate. Subsequent cross-linking via thiol−ene photo-
addition leads to the formation of LPEI-containing hydrogels
with a predetermined amount of amine groups.
Both the copolymers and the hydrogels are characterized by
means of NMR and IR spectroscopies. The synthesized systems
are investigated regarding their structure and swelling ability.
The DNA interaction of the copolymers and the hydrogels is
studied using the ethidium bromide assay (EBA; DNA binding)
and a heparin assay (DNA release).
■ EXPERIMENTAL SECTION
Materials. PEtOx (50,000 g/mol), pyridine, 4-N,N-dimethylami-
nopyridine (DMAP), ethanol, 3,6-dioxaoctane-1,8-dithiol, and 2,2-
dimethoxy-2-phenylacetophenone (DMPA), and genomic DNA
sodium salt from herring testes (gDNA) were obtained from Sigma
Aldrich. Ethidium bromide solution (1%) was purchased from Carl
Roth (Karlsruhe, Germany). N-Succinimidyl-4-pentenate was prepared
according to literature procedures.28
General Methods and Instrumentation. The hydrolysis of
PEtOx was performed under microwave irradiation in an Initiator Sixty
single-mode microwave synthesizer from Biotage, equipped with a
noninvasive IR sensor (accuracy 2%). 1H NMR spectra were recorded
at room temperature using a Bruker AC 300 MHz spectrometer or a
Bruker AC 250 MHz spectrometer, respectively. 13C NMR was
recorded at 100 MHz. Chemical shifts are reported in parts per million
(ppm, δ scale) relative to the residual signal of the deuterated
methanol. Solid state NMR measurements were performed on a
Bruker Avance 400 spectrometer. The dry hydrogels were measured
with 4 mm zircon-oxid rotors at 12.5 kHz. Swollen samples (12 h in
D2O) were measured using Kel-F rotors from Bruker-Biospin at 6.5
kHz. Tetrakis-trimethylsilylsilan (1H) and adamantan (13C) were used
as standards. 1H NMR was measured for 6 s, for 13C NMR 70000
scans were carried out. Size exclusion chromatographies (SEC) were
performed on an Agilent Technologies 1200 Series gel permeation
chromatography system equipped with a G1329A autosampler, a
G131A isocratic pump, a G1362A refractive index detector, and both a
PSS Gram 30 and a PSS Gram 1000 column placed in series. As eluent
a 0.21% LiCl solution in N,N-dimethylacetamide (DMAc) was used at
1 mL min−1 ﬂow rate and a column oven temperature of 40 °C. Molar
masses were calculated using poly(styrene) as standard. Fourier
transform infrared (FT-IR) spectra were recorded on a FT-IR
spectrometer IRAﬃnity-1 (Shimadzu) using the reﬂection method.
The water uptake measurements from the gas phase were
performed using a TGA Q5000 SA thermogravimetric analyzer from
TA Instruments Eschborn, Germany. For the data evaluation the
“Universal Analysis” software was used. The water uptake of the
hydrogels from the liquid state was measured gravimetrically. The used
ﬁlter tubes were centrifuged with a Multifuge 1S-R from Thermo
Scientiﬁc, and the swelling values (Qeq) were calculated according to
literature.34 The ﬂuorescence measurements were recorded on the
microplate reader Inﬁnite M200 PRO. The samples were excited at
525 nm and the emission was measured at a wavelength of 605 nm in a
temperature range between 25 and 30 °C. Well plates were obtained
from Sigma-Aldrich (NunclonTM Surface, 96 well, F-bottom) and
centrifuge ﬁlter tubes from Costar (Spin-X, cellulose acetate
membrane, 0.45 μm).
Microscopic detection of the DNA binding of hydrogels was
performed using a ﬂuorescence microscope (Cell Observer Z1, Carl
Zeiss, Jena, Germany) equipped with a mercury arc UV lamp and the
appropriate ﬁlter combinations for excitation and detection of
emission. The ﬂuorescence signal was captured directly in the wells.
Images of a series (11 × 11 pictures per well) were captured with a
10× objective using identical instrument settings (e.g., UV lamp
power, integration time, and camera gain) and spots of the 12-well
plate were addressed using an automated XY table.
Linear Poly(ethylene imine). Poly(2-ethyl-2-oxazoline) (50,000
g/mol, PDI = 2.0; 5.0 g) was treated with an excess of 6 M aqueous
hydrochloric acid (30 mL) for 1 h at 130 °C in a microwave
synthesizer.35 The excess of HCl and the resulting propionic acid were
removed under reduced pressure and the obtained LPEI hydrochloride
was dissolved in water. After addition of 3 M NaOH up to a pH value
of 9, precipitation occurred. The LPEI was ﬁltered oﬀ, recrystallized
from water, dissolved in methanol, and precipitated into 650 mL of
ice-cold diethyl ether. The white solid was dried at 85 °C under high
vacuum and the degree of hydrolysis was determined by 1H NMR by
correlating the integrals of the PEI backbone and the remaining methyl
group of the PEtOx side chain (yield: 3.0 g). 1H NMR (250 MHz,
MeOD): δ 2.95−2.52 (N-CH2), 1.45−0.81 (CH3 EtOx) ppm. FT-IR
(ATR): 3175 (OH, NH), 2866 (CH asym/sym str), 1485 (C−H def),
1281, 1134 (C−N str), 1045 (C−N) cm−1.
N-Succinimidyl-4-pentenate. The synthesis of N-succinimidyl-4-
pentenate was performed with minor changes according to a
procedure described earlier by Gress et al.28 4-Pentenoic acid
(30.738 g, 307 mmol) and N-hydroxysuccinimide (56.401 g, 490
mmol) were dissolved in 800 mL of dichloromethane. To the solution,
N,N′-dicyclcohexylcarbodiimide (74.334 g, 360 mmol) was added.
After stirring for 23 h at room temperature, the white precipitate was
ﬁltered oﬀ and the ﬁltrate was evaporated to dryness under reduced
pressure. The residue was dissolved in 450 mL of diethyl ether and
150 mL of water. After separation, the organic phase was washed ﬁve
times with water. The organic layer was dried over sodium sulfate and
the solvent was removed. The high viscous product was dried in high
vacuum (5 × 10−2 mbar) at room temperature for three days and
crystallized in the freezer at −18 °C for two days. The activated acid,
N-succinimidyl-4-pentenate, was obtained as a white solid (yield: 54.9
g, 91%). 1H NMR (250 MHz, CDCl3): δ 5.82 (HCCH2), 5.03
(HCCH2), 2.82 (CH2 NHS), 2.70 (CH2-CH2-CO), 2.48 (CH2-
CH2-CO) ppm. FT-IR (ATR): 2932 (CH asym/sym str), 1802
(CHCH), 1728 (CO), 1643, 1528 (C−H def), 1369, 1204 (C−
N str), 1065 (C−N str) cm−1.
Poly(2-(3-butenyl)-2-oxazoline-co-ethylene imine). The syn-
thesis is exempliﬁed by the copolymer with a 50% PEI content. LPEI
(0.475 g) and the catalyst 4-N,N-dimethylamino-pyridine (DMAP,
0.117 g, 1.0 mmol) were dissolved in a microwave vial in pyridine at 80
°C. In a second vial, a deﬁned quantity of N-succinimidyl-4-pentenate
(1 equiv per EI unit, 1.015 g, 5.2 mmol for 50% PEI) was dissolved in
the same solvent. The two solutions were combined to a 4 wt %
mixture of LPEI and stirred for 20 h at 80 °C. Afterward, the mixture
was added dropwise into 500 mL of cold diethyl ether. The
precipitated copolymer was ﬁltered oﬀ and washed with 40 mL of
diethyl ether. The residue was dried under reduced pressure to
constant weight. The side product N-hydroxysuccinimide (NHS) was
removed by dialysis in a regenerated cellulose membrane (Spectra/
Por, Rancho Dominguez, CA, molar mass cutoﬀ 3500 g/mol) against
water. 1H NMR (250 MHz, MeOD): δ 6.00−5.74 (HCCH2),
5.18−4.93 (HCCH2), 3.79−3.36 (NR-CH2-CH2), 3.12−2.61 (NH-
CH2-CH2), 2.63−2.59 (NHS), 2.60−2.17 (CH2 ButEnOx), 1.41−0.80
(CH3 EtOx) ppm, PEI = 50%. SEC (DMAc, LiCl): Mn = 10700 g·
mol−1, PDI = 1.44. FT-IR (ATR): 3280 (OH, NH), 2870 (CH asym/
sym str), 1640 (CO), 1420 (C−H def), 1240 (C−N str), 1080 (C−
N str) cm−1.
Poly(2-(3-butenyl)-2-oxazoline-co-ethylene imine)-Based
Hydrogel. The synthesis is exempliﬁed by the gel starting from the
50% PEI containing copolymer described above. In a microwave vial,
poly(2-(3-butenyl)-2-oxazoline-co-ethylene imine) with 50% PEI
content (0.103 g) was dissolved in ethanol. In a second vial, the
Biomacromolecules Article
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photoinitiator 2,2-dimethoxy-2-phenylacetophenone (0.013 g, 0.05
mmol) and the bis-functional thiol, 3,6-dioxaoctane-1,8-dithiol (45 μL,
0.28 mmol), were dissolved in ethanol (0.9:1.0 thiol/double bond).
The combined solutions (10 wt %) were degassed with nitrogen for 30
min. Afterward, the clear solution was exposed to UV light (365 nm)
for 24 h. The occurring gelation announced the successful synthesis of
a three-dimensional network. Subsequently, the obtained gel was
washed several times with ethanol (150 mL) and water (150 mL) for
20 min, respectively, and dried by lyophilization.27,32
Swelling Value. Qeq 74%. Solid state
13C NMR (100 MHz): δ
173.5, 138.6, 116.4, 71.1, 47.7, 39.4, 32.3 ppm. Solid state 1H NMR
(400 MHz, swollen state): δ 5.94 (HCCH2), 5.12 (HCCH2),
4.37−3.25 (N-CH2, CH2 EDDET), 3.30−2.07 (CH2 ButEnOx, CH2-
S-CH2), 2.02−1.22 (RS-CH2-CH2-CH2) ppm. FT-IR (ATR): 3294
(OH, NH), 2886 (CH asym/sym str), 1636 (CO), 1421 (C−H
def), 1367, 1292, 1234, 1103 (C−N str), 1038 (C−N str) cm−1.
Ethidium Bromide Assay (EBA) of P(ButEnOx-co-EI) and
Release Studies. The interaction between genomic DNA (gDNA)
and cationic copolymers was detected by ﬂuorescence measurements.
The EBA was carried out by a procedure adapted from literature.19
gDNA (7.5 mg mL−1) and EB (0.4 mg mL−1) were dissolved in HBG-
buﬀer (HEPES buﬀered glucose, pH 7) and incubated for 10 min at
room temperature. A total of 100 μL of the gDNA-EB solution were
transferred to the wells of a black 96-well plate containing copolymers
at deﬁned concentrations (N/P ratios) with diﬀerent PEI contents.
Fluorescence was measured after 15 min of incubation in a repeat
determination. A mixture containing only gDNA, EB, and HBG buﬀer
served as calibration standard.
For release studies, 100 μL of the gDNA-EB solution were
transferred to a well-plate as described above and the copolymers (3.6
μL of a 1 mg mL−1 stock solution, respectively) were added. After
incubation, the ﬂuorescence was measured and deﬁned as start value.
Subsequently, 10 μL of a heparin stock solution (3 mg mL−1) was
added to each of the samples and the ﬂuorescence was measured at
deﬁned times.
EBA of P(ButEnOx-co-EI)-Based Hydrogels and Release
Studies. The hydrogels (1.7 to 2.0 mg) were swollen for 19 h in
250 mL of HBG buﬀer (pH 7). Subsequently, 1 mL of gDNA-EB
solution (containing 7.5 mg gDNA per mL and 0.4 mg EB per mL)
was added. The sample aliquot of 50 μL was taken at deﬁned times
and returned after ﬂuorescence measurement. Microscopic detection
of the resulting ﬂuorescence signal was performed at diﬀerent time
points (0, 1.5, and 18 h).
The release studies were performed by adding 1 mL of a mixture of
heparin (6 mg mL−1) and EB (0.4 mg mL−1), dissolved in HBG buﬀer,
to the swollen and loaded hydrogel samples. In addition, the
temperature was increased up to 90 °C. Aliquots of 50 μL were
taken at deﬁned times and returned after ﬂuorescence measurement.
■ RESULTS AND DISCUSSION
Synthesis and Characterization of a Copolymer
Library of P(ButEnOx-co-EI)s. Starting from commercially
available poly(2-ethyl-2-oxazoline) (PEtOx, 50,000 g/mol),
LPEI was prepared by acidic hydrolysis (degree of hydrolysis >
99%) using a microwave synthesizer (Scheme 1a).35 Sub-
sequently, LPEI was reacted in an amidation reaction with N-
succinimidyl-4-pentenate to introduce alkene functionalities
into the polymer (Scheme 1b). To this end, LPEI and the
catalyst 4-(dimethylamino)-pyridine (DMAP) were dissolved
in pyridine at 80 °C and mixed with the activated acid. Due to
the negligible eﬀect of the side product N-hydroxysuccinimide
on the formation of hydrogels, the step of dialysis (performed
for 71% PEI containing copolymer) was skipped for further
reactions.
Using this method, an eight-membered library of
P(ButEnOx-co-EI)s (C1−C8) with varying amounts of
secondary amine groups was synthesized (Table 1).
1H NMR spectroscopy showed the successful conversion of
LPEI to the copolymers. The percentage of remaining LPEI
units in the copolymer was determined by correlating the
integrals of the single proton signal of the double bond (δ = 5.9
ppm, HCCH2, E) to the ones of the LPEI backbone (δ = 3.0
to 2.6 ppm, HN-CH2-CH2, B; Figure 1). Moreover, the
appearance of the signals of the 4-pentenate protons (δ = 2.6 to
Scheme 1. Schematic Representation of the Synthesis of (a) Linear Poly(ethylene imine) by Acidic Hydrolysis of Poly(2-ethyl-2-
oxazoline); (b) Copolymer Poly(2-(3-butenyl)-2-oxazoline-co-ethylene imine) Starting from Linear Poly(ethylene imine); and
(c) Hydrogel by Cross-Linking the Copolymer via Thiol−Ene Photoaddition
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2.2 ppm, CH2 ButEnOx, D), the protons of the double bond (δ
= 5.0 ppm, HCCH2, F) and the oxazoline backbone (δ = 3.8
to 3.4 ppm, RN-CH2-CH2, C) prove the proposed structure of
the synthesized polymers. The successful conversion was also
shown by infrared spectroscopy (IR). After the reaction, a
carbonyl vibration of the oxazoline units appears at 1,636 cm−1
(νCO; Figure 2).
Mass spectrometry (MS) of the copolymers is not possible
due to the high molar masses (>32,000 g/mol), which are
diﬃcult to transfer to the gas phase. However, using MALDI-
TOF-MS, we could obtain a complex isotopic pattern of a low
molar mass copolymer (45% PEI content, Mn ∼ 1,650 g/mol,
1H NMR: Mn′ = 1,800 g/mol). The results are shown in the
Supporting Information (Figure S1). Clearly the repeating units
of the copolymer can be seen, but due to the complexity of the
spectrum, a further assignment is nearly impossible.
Up to a content of 82% PEI, the copolymers are soluble in
water. It is known that above a PEI content of 85% the
copolymers only dissolve at elevated temperatures.36 However,
all the copolymers showed good solubility in organic solvents
such as alcohols (e.g. methanol).
Characterization by size exclusion chromatography (SEC)
revealed the formation of polymers with polydispersity indices
(PDI values) between 1.35 and 1.64 (Table 1). The molar
masses obtained by SEC diﬀer from the molar masses
calculated from 1H NMR (Mn′), which are based on the
molar mass data of the poly(2-ethyl-2-oxazoline) precursor
provided by the supplier. Possible cross-linking or other side
reactions are not taken into account. The low molar mass
values measured by SEC can be explained considering the
diﬀerent physicochemical properties, that is, the diﬀerent
hydrodynamic volumes of the copolymers and the used PS
calibration standard.
Hydrogel Synthesis and Characterization. LPEI-based
hydrogels were formed by the reaction of the precursor
copolymers P(ButEnOx-co-EI)s (C3−C8) with 3,6-dioxaoc-
tane-1,8-dithiol (EDDET; Scheme 1c) in a thiol−ene photo-
addition reaction. It was performed under UV light using 2,2-
dimethoxy-2-phenylacetophenone (DMPA) as initiator. In this
way, a library of six hydrogels (H3−H8) was synthesized
(Figure 3). Due to an insuﬃcient amount of double bonds for
cross-linking, copolymers with a PEI content above 82% (C1,
C2) did not form hydrogels at a polymer concentration of 10
wt %, which was adapted from literature.27 Gelation occurred
Table 1. Summary of the Characterization Data for the
P(ButEnOx-co-EI)s (C1−C8): PEI Content and SEC Data
aPercentage of remaining LPEI units determined by 1H NMR
spectroscopy. bDetermined by 1H NMR (calculated from LPEI:
25,000 g/mol, PEI content). cDetermined by SEC (eluent: DMAc +
0.21% LiCl, calibration against polystyrene). *Not soluble in SEC
eluent DMAc.
Figure 1. 1H NMR spectrum (MeOD, 250 MHz) of C5 (50% PEI)
produced from linear poly(ethylene imine) (580 units; *1 side-product
N-hydroxysuccinimide, *2 remaining 2-ethyl-2-oxazoline side chains
∼1%).
Figure 2. IR spectra of the starting linear poly(ethylene imine)
homopolymer and the synthesized copolymer C5 (50% PEI;
determined by 1H NMR spectroscopy of the precursor copolymers).
Figure 3. Swelling values Qeq depending on the amount of
poly(ethylene imine) units in formed hydrogels H3−H8 (T = 25.5
°C). Linear poly(ethylene imine) was added as reference (repeated
determination).
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after an irradiation time between 150 min for H3 and 5 min for
H8. Moreover, an eﬀect of concentration of the prepolymer
could be observed. Further information can be found in the
Supporting Information (Table S1).
When the reaction was performed under the same conditions
but without the dithiol, neither cross-linking nor gelation was
observed.
The swelling behavior of the synthesized hydrogels was
investigated gravimetrically using centrifuge ﬁlter tubes.19 The
ﬁlter tubes were saturated with water and the excess water was
removed by centrifugation (3,000 rpm, 10 min). The
determined mass of the tube was set to m0. After addition of
the hydrogel (m0,gel), the sample weight could be determined by
eq 1.
= −m m mgel 0,gel 0 (1)
Subsequently, the hydrogel sample was swollen in water for 24
h. The ﬁlter tube was centrifuged again (3,000 rpm, 10 min)
and weighted (mwet) to determine the mass of the swollen gel
(msw) using eq 2.
= −m m msw wet 0 (2)
The swelling value Qeq was calculated according to literature
(eq 3).34
=
−
×Q
m m
m
100%eq
sw gel
sw (3)
The formed hydrogels revealed a water uptake up to a
multitude of their own mass (Qeq = 23−74%) from the liquid
phase. The ability of the formed networks to absorb water is
ascribed to the hydrophilic parts of the cross-linker and the
oxazoline units. But also the LPEI segments have hygroscopic
properties and can exhibit diﬀerent hydrated states.37−39 As a
reference, pure LPEI (which is insoluble in cold water) was
investigated regarding its swelling value (Qeq = 44%).
A maximum of the swelling values of the investigated
hydrogels was reached for a PEI content of 50% (H5, Figure 3)
with 74%. This behavior can be explained with two competing
trends. Starting from pure LPEI as reference, a decreasing PEI
content, accompanied with an increasing amount of water-
soluble gel components, leads to higher swelling values. The
decreasing swelling values at LPEI contents lower than 50% can
be ascribed to a higher network density, caused by a higher
degree of cross-linking for these polymers. The increased
linking density and the associated decrease of the degrees of
freedom of the polymer chains limit the amount of water, which
can be incorporated within the polymer network. This causes
the low swelling of the 5% PEI containing gel. Compared to
PEtOx-containing hydrogels with similar degrees of cross-
linking (Qeq = 97−98%
19), the swelling values are signiﬁcantly
decreased, which is caused by the lower hydrophilicity of the
LPEI systems.
The water uptake behavior from the gas phase was analyzed
for H5 (50% PEI content) at varying humidity levels using a
thermogravimetric analysis (TGA) setup, which was already
described for the investigation of hydrophilic polymers.40 The
TGA diagram showed the adsorption of water molecules to the
hydrogel network as a function of the weight change (%) and
the relative humidity (%) at a constant temperature (25 °C).
Before starting the measurement, the sample was heated to 60
°C at 0% humidity to completely dry the sample. After the
weight of the gel was constant, its mass was set as mgel
(compare to eq 1). Subsequently, the relative humidity was
gradually increased to 90%, whereupon a weight change of up
to 30% (msw, eq 2) could be observed (equates to Qeq = 23%),
with an exponential increase. This value is identical to the
swelling behavior of the 5% PEI containing hydrogel
determined from the liquid phase. By decreasing the relative
humidity in the same way, the desorption curve showed an
identical trend, stating a reversibility of the swelling process. In
comparison to the swelling studies from the liquid phase (for
PEI content >5%), water uptake from the gas phase is much
less eﬃcient (about 10×), as depicted in Figure 3.
To conﬁrm the structure of hydrogel H5 (50% PEI content),
solid state NMR measurements were performed. In Figure 4, a
comparison of the 13C NMR spectrum of the copolymer C5
and the solid state 13C NMR spectrum of the resulting puriﬁed
hydrogel H5 is depicted. An important evidence for a successful
synthesis is the appearance of the signal of the cross-linker (D)
at 71.0 ppm. In addition, a solid state 1H NMR spectrum was
recorded (Figure 5). To improve the resolution, a special
method for the sample preparation was used. The gel was
swollen for 16 h inside a Kel-F rotor in D2O to increase the
degrees of freedom of the polymer chains, which was placed
into the spinning tube. Signals between 2.0 and 1.2 ppm (RS-
CH2-CH2-CH2) belonging to the EDDET cross-linker further
demonstrated the success of the reaction. Both 13C and 1H
NMR spectra revealed an incomplete conversion of the double
bonds that, hence, can be used for further functionalization.
DNA Binding Studies. After the successful synthesis of
copolymers and hydrogels with well-deﬁned LPEI contents,
their ability to bind and release DNA was investigated using an
ethidium bromide assay (EBA). Genomic herring DNA was
treated with ethidium bromide (EB) resulting in a ﬂuorescent
DNA-EB complex, which could be detected using a
ﬂuorescence microscope. The assay allowed to monitor the
interaction between DNA and polymer/hydrogel by a displace-
ment of EB resulting in a decrease of the ﬂuorescence
intensity.41
The results of the EBA for the chosen copolymers
P(ButEnOx-co-EI)s (C3−C5, C7) are depicted in Figure 6a.
Figure 4. Solid state 13C NMR spectrum of the 50% PEI containing
copolymer C5 (D2O, 63 MHz) and the resulting hydrogel H5 (100
MHz).
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As expected, the system with a high content of LPEI showed an
increased binding capacity and, hence, a decreased ﬂuorescence
intensity. At a nitrogenpolymer to phosphateDNA (N/P) ratio
higher than 2, a constant ﬂuorescence level was reached,
meaning that further excess of positively charged copolymers
was not able to replace more EB. The copolymer with the
highest charge density (71% PEI content) showed the highest
complexation eﬃciency of all investigated copolymers, with a
decrease in ﬂuorescence intensity of 70%. As reference the
LPEI precursor was used, which led to a ﬂuorescence intensity
decrease of about 90%.
Three hydrogels with diﬀerent PEI contents, namely, H4
(62%), H5 (50%), and H7 (36%), were chosen to study their
DNA binding and release capability. Due to the high molar
masses and the large network structures, low N/P ratios, as
used for the copolymers, were not suitable. Hence, the EBA
procedure had to be adjusted and N/P ratios between 250 and
500 were investigated (Figure 6b). To obtain comparable
results for hydrogels, similar masses were used (1.7−2.0 mg).
Prior to the EBA measurements, the hydrogel samples were
swollen for 19 h in a 96-well plate in 250 μL of HBG buﬀer
solution, respectively. The large excess of buﬀer allowed a
complete swelling of the hydrogels independent of the PEI
content and swelling value. Moreover, the concentration after
the addition of 1 mL stock solution to each swollen sample was
nearly identical. For each measurement an aliquot of 50 μL of
each sample was taken at deﬁned times and returned afterward.
A mixture of 250 μL of HBG buﬀer and 1 mL of stock solution
served as reference for each measuring point. To exclude the
decrease of ﬂuorescence intensity due to the degradation of the
DNA-EB complex, the reference sample was treated and stored
exactly as the other samples.
A similar behavior as for the copolymers was observed for the
corresponding hydrogels. Besides the decrease in ﬂuorescence
intensity over time, a trend dependent on the PEI content was
observed. The gel H4 with the highest amount of PEI units
(62%) showed the highest binding capacity with a ﬂuorescence
level of 20%, which was signiﬁcantly lower than the value of the
corresponding copolymer. For the 50% PEI containing gel,
similar results to the corresponding copolymer were obtained.
The hydrogel H7 with 36% of LPEI showed no DNA binding.
A possible explanation is the dense structure of the hydrogel
due to the high amount of cross-linking sites hindering the
access of DNA to the hydrogel network. This fact also causes
the long time required for a complete DNA binding (95 h).
Furthermore, the low swelling values and, thus, the inﬂexibility
of the network, led to a time-consuming complexation process.
These long adsorption periods might indicate a diﬀusion
controlled process. To sum up, a high PEI content seems to be
the predominant factor for high binding capacities of the
hydrogels studied as demonstrated by the remarkable value of
H4. However, the amount of amine groups is limited by the
number of functional sides (here alkene groups) necessary for
the formation of stable hydrogels. In addition, the DNA
binding of the hydrogel sample H4 was monitored using a
ﬂuorescence microscope (Figure 7). The photometric measure-
ments showed the decrease of the ﬂuorescence intensity of the
DNA-EB complex over time after the addition of the hydrogel.
A DNA-EB solution of the same concentration served as
reference and showed no indications of degradation of the dye.
In contrast to the DNA investigations of the supernatant of the
P(ButEnOx-co-EI) copolymers and the corresponding hydro-
gels, the microscopic study was performed with the complete
Figure 5. Comparison of the 1H NMR spectrum of the 50% PEI
containing copolymer C5 (MeOD, 250 MHz) and the solid state 1H
NMR of the resulting hydrogel H5 (swollen in D2O, 400 MHz).
Figure 6. Binding of DNA (ethidium bromide assay)41 to (a) copolymers C3−C5 and C7 at increasing nitrogen/phosphate ratios (triple
determination) and (b) hydrogel samples H4, H5, and H7 at nitrogen/phosphate ratios above 250 (repeated determination) with diﬀerent PEI
content via ﬂuorescence measurements.
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sample including the hydrogel. Since the bound DNA still has
free coordination sides for EB, a ﬂuorescence signal is
detectable in the area of the hydrogel.
Besides an eﬀective DNA binding, its release from the
hydrogel and the copolymer, respectively, represents an
essential step for further applications. The DNA release was
studied using a heparin assay. Heparin is a polyanion with
multiple negative charges per repeating unit, which can
eﬀectively bind to the positively charged hydrogel or
copolymer, causing the release of the DNA. Thus, the latter
can intercalate again with free EB, which was added in the same
concentrations as before. The formation of the DNA-EB
complex led to an increase of the ﬂuorescence intensity. For the
copolymers, the DNA was released very fast. Within 4 min, the
ﬂuorescence intensity increased rapidly up to a constant level of
nearly 90% (Figure 8a). As reference, a mixture of 250 μL of
HBG buﬀer and 1 mL of DNA-EB stock solution was chosen. It
was treated with heparin in the same way as the copolymers,
and the resulting ﬂuorescence intensity was set to 100%.
The hydrogels showed a diﬀerent behavior. Here, neither the
addition of heparin (5% release) nor an increase of temperature
(up to 90 °C, 10%) resulted in an eﬃcient release. However, a
combination of both led to a detachment of nearly 50% of the
bound DNA within 80 min (Figure 8b). This behavior could be
associated with the PEI segments of the synthesized hydrogels.
LPEI is not soluble in cold water and the PEI components of
the hydrogels could form clusters within the network that
inhibit an eﬃcient release due to sterical reasons. At higher
temperatures, the PEI segments melt and a replacement of
DNA with heparin becomes possible.
■ CONCLUSION
In summary, a new and eﬃcient method to obtain hydrogels for
the binding and release of DNA with a controlled amount of
amine binding sides was developed. To this end, a new class of
copolymer containing 2-butenyl-2-oxazoline and ethylene imine
units was synthesized by partial functionalization of LPEI with
N-succinimidyl-4-pentenate. An eight-membered library of
P(ButEnOx-co-EI)s was prepared, and subsequently, the double
bonds were exploited for cross-linking via thiol−ene photo-
addition using bis-functional 3,6-dioxaoctane-1,8-dithiol. Com-
pared to the formation of PEI hydrogels by cross-linking the
free amines, the presented approach allows the exact adjust-
ment of the amount of free amines in the copolymer and, thus,
within the hydrogel. Both copolymers and hydrogels were
characterized by means of NMR spectroscopy and FT-IR
spectroscopy. Furthermore, the swelling and deswelling
behavior of the hydrogels from liquid and gas phase was
investigated, showing that the water uptake from the liquid
phase is 10× more eﬃcient. Swelling values up to 74% were
observed.
The DNA studies showed that copolymers and hydrogels are
able to bind and release DNA reversibly via the secondary
amine groups with binding capacities strongly depending on
the PEI content. The copolymers bound up to 70% of the
initial DNA. Because of their large three-dimensional networks,
the hydrogels exhibited a much higher binding capacity for the
appropriate PEI contents. However, due to the low swelling
values compared to POx-based hydrogels and, thus, the
inﬂexibility of the network, the DNA uptake was rather slow,
probably indicating a diﬀusion-controlled process.
The DNA release studies were performed using a heparin
assay. While the copolymers at room temperature rapidly
Figure 7. Microscopic pictures of DNA binding to hydrogel H4 (62%
PEI) measured by ﬂuorescence microscopy without DNA/EBA and
after addition of DNA/EBA at deﬁned times.
Figure 8. Time-dependent release of DNA from (a) copolymers C3−C5 and C7 (heparin, triple determination) at a nitrogen/phosphate ratio of 2
and (b) hydrogel samples H4, H5, and H7 at nitrogen/phosphate ratios above 250 (heparin, 90 °C, repeat determination) with diﬀerent PEI
content via ﬂuorescence measurements.
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released up to 90% of the initial DNA quantity after heparin
addition, the hydrogels released 50% at elevated temperatures.
To accelerate the binding and release of genetic material,
further studies, dealing with the improvement of the swelling
behavior of the hydrogels, have to be performed. Hence,
hydrogels starting from a precursor poly(2-ethyl-2-oxazoline-co-
ethylene imine) instead of linear poly(ethylene imine) should
be investigated. This will be part of a follow-up study.
In addition, solid NMR spectroscopy revealed the presence
of unreacted alkene groups, which could be used for further
functionalizations like surface attachment. The treated surfaces
are available for DNA binding and release studies in terms of
chip-based point-of-care diagnostics.
Besides its use in hydrogel synthesis, the copolymer
P(ButEnOx-co-EI) represents an interesting molecule for
other applications, such as gene delivery or gene silencing.
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